Occupational exposure to formaldehyde - genotoxic damage and susceptibility evaluation in anatomical pathology laboratory workers by Solange Cristina Bastos da Costa
 Solange Cristina Bastos da Costa 
 
 
OCCUPATIONAL EXPOSURE TO FORMALDEHYDE.  
GENOTOXIC DAMAGE AND SUSCEPTIBILITY EVALUATION IN ANATOMICAL 
PATHOLOGY LABORATORY WORKERS 
 
 
 
                 
 
Tese de Candidatura ao grau de Doutor em 
Ciências Biomédicas, submetida ao Instituto de 
Ciências Biomédicas Abel Salazar da 
Universidade do Porto. 
 
Orientador – Doutor João Paulo Teixeira 
Categoria – Investigador Auxiliar 
Afiliação – Instituto Nacional de Saúde Doutor 
Ricardo Jorge 
 
Co-orientadora – Doutora Beatriz Porto 
Categoria – Professora Auxiliar 
Afiliação – Instituto de Ciências Biomédicas 
Abel Salazar da Universidade do Porto 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The experimental work presented in this thesis was performed at the: 
 Environmental Health Department of the National Institute of Health, Porto, 
Portugal;  
 Department of Nutrition of the Institute of Basic Medical Sciences, University of 
Oslo, Oslo, Norway; 
 Toxicology Unit of the Department of Psychobiology, University of A Coruña, A 
Coruña, Spain; 
 Toxicology Laboratory and Farmacognosia Laboratory of the Faculty of 
Pharmacy, University of Porto, Porto, Portugal; 
 Department of Genetics of the Faculty of Medical Sciences, New University of 
Lisbon, Lisbon, Portugal. 
 
Statistical analysis was performed at the Toxicology Unit of the Department of 
Psychobiology, University of A Coruña, Spain. 
 
 
 
This work was supported by the Portuguese Foundation for Science and Technology 
(FCT) under the grant SFRH/BD/46929/2008, under the QREN - POPH - Type 4.1 - 
Advanced Training, subsidized by the European Social Fund and national funds from the 
MCTES. 
 
 
. 
 
 
 
 
 
 
 
 
 
 
 
 
  
CONTENTS 
   
Original Publications v 
List of Figures vii 
List of Tables viii 
List of Abbreviations x 
Abstract xi 
Resumo xiii 
Preamble xvii 
I. REVIEW OF THE LITERATURE  
 1. Introduction 3 
  1.1 Genotoxicity and Carcinogenicity 4 
  1.2 Human exposure assessment 5 
 2. Formaldehyde 9 
  2.1 Physical and Chemical properties 10 
  2.2 Economic importance 10 
  2.2.1 Production 10 
  2.2.2 Commercial uses and Applications 11 
  2.3 Human Exposure    12 
  2.3.1 Environmental 12 
  2.3.2 Occupational 14 
  2.4 Toxicokinetic and Metabolism 15 
  2.5 Health Effects 17 
  2.5.1 Sensory irritation and related symptoms 17 
  2.5.2 Sensitisation 19 
  2.5.3 Genotoxicity 20 
  2.5.4 Carcinogenicity   23 
  2.5.4.1 Epidemiological studies 23 
  2.5.4.2 Animal studies 29 
  2.5.4.3 Mechanisms of carcinogenesis 30 
  2.6 Exposure to formaldehyde in Portuguese workplaces 32 
II. PRESENT STUDY  
 1. Aim of the study 37 
 2. Study Population 39 
  2.1 General characterisation 39 
  2.1.1 Contact with study subjects 40 
  2.1.2 Professional activity  41 
i 
  2.2 Biologic samples collection 41 
  2.3 Statistical analysis 42 
 3. Air monitoring and biomarkers of exposure 45 
  3.1 Overview 45 
  3.1.1 Air monitoring (guidelines and standards) 45 
  3.1.1.1 Formaldehyde occupational exposure and 
regulation 
46 
  3.1.2 Biomarker of exposure-internal dose 47 
  3.1.2.1 Formic acid in urine as a biomarker of formaldehyde 
internal dose 
47 
  3.2 Material and Methods 50 
  3.2.1 Determination of formaldehyde airborne concentration 50 
  3.2.2 Determination of formic acid concentrations in urine 
samples 
50 
  3.3 Results 53 
  3.3.1 Formaldehyde air monitoring and exposure biomarker 53 
  3.3.1.1 Effect of exposure, lifestyle and work-related factors 54 
  3.4 Discussion 55 
 4. Biomarkers of Effect 59 
  4.1 Overview 59 
  4.1.1 Chromosomal Aberrations 60 
  4.1.2 Micronucleus assay 64 
  4.1.2.1 Micronucleus assay in lymphocytes  65 
  4.1.2.2 Micronucleus assay in exfoliated buccal cells  67 
  4.1.3 Sister chromatid exchanges 69 
  4.1.4 Single cell gel electrophoresis (Comet assay) 72 
  4.1.5 T Cell Receptor mutation assay 75 
  4.1.6 Immune markers: Lymphocytes subpopulations 76 
  4.2 Material and Methods 80 
  4.2.1 Lymphocytes culture 80 
  4.2.2 Chromosomal Aberrations (CAs) Assay 80 
  4.2.3 Lymphocyte Cytokinesis-Block Micronucleus Test  82 
  4.2.4 Buccal Micronucleus Cytome Assay 82 
  4.2.5 Sister Chromatid Exchange (SCE) Test 83 
  4.2.6 Comet Assay 84 
  4.2.7 TCR mutation assay 85 
  4.2.8 Lymphocyte subpopulations assessment 85 
  4.3 Results 86 
  4.3.1 Biomarkers of genotoxicity 86 
ii 
 
  4.3.1.1 Effect of exposure, lifestyle factors and parameter-
specific confounders 
87 
  4.3.2 Immune Markers: Lymphocytes subpopulations 91 
  4.3.2.1 Effect of exposure, lifestyle factors and parameter-
specific confounders 
91 
  4.3.3 Effect of work-related factors 93 
  4.3.4 Correlations between biomarkers 95 
  4.4 Discussion 97 
  4.4.1 Biomarkers of genotoxicity  97 
  4.4.2 Immune-markers: Lymphocytes subpopulations 105 
  4.4.3 Effect of lifestyle factors and parameter-specific 
confounders on the biomarkers studied 
109 
  4.4.3.1 Biomarkers of genotoxicity 109 
  4.4.3.2 Lymphocyte subpopulations 111 
  4.4.4 Correlations between biomarkers 112 
 5. Biomarkers of Susceptibility 114 
  5.1 Overview 114 
  5.1.1 Genetic polymorphisms as susceptibility biomarkers 114 
  5.1.2 Genetic Polymorphisms, DNA damage and cancer risk 114 
  5.1.3 Xenobiotic-metabolising enzymes 116 
  5.1.3.1 Polymorphisms of phase I enzymes studied:  
Cytochrome P450 family 
116 
  5.1.3.2 Polymorphisms of Phase II enzymes studied:  
Glutathione S-transferases  
119 
  5.1.4 DNA Repair 122 
  5.1.4.1 DNA Repair pathways 123 
  5.1.4.2 Polymorphisms of the BER pathway studied 128 
  5.1.4.3 Polymorphisms of the DSBs repair pathway studied 131 
  5.1.4.4 Polymorphisms of the FANC repair pathway studied 134 
  5.2 Material and Methods 138 
  5.2.1 DNA extraction 138 
  5.2.2 Genotyping of polymorphisms in gene involved in the 
metabolism 
138 
  5.2.2.1 CYP2E1 138 
  5.2.2.2 GSTM1 and GSTT1 139 
  5.2.2.3 GSTP1 139 
  5.2.3 Genotyping of polymorphisms in genes involved in DNA 
repair. 
140 
  5.2.3.1 XRCC1, PARP1, MUTYH, RAD51, BRIP1 and FANCA 140 
  5.2.3.2 XRCC2 and XRCC3 141 
iii 
 
 
 
 
 
 
 
 
 
 
  5.3 Results 144 
  5.3.1 Genotype distribution of polymorphisms in the study 
population 
144 
  5.3.2 Analysis of association between the genetic 
polymorphisms and biomarkers studied 
146 
  5.4 Discussion 148 
III. GENERAL CONCLUSIONS 155 
IV. REFERENCES 161 
V. ANNEXES  
 ANNEX I  
 ANNEX II  
 ANNEXIII  
 PUBLICAÇÕES DE APOIO À TESE DE DOUTORAMENTO  
 ACKNOWLEDGMENTS 261 
iv 
 
ORIGINAL PUBLICATIONS 
 
The present work contains techniques and/or data also presented in the following 
scientific papers: 
 
 Costa S., García-Lestón J., Coelho M., Coelho P., Costa C., Silva S., Porto B., Laffon 
B., Teixeira J.P. (2013) Cytogenetic and immunological effects of formaldehyde in a group 
of exposed workers. Journal of Toxicology and Environmental Health Part A 76:217–229.  
 Costa S., Brandão F., Coelho M., Costa C., Coelho P., Silva S., Porto B., and Teixeira 
J.P. 2013. Micronucleus frequencies in lymphocytes and buccal cells in formaldehyde 
exposed workers. WIT Transactions on Biomedicine and Health, 16: 83-94. 
 Costa, S., Pina, C., Coelho, P., Costa, C., Silva, S., Porto, B., Laffon, B. and Teixeira, 
J.P. 2011. Occupational exposure to formaldehyde: genotoxic risk evaluation by comet 
assay and micronucleus test using human peripheral lymphocytes. Journal of Toxicology 
and Environmental Health Part A, 74(15-16): 1040-1051. 
 Costa, S., Coelho, P., Costa, C., Silva, S., Mayan, O., Santos, L.S, Gaspar, J.and 
Teixeira, J.P. 2008. Genotoxic damage in pathology anatomy laboratory workers exposed 
to formaldehyde. Toxicology, 252(1-3): 40-48. 
 Ersson, C., Møller P.; Forchhammer, L.; Loft, S., Azqueta, A., Godschalk, R.W.L., van 
Schooten, F.J., Jones, G.D., Higgins, J.A., Cooke, M.S., Mistry, V., Karbaschi, M., Phillips, 
D.H., Sozeri O, Routledge, M.N., Nelson-Smith, K., Riso, P., Porrini, M., Matullo, G., 
Allione, A., Stepnik, M., Ferlińska, M., Teixeira, J.P., Costa, S., Corcuera, L.A. López de 
Cerain, A., Laffon, B., Valdiglesias., V., Collins, A., Möller, L. 2013. An ECVAG inter-
laboratory validation study of the comet assay: inter-laboratory and intra-laboratory 
variation of DNA strand breaks and FPG-sensitive sites in human mononuclear cells. 
Mutagenesis, 28: 279–286. 
 Forchhammer, L., Ersson, C., Loft, S., Möller, L., Godschalk, R.W.L., Jones, G.D., 
Higgins, J.A., Cooke, M., Mistry, V., Karbaschi, M., Collins, A.R., Azqueta, A., Phillips, 
D.H., Sozeri, O., Routledge, M.N., Nelson-Smith, K., Riso, P., Porrini, M., Matullo, G., 
Allione, A., Stępnik, M., Komorowska, M., Teixeira, J.P., Costa, S., Corcuera, L.A., López 
de Cerain, A., Laffon, B., Valdiglesias. V., Møller P. 2012. Inter-laboratory variation in 
DNA damage using a standard comet assay protocol. Mutagenesis, 27: 665-672. 
 Lorenzo, Y., Costa, S., Collins, A.R., Azqueta, A. 2012. The comet assay, DNA damage, 
DNA repair and cytotoxicity: Hedgehogs are not dead. Mutagenesis 28(4):427-32.  
v 
  Forchhammer, L., Johansson, C., Loft, S., Möller, L., Godschalk, R., Langie, S., Jones, 
G.D., Kwok, R.W., Collins, A.R., Azqueta, A., Phillips, D.H., Sozeri, O., Stepnik, M., Palus, 
J., Vogel, U., Wallin, H., Routledge, M.N., Handforth, C., Allione, A., Matullo, G., Teixeira, 
J.P., Costa, S., Riso, P., Porrini, M., Møller, P. 2010. Variation in the measurement of 
DNA damage by comet assay measured by the ECVAG inter-laboratory validation trial. 
Mutagenesis, 25: 113-123. 
 
And book chapters: 
 
 Costa, S., and Teixeira, J. P. 2013. Toxicology. In Encyclopedia of Toxicology, 3rd 
Edition, Elsevier (in press). DOI: 10.1016/B978-0-12-386454-3.00440-1 
 Costa, S., and Teixeira, J. P. 2013. Comet Assay. In Encyclopedia of Toxicology, 3rd 
Edition, Elsevier (in press). DOI:10.1016/B978-0-12-386454-3.00672-2  
 
vi 
 LIST OF FIGURES 
   
Figure 1. A simplified diagram of the cascade of events from exposure to 
clinical disease showing the relationships among exposure, effect and 
susceptibility biomarkers 
8 
  
Figure 2.  Formaldehyde 2D and 3D chemical structure 10 
  
Figure 3.  Fate and metabolism of formaldehyde 17 
  
Figure4. Frequency of the daily consumption of tea, coffee, fruit, 
vegetables, fish, meat and vitamin supplements by study groups 
40 
  
Figure 5. Distribution ratio (%) of the FA-exposed workers by professional 
category 
41 
  
Figure 6. Example of formation of a Chromosome-type aberration (CSAs) 62 
  
Figure 7. Example of formation of Chromatid-type aberration (CTAs) 62 
  
Figure 8.  Photomicrograph (A) and a scheme (B) representation of a 
section of buccal mucosa showing the various cell layers 
68 
  
Figure 9.  Diagrammatic representation  of the sequential spatio-temporal 
origins of the different buccal cell-stages 
69 
  
Figure 10.  Mechanism of SCEs formation 70 
  
Figure 11. Schematic picture representing a comet of a damaged cell and 
image 
73 
  
Figure 12.  Comet assay images 73 
  
Figure 13. Chromosomal aberrations observed in metaphase lymphocytes 
(1250x)   
81 
  
Figure 14. Scored micronucleus (MN) images (500x) 82 
  
Figure 15. Images of cell metaphases scored for SCE test (1250x) 84 
  
Figure 16. Both environmental and host factors acts in concert in individual 
susceptibility (genetic and acquired ) for disease development 
115 
  
Figure 17. DNA Repair pathways 125 
  
Figure 18. Interaction of the FANC proteins in the recognition of an ICL in S 
phase 
127 
  
Figure 19. Simplified model of the mechanism of ICL repair process 
involving NER, TLS and HR 
128 
  
Figure 20. Association among the various factors involved in individual’s 
response to an exogenous insult and potential biologic effects 
137 
vii 
LIST OF TABLES 
   
Table I. General physical and chemical properties of formaldehyde 10 
  
Table II. Characteristics of the study population 39 
  
Table III. Occupational exposure limits for airborne formaldehyde 
(standards and guidelines) 
46 
  
Table IV. Results of FA-external exposure and biomarker of exposure 53 
  
Table V. Effect of exposure, gender, age and smoking habits on the levels 
of FMU with estimates of mean ratios (MR) 
54 
  
Table VI. Results of biomarkers of genotoxicity in the study groups 86 
  
Table VII. Results of aberrant cells and multiaberrant cells in the study 
groups 
87 
  
Table VIII. Effect of exposure, gender, age and smoking habits on the 
frequencies of CA-total, CSAs, CTAs, gaps and aneuploidies with 
estimates of mean ratios (MR) 
88 
  
Table IX. Effect of exposure, gender, age and smoking habits on the 
frequencies of MNL, SCE, MNB and BNbud with estimates of mean ratios 
(MR) 
89 
  
Table X. Effect of exposure, gender, age and smoking habits on the 
frequencies of %TDNA and TCR-Mf with estimates of mean ratios (MR) 
90 
  
Table XI. Results of lymphocyte subpopulations in the study groups 91 
  
Table XII. Effect of FA-exposure, gender, age and smoking habits on 
lymphocyte subpopulations with estimates of mean ratios (MR) 
92 
  
Table XIII.  Influence of FA exposure level, exposure duration and 
professional activity on micronuclei in lymphocytes (MNL), nuclear buds in 
buccal cells (BNbud) and %CD16+56+ cells, with estimates of mean ratios 
(MR) 
94 
  
Table XIV. Influence of FA-exposure level of exposure categorized by 
tertiles on micronuclei in lymphocytes (MNL), nuclear buds in buccal cells 
(BNbud) and %CD16+56+ cells, with estimates of mean ratios (MR) 
94 
  
Table XV. Association between biomarkers of genotoxicity 95 
  
Table XVI. Detailed information on selected SNPs 141 
  
Table XVII. PCR-RFLP details for the XRCC2 (rs3218536), XRCC3 
(rs861539), GSTP1 (rs1695) and CYP2E1 (rs6413432) polymorphisms 
143 
  
Table XVIII. Frequency of genotypes involved in xenobiotic metabolism in 
the study population 
144 
  
viii 
 Table XIX. Genotype frequency of genes involved in DNA repair in the 
study population 
145 
  
Table XX. Influence of biomarkers of susceptibility on genotoxicity 
parameters and immune markers (only significant effect are included) 
146 
ix   
 LIST OF ABBREVIATIONS 
   
ADH  alcohol dehydrogenase MN micronuclei 
ALDH aldehyde dehydrogenases MNB micronuclei in buccal cells 
BMCyt buccal micronucleus cytome 
assay 
MNL micronuclei in lymphocytes 
BM buccal mucosa NAD+ nicotinamide adenine 
dinucleotide 
BNbud nuclear buds in buccal cells NADPH nicotinamide adenine 
dinucleotide phosphate 
CAs chromosomal aberrations Nbud nuclear buds 
CBMN  cytokinesis-block micronucleus  
assay 
OECD Organisation for Economic    
Co-operation and 
Development 
CD clusters of differentiation %TDNA percentage DNA in tail 
CD3+ total T cells PBLs peripheral blood lymphocytes 
CD4+ T-helper cells ROS reactive oxygen species 
CD8+ T-cytotoxic cells SCE sister chromatid exchange 
CD19+ B cells   
CD16+56+ natural killer cells SCGE single cell gel electrophoresis 
CSAs chromosome-type aberrations SD standard deviation 
CTAs chromatid-type aberrations SE Standard error mean 
DSB double strand break SSB single strand break 
EH environmental health SNPs single nucleotide 
polymorphisms 
EU European Union Tc T-cytotoxic cells 
FA formaldehyde TCR T Cell Receptor 
FDH glutathione-dependent 
formaldehyde-dehydrogenase 
TCR-Mf TCR mutation frequency 
FEMA US Federal Emergency 
Management Agency 
Th T-helper cells 
FEV forced expiratory volume TWA time-weighted average 
FISH fluorescence in situ 
hybridization 
US United States of America 
FVC forced vital capacity WHO World Health Organization 
GSH glutathione   
HR homologous recombination    
IARC International Agency for 
Research on Cancer 
  
MHC major histocompatibility 
complex 
  
x 
ABSTRACT 
 
Formaldehyde (FA) is a high-volume production chemical produced worldwide with a large 
range of industrial and medical uses. At room temperature is a flammable and colourless 
gas with a strong pungent odour. Given its economic importance and widespread use, 
many people are exposed to FA both environmentally and/or occupationally. Over the last 
two decades, several epidemiological studies have revealed an increased risk of cancer 
development among workers exposed to FA, namely nasopharyngeal cancer and myeloid 
leukaemia. Based on these findings plus supporting evidence from animal studies and 
data on mechanisms of carcinogenesis FA status was recently revised and classified as a 
human carcinogen. FA’s genotoxicity is confirmed in a variety of experimental systems 
ranging from bacteria to rodents. However, data from human studies is conflicting and 
needs further investigation in particular the biological evidence of FA’s ability to induce 
(geno)toxicity on distant-site tissues. In addition, published studies on the immunological 
effects of FA indicate that this compound may be able to modulate immune responses, 
although data in exposed subjects are still preliminary. The highest level of human 
exposure to FA occurs in occupational settings. Several studies point to pathology and 
anatomy laboratories as one of the occupational settings where workers are frequently 
exposed to levels of FA near or superior to recommended limit values.  
The aim of the present study was to evaluate the occupational exposure to FA in a 
multistage approach relating the exposure with different biomarkers (dose and effect) and 
individual susceptibility. Eighty-five workers from hospital anatomical pathology 
laboratories exposed to FA and eighty-seven non-exposed controls took part in the study. 
Air monitoring was performed in worker’s breathing zone for representative working 
periods and the level of FA-exposure in workplace air was estimated. Formic acid in urine 
was investigated as a potential biomarker of internal dose for FA occupational exposure. 
Genotoxicity was evaluated in peripheral blood lymphocytes (PBLs) by means of 
cytogenetic alterations (chromosomal aberrations, CAs; micronucleus, MN; sister-
chromatid exchange, SCE), DNA damage (comet assay, percentage of tail DNA, %TDNA) 
and T-cell receptor (TCR) mutation assay. The frequency of MN in exfoliated buccal cells 
a first contact tissue was also assessed. Percentages of different lymphocyte 
subpopulations were selected as immunotoxicity biomarkers. In addition, the effect of 
polymorphic genes of xenobiotic metabolising enzymes (CYP2E1, GSTM1, GSTT1, 
GSTP1) and DNA repair enzymes (FANCA, RAD51, XRCC2, XRCC3, XRCC1, PARP1, 
MUTYH, BRIP1) on the endpoints studied were determined.  
xi 
The mean level of FA-exposure was 0.38±0.03 ppm, exceeding recommended limit 
values, as observed in other studies. The concentration of formic acid in urine increased 
significantly in workers compared to controls, but no significant correlation was found with 
the FA-level of exposure. All cytogenetic endpoints and DNA damage evaluated by comet 
assay were significantly increased in PBLs of FA-exposed workers compared to controls. 
Further, exposed workers showed higher frequencies of MN formation in both PBLs and 
exfoliated buccal cells. A significant positive correlation was found between MN frequency 
in these two tissues and FA-levels of exposure and duration, which confirms MN 
sensitivity to evaluate the genotoxic action of FA in occupational exposed subjects. The 
exposed group also presented significant alterations in the percentage of cytotoxic T 
lymphocytes, natural killer (NK) cells and B lymphocytes in comparison with control group. 
Concerning the effect of susceptibility biomarkers on the different endpoints studied, 
results suggest that polymorphisms in CYP2E1, GSTP1 and GSTM1 metabolic genes are 
associated with increased genetic damage in FA-exposed subjects. Furthermore, a 
polymorphic gene involved in FANC repair pathway, FANCA, significantly altered the level 
of genetic damage induced by FA exposure, revealing a potential novel repair pathway 
involved in the repair of genetic lesions caused by FA-occupational exposure. 
Data obtained in the present study show that workers in anatomical pathology laboratories 
are exposed to air-levels of FA greater than recommended criteria, indicating a potential 
risk to workers’ health. Further, FA-exposed workers presented higher levels of genetic 
damage compared to controls. Genotoxic endpoints analysis are of great interest in risk 
assessment of occupational carcinogens because they precede by a long time the 
potential health effects, thus offering a greater potential for preventive measures. The 
results of the present biomonitoring study emphasise the need of more effective measures 
in order to protect the workers from potentially hazard health effects due to occupational 
exposure to FA. Implementation of security and hygiene measures, such as periodic air 
sampling and medical surveillance, as well as good practice campaigns may be crucial to 
decrease risk. The obtained information may also provide new important data to be used 
by health care programs and by governmental agencies responsible for setting the 
acceptable levels for occupational exposure to FA.  
 
xii 
RESUMO 
 
O Formaldeído (FA) é um dos compostos químicos mais utilizados em todo o mundo, 
apresentando-se, em condições normais de pressão e temperatura, como um gás incolor 
de odor característico e intenso. A sua aplicação é multifacetada e transversal a 
praticamente todas as atividades, sendo que a exposição humana a este composto 
assume particular importância a nível industrial e no sector da saúde, onde é bastante 
utilizado. Ao longo das últimas duas décadas vários estudos epidemiológicos revelaram 
uma associação entre a exposição ocupacional a este aldeído e incidência de cancro 
nasofaríngeo e leucemia (do tipo mieloide) entre trabalhadores do sector industrial e da 
saúde. Com base nestes estudos e em dados obtidos em ensaios experimentais com 
animais o FA foi recentemente reclassificado agente carcinogénico humano pelas 
principais agências mundiais. O potencial genotóxico do FA está largamente descrito 
tanto in vitro como in vivo desde bactérias até roedores. No entanto, em estudos de 
biomonitorização humana, o caracter genotóxico do FA é inconclusivo, e carece de mais 
investigação em especial no que concerne ao seu efeito em tecidos distantes do local de 
absorção. Por outro lado, alguns autores reportaram que o FA poderá influenciar 
parâmetros imunológicos e por conseguinte afetar a resposta imunitária. Vários estudos 
apontam os laboratórios de anatomia patológica como sendo um dos cenários 
ocupacionais em que os trabalhadores estão expostos a elevados níveis de FA. Nestes 
laboratórios decorrem atividades de rotina que implicam a libertação de vapores de FA, 
com consequente inalação por parte dos trabalhadores, pela utilização de formol usado 
em procedimentos anatomopatológicos para conservar e armazenar biópsias e peças 
cirúrgicas.  
O objetivo do presente estudo foi avaliar a exposição ocupacional a FA em profissionais 
dos Serviços Hospitalares de Anatomia Patológica, utilizando para isso uma abordagem 
múltipla de modo a relacionar diferentes tipos de biomarcadores de dose, efeito e 
suscetibilidade. A integração dos resultados dos diferentes biomarcadores estudados 
permitir-nos-á investigar a relação entre a exposição ao FA e possíveis efeitos biológicos 
adversos, consequentes da exposição profissional a este composto. 
Para o efeito foi estudada uma população de 85 profissionais dos Serviços Hospitalares 
de Anatomia Patológica, expostos ao FA no seu ambiente de trabalho e 87 indivíduos 
com historial ocupacional de não exposição ao FA e com características demográficas, 
de idade, sexo e hábitos tabágicos, semelhantes ao grupo exposto. 
xiii 
A avaliação da exposição ocupacional a FA foi realizada pela medição da concentração 
do FA no ar no local de trabalho e pela análise de diferentes indicadores biológicos. Para 
estimar o nível de exposição do FA nos Serviços de Anatomia recorreu-se à amostragem 
contínua de ar no posto de trabalho, representativa do ar inalado pelos trabalhadores. Os 
níveis de ácido fórmico na urina foram quantificados, por forma a estudar a sua potencial 
aplicação como biomarcador de dose interna de exposição ocupacional a FA. O estudo 
do dano genético foi avaliado em linfócitos do sangue periférico através de diversos 
biomarcadores de efeito, nomeadamente, alterações citogenéticas (frequência de 
aberrações cromossómicas, AC; micronúcleos, MN; e trocas entre cromatídeos irmãos, 
SCE), dano a nível do ADN, mediante o teste do cometa, e o teste de mutação do recetor 
das células T (TCR). A frequência de MN em células da mucosa bucal foi também 
avaliada. As possíveis alterações no sistema imunitário foram estudadas pela análise das 
percentagens das diferentes subpopulações linfocitárias. A fim de detetar diferenças 
genéticas responsáveis por variações na suscetibilidade dos indivíduos à exposição a FA, 
foram investigados polimorfismos de genes relacionados com o metabolismo (CYP2E1, 
GSTM1, GSTT1, GSTP1) e polimorfismos envolvidos no mecanismo de reparação de 
lesão do ADN (FANCA, RAD51, XRCC2, XRCC3, XRCC1, PARP1, MUTYH, BRIP1). 
Para o grupo de trabalhadores estudados, tendo em conta a jornada de trabalho obteve-
se um valor médio de exposição ao FA de 0.38 ± 0.03 ppm. O grupo exposto apresentou 
em média valores urinários de ácido fórmico estatisticamente superiores ao grupo 
controlo, no entanto não foi observada associação com os níveis de exposição no ar. Os 
resultados obtidos para os indicadores biológicos de genotoxicidade revelaram que os 
indivíduos expostos apresentaram, em média, maior dano genético comparativamente 
aos indivíduos do grupo controlo. Foi observado no grupo exposto um aumento 
significativo na frequência de AC, de SCE e no dano do ADN avaliado pelo teste do 
cometa. Observou-se ainda, nos trabalhadores, um aumento significativo na frequência 
de MN em linfócitos e em células da mucosa bucal. Foram encontradas associações 
(positivas) estatisticamente significativas entre a frequência de MN em ambos os tecidos, 
a duração (MN em linfócitos) e os níveis de exposição a FA (MN bucais), confirmando a 
sensibilidade deste biomarcador para avaliar o efeito genotóxico do FA em indivíduos 
ocupacionalmente expostos. Os profissionais dos serviços de Anatomia Patológica 
apresentaram também alterações nas percentagens de subpopulações linfocitárias, 
designadamente em células T citotóxicas, células natural killer e linfócitos B, 
comparativamente com o grupo controlo. No que concerne ao efeito dos polimorfismos 
genéticos na frequência dos diferentes biomarcadores, observou-se um aumento 
significativo do dano genético associado aos polimorfismos estudados nos genes 
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CYP2E1, GSTM1 e GSTT1 que codificam enzimas envolvidas na metabolização de 
xenobióticos. O mesmo efeito foi observado num dos genes que integram o sistema de 
reparação FANC, FANCA, revelando assim o envolvimento deste mecanismo na 
reparação da lesão genética induzida pela exposição ocupacional a FA. 
No presente estudo constatou-se que os profissionais dos Serviços de Anatomia 
Patológica estão expostos a níveis de FA superiores a valores recomendados. Foi 
também observado um aumento significativo na frequência de biomarcadores de dano 
genético comparativamente com o grupo controlo. Face ao exposto, torna-se necessário 
tomar medidas de controlo. A primeira abordagem no controlo da exposição a um produto 
químico perigoso é analisar a possibilidade da sua substituição. Na sua impossibilidade, 
devem adotar-se medidas que reduzam ao mínimo o risco de exposição profissional, 
nomeadamente a implementação de boas práticas de trabalho e a formação dos 
trabalhadores nesses princípios. Os trabalhadores deverão também ser informados sobre 
a correta utilização dos meios de prevenção (coletiva e individual) e sua manutenção, de 
modo a minimizar os riscos inerentes às suas atividades. Paralelamente deverá proceder-
se a melhorias nos locais de trabalho nomeadamente no que diz respeito às condições 
de exaustão e ventilação. Deve ser também assegurado um programa de vigilância da 
saúde dos trabalhadores que permita uma avaliação contínua dos riscos na saúde de 
natureza profissional e subsidie medidas e ações preventivas adequadas ao controle da 
exposição. 
 
 
 
 
 
 
 
 
 
 
 
 
xv 
  
 
 
xvi 
PREAMBLE 
 
The modern way of life, along with population growth, is sustained by an industrial 
production never before attained, in which chemicals have become essential elements for 
the well-being and functioning of contemporary societies. Global production has increased 
over the time for 1 million tonnes in 1930 to 400 million tonnes today. Nonetheless, in 
spite of the value and usefulness of chemical products, their production, use and disposal 
can be harmful to human health and the environment. An important aspect of public health 
protection is the prevention or reduction of exposures to environmental agents that 
contribute, either directly or indirectly, to increased rates of premature death, disease, 
discomfort or disability. This assumes particular importance in occupational settings where 
the exposure to potential hazardous agents (in intensity, frequency and duration) is more 
significant. Chemical substances constitute the more extensive group of occupational risk 
factors, contributing significantly to the morbidity of the working population. The number of 
hazardous substances to which workers are exposed grows on a daily basis, reaching 
more than 100 000 in nowadays figures. For the most, there is little or none information 
about toxicity and potential health effects. 
Measurement or estimation of actual worker exposure, along with appropriate evaluation 
of biologic parameters and assumptions about health effects or safety limits, is the 
standard method used to determine whether intervention is necessary and which forms of 
intervention will be more effective. During recent years, measures and strategies designed 
to prevent, control, reduce or eliminate occupational hazards and risks have been 
developed and applied, yet, despite continuous if slow improvements, work related 
diseases are still frequent (Alli, 2008) and in some cases, such as cancer, are rising 
(Clapp, 2008) thus their cost in terms of human suffering and economic burden continues 
to be significant.  
In a recent survey conducted by the Portuguese Toxicology Association (ApTox) on the 
emerging issues in Environmental Health (EH) in Portugal, chemical exposure was 
identified by EH professionals as one of the principle hazards that currently contribute to 
most health problems in occupational settings. It was further predicted that in the next 5 to 
10 years exposure to airborne chemicals will be the primary source of concern. 
Furthermore, during this period, the health points of concern are most likely to be 
respiratory and neoplastic disorders. 
Formaldehyde is a high-volume production chemical produced worldwide with a large 
range of industrial and medical applications. It was recently reclassified as a human 
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carcinogen, based on increased evidence of cancer risk among subjects exposed to high 
measures (exposure level or duration) of airborne formaldehyde in the workplace. Several 
studies point the pathology and anatomy laboratories as one of the occupational settings 
where workers are more exposed to this aldehyde. Although formaldehyde genotoxicity 
and carcinogenic potentials are well documented in mammalian cells and in rodents, 
genotoxic effects and carcinogenic properties in humans are still conflicting and need 
more investigation.  
The present study addresses the need for a policy-oriented research focused on the 
development of integrated approaches regarding the health risk assessment of 
populations occupationally exposed to hazard compounds. The prime objective is to 
provide rigorous information on the potential genotoxic effects of formaldehyde 
occupational exposure, towards a better understanding of the mechanisms of genotoxicity 
that may contribute to formaldehyde carcinogenicity in workers. 
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1. INTRODUCTION 
 
“Preventing cancer is possible when we act on what we know.” 
(Clapp et al., 2008) 
 
Humans are daily exposed to a variety of potentially harmful agents in the air they 
breathe, the liquids they drink, the food they eat and products they use (IPCS, 2002a). 
Long-standing evidence of the bond between health and the environment has led to the 
recognition of the need for sustainable development. On the other hand, there is an 
increasing global awareness of the inevitable limits of individual health care and the need 
to complement such services with effective public health strategies.  
According to the World Health Organisation (WHO), cancer is a leading cause of death 
worldwide (WHO, 2013). Additionally, at least 200,000 people die every year from 
occupational or work-related cancers (WHO, 2007).  
Most individuals spend one-third of their life in the workplace. Workers are often in contact 
with carcinogenic agents at higher levels than the general population, resulting in 
accumulation of exposure effects over lifetime. Many occupational diseases, including 
work-related cancers, are characterised by long latency periods and therefore are difficult 
to recognise until the clinical manifestation of their symptoms. Early detection of a 
professional risk situation can significantly decrease the occurrence of deleterious effects 
on worker’s health. Thus, preventing individual exposure to carcinogens may prevent the 
disease. 
Indeed, estimations show that at least one–third of all cancer cases of environmental and 
occupational origin can be prevented based on current knowledge (Espina et al., 2013). 
This is best exemplified by the decline in lung cancer cases in males from the reduction in 
tobacco smoking, or by the drop in bladder cancer among dye workers from the 
elimination of exposure to specific aromatic amines (Clapp et al., 2008; Jemal et al., 
2011).  
Exposure assessment aims at prevention. Establishing the health effects of various 
activities and exposures requires information about the levels of exposure and the 
biological effects resulting from the interaction between the organism and the chemical 
agent. The resulting data provides a basis for designing effective prevention and 
mitigation strategies.  
3 
REVIEW OF THE LITERATURE 
 
The current global labour force stands at about 45% of the world’s population. Their work 
sustains the economic and material basis of society which is critically dependent on their 
working capacity. Thus health at work and healthy work environments are among the 
most valuable assets of individuals, communities and countries, and are critical 
components for sustainable development. 
 
1.2 GENOTOXICITY AND CARCINOGENICITY 
Genotoxicity is a comprehensive term that refers to the ability of an agent to damage DNA 
and/or cellular components regulating the fidelity of the genome and includes all adverse 
effects on genetic material (Eastmond et al., 2009). Genomic damage may be induced by 
several exogenous (exposure to genotoxic agents, lifestyle factors) and endogenous 
factors (genetic variants) (Holland et al., 2008). If the damage induced is not properly 
repaired it may give rise to genetic alterations that may ultimately lead to neoplasia and 
cancer (Rueff et al., 2002). Thus, genomic damage is probably the most important 
fundamental cause of developmental and degenerative disease.  
Carcinogenesis is a multistep process that results from the accumulation of several 
genetic alterations controlling either cell death or cell proliferation leading to a progressive 
transformation of normal cells into highly malignant derivatives (Hanahan and Weinberg, 
2000). Cancer is characterised by karyotypic instability, aberrant gene expression and 
uncontrolled cellular proliferation. Neoplasias may arise either from inherited mutations or 
from de novo mutations in somatic tissue (Jefford and Irminger-Finger, 2006). However, 
they are not only a consequence of DNA sequence mutations, but also from changes in 
the activities of genes and chromosomal regions (epimutations1) (Banno et al., 2012). 
Human carcinogenesis is the outcome of a complex series of interactions between 
exogenous and endogenous processes (Kyrtopoulos, 2006). Although risk factors such as 
tobacco use, genetic predisposition, alcohol consumption, unhealthy diet, among others, 
play a major role in carcinogenesis process, a range of environmental variables and 
occupational exposures also contribute significantly to the global cancer burden (Clapp et 
al., 2008; Espina et al., 2013). Indeed, over the last years, several epidemiological studies 
have revealed an increased risk of cancer development at various sites among subjects 
exposed to chemicals namely in occupational settings. 
 
1 abnormal transcriptional repression in active genes and/or abnormal activation of usually repressed genes (Banno et al., 
2012). 
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1.3 HUMAN EXPOSURE ASSESSMENT  
Exposure assessment is a crucial procedure for the identification, evaluation and control 
of workplace hazards. 
Human monitoring is a frequently used approach to provide early warning signals of 
excessive exposure to toxic substances and for prediction of health risks. Overall, it 
consists on a routine evaluation and interpretation of environmental and/or biological 
parameters, in order to detect possible health hazards before the poisoning or illness 
occur. In addition, it may contribute to define exposure limits for minimising the likelihood 
of significant health risks (Teixeira, 2004).  
The exposure can be assessed by measuring the concentration of the chemical agent in 
environmental samples, such as air (Environmental Monitoring) and/or by measuring 
biological endpoints (Biological monitoring), called biomarkers or biological indicators. 
Generally, these two methods are used simultaneously, since they provide different but 
complementary information (IPCS, 2002a). 
Environmental monitoring is the measurement of agents present at the workplace to 
evaluate ambient exposure and health hazard compared to an appropriate reference 
value. It quantifies or estimates the level of the chemical pollutant to which a worker is 
exposed during a task and/or workday. However, it represents only a snapshot of 
exposure in time and may not adequately reflect fluctuations in exposures. Furthermore, 
external exposure assessment does not take into consideration personal working habits or 
individual characteristics that may influence the uptake of the chemical agent. 
Biological monitoring is any measurement reflecting an interaction between a biological 
system and an environmental agent, which may be chemical, physical or biological (IPCS, 
1993). It provides an integrated measure of the level of exposure to chemicals through 
different pathways and exposure routes.  Hence, it is essential not only for evaluating 
hazards to human health but also for developing strategies to improve occupational health 
and safety conditions and to assess the efficiency of the implemented policies.  
The aim of human biomonitoring studies is to assess the risk of deleterious health effects 
by analysing the relationship between internal exposure and the biological effects in target 
cells. Selection of the optimal assay and tissue for analysis for any particular exposure 
situation should be based, whenever possible, on exposure type and duration, exposed 
population characteristics, endpoint mechanism, and the expected target tissue. Most of 
the time surrogate tissues (e.g. lymphocytes) rather than target tissues are studied for 
practical, methodological and ethical reasons (Albertini et al., 2000).  
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Biological monitoring encompasses the use of biomarkers as indicators to signal events of 
exposure to potential carcinogenic chemicals. Biomarkers are valuable tools in human 
biomonitoring studies, because they are intermediates between exposure and clinical 
manifestation of the disease, representing the whole continuum from external exposure to 
effect. It should be added that the detection of a biomarker not necessarily indicate the 
presence of a disease or toxic process, it may only indicate exposure of the organism to a 
substance (Juberg, 1999).  
Biomarkers are traditionally classified into three types, biomarker of exposure, effect and 
susceptibility.  
Biomarker of exposure- is the xenobiotic chemical itself, its metabolites or the product of 
an interaction between a chemical and its target molecule or cell that is measured in a 
compartment within an organism (IPCS, 1993). Generally, their presence only indicates 
that an exposure has occurred. A biomarker of exposure can be defined as a biomarker of 
internal dose, when the amount of a chemical or its metabolites is quantified in a biologic 
tissue or fluid (e.g. lead in blood) or as a biomarker of biologically effective dose, when it 
concerns the interactions between the chemical or its metabolites with target cellular 
macromolecules forming measurable covalent complexes (e.g. DNA-adducts or protein-
adducts) (Teixeira, 2004).  
Biomarker of effect- is defined as a measurable biochemical, physiological, behavioural, 
functional or other alteration within an organism that might be elicited by the exposure and 
depending upon the magnitude can be recognized as associated with an established or 
possible health impairment or disease (IPCS, 1993). It may represent an event that can 
be correlated with, and possibly predictive of, a deleterious health effect (NRC, 2006). 
These biomarkers are extensively used tools in occupational studies to evaluate the 
genotoxic potential of hazardous chemicals. Cytogenetic alterations, such as 
chromosomal aberrations and micronuclei are the most used endpoints. Moreover, it is 
well-established that chromosome aberrations in human lymphocytes predict a risk of 
cancer (Hagmar et al., 1998) the same association was recently confirmed for micronuclei 
in lymphocytes (Bonassi et al., 2007). Furthermore, the increased frequency of these 
indicators in exposed workers is a quite consistent finding in most studies (Suspiro and 
Prista, 2011), including in cancer-patients (Hagmar et al., 1998). The measurements of 
biomarkers of effect generally reflect events that take place at the latter end of the 
continuum between exposure and disease manifestation. Effect biomarkers, such as 
chromosomal aberrations or somatic mutations are not chemical specific, and therefore 
the association with an exposure must be established by an independent measure, such 
as environmental monitoring or simultaneous measurement of a biomarker of exposure. 
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Although they are less specific in identifying a single causative agent, they can be more 
predictive of ultimate toxicity. However, this will also depend on the individual variation in 
response to the exposure (Lutrell et al., 2008).  
Biomarker of susceptibility- is an indicator of an inherent or acquired limitation of an 
organism to respond to the challenge of exposure to a specific chemical agent(s) (IPCS, 
1993). Generally, it is used to identify whether a person or groups of people are 
susceptible to damage caused by certain chemical or other toxicant. This class of 
biomarkers serves to describe individual variations in the relationship of biomarkers of 
exposure and biomarkers of effect. These variations may help explain why different 
individuals with similar experiences of environmental exposure sometimes produce 
markedly different levels of biomarkers of exposure and/or biomarkers of effect, which in 
turn may correlate with different severities of clinical symptoms. These differences may 
arise from genetic or non-genetic factors. Genetic factors include polymorphisms that may 
lead to different individual capacities to activate, detoxify or repair DNA lesions arising 
from exposure to a chemical. Non-genetic indicators include among others, nutritional 
status, health status, lifestyle and age. These factors are independent of exposure but 
they identify those individuals in a population who may be more susceptible or resistant to 
the effects of a hazardous exposure. 
Each of these biomarkers provides different information and consequently has its own set 
of advantages and disadvantages relating to its specificity, relevance to the toxic pathway, 
existence following exposure and difficulty of analysis (Teixeira, 2004). Ideally, it should 
be used various combinations of biomarkers or apply the same biomarker in different 
tissues or biological fluids in order to obtain more complex and comprehensive information 
and further expand the possibility to investigate the biological consequences of the 
exposure.  
Given the above, estimation of the external exposure to an agent, the response of the 
organism to that agent and its potential susceptibility to toxic effects are all crucial 
parameters when assessing potential health effects associated to the exposure to an 
agent in the workplace. The basic tenets of biomarker-based environmental genotoxicity 
assessment are illustrated in Figure 1. 
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Figure 1. A simplified diagram of the cascade of events from exposure to clinical disease showing the 
relationships among exposure, effect and susceptibility biomarkers (adapted from Manini et al. (2007)) 
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2. FORMALDEHYDE 
 
“You can run, but you can’t formalde(hide)” 
In a carton by Mike Baldwin 
 
Formaldehyde was first synthesised by Aleksandr Butlerov in 1859, but was only in 1868 
that it was conclusively identified by August von Hofmann, as the product obtained from 
passing a mixture of air and methanol over a heated platinum spiral. In fact, this 
production method laid the foundation for the modern manufacturing process of 
formaldehyde, via methanol oxidation using a metal catalyst (copper, molybdenum alloy, 
platinum or silver). At the end of the 19th century, formaldehyde was already used as a 
regular medical preservative and embalming agent. By the early 20th century driven by 
science and technology development, Leo Baekeland used a phenolformaldehyde resin to 
invent the first synthetic polymeric material, a hard moldable plastic, precursor of modern 
synthetic plastics. In 1940s, the first commercial particleboard was produced and a 
revolution was launched in the furniture and construction industries. Commercial 
applications continue to grow and today formaldehyde has an important role in both 
medical laboratory procedures and in the production of domestic and industrial goods that 
have become decisive in everyday life. 
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2.1 PHYSICAL AND CHEMICAL PROPERTIES 
Formaldehyde (FA) is the most simple of all aliphatic aldehydes. It is a low-molecular 
weight organic compound, highly reactive, that readily combines with many chemical 
substances. At room temperature, FA is a flammable and colourless gas with a strong and 
distinctive odour. It is also known as methanal, methylaldehyde or oxymethylene.  
FA is soluble in water, alcohols, and other polar solvents, but has a low degree of 
solubility in non-polar fluids. In dilute aqueous solution, the predominant form of FA is its 
monomeric hydrate, methylene glycol (or methanediol). Since it is rapidly polymerised at 
room temperature, methanol and other substances (e.g. amine derivatives) are frequently 
added as stabilisers to reduce intrinsic polymerisation. FA chemical structure is shown in 
Figure 2, its physical and chemical properties are listed in Table I.  
 
 
 
2.2 ECONOMIC IMPORTANCE  
 
2.2.1 Production  
FA is a building-block of numerous compounds that are used in a wide array of materials 
and products. Due to its versatile properties and inexpensive production, FA is an 
economically important chemical produced worldwide. Generally FA is produced near the 
point of consumption because while it is easy to make, is costly to transport and can 
develop stability-associated problems during transportation and storage. As a result, 
international trade is minimal (NTP, 2011) and FA demand is provided by domestic 
industry.  
IUPAC Name   Methanal 
CAS Number  50-00-0 
Structural Formula  CH2O 
Relative molecular mass  30.03 
Density (-20ºC)  0.82 
Boiling point  -19.1 ºC 
Melting point  -92 ºC 
Convertion  1ppm = 1.2 mg/m3 
Figure 2. Formaldehyde 2D 
and 3D chemical structure.  
Table I. General physical and chemical properties of 
formaldehyde. 
Adapted from NIOSH (1994) and IARC (2006) 
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FA is a high-volume production chemical with a global annual production and 
consumption of approximately 29 million tonnes (IHS, 2012). The European Union (EU) is 
the second largest producer, after Asia, producing over 7 million tonnes of FA each year, 
which accounts for about 25% of global production. China is the largest asian market, 
accounting alone for 34% of the world demand. The third larger market is the United 
States (U.S.), with an annual production of about 5 million tonnes (NTP, 2011). In fact, FA 
and FA-related products are allegedly responsible for more than 5% of the annual U.S 
Gross National Product (Zhang et al., 2009).  
Moreover, it is forecast that the world consumption of FA will continue to grow, reaching 
an average rate of almost 5% per year throughout 2011–2016, especially due to 
increasing demand of fast growing economy countries industry (IHS, 2012). 
 
2.2.2 Commercial uses and applications 
FA is the most commercially important aldehyde, usually marketed as a 37 % (by weight) 
aqueous solution named formalin. Formalin also contains methanol (up to 15%) and other 
substances (several hundred milligrams per litre) that act as stabilisers. FA is also sold, to 
a lesser extent, in its solid form, either as a polymer, paraformaldehyde, or as a cyclic 
trimer, 1,3,5-trioxane. 
The main industrial application of FA is in the manufacture of resins, namely, phenol-, 
urea-, melamine- and polyacetal resins.  
Phenolformaldehyde and urea-formaldehyde resins are extensively used in furniture and 
construction industry as binders or adhesives for wood composites (sterling board, 
plywood, particleboard, fiberboard, hardwood plywood). Other applications include 
structural and acoustical insulation, foundry materials and heat-resistant components for 
automotive and aerospace applications and housewares. In addition, urea-formaldehyde 
resins are used in glass fiber roofing mats and paints. Melamine-formaldehyde resins are 
the raw material of several decorative applications including furniture, tableware, flooring, 
acrylic clear coats and paper finishing. The polyacetal resins are the most diversified with 
applications ranging from knife handlers, zippers, insulin pens, guitar picks and Bagpipes 
to automotive and consumer electronics. The leather, textile, rubber and cement 
industries are other examples where FA-based resins are widely used. 
Another major application of FA is as an intermediate in the synthesis of other industrial 
chemicals including numerous organic compounds (e.g. 1,4-butanediol, pentaerythritol) 
and derivative substances, that in turn, will be used to make other products downstream 
(e.g. dyes, perfumes, vitamins). 
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FA is also used in agriculture, in controlled-release nitrogen fertilisers, crop protection 
agents and as a preservative in animal feeds. In a recent resolution, EU has decided to 
ban from the market FA-containing biocidal products for use as feed preservatives, from 
July 2015 (EU, 2013). 
This aldehyde can be further applied as an anti-corrosive agent in electroplating 
processes and in the development of photographic films. 
FA is also used in cosmetic products as a preservative and antimicrobial agent, namely in 
shampoos, deodorants, lotions, toothpaste, lipstick, mouthwashes, nail polish and hair 
products. Although FA per se is now rarely used in cosmetics, the use of FA-releasing 
preservatives is common. 
FA application further extends to the health sector where it is used: i) in vaccines (as an 
inactivating agent) and pharmaceutical products; ii) to disinfect and sterilised hospital 
wards and medical equipment; iii) to preserve and embalm biological specimens. 
In many instances, because FA is a long-established material with versatile properties, 
few compounds can replace it without compromising quality, performance and cost, which 
hinders its substitution to both producers and users. 
 
2.3 HUMAN EXPOSURE    
Given its economic importance and widespread use, many people are exposed to FA both 
environmentally and occupationally. The major route of exposure to FA is inhalation 
(IARC, 2006). Although environmental exposure typically occurs at much lower levels than 
occupational exposure, people are exposed to FA at some concentration in their daily 
lives. FA is also a naturally occurring biological compound present in all cells, tissues and 
body fluids (IARC, 2006). 
According to WHO (2000) the estimates for the daily intake of FA in ambient air can vary 
between 0.002 and 0.04 mg/day mean values. On the other hand, for indoor air the 
average intake levels can differ between 0.3 and 0.6 mg/day. However, indoor air 
concentrations can be substantially increased with tobacco smoking, rising up to 0.5 to 3.5 
mg/day. WHO also predicts that the mean daily intake of FA from occupational exposure 
is up to 8 mg/day, being variable according to the work in question.  
 
2.3.1 Environmental  
FA is ubiquitous in the environment and has been detected in indoor and oudoor air, soil, 
food, surface water, groundwater, treated and bottled water (NTP, 2011). 
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FA is formed primarily by the combustion of organic materials and by a variety of natural 
and anthropogenic activities. 
Combustion sources include automobiles and other internal combustion engines, power 
plants, waste incinerators, refineries, wood stoves, forest fires and tobacco smoking. FA is 
also formed in the early stages of residual plant decomposition in the soil.  
Secondary formation of FA occurs in the atmosphere through the photochemical oxidation 
of natural and anthropogenic hydrocarbon pollutants present in the air. In some instances, 
given the diversity and abundance of FA precursors in urban air, secondary production 
may exceed direct air emissions (IPCS, 2002b). 
For the general population the major sources of FA exposure include combustion sources, 
tobacco smoke, offgassing from numerous construction and home-furnishing products, 
and offgassing from consumer goods.  
FA levels in indoor air are often higher by one order of magnitude or more than those 
outdoors (IARC, 2006). The most significant source of indoor contamination is the release 
from newly home furnishings, primarily from wood pressed products made with urea-
formaldehyde resins. These emissions are able to cause FA-exposure related symptoms 
in residents or occupants especially irritation of the eyes and upper airways (Salthammer 
et al., 2010). The most known example has occurred in the US, involving hurricane victims 
and government-provided FEMA (Federal Emergency Management Agency) trailers. 
Numerous victims of Hurricanes Katrina and Rita suffered adverse health effects 
(respiratory and other symptoms) as a result of being housed in FEMA trailers containing 
levels of FA 2-fold higher than the reference level. The FA was emitted from the materials 
used to build the mobile homes (CDC, 2008). 
The general population can also be exposed to FA from consumer goods containing FA 
and from ingestion of food and water (IARC, 2006). Some of the products that often 
contain FA-releasers are cosmetics, household cleaning agents, soaps, shampoos, paints 
and lacquers (IPCS, 2002b).  
Food and water contain measureable concentrations of FA, but the significance of 
ingestion as a source of FA exposure is not considered relevant (IPCS, 2002b; NTP, 
2011). In food FA can be present either naturally (e.g. fruit, vegetables, shellfish) or as 
result of inadvertent contamination. FA-hydrated form, methylene glycol, can be found in 
surface water or groundwater but usually it is biodegraded within 1 to 15 days (IPCS, 
2002b). In treated and drinking water FA is formed primarily through oxidation of organic 
matter during ozonation or chlorination treatment (NTP, 2011), yet its concentration is 
usually less than 100 μg/L (IPCS, 2002b).  
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2.3.2 Occupational 
The major source of exposure to airborne FA occurs in the work environment. 
Occupational exposure to FA is transversal to a wide variety of professions and industries. 
In the early 1990s it was estimated that approximately 1 million workers in the EU (near 
36 000 in Portugal) and 2 million in the US were exposed to FA (FIOH, 1999; NTP, 2011). 
Although no current data is available in the literature, given that FA-world demand has 
grown over the last decades, it is safe to speculate that the number of individuals 
occupationally exposed to FA is now higher. 
In occupational settings, FA occurs mainly as a gas, hence the major route of exposure is 
inhalation. Nevertheless, workers may also be exposed through dermal contact (formalin 
solutions) or by inhalation of FA-particulates such as powdered resins or wood dust (NTP, 
2011). 
Given its economic importance and wide spread use, occupational exposure to FA 
involves not only individuals employed in the direct manufacture of FA and products 
containing it, but also those using the products. Overall, the exposure to FA occurs in 
three main work-related scenarios:  
- production and use of formalin in chemical industry (e.g., synthesis of resins) and 
in medical laboratories as a preservative and disinfectant agent.  
- release from FA-based resins in which it is present as a residue and/or  through 
their hydrolysis and decomposition by heat, during the manufacture of  wood 
products, textiles and plastics.  
- the pyrolysis or combustion of organic matter, e.g. in engine exhaust gases or 
during firefighting.  
Another workplace circumstance that in the last few years has raised some concern is the 
FA emission from hair straightening products during hair treatment in hairdresser salons; 
although as shown by Pierce et al. (2011) this appeared to be limited to some specific 
products. 
The occupational groups considered to be more at risk, either by duration or level of 
exposure, are industrial workers from chemical industries and plywood factories, 
embalmers and pathology and anatomy laboratory workers (IARC, 2006). 
According to IARC (2006) the highest exposures to this aldehyde were measured in the 
past in industrial settings (e.g. varnishing of furniture and wooden floors, garment 
industry). However, recent legislation (e.g. resins that release less FA) and improved 
ventilation have resulted in decreased levels of exposure in many industrial workplaces. 
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Exposures to levels of up to 3 parts per million (ppm) have been reported for embalmers 
and for hospital laboratory professionals, such as anatomy and pathology workers (IARC, 
2006). A recent study assessing the airborne exposure to FA in an industrial unit and 
anatomy pathology laboratory reveal higher levels of FA in the lab compared to the 
industrial setting (Viegas et al., 2010). 
Furthermore, numerous epidemiological studies indicate a significant association between 
cancer risk and occupational exposure to FA (Hauptmann et al., 2004; Zhang et al., 
2009). In fact, a recent study reported that the estimated cancer risk of laboratory 
technicians exposed to FA was 20% higher than the general population (Pilidis et al., 
2009). 
 
2.4 TOXICINETIC AND METABOLISM 
The toxicokinetic behavior of FA has been the subject of several studies in a number of 
mammal species, and although there may be quantitative differences between them, the 
fate of FA is qualitatively similar among species (IARC, 2006).  
The major route of exposure to FA is inhalation. At room and body temperatures, FA 
hydrates rapidly and it is in equilibrium with its hydrated form methylene glycol (or 
methanediol) (NTP, 2011). Owing to its reactivity and solubility, FA is readily absorbed 
from the respiratory tract following inhalation. In obligate nose breathers, such as rodents, 
absorption and deposition occur primarily in the nasal passages. In humans, which are 
oronasal breathers, it is likely to occur primarily in the nasal passages and oral mucosa, 
but also in the trachea and bronchus (Kimbell et al., 2001). Species-specific differences of 
FA uptake and consequent associated effects (such as cell proliferation or reaction with 
other macromolecules) are determined by nasal airflow (nasal anatomy, ventilation) and 
breathing patterns rather than metabolism of the parent compound (Herausgegeben et al., 
2006). 
After oral exposure, FA is rapidly absorbed from the gastrointestinal tracts. In contrast, 
dermal uptake following application appears to be very slight, however it is able to 
penetrate skin (IARC, 2006).  
FA is present at low levels in most living organisms. Physiological amounts of FA are 
endogenously formed from serine, glycine, methionine and choline, and also by 
demethylation of N-, O- and S-methyl compounds (IARC, 2006). 
Nevertheless, regardless of its origin, endogenous or exogenous, FA has the same 
metabolic pathway in the organism (Figure 3) (ATSDR, 1999; IARC, 2006).  
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After absorption, FA is rapidly metabolised by oxidation to formate. The detoxification 
process takes place in all cells and can involve different enzyme systems. The primary 
and most important enzyme for the metabolic inactivation of FA is the glutathione-
dependent formaldehyde-dehydrogenase (FDH) (also known as alcohol dehydrogenase 
class 32; Koivusalo et al., 1989). FDH is highly specific for the FA-glutathione adduct, S-
hydroxymethylglutathione, formed spontaneously in the cytosol from FA and glutathione 
conjugation. Formation of FA-glutathione adduct efficiently counteracts the presence of 
free FA, a reaction that is determined by the fact that glutathione is an abundant molecule 
in the cell. FDH oxidises S-hydroxymethylglutathione to S-formylglutathione, in the 
presence of NAD. This intermediate is then metabolised by S-formylglutathione hydrolase 
to yield formate and reduced glutathione (IPCS, 1989).  
The activities of FDH are two to three orders of magnitude lower than those of S-
formylglutathione hydrolase and thus the FDH-catalysed step is rate-limiting (IARC, 2006).  
A secondary pathway involves the two aldehyde dehydrogenases (ALDH), ALDH1A1 (in 
cytosol) and ALDH2 (in mitochondria). Both enzymes have affinity for free FA but their Km 
values are higher than the Km displayed by FDH for S-hydroxymethylglutathione (Just et 
al., 2011). Therefore, FDH is probably the predominant enzyme responsible for the 
oxidation of FA at physiologically relevant concentrations, while ALDH enzymes contribute 
increasingly when the concentrations of FA increase (Just et al., 2011). Furthermore, 
some studies showed that FDH activity do not increase in response to FA exposure 
(Casanova-Schmitz et al., 1984; Øvrebø et al., 2002) thus no increase in metabolism 
occurs and non-metabolised FA is probably bound to macromolecules. 
Other alternative metabolic pathways include, FA oxidation to formate by catalase, but 
only in the presence of hydrogen peroxide (H2O2); and FA reduction to methanol by a 
cytosolic alcohol dehydrogenase class 1 (ADH1) (IARC, 2006) (Figure 3). 
Being normal components of intermediary metabolism, neither FA nor formate are stored 
to any significant extent in any tissue. Formate is either excreted in the urine, as formic 
acid, or oxidised to carbon dioxide and exhaled. 
Moreover, both FA and formate can be further incorporated into other cellular molecules, 
entering the 1 carbon intermediary metabolic pool, which involves the folic acid metabolic 
pathway for synthesis of nucleic acids, amino acids, and macromolecules (ATDSR, 1999).  
2
the systematic name for the enzyme is formaldehyde: NAD+ oxidoreductase (IUBMB code EC 1.2.1.46). Other names for 
this enzyme are formaldehyde dehydrogenase, NAD-linked formaldehyde dehydrogenase and NAD-dependent 
formaldehyde dehydrogenase. 
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The kinetics of FA metabolism and the effects on its rate of various enzyme inhibitors 
have been studied (IARC, 2006). In isolated rat hepatocytes, depletion of glutathione or 
inhibition of the metabolic enzymes, FDH, ALDH2 or ADH1 were found to decrease FA 
metabolism and to increased cytotoxicity in a dose-dependent manner, through reactive 
oxygen species (ROS) production (Teng et al., 2001). Recent studies have identified 
ALDH2 as the primary enzyme responsible for the detoxication of aldehydes in 
haematopoietic stem cells, the lack of this enzyme results in hypersensitivity of 
haematopoietic stem cells to exogenous aldehydes, by accumulating DNA damage 
(Langevin et al., 2011; Garaycoechea et al., 2012). Thus, it is reasonable to assume that 
individuals with lower levels of glutathione as well as those with deficiencies in any of the 
above enzymes (by altered genes or polymorphisms) will be more susceptible to FA 
toxicity.  
 
 
Figure 3. Fate and metabolism of formaldehyde (adapted from Teng et al. (2001) and IARC (2006)). 
 
2.5 HEALTH EFFECTS 
 
2.5.1 Sensory irritation and related symptoms 
FA has a pungent and suffocating odour and at certain concentrations is a strong irritating 
gas (ATDSR, 2010).  
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The respiratory tract, especially the upper respiratory tract, is a critical target of the irritant 
action of inhaled-FA, as shown by human acute controlled exposure studies, by studies 
on humans exposed acutely or repeatedly under occupational or residential conditions, 
and by studies of animals exposed by inhalation for acute, intermediate, and chronic 
durations (IARC, 2006; ATDSR, 2010). 
Most humans detect and/or recognise FA odour at concentrations below 1 ppm (ATDSR, 
2010), but the odour threshold has been reported to be between 0.05 and 0.18 ppm (Arts 
et al., 2006). The most common exposure effects to FA vapours comprise sensory 
irritation of the eyes, nose and throat, with eye irritation generally accepted as the most 
sensitive endpoint.  
Odour perception and the threshold for sensory irritation are sometimes not clearly 
differentiated, it generally exist on a concentration gradient, but may overlap (Gaffney and 
Paustenbach, 2007). In FA case, however, the progression of responses is clear, with 
human studies showing that for most individuals, odour perception generally precedes 
sensory irritation (Golden, 2011). Importantly, odour perception and sensory irritation are 
different and distinct physiological processes. Upon substance inhalation odour is the 
sensation of smell carried by the olfactory nerve (first cranial nerve), while sensory 
irritation involves stimulation of the trigeminal nerve endings, and near triggering 
concentrations is generally considered to be a physiological and not a toxic response 
(Gaffney and Paustenbach, 2007; Golden, 2011).  
Sensory irritation encompasses a graded series of responses related to the concentration 
of FA in the air and is generally categorised as ranging from slight to moderate (mucosa 
irritation) to severe (e.g. difficulty in breathing).  The response also depends on the length 
of exposure and individual sensitivity.  
The most common symptoms, irritation of the eyes, nose, and throat, along with increased 
tearing, occurs at FA-concentrations of about 0.3 - 3 ppm in the air. 
Other symptoms described by individuals exposed to FA include sneezing, coughing, 
sinus, sore throat and nausea (Lang et al., 2008). In fact, clinical symptoms of eye 
soreness (68%), lacrimation (60%), eye fatigue (45%), rhinorrhea (38%), and throat 
irritation (43%) were reported in a survey involving 143 medical students exposed to a 
mean FA concentration of 2.4 ppm, during a course (15 hours/week for 2 months) 
(Takahashi et al., 2007). Similar symptoms were also described by students but at a lower 
airborne FA concentration, 0.72 ppm (6-8 hours/day for 3 months) (Wei et al., 2007). 
Neurological effects due to FA exposure were also reported by a few studies namely, 
decrease performance in short-term memory tests and in the ability to concentrate (Bach 
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et al., 1990; ATDSR, 2010). Indeed, in animal studies impaired learning/memory and 
altered motor activity were reported following acute- and intermediate-duration exposure 
to FA (ATDSR, 2010). 
Changes in human pulmonary function, detected by spirometry tests (FEV, FVC), are 
assumed to occur at 0.6 ppm (ATDSR, 2010), but probably as protective response of the 
organism to the exposure, since the exposure to sensory irritants of the upper respiratory 
tract often cause slower breathing or even breath holding (Gaffney and Paustenbach, 
2007). Volunteers (healthy and asthmatic) in acute controlled exposure studies showed no 
significant changes in pulmonary function after exposure to FA. In chronic exposures, 
some authors reported a decrease in pulmonary function of workers exposed to FA 
(Akbar-Khanzadeh et al., 1994; Fransman et al., 2003; Tang et al., 2009), while others 
found no exposure-related differences (Arts et al., 2006; ATDSR, 2010).  
Increased numbers of eosinophils and protein exudation following FA exposure (0.4 ppm) 
were found in nasal lavage studies confirming the irritative effect of FA; a non-specific pro-
inflammatory effect of FA was suggested by the authors (Pazdrak et al., 1993). 
Nasal epithelial lesions have been observed consistently across a few occupational 
studies (ATDSR, 2010). In addition, clinical findings of upper respiratory tract inflammation 
were reported in 41% of workers exposed to FA (0.71 ppm) namely, hypertrophy or 
atrophy of the upper respiratory mucous membranes, chronic pharyngitis, rhinitis, 
rhinosinusitis, and rhinopharyngitis (Lyapina et al., 2004).  
 
2.5.2 Sensitisation 
FA (vapour) is considered an etiologic factor in occupational asthma, but although it may 
cause asthma in some individuals, this occurs rarely (Ezratty et al., 2007) and it cannot be 
regarded as a potent asthmogenic agent (Kim et al., 2001).  
In fact, over the years, the association between FA-exposure and asthma (or exacerbation 
of) has been controversial, with investigations providing limited evidence of a causal 
relationship.  
Nevertheless, a few case-reports of asthma associated to occupational exposure to FA 
were confirmed by bronchial provocation tests (Kim et al., 2001; IARC, 2006; Tang et al., 
2009). The mechanism of FA-induced asthma remains unclear (Kim et al., 2001). 
However, it seems to be related to a delayed-type hypersensitivity reaction, since the 
subjects showed a latent period of symptomless reaction after exposure (IARC, 2006).  
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A review on controlled chamber studies involving asthmatic volunteers found that acute 
exposures to FA up to 3 ppm are unlikely to provoke asthma in an unsensitised asthmatic 
(Liteplo and Meek, 2003), yet high levels of FA may probably cause asthmatic reactions 
by an irritant mechanism (IARC, 2006).  
Interestingly, a non-occupational study reported a significant relationship between asthma 
in children and residential indoor concentration of FA, at low levels (above 0.05 ppm) 
(Rumchev et al., 2002). This finding was recently explored by a meta-analysis of seven 
peer reviewed studies which confirmed the positive association between indoor inhalation 
of FA and induction/exacerbation of asthma in children (McGwin et al., 2010). Some 
authors however stated that these reports were confounded by potential co-exposures 
and other factors (Arts et al., 2006; Golden, 2011). Among adults, a few studies have 
reported a positive association between indoor levels of FA and asthma while others have 
not (McGwin et al., 2010). The effects of FA-indoor levels appear to be less evident in 
adults than in children (especially in asthmatics) living in the same household 
(Krzyzanowski et al., 1990).  
The question whether FA vapour exposure is a risk factor for occupational or childhood 
asthma (or its exacerbation), or not, or may act in concert with other identified or as yet 
unidentified factors, still remains unanswered (Golden, 2011). Further data from other 
studies suggested a possible association between exposure to FA and allergic 
sensitisation to common aeroallergens in children and in asthmatic subjects (Garrett et al., 
1999; Casset et al., 2006) however a recent study found no significant deleterious effect 
on airway allergen responsiveness of subjects with intermittent asthma (Ezratty et al., 
2007). 
FA (formalin solution) is a known skin sensitizer and one of the common causes of allergic 
contact dermatitis (IARC, 2006). Skin sensitivity to FA has been associated with many 
situations of dermal exposure, including contact with formalin, FA-containing resins, FA-
treated fabrics and FA containing household products (Kim et al., 2001). Furthermore, FA 
has been widely reported to cause dermal allergic reactions in occupationally exposed 
workers, namely, laboratory workers, hairdressers, textile workers and industry workers 
(Kim et al., 2001; Aalto-Korte, 2008). 
 
2.5.3 Genotoxicity  
In the last two decades, a large number of studies were published on the genotoxicity of 
FA in a variety of biological systems and endpoints. The vast majority demonstrate FA 
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genotoxicity in a multiple of experimental in vitro and in vivo models and in exposed 
humans.  
In fact, FA has given positive results for almost all genetic endpoints evaluated in bacteria, 
non-mammalian eukaryotes (yeast, fungi, plants, insects, nematodes), in vitro studies with 
proliferating mammalian cell lines, and in vivo animal studies (IARC, 2006; NTP, 2011). 
The evidence of FA-induced mutations in vitro experimental systems is consistent and 
generally associated with clastogenic effects and direct DNA mutation.  
FA showed mutagenic potential in Salmonella typhimurium and Escherichia coli, with or 
without metabolic activation, including forward and reverse mutations (Schmid et al., 
1986; IARC, 2006) and microsatellite instability (Wang et al., 2007).  
Studies in non-mammalian eukaryotes and plants were also positive for forward and 
reverse mutations, lethal mutations and DNA single-strand breaks (IARC, 2006). For 
example, yeast strains deficient in repair pathways showed to be more susceptible to the 
mutagenic effects of FA (Magaña-Schwencke and Ekert, 1978). 
Similarly, in vitro treatment of mammalian cells with different concentrations of FA induced 
several genotoxic endpoints including, deletions, point mutations, insertions, cell 
transformation, cytogenetic alterations (chromosomal aberrations, sister chromatid 
exchanges and micronucleus), DNA-protein crosslinks, DNA single-strand breaks and 
DNA- adducts (IARC, 2006).  
In fact, chromosomal aberrations (CAs), sister chromatid exchanges (SCEs) and 
micronucleus (MN) were all increased in vitro in several human and rodent primary cells 
and cell lines (IARC, 2006, 2012). Schmid and Speit (2007) observed elevated MN 
formation in human lymphocytes isolated from whole blood cultures after in vitro exposure 
to FA (at 44h). Further evidence of FA-induced MN was found in DNA-repair-deficient cell 
lines (Ridpath et al., 2007), indicating the importance of certain repair pathways in the 
prevention of DNA lesions caused by FA exposure. A549 human lung cells and V79 
Chinese hamster cells showed increased frequency of SCEs after treatment with different 
concentrations of FA. One hour after the addition of the agent to the A549 cells, the 
culture medium still retained the capacity to produce SCEs in non-exposed V79 cells, 
suggesting that genotoxicity persists despite the high reactivity of FA with macromolecules 
in the culture medium (Neuss and Speit, 2008; IARC, 2012).  
Other in vitro studies described the formation of DNA-protein crosslinks in mammalian 
cells treated with FA (Conaway et al., 1996). Some of the proteins enrolled in these 
lesions were identified in cellular functions, namely transcription, gene regulation, DNA 
replication, and DNA repair (Qiu and Wang 2009). 
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It has also been reported that FA is able to induce hydroxymethyl adducts in mammalian 
DNA. For instance, DNA adducts were formed in an experimental reaction with FA and 
deoxyribonucleosides (Cheng et al., 2008a), DNA from human placenta (Zhong and Hee 
2004) and DNA from human nasal epithelial cells (Speit et al., 2008). In addition, Lu et al. 
(2009) demonstrated the formation in vitro of an adduct between DNA and S-
hydroxymethylglutathione, a key intermediate in cellular FA detoxication (please see 2.4).  
Laboratory animals inhaling FA have generally shown more genotoxic effects in the nasal 
tissues. In rats FA vapour inhalation resulted in CAs in pulmonary lavage cells (Dallas et 
al., 1992), MN induction in the gastrointestinal tract (Migliore et al., 1989), DNA-protein 
crosslinks in the nasal mucosa and fetal liver (IARC, 2006), DNA strand breaks in 
lymphocytes and liver (Im et al., 2006; Wang and Liu, 2006) and dominant lethal 
mutations (Odeigah PG, 1997). However, no significant increase in CAs, MN or SCE 
frequencies were found in peripheral blood of rats (IARC, 2006, 2012). 
A number of human biomonitoring studies have examined the genotoxic effect of FA in 
occupationally exposed populations, with both positive and negative outcomes. A wide 
variety of genotoxic endpoints has been investigated, particularly cytogenetic alterations, 
DNA damage and more recently DNA adducts. A fundamental aspect in the assessment 
of genotoxic effects of FA in exposed humans is whether genotoxicity is limited to first 
contact  tissues or not. Therefore, genotoxic evaluations had focused on local-site tissues 
such as nasal and buccal mucosa cells or in circulating blood lymphocytes, nevertheless, 
there are few studies published that combined these two type of tissues (Ye et al., 2005; 
Viegas et al., 2010; Costa et al., 2013).  
Several studies have reported a significant increased frequency of MN (buccal, nasal and 
lymphocytes) (Suruda et al., 1993; He et al., 1998; Orsière et al., 2006), SCEs (He et al., 
1998; Shaham et al., 1997, 2002),  CAs (He et al., 1998, Jakab et al., 2010), DNA-protein 
crosslinks (Shaham et al., 1997, 2003) and DNA damage (by Comet assay) (Yu et al., 
2005; Costa et al., 2008) in FA-exposed workers, namely, industry workers, embalmers 
and pathology and anatomy workers. 
A few studies have identified and quantified FA adducts in occupational exposed 
individuals and in smokers (FA is one of the main components of tobacco). Pala et al. 
(2008) reported a significant increase in FA- serum albumin conjugates in a small group of 
FA- exposed laboratory workers compared to referents. Further, a recent study by Bono et 
al. (2010) found a significant increase on the frequency of leukocyte malondialdehyde-
deoxyguanosine adducts (M1-dG), a biomarker of oxidative stress and lipid peroxidation 
in a group of FA-exposed pathologists compared to controls. In smokers (≥ 10 
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cigarettes/day), Wang et al. (2009a) has identified a specific FA-DNA adduct. The N6-
hydroxymethyldeoxyadenosine (N6-HOMe-dAdo) adduct was detected in 29 of the 32 
smokers and in 7 of the 30 non-smokers, the difference was statistically significant. 
Furthermore, besides the tobacco smoke, authors proposed other minor sources of FA, 
namely as a by-product of another tobacco-specific compound or as result of lipid 
peroxidation or inflammation. 
Also of note, a set of 89 miRNAs were significantly dysregulated in human lung cells 
treated with FA. Mapping of changed miRNAs and predicted mRNA targets revealed an 
association between FA exposure and inflammatory response pathways (Rager et al., 
2011).  
The formation of FA-DNA adducts in leukocytes of FA exposed subjects demonstrate that 
inhaled FA is able to enter systemic circulation and produce genotoxic effects in 
circulating cells, which may ultimately lead to carcinogenesis in distal sites. 
Furthermore, it is believed that FA-genotoxicity and cytotoxicity have a key role in FA- 
related human carcinogenesis (NTP, 2011).  
Genotoxic endpoints analysis, either cytogenetic alterations or DNA adducts, are of great 
interest in risk assessment of occupational carcinogens because they precede by a long 
time the potential health effects, thus offering a greater potential for preventive 
intervention (Mayeaux R., 2004). 
 
2.5.4 Carcinogenicity   
In 2004, the International Agency for Research on Cancer, IARC, reclassified FA from 
Group 2A, probably carcinogenic to humans, to Group 1, carcinogenic to humans (IARC, 
2006). Recently, the US National Toxicology Programme (NTP) has revised FA 
carcinogenic status and after a rigorous scientific review, FA was listed in the NTP 
12th Report on Carcinogens as known to be a human carcinogen (NTP, 2011). Both 
reclassifications are based on sufficient epidemiological evidence from human studies, 
experimental evidence in animals and supporting studies on mechanisms of 
carcinogenesis.  
 
2.5.4.1 Epidemiological studies 
Numerous epidemiological studies have evaluated the relationship between cancer risk 
and exposure to FA in occupational settings, with focus on industry workers, embalmers 
and health professional groups namely physicians, pathologists and anatomists. 
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Epidemiological studies have demonstrated a causal relationship between exposure to FA 
and cancer in humans (NTP, 2011). Causality is indicated by consistent findings of 
increased risks of nasopharyngeal cancer and leukaemia, among individuals with higher 
measures (exposure level and duration) of exposure to FA, which cannot be explained by 
chance, bias or unrecognized confounding effects (NTP, 2011; IARC, 2012). In addition, a 
positive association was observed between exposure to FA and sinonasal cancer (IARC, 
2012). A number of studies have also found associations between FA-exposure and 
cancer at other sites, including the oral cavity, oro- and hypopharynx, pancreas, larynx, 
lung and brain, however, the overall evidence does not support a causal role for FA in 
these cancers (NTP, 2011; IARC, 2012).  
Some of the more important studies implicated in FA carcinogenicity in humans are briefly 
described below. 
 
Nasopharyngeal cancer  
The nasopharynx comprises the upper part of the throat that lies behind the nose. Studies 
have shown that all three histological types of nasopharyngeal cancer (undifferentiated 
carcinoma and keratinising and non-squamous cell carcinoma) start from the epithelial 
cells of the nasopharynx. The nasopharyngeal cancer is a rare cancer representing about 
0.7% of the global cancer burden (Jemal et al., 2011).  
The sufficient epidemiological evidence that FA causes nasopharyngeal cancer comes  
from five case–control studies and from the largest and most informative cohort study 
available to date involving workers from ten US industries (25 619 subjects), conducted by 
the National Cancer Institute (NCI). 
In the NCI cohort study, a statistically significant excess of deaths from nasopharyngeal 
cancer was found in subjects occupationally exposed to FA in comparison with the 
general population (Hauptmann et al., 2004). Furthermore, a highly significant exposure–
response correlation was observed between cancer mortality rate and peak (ppm) and 
cumulative exposures (ppm-years). Controlling for co-exposure to other potential 
occupational carcinogens and bias did not alter the exposure-response relationship. All 
cases were in the highest level of exposure category, most of which occurred in one plant, 
Plant 1.  
A separate case-control study nested in NCI cohort was conducted to investigate if the 
excess mortality from nasopharyngeal cancer found in Plant 1 were related to other 
factors, namely, occupational history outside the FA industry. Marsh et al. (2007) found 
that silversmithing, prior to or after employment in Plant 1, was associated to 
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nasopharyngeal cancer risk and concluded that the observed excess of nasopharyngeal 
cancers may be due to other occupational exposures rather than FA exposure, e.g 
silversmithing. However, several authors observed that while there was some indication of 
influence by activities as a silversmith, confounding alone did not explain the relatively 
high number of deaths from nasopharyngeal cancer found in this plant (Nielson et al., 
2010; IARC, 2012). Furthermore, in Hauptmann et al. (2004) risks related to duration, 
cumulative, and average intensity of FA exposure did not decrease when silversmithing or 
other metal work were added as adjustment variables, indicating that silversmithing did 
not confound the association between FA and nasopharyngeal cancer. 
Recently, the NCI cohort study was extended by 10 years (through 2004) the results from 
this update continue to indicate a link between FA occupational exposure and 
nasopharyngeal cancer, consistent with previous findings (Beane et al., 2013). 
Increase incidences of deaths from nasopharyngeal cancer were also found in two other 
cohort studies: in a Danish study of proportionate cancer incidence, among subjects 
working in companies that manufactured or used FA (Hansen and Olsen, 1995) and in a 
proportionate mortality analysis of the largest US cohort of embalmers (Hayes et al., 
1990).  
Conversely, no excesses of nasopharyngeal cancer mortality was detect in other large 
cohort studies, two among industrial workers (Coggon et al., 2003; Pinkerton et al., 2004) 
and one among embalmers and funeral directors (Walrath and Fraumeni 1983). However, 
in these studies the number of cases were fewer than expected and the statistical power 
to detect an effect on nasopharyngeal cancer (rare cancer) was low (IARC, 2006). 
Five of seven case-control studies showed consistent findings of increased risk of 
nasopharyngeal cancer among individuals with the highest or overall exposure to FA, but 
not all were statistically significant (Vaughan et al., 1986, 2000, Roush et al., 1987, West 
et al., 1993, Hildesheim et al., 2001). 
The studies by Vaughan et al. (2000) (multi-center) and Hildesheim et al. (2001) are 
regarded as the most informative because of their size, their exposure assessment and 
more importantly the evaluation of potential confounders (IARC, 2012). In both case-
control studies, risks of nasopharyngeal cancers increased with exposure duration (years) 
and cumulative (ppm-years) exposure to FA.  
Furthermore, Vaughan et al. (2000) stratified the analysis by histological subtype of 
nasopharyngeal cancer and used several different measures of exposure to evaluate risk. 
A statistically significant exposure-response trend was found for squamous and 
unspecified epithelial carcinomas. The risk of nasopharyngeal cancer, all types, was also 
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increased, but only for workers whose exposure duration were the longest, and not 
necessarily the highest.  
On the other hand, Hildesheim et al. (2001) found some evidence of increasing risk of 
nasopharyngeal cancer with duration of exposure, but the observed trend did not reach 
statistical significance. However, a strong effect was observed for Epstein-Barr 
seropositive (EBV) individuals. In fact, a significant increase in risk of nasopharyngeal 
cancer was found among those ever-exposed to FA and EBV positive. It has been 
suggested that FA may have an indirect influence in EBV reactivation through 
deregulation of nitrosothiol homeostasis and in addition may also interact with the virus to 
promote epithelial cell transformation (Thompson and Grafström, 2009).  
Overall, in the five case-control studies higher risks were found among FA-exposed 
individuals in the high-exposure groups (Vaughan et al., 1986, Roush et al., 1987) or with 
more years since first exposure (West et al., 1993). Some studies also reported that the 
risk remained elevated after consideration of/or adjustment for tobacco smoking (West et 
al., 1993; Vaughan et al., 2000; Hildesheim et al., 2001) or exposure to wood dust 
(Vaughan et al., 2000; Hildesheim et al., 2001). 
However, other case-control studies did not find an association between FA exposure and 
nasopharyngeal cancer (Armstrong et al., 2000, Hauptmann et al., 2009). 
A few meta-analyses with some of the above studies, cohort and/or case-controls, are 
available in the literature, but with contrasting results. Bosetti et al. (2008) did not found a 
significant increase in nasopharyngeal cancer risk in three cohort mortality studies. On the 
other hand, Bachand et al. (2010) found a near significant risk in a meta-analysis of seven 
case-control studies, while for six cohort studies no significant increase was detected 
(after exclusion of Plant 1 data of NCI cohort). 
 
Lymphohematopoietic cancer 
An excess of mortality from leukaemia or combined lymphohematopoietic cancer (cancer 
of the lymphatic and blood-forming systems) has been consistently observed in 
epidemiological studies involving embalmers, funeral directors and health professionals, 
namely, pathologists and anatomists (IARC, 2006, 2012). 
Several of these studies, however, only examined cancer outcomes by occupation and 
occupational characteristics (e.g., duration of employment) without exposure assessment. 
A recent nested case-control study by Hauptmann et al. (2009) examined exposure-
response relationships for lymphohematopoietic malignancies among embalmers and 
funeral directors by metrics of exposure (average, cumulative, peak, and duration of 
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embalming) based on lifetime work histories, practices and predicted FA-exposure levels. 
Mortality from myeloid leukaemia was significantly elevated among ever-embalmers and 
significant trends were observed with duration and peak exposure to FA.  
Three of the largest cohorts in industrial settings were updated, and two found evidence of 
an excess of deaths from leukaemia and lymphohematopoietic cancer associated with FA 
exposure, namely in the US NCI industrial cohort (Hauptmann et al., 2003; Beane et al., 
2009) and in the US cohort of garment workers (Pinkerton et al., 2004). Conversely, no 
excess of mortality for leukaemia was found among workers exposed to FA in a British 
industrial cohort study (Coggon et al., 2003). 
Overall, the above studies found positive exposure-response relationships for combined 
lymphohematopoietic cancer or specific subtypes, but the strongest association observed 
was for myeloid leukaemia (NTP, 2011). For instance, in Meyers et al. (2013) although 
myeloid leukaemia mortality was elevated in garment workers compared to the US 
population, the overall leukaemia mortality was not.  
The large embalmers nested case-control study by Hauptmann et al. (2009) and the 
cohort studies updates of NCI industrial workers (Hauptmann et al., 2003; Beane et al., 
2009) are considered to be the most informative studies for myeloid risk evaluation related 
to FA exposure (NTP, 2011). In these studies, statistically significant exposure-response 
relationships were observed with peak, average exposure and duration of exposure to FA. 
Controlling for co-exposure to other potential occupational carcinogens did not alter the 
findings. 
In Beane’s et al., (2009) follow-up study the overall risk of myeloid leukaemia although 
elevated was declined compared to previous reports. This finding is consistent with largest 
risks occurring closer in time to relevant exposure (Beane et al., 2009) and resembles the 
wavelike pattern of the relative risks over time seen for known leukaemogenic agents (e.g. 
benzene) (Beane et al., 2009; NTP, 2011).   
Few case control studies have assessed the relationship between FA-exposure and risk 
for leukaemia (Linos et al., 1990; Partanen et al., 1993; Blair et al., 2001). No clear 
association was found in any of the studies, probably due to the small number of exposed 
cases and limited statistical power to analyse exposure-response associations (Zhang et 
al., 2009). 
Three meta-analysis were recently published with contrasting results. The meta-analysis 
by Zhang et al. (2009), which included 15 cohort and case control studies found a 
significantly elevated risk of leukaemia, specially, myeloid leukaemia. In opposition, a 
27 
REVIEW OF THE LITERATURE 
meta-analysis by Bachand et al. (2010) did not find a significantly elevated risk for 
leukaemia or subtypes associated to FA-exposure in the studies selected for analysis.  
Bosetti et al. (2008) found an elevated risk of leukaemia across studies of professional 
groups (pathologists, anatomists and embalmers) but not across studies of industrial 
workers. This finding is consistent with observations by Hauptmann et al. (2009) that 
embalmers have longer duration of FA-exposure, higher cumulative exposure and are 
more likely to be exposed to peak exposure levels greater than 4 ppm than industrial 
workers. 
 
Sinonasal cancer 
Sinonasal cancer is a rare disease with an annual incidence of about 1 per 100 000 and it 
comprise cancers of the nasal cavity and paranasal sinus (Luce et al., 2002).  
A number of case–control studies have shown a positive association between sinonasal 
cancers and occupational exposure to FA (Olsen et al., 1984, Olsen and Asnaes 1986, 
Roush et al., 1987, Luce et al., 1993). In most studies, the significant increase of 
sinonasal cancer risk was associated with FA exposure–response patterns, even among 
workers with low or no exposure to wood dust or after adjusting for exposure to wood 
(Olsen et al., 1984, Olsen and Asnaes 1986, Luce et al., 1993, 2002).  
Elevated risks were found for the two major types of sinonasal cancer types, 
adenocarcinoma and squamous-cell carcinoma, but in some studies, the association was 
stronger for the adenocarcinoma (Luce et al., 1993, 2000; NTP, 2011).  
The increased risk of adenocarcinoma among FA-exposed workers was confirmed in a 
pooled analysis study, which collected and re-analysed data from 12 case-control studies 
(Luce et al., 2002), furthermore the increased risk was followed by an increased 
cumulative exposure (ppm-years).  
Other case-control studies did not find an association between FA exposure and 
sinonasal cancer (Vaughan et al., 1986; IARC, 2012) due probably to the small sample 
size (NTP, 2011).  
Collins et al. (1997) meta-analysis found a significant association between FA-exposure 
and mortality from sinonasal cancers, nonetheless the author pointed out that the result 
was probably confounded by concomitant wood dust exposure detected in few of the 
studies included. 
Mix results were found with regard to cohort studies. A statistically significant excess of 
sinonasal cancer was obtained in a Danish cohort study among workers exposed to FA 
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(Hansen and Olsen, 1995)  and a non-significant excess of deaths from sinonasal cancer 
was found in the NCI cohort, among industry workers exposed to FA (Hauptmann et al., 
2004).  
No increase in deaths from sinonasal cancers was found in other large cohort studies, 
(industry workers, Coggon et al., 2003; garment workers, Pinkerton et al., 2004) nor in a 
meta-analyses of eight industrial cohort studies (Bosetti et al., 2008).  
It should be noted that in these cohort studies the statistical power to detect an 
association between FA exposure and sinonasal cancer (rare cancer) was limited, and 
even the larger cohort studies had insufficient numbers of exposed workers and expected 
deaths (e.g. approximately three in the NCI cohort) (NTP, 2011).  
Nonetheless, based on the data available the NTP commission found that there was 
sufficient epidemiological evidence that FA occupational exposure cause sinonasal cancer 
in humans (NTP, 2011). On the other hand, the IARC (2006, 2012) working group 
concluded that the existing studies only offered limited positive evidence of a causal 
relationship between FA exposure and sinonasal cancer (IARC, 2006). The major 
limitations identified were the concomitant exposure to wood-dust, strongly associated 
with sinonasal cancer in some case-control studies, and the discordant results between 
the cohort and case control studies, which may be due to lack of statistical power or could 
indicate the confounding effect of wood dust (IARC, 2012). 
 
2.5.4.2 Animal studies 
FA exposure caused tumours in two rodent species (rats and mice) at several different 
tissue sites and by two different routes of exposure (inhalation and ingestion) (NTP, 
2011).  
First evidence of the carcinogenic potential of FA came from long-inhalation studies with 
rodents (IPCS, 1989). These studies demonstrate that high concentrations of FA can 
cause irreversible damage to the nasal epithelium of rats and that in some cases rats 
exposed continually to these concentrations developed neoplasia (Merck and Speit, 
1998). 
In five studies the long-term inhalation exposure to FA caused nasal tumours, both benign 
(polypoid adenoma) and malignant (predominantly squamous-cell carcinoma but also 
adenocarcinoma and carcinoma) in two rats strains: male and female F344 rats 
(Monticello et al., 1996, Kamata et al.,1997) and in male Sprague-Dawley rats 
(Sellakumar et al., 1985; IARC, 2006). Nasal lesions were also observed in male B6C3F1 
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mice (Kerns et al., 1983) and in male Wistar rats in a short-term exposure study (13 
weeks) (Feron et al., 1988). Although the increased incidences of nasal tumours were not 
statistically significant in these last studies, they were considered exposure-related and 
biologically relevant because of the rarity of this type of tumour (NTP, 2011). 
Studies on oral administration of FA in rats via drinking water showed to increase the 
incidence of fore-stomach tumours in male rats (IARC, 2006). Moreover, increased 
incidences of rare malignant gastrointestinal tumors were observed in female Sprague-
Dawley rats exposed to FA in utero and throughout life via drinking water (Soffritti et al., 
1989; IARC, 2006). In a similar study, the life-long ingestion of FA caused increased 
incidences of total malignant tumors in Sprague-Dawley rats including, testicular tumors in 
males, mammary-gland tumors in females and hemolymphoreticular tumors in both male 
and females of the high-exposure groups (Soffritti et al., 2002). IARC (2006) noted several 
limitations in these last two studies, namely the lack of historical control data, the 
misclassifications of lymphomas and leukaemia and discrepancies in tumour incidences. 
No tumors were observed in skin by topical applications of FA solutions in mice (Iversen 
et al., 1986). With respect to other species, no tumors were found in monkeys exposed to 
FA by inhalation; probably because of the small number of animals exposed and short 
exposure duration (NTP, 2011). 
 
2.5.4.3 Mechanisms of Carcinogenesis 
The mechanisms by which FA causes cancer are not completely understood, but most 
likely involve multiple modes of action, such as DNA reactivity, gene mutation, epigenetic 
effects, glutathione depletion, oxidative stress, chromosomal breakage, cytotoxicity and 
aneuploidy (NTP, 2011).  
 
Upper airway cancers 
Mechanistic studies in humans and experimental animals support the evidence that FA 
causes nasopharyngeal (IARC, 2006; NTP, 2011) and sinonasal cancer (NTP, 2011). The 
existing data strongly indicate that genotoxicity plays a key role in the carcinogenesis of 
FA in nasal tissues and also that cellular replication (in response to FA-induced 
cytotoxicity) promotes the carcinogenic response of the upper airway tissues (Conaway et 
al., 1996; McGregor et al., 2006).  
Indeed, several studies show that inhaled FA is capable of causing genetic damage in the 
nasal epithelium of both experimental animals (e.g. DNA- protein cross-links above 6 
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ppm) and humans (e.g. buccal and nasal MN) (Conaway et al., 1996; Viegas et al., 2010; 
Costa et al., 2013). 
Moreover, computational fluid dynamic model studies that have predict and compare FA- 
local airflow in the nasal passages of experimental animals showed that airway deposition 
and cytotoxicity-induced by cellular proliferation are important variables in the 
carcinogenicity of FA to nasal cells (Kimbel et al., 2001). 
In rats, regional FA flux was correlated with the anatomical distribution of FA-induced 
lesions (squamous metaplasia) and DNA-protein crosslinks (Georgieva et al., 2003). FA-
cytotoxicity in the nasal epithelium may result in cellular proliferation and in the promotion 
of chemically induced spontaneous mutations which may contribute to a carcinogenesis 
process (Monticello and Morgan, 1997). Indeed, cell-proliferation rates were correlated 
with the site specificity of nasal tumors (Monticello et al., 1989; Monticello and Morgan, 
1997). However, FA exposure also causes cytotoxicity and cellular proliferation at 
anatomical sites that are not thought to be the origin of the squamous-cell carcinoma, 
suggesting that factors other than cellular proliferation may play a role in FA-induced 
nasal cancers (NTP, 2011). 
 
Lymphohematopoietic cancer 
As discussed above, several epidemiological studies found evidence of an association 
between exposure to FA and leukaemia. These findings have raised some discussion in 
the scientific community. Owing to its reactive nature it has been considered unlikely that 
inhaled FA is able to damage directly the stem cells in bone marrow as classical 
leukaemogens and cause leukaemia (Zhang et al., 2010a). In fact, some authors strongly 
stated that the fact of inhaled FA enter systemic circulation, reach bone marrow and 
cause leukaemia is biologically implausible and FA genotoxic and carcinogenic action are 
limited to local effects, in the area of first contact where is rapidly metabolised (Heck and 
Casanova, 2004; Franks, 2005; Speit, 2006). In addition, some studies have showed that 
the endogenous concentration of FA in the blood of humans, monkeys, and rats (2-3 μg/g) 
does not increase after inhalation (Heck and Casanova, 2004). Furthermore, the biological 
evidence of systemic (geno-) toxic effects of FA in both animal and human studies is still 
insufficient and conflicting, with both positive and negative outcomes (IARC, 2006, 2012). 
However, it has been previously suggested that FA could potentially reach bone marrow 
directly in its hydrate methanediol form. Although endogenous FA is usually rapidly 
metabolised by GSH-dependent pathways, excess levels such as those encountered 
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occupationally could in fact saturate metabolic capacity and lead to genotoxicity in DNA 
and chromosomes (Zhang et al., 2010b). 
Additionally, there is consistent evidence for systemic distribution of FA in humans 
showed by increased levels of FA-albumin adducts in serum in occupational exposed 
subjects (Pala et al., 2008; Bono et al., 2010) and in smokers (Wang et al., 2009a), as 
well as, numerous studies in humans and experimental animals that have demonstrated 
that inhaled FA can cause hematologic effects, genotoxicity in circulating lymphocytes 
(Costa et al., 2008, 2011), and cancer at distal sites (e.g. myeloid leukaemia).  
Nevertheless, the mechanisms by which FA causes myeloid leukaemia in humans are not 
known. A recent work by Zhang et al. (2009, 2010b) suggested two possible pathways by 
which FA could act as a leukaemogen in humans. One, by damaging hematopoietic 
stem/progenitor cells circulating in peripheral blood and the other, by damaging primitive 
pluripotent stem cells present within the nasal turbinates and/or olfactory mucosa (Zhang 
et al., 2009). In both models, the damaged stem/progenitor cells would then travel to the 
bone marrow and become initiated leukemic stem cells, potentially developing into 
leukaemia following a latency period (Zhang et al., 2010b). Given the likely dynamics of 
stem cell turnover between the nasal/oral passages, blood and bone marrow, sufficient 
stem cells could be targeted through these two alternative models, focused around 
genotoxicity, to induce leukaemia, under conditions of chronic high FA exposure (such as 
occupational exposure) (Zhang et al., 2009).  
Overall, the available evidence taken together does not indicate that such mechanisms 
are implausible (NTP, 2011; IARC, 2012). New in vitro data demonstrate FA’s ability to 
induce genotoxicity in mouse erythropoietic cells and suppress human erythroid 
progenitor cells expansion supporting the potential of adverse effects of FA on 
hematopoietic stem/progenitor cells (Ji et al., 2014). Furthermore, MN formation in mouse 
erythrocytes occurred in a dose-dependent manner, suggesting that chromosomal 
damage may be one potential mechanism underlying FA induced leukemogenesis. 
Additionally, it was recently reported that a FA-detoxifying enzyme (ALDH2) is involved on 
aldehyde detoxication in haematopoietic stem cells (Langevin et al., 2011; Garaycoechea 
et al., 2012). Thus, the biological plausibility of FA-induced leukemogenesis cannot be 
excluded. 
 
2.7 EXPOSURE TO FORMALDEHYDE IN PORTUGUESE WORKPLACES 
To our knowledge, Mayan et al. (1995) conducted the first study in Portugal on 
occupational exposure to FA. The aim was to assess the working conditions of health 
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professionals exposed to FA from histology, pathology and anatomy laboratories and to 
evaluate the neurobehavioral impact of such exposure on workers. Results on 
neurobehavioral indices were inconclusive. However, the values of FA concentration 
found in the labs were near or above 1 ppm, the higher levels were obtained during 
specific pathology and anatomy tasks. A later study by Ferro et al. (2005) confirmed these 
findings in five hospital pathology anatomy laboratories located in Lisbon. Similarly, an 
independent study conducted in the north and centre of Portugal found that the level of 
exposure of these professionals exceed the national recommended criteria of 0.3 ppm 
(Costa et al., 2008). Furthermore, in this study, the authors also evaluated the biologic 
effects of FA-exposure and for all the genotoxic endpoints studied significant increases 
were found in FA-exposed group compared with controls (Costa et al., 2008). These 
findings were further replicated in two other studies on FA-exposed health professionals 
and industrial workers (Viegas et al., 2010; Ladeira et al., 2011). 
In a survey to assess the symptomatology of a group of medical students exposed to FA 
during an anatomy class (2h) most students reported symptoms of eye (96%), nose (83%) 
and throat irritation (65%) (Almeida et al., 2000) in accordance to described elsewhere 
(Takahashi et al., 2007; Wei et al., 2007). 
Viegas and Prista (2007) in order to identify a possible relationship between occupational 
exposure to FA and nasopharyngeal cancer investigated by means of personal interviews 
the occupational history of a group of patients of the Portuguese Institute of Oncology 
diagnosed with nasopharyngeal cancer. In spite of some limitations, identified by the 
authors, the study allowed to verify a possible relationship between the exposure to this 
aldehyde and the development of the considered effect. 
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II. PRESENT STUDY 
 
 
 
 
 
 
 
 
PRESENT STUDY 
1. AIM  
 
Exposure to a chemical carcinogen involves a continuum of events from absorption, 
metabolism, DNA damage and DNA repair, resulting, in the worst case, in the 
development of cancer (Perera and Weinstein, 2000). Various biomarkers may be used to 
follow these events in order to elucidate the mechanisms of the genotoxic/carcinogenic 
process as well as the individual response to hazard chemical compounds.  
The prime objective of the present study was to evaluate the occupational exposure to 
formaldehyde (FA). In particular, to assess the potential genotoxic effects of FA exposure, 
through differentiation of external versus internal levels and taking into account individual 
susceptibility (polymorphic genes in xenobiotic metabolising and DNA repair pathways) on 
the biomarkers of effect.  
Therefore the proposed objectives for this study were: 
i. To estimate the mean level of environmental FA exposure to which the anatomical 
pathology laboratory workers were exposed during their work shift; 
ii. To investigate the use of formic acid in urine as a biomarker of exposure to FA; 
iii. To assess if exposure to FA could cause cytogenetic alterations in peripheral blood 
lymphocytes (PBLs) evaluated by means of chromosomal aberrations (CAs), sister-
chromatid exchange (SCE) tests, and DNA damage, evaluated by means of comet 
assay; 
iv. To evaluate if FA exposure could cause cytogenetic alterations measured by means 
of micronuclei frequency in exfoliated buccal cells, a first contact tissue, and in PBLs, a 
systemic tissue; 
v. To assess if FA exposure could induce somatic mutations evaluated by T-cell 
receptor mutation assay (TCR-Mf); 
vi. To examine if FA exposure could influence the major lymphocyte subsets, namely 
total T lymphocytes (%CD3+), T-helper lymphocytes (%CD4+), T-cytotoxic lymphocytes 
(%CD8+), B lymphocytes (%CD19+) and natural killer (NK) cells (%CD16+56+); 
vii. To clarify the potential role of the genetic polymorphisms in genes related to the 
metabolic pathway of FA (CYP2E1, GSTM1, GSTT1, GSTP1) and the repair of DNA 
lesions (FANCA, RAD51, XRCC2, XRCC3, XRCC1, PARP1,  MUTYH, BRIP1) in 
modulating individual levels of biomarkers related to FA exposure. 
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In all the exposure and effect biomarkers studied, the role of potential confounding factors 
(age, diet, gender and smoking status) was also evaluated.  
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2. STUDY POPULATION 
 
2.1 GENERAL CHARACTERISATION 
Study population consisted of 172 subjects, 85 workers exposed to formaldehyde (FA) 
from nine Hospital Anatomical Pathology laboratories, located in the North and centre of 
Portugal working for at least one year, and 87 non-exposed control employees working in 
the same area in administrative offices and without occupational exposure history to FA.  
Health conditions, general medical history, medication, diagnostic tests (X-rays, etc.) and 
relevant individual information such as, age, smoking habits and alcohol consumption, 
were assessed by means of questionnaires. The questionnaire (Annex I) also included 
information on dietary habits according to Bonassi et al. (2011). Subjects of the exposed 
group also gave information related to working practices namely use of personal 
protective equipment, years of employment, specific symptoms related to FA exposure 
and chronic respiratory diseases such as asthma or others. All individuals who agreed to 
participate in the study were fully informed about the procedures and objectives of the 
work in progress and each subject prior to the study signed an informed consent form. 
Ethical approval for this study was obtained from the Ethical Board of the National Institute 
of Health. 
The general characteristics of both groups are described in Table II. 
 
Table II. Characteristics of the study population 
  Controls  Exposed   
  (N=87)  (N=85)  p-value 
       
Gender      0.921b 
Females  67 (77%)  66 (78%)   
Males  20 (23%)  19 (22%)   
Age (years) a  38.9 ± 11.0  39.8 ± 9.5  0.571c 
Years of employment a    12.0 ± 8.2   
Smoking Habits       
 Non-smokers  65 (75%)  64 (75%)   
 Smokers  22 (25%)  21 (25%)   
Years smoking a  
 
21.7 ± 11.3  
 
20.4 ± 11.0  0.704c 
Cigarettes/day a  
 
13.7 ± 6.9  
 
11.0 ± 5.8  0.160c 
Packs/year a  
 
14.8 ± 11.5  
 11.2 ± 8.1  0.248
c 
a Mean± standard deviation 
b Chi-square test (bilateral) 
c t- Student test 
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Smoking habits groups were established as non-smokers and smokers, since the number 
of ex-smokers (subjects that stop smoking for at least 2 years) was low and the average 
years as ex-smokers was higher than 9 years (controls,17 years; exposed, 10 years).  
Data regarding dietary habits namely the daily consumption of tea, coffee, fruits, 
vegetables (salad and soup), protein intake (fish and meat) and vitamin supplements 
show similar dietary habits in control and exposed groups (Figure 4).  
 
 
 
Figure 4. Frequency of the daily consumption of cups of tea/coffee, fruit (units), vegetables/fish/meat 
(meal) and vitamin supplements (intake) by study groups. 
 
2.1.1 Contact with study subjects 
The hospital units were identified through the National Healthcare Service web portal. 
Fifteen institutions with Anatomical Pathology Departments were selected within the 
desired geographic areas. A brochure with a brief description of the study and aims 
(Annex II) accompanied the first contact by letter. Besides promoting the study and 
generating interest, the main objective was to seek institutional approval to conduct the 
study and authorisation to contact the target professionals. Nine hospitals agreed to 
participate, two declined, one was not included in the study by time restraints, and three 
did not respond to contact. After institutional consent, the second step was the direct 
contact with the professionals to describe the project and to clarify any questions about 
the study and the nature of the participation required. A second visit was necessary to 
characterise the workplace and identify additional monitoring sites relevant for subsequent 
FA air evaluation. Overall, 63% of the workers agreed to participate in the study. The 
same procedure was followed for control subjects.  
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2.1.2 Professional activity (brief description) 
Specialised and non-specialised health professionals compose a Hospital Anatomical 
Pathology Department. The non-specialised professionals include hospital orderlies 
(cleaning of equipment and facilities) and administrative staff (logistic activities, reception 
of biological specimens). The specialised health professionals comprise anatomo-
pathology physicians and anatomo-pathology technicians. In general, there are four main 
lab areas or activities namely cytology, histology, macroscopic analysis (or registry) of 
biopsy specimens and microscopic examination. Anatomo-pathology physicians are 
mainly engaged in macroscopic and microscopic examination of biological specimens, 
whereas anatomo-pathology technicians are allocated to all lab activities mentioned 
above. Depending on the task and work location in the lab, all four professional categories 
are potentially exposed to FA. 
The distribution by professional activity of the FA-exposed workers participating in this 
study is shown in Figure 5.  
 
 
Figure 5. Distribution ratio (%) of the FA-exposed workers by professional category. 
 
2.2 BIOLOGICAL SAMPLES COLLECTION 
All biological samples were coded and analysed under blind conditions. All biological 
samples were collected simultaneously. Venous blood samples (15 mL) were collected 
from each donor, between 10 and 11 am. Prior to buccal cells collection subjects were 
asked to rinse the mouth with tap water to removed unwanted debris. For every subject, 
an individual sample from each cheek (left and right) was collected, and suspended in 
buccal cell buffer. Both cheeks were sampled using separate cytobrushes (Deltalab). A 
spot urine sample was also collected at the end of the shift in sterile polyethylene 
containers (50mL) and frozen at –20 ºC until analysis. After collection, all biological 
samples were transported in a cooler (4 ºC, transport within 2h maximum). Blood samples 
and buccal cells suspensions were immediately processed in the laboratory for the 
different methodologies used in the study. 
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2.3 STATISTICAL ANALYSIS 
A general description of the study population was performed through univariate analysis. 
The distribution within the study groups of socio-demographic and lifestyle factors was 
evaluated with the Student's t-test for continuous variables and the Pearson's Chi-square 
test for categorical variables. 
The effect of exposure was preliminarily assessed by Student's t-test. A logarithmic 
transformation of the data was applied to the following variables: urinary formic acid 
(FMU), percentage of DNA in the comet tail (% TDNA), TCR-Mf (T-cell receptor mutation 
frequency), CD4+/CD8+ ratio and B lymphocytes (%CD19+) to achieve a better 
approximation to the normal distribution. No transformation was needed for SCE (sister 
chromatid exchange), total T lymphocytes (%CD3+), T-helper lymphocytes (%CD4+),       
T-cytotoxic lymphocytes (%CD8+) and natural killer (NK) cells (%CD16+56+). As no 
improvement was achieved with transformation, the Mann–Whitney U-test was applied to 
all parameters obtained from chromosomal aberrations (CAs) test (total-CAs; 
chromosome-type aberrations, CSAs; chromatid-type aberrations, CTAs; gaps; 
aneuploidies; aberrant cells and multiaberrant cells), micronuclei in PBLs (MNL), 
micronuclei in exfoliated buccal cells (MNB) and nuclear buds in exfoliated buccal cells 
(BNbud). 
A multiple regression analysis was performed to estimate the effect of exposure and 
possible confounders. For each biomarker, the method best fitting the data was chosen 
after an investigation of the data distribution. Linear regression was applied on the log-
transformed %TDNA and all lymphocyte subsets; Poisson regression on non-transformed 
data was fitted for SCE, MNB, BNbud and multiaberrants, and on log-transformed data for 
TCR-Mf; lastly, negative binomial regression on non-transformed data was carried out for 
MNL, total-CAs, CTAs, CSAs, gaps, aberrants and aneuploidies. All models included age, 
gender and smoking habits, and parameter-specific actual confounders. Mean ratio (MR) 
was used as the point estimate of effect accompanied by its 95% confidence interval (CI). 
Moreover, independent variables such as, alcohol consumption, vaccination status and 
oral intake of contraceptives or hormonal replacement were evaluated, however due to 
extremely small number of subjects or lack of responsiveness/ dubious answers these 
variables were not included in the final regression models. 
An ancillary regression analysis was carried out to assess the effect of FA exposure level, 
exposure duration and professional activity, only in the exposed population. Adjustment 
for age, gender, smoking habits and actual confounders was applied. Since the personal 
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protective equipment (PPE) used by professionals (masks) was not the appropriate one 
for FA-airborne exposure this factor was not included in the analysis. 
A possible role as effect modifiers of genetic polymorphisms, as candidate biomarkers of 
susceptibility, on the alterations induced by the exposure was also tested. As the number 
of homozygous variant individuals was low (or inexistent) for most genes studied, these 
were merged with the group of heterozygous subjects, assuming a dominant model for 
their inheritance. Mann-Whitney U-test was employed to test for associations between 
biomarkers of exposure and effect and a particular genotype. Differences in genotype 
distributions were evaluated by the Pearson's Chi-square test.  
Associations between variables were analysed by Spearman's rank correlation. The level 
of statistical significance was set at 0.05. All analyses were performed using the IBM 
SPSS Statistics V. 20 software and STATA/SE 12.0 for Windows software. 
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3. AIR MONITORING AND BIOMARKERS OF EXPOSURE 
 
3.1 OVERVIEW 
 
3.1.1 Air monitoring (guidelines and standards) 
The basis for the prevention and control of health risks due to occupational exposure to 
chemicals are guidelines and standards. Their primary aim is to protect human health 
from adverse effects of indoor exposure to air pollution and to eliminate or minimise 
exposure to agents that are or are likely to be hazardous. The guidelines are based on a 
comprehensive review and evaluation of the accumulated scientific knowledge available 
at the time of their development and often include expert judgment. They have the 
character of recommendations and may serve as scientific basis to assist policy-makers 
and regulatory authorities in setting legally binding limits, the standards. Other factors 
beyond the toxicological and epidemiological data are taken into account in setting 
regulatory standards. These factors include environmental, social, cultural and economic 
conditions, as well as technical feasibility. Nevertheless, governments and regulatory 
authorities may adopt the recommended limits as legally enforceable standards. 
Whether it is guideline or standard, they represent the highest concentration in the air of a 
chemical under which it is believed that nearly all workers may be repeatedly exposed, 
day after day, over a working lifetime, without adverse health effects. The nearly all refers 
to individual susceptibility (genetic predisposition), social-demographic factors (age, 
gender, ethnicity, lifestyle) or others (previous exposures) that may induce an adverse 
biological response to a particular chemical at a concentration equal or lower than the limit 
level (ACGIH, 2013). 
Three categories of occupational exposure limits (OELs) are usually used to classify the 
exposure: i) time-weighted average (TWA), concentration that should never be exceeded 
during workday (8h) or workweek (40h); ii) short-term exposure limit (STEL), 
concentration that should never be exceeded in 15 min exposure at any time during a 
workday; iii) ceiling (C), concentration that should never be exceeded during any part of 
working exposure (direct value). For some substances, a TWA alone or with a STEL is 
relevant, for others only a C-level is applicable, it depends on the toxicological properties 
of the chemical and nature of the work.  
OELs are express in parts per million (ppm) or mg/m3 for compounds that normally exist 
as a gas or vapour at room temperature and pressure.  
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A “healthy” workplace environment also includes providing instructions, procedures, 
training and supervision to encourage people to work safely and responsibly. When 
engineering controls or safe systems are not feasible or effective to reduce the risk to 
acceptable levels the use of personal protective equipment (PPE) as a control measure 
may aid to prevent the exposure and thus minimise the risk. Nevertheless, PPE does not 
eliminate/control the hazard at source and therefore if the equipment fails or if it is not 
suitable for the chemical in question the workers will not be protected. 
 
3.1.1.1 Formaldehyde occupational exposure and regulation 
Occupational exposure standards and guidelines for airborne-formaldehyde (FA) set by 
countries or major international organisations are listed in Table III. The exposure limits 
recommended by the European Scientific Committee were also included (SCOEL, 2008). 
FA-air concentration in workplace is legally regulated all over the world with defined TWA, 
STEL and C-levels of exposure ranging all three from 0.3 to 2 ppm (IARC, 2006). 
 
Table III. Occupational exposure limits for airborne formaldehyde (standards and 
guidelines. 
Country/Organisations  OELs (category)  References 
China  0.4 ppm (C)  Tang et al. (2009) 
European Commission*     
SCOEL  0.2 ppm (TWA)   SCOEL (2008) 
  0.4 ppm (STEL)   
France  0.5 ppm (TWA)  AFSSET (2008) 
  1 ppm (STEL)   
Germany  0.3 ppm (TWA)  IARC (2006) 
  0.6 ppm (STEL)   
  1 ppm (C)   
Norway  0.5 ppm (TWA)  IARC (2006) 
Portugal  0.3 ppm (C)  IPQ (2007) 
Spain  0.3 ppm (C)  IARC (2006) 
United Kingdom  2 ppm (TWA)  HSE (2011) 
  2 ppm (STEL)   
United States of America     
ACGIH  0.3 (C)  ACGIH (2013) 
OSHA  0.75 ppm (TWA)  OSHA (2011) 
  2 ppm (STEL)   
* values recommended by the Scientific  Committee on Occupational Exposure Limit Values (SCOEL). 
 C, ceiling; TWA, time-weighted average; STEL, short-term exposure limit. 
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Over the time the expansion of scientific knowledge, production of new studies and the 
updating of evaluation criteria have led to the global review of the FA’s occupational 
exposure limits (OELS) resulting in a reduction of the limit levels (Binetti et al., 2006). 
Nevertheless, although the number of scientific data on FA toxicity and potential cancer 
risk has increased in the last decade, the OELs in most countries remain the same (in 
some the values are not revised since the early 1990s, e.g. US, France), which impairs 
the establishment of more rigorous protective measures of the worker´s health. Thus, the 
review by policy-makers of the exposure limit values in light of recent implication of FA 
carcinogenicity is essential to minimise the risk. 
Portuguese Standard 1796:2007 establishes the OELs of chemical agents. The OEL for 
FA is 0.3 ppm (IPQ, 2007), meaning the maximum safe FA-airborne concentration that 
should never be exceeded during any length of time.  
 
3.1.2 Biomarker of exposure-internal dose 
A biomarker of internal dose indicates that exposure to a particular compound has taken 
place by measuring the compound or its metabolite(s) in body fluids. Although human 
exposure to a particular chemical may be estimated by using workplace air monitoring 
there is individual variability in absorption, distribution, metabolism and excretion. 
Therefore, it is preferable to measure the actual amount of the compound, or its 
metabolite(s) in a tissue or fluid from an individual in order to estimate the actual exposure 
rather than the expected exposure. However, biomarkers of internal dose do not reveal to 
what extent the metabolised agent has affected the target tissues or cells.  
 
3.1.2.1 Formic acid in urine as a biomarker of FA internal dose 
For occupational biomonitoring, the investigation of potential dose biomarkers that might 
give information on the actual exposure of the body to a specific chemical is of paramount 
importance. Ideally, any biomarker of exposure should be specific for the exposure of 
interest, detectable in small quantities, correlated with prior exposure, measurable by non-
invasive techniques and able to be accurately quantified (Manini et al., 2007). The aim is 
to use them as a routine monitoring method allowing a quick assessment of the worker’s 
exposure and if needed a rapid implementation of safety measures. In addition, it also 
provides information about the efficacy of any preventive measure already adopted.  
Nowadays, sensitive analytical techniques allow accurate identification and measurement 
of stable elements with relative small sample volumes in a relative short time. Urine is the 
preferred biological matrix since it is non-invasive and easily accessible allowing a more 
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systematic and regular monitoring. Although variation in liquid intake and liquid loss may 
result in large differences in concentrations of substances in urine, this variation can be 
corrected by creatinine concentration of the urine (Herber et al., 2001).  
Over the years, methods for the determination of FA in blood (Lou et al., 2001), breath 
(Lin et al., 1995; Moser et al., 2005), and urine (Takeuchi et al., 2007) have been 
published. However, FA is a very unstable chemical molecule, highly reactive and readily 
metabolised, so its concentration in body fluids or expired air is not expected to be a 
reliable biomarker of exposure, even for acute exposures (ATSDR, 1999). 
A more promising indicator for FA exposure is the level of formic acid in urine. After 
absorption, FA is rapidly metabolised by oxidation to formate. Formate is excreted in 
urine, as formic acid, or oxidised to carbon dioxide and exhaled. Therefore, theoretically 
the exposure to FA may potentially generate a shift in the formic acid levels in the urine of 
exposed individuals.  
In fact, a few studies have reported higher concentrations of formic acid concentrations in 
urine of FA-exposed subjects (Schmid et al., 1994; Cheng et al., 2008b; Mautempo et al., 
2010). However, the suitability of the formic acid excretion in the urine as a parameter for 
the biological monitoring of exposure to FA is a quite controversial issue (Schmid et al., 
1994). Formic acid is a metabolite of other compounds (e.g. methanol) and an 
endogenous product of several metabolic pathways. In addition, a diet rich in 
carbohydrates and proteins (glycine) appears to alter its concentration in urine 
(Gottschling et al., 1984). Human baseline concentrations of formic acid in urine may 
range between 6.5 mg/g creatinine and 23 mg/g creatinine (Heinzow and Ellrott, 1992; 
Schmid et al., 1994; HCN, 2005; IARC, 2006). 
An analytical method using gas chromatography with flame ionization detection (GC/FID) 
was developed and applied by Mautempo et al. (2010) for quantify formic acid in human 
urines. The sample preparation involves a derivatization process (with a methanolic 
solution) and solid phase micro-extraction (SPME). The developed method was shown to 
be selective, accurate, precise and linear for formic acid determination in urine of FA- 
exposed workers from an industrial unit.  
For GC analysis of organic acids a derivatization step is generally needed to yield 
compounds more volatile and less polar (Vas et al., 2004). This can be achieved by an 
esterification reaction of the acid with an alcohol, which involves a nucleophilic substitution 
usually catalysed by a strong acid (H2SO4) or a Lewis acid (Boucharat et al., 1998).  
Currently, the analytical techniques applied for extraction and concentration of volatile 
compounds from biological matrices are based on headspace analysis by solid-phase 
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micro-extraction (SPME). The non-solvent SPME technique first developed by Pawliszyn 
and co-workers integrates sampling, extraction, concentration and sample introduction 
into a single procedure (Pawliszyn, 1999). A number of reports are present in the literature 
addressing the usefulness of SPME analyses of drugs and xenobiotic substances in body 
fluids, including formic acid in urine (Lee et al., 1999). 
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3.2 MATERIAL AND METHODS 
 
3.2.1 Determination of Formaldehyde airborne concentration 
Air sampling was performed in the workers breathing zone for representative working 
periods (60 min each sample) during formaldehyde (FA) specific related tasks. Other 
workplace sites considered relevant to the assessment were also sampled. Air sampling 
and FA analysis were performed according to the NIOSH method no. 3500 (NIOSH, 
1994), with minor adjustments. All chemicals used were of analytical grade. Briefly, air 
samples were collected in impingers bottles with 1% sodium bisulfite solution connected 
to a battery-powered air sampling pumps operating at a flow rate of 1L/min. Each 
sampling was done in duplicate. An aliquot of the sampled solution (4mL) was reacted 
with 1% chromotropic acid solution (Merck) in the presence of H2SO4 (95%-97%, Merck) 
to form a purple mono-cationic chromogen. Freshly prepared standard solutions and blank 
followed the same treatment. The absorbance of the coloured complex was analysed 
using a UV/VIS spectrophotometer (ATI UNICAM) at 580 nm (Fagnani et al., 2003). 
Analysis of the samples allowed the calculation of the eight hour (8h) time weighted 
average (TWA) level of exposure to FA for each subject. 
 
3.2.2 Determination of formic acid concentrations in urine samples 
Urinary formic acid was quantified according to Mautempo et al. (2009) with few 
modifications. Urinalysis was performed by gas chromatography with flame ionization 
detection (GC-FID).  
Based on previous studies the agent selected for formic acid derivatization was methanol 
(Mautempo et al., 2009). This reaction, in the presence of boron trifluoride (BF3), yields 
methyl formate, the target analyte. 
The extraction and concentration of the analyte was achieved by solid-phase 
microextraction (SPME). Several commercial fibres for SPME are currently available to 
extract volatile compounds. According to supplier recommendations (Supelco, Bellefonte, 
PA, USA) the fibre used in this procedure was coated with divinylbenzene/ 
polydimethylsiloxane (DVB/PDMS), 65 µm.  
 
Samples and Standards preparation 
All chemicals used were of analytical grade. Acetonitrile was the compound chosen as 
internal standard (Lee et al., 1999; Berode et al., 2000; Lee and Berode, 2005). 
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Prior to the analysis, the urine samples were thawed at 4 ºC and centrifuged (453xg, 5 
min). 
All calibration standard solutions were prepared in urine by different dilutions of an 
intermediary solution of ammonium formate salt (Alpha-Aesar), also in urine. These 
solutions were all freshly prepared. The working range of standard concentrations (5–50 
mg/L) was selected based on the human baseline content of formic acid in urine reported 
in literature (Heinzow and Ellrott, 1992; Schmid et al., 1994; HCN, 2005; IARC, 2006). All 
samples (and duplicates), standard solutions (and blank) and fortified test samples 
followed the same analysis procedure.  
 
Procedure  
To a 20-mL vial containing 4660 μL of urine and a small PTFE-coated stirring bar, was 
added 300 μL of BF3-methanol 10% (w/w, Fluka) and 40 μL of acetonitrile solution 
10mg/L (Merck). The vial was then sealed with a polypropylene cap with PTFE/silicon 
septum and stirred vigorously in a vortex mixer for 10 sec. This mixture was heated for 10 
min on an aluminium block heater at 80°C. After derivatization the vials were cooled at 
room temperature. 
 
Headspace-Solid Phase Microextraction 
The piercing needle of the SPME device was passed through the septum. The sample 
was stirred (260 rpm) at 50°C on an aluminium block heater for 5 min to reach headspace 
equilibrium. The fibre was then exposed to the headspace for 10 min (260 rpm, 50°C) to 
allow adsorption of the interest compounds (methyl formate, acetonitrile). Afterward, the 
fiber was carefully pulled into the needle sheath and the SPME device was removed from 
the vial. It was immediately inserted into the GC port and exposed in the injection port for 
1 min for complete desorption.  
 
GC conditions and sample analysis 
GC analyses were carried out on a ThermoFinnigan Model Focus gas chromatograph 
equipped with a flame ionization detection (FID) system.  
The injection port of the chromatograph was installed with a glass liner appropriated for 
split analysis. The analyses were performed under the following chromatographic 
conditions: Varian WCOT silica capillary column, CP-Wax 57-CB, 25 m × 0.25 mm i.d, DF 
= 0.2 μm; sample injection in a split mode with 1:7 rate and 11mL/min flow; helium as the 
carrier gas at a constant flow of 1.5 mL/min. The FID temperature was 220 ºC, and the 
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injector temperature was 220°C. The oven temperature was 32 ºC followed by an 
increase of 5 ºC/min until 200 ºC. The total GC analysis run time was 12 min.  
SPME fibre was conditioned in GC injector port in the beginning of analyses, between 
samples and at the end of each analysis session (8-10 injections) for 10 min, at 250 °C. 
Prior analyses allowed the identification of the interest compounds in the chromatogram 
by comparing their retention times with those obtained from reference samples, and by 
comparison with data reported in the Mautempo et al. (2009) study. Retention time for 
methyl formate and acetonitrile (internal standard) was respectively 1.9 min and 4.9 min.  
Area peak ratios of methyl formate to internal standard were calculated for each sample, 
formic acid concentration was determined by linear regression performing calibration 
curves in the concentration ranges between 5–50 mg/L. As quality control criteria, only 
calibration curves with correlation coefficients equal or superior to 0.995 were accepted.  
For each subject the formic acid concentration was corrected with the creatinine value and 
expressed as mg/g creatinine. Creatinine was determined using CREAJ Gen2 kit (Roche 
Diagnostics) on COBAS INTEGRA 800, according to manufacturer instructions. 
 
Validation and acceptance criteria 
The method was validated following the analytical performance parameters established by 
Eurachem validation guide (1998). 
The line of best fit was determined by linear regression performing calibration curves in 
the concentration ranges between 5–50 mg/L. The variance across the linear range was 
statistically evaluated using the two limit concentration standards, 5 and 50 mg/L; no 
significant differences were found, the working range was well fitted. The linearity of the 
working range was also assessed and proved to be linear with a correlation coefficient of 
0.999. Relative percentage difference (RPD) of inter-day and intra-day duplicate samples 
were equal or below 10%. Precision studies under repeatability conditions were also done 
across the working range. For each standard concentration the calculated coefficient of 
variation (CV%) (n=10) was equal or below 15%. The percentage of recovery (%R) of the 
analyte from fortified samples ranged between the acceptable criteria interval of         
80%-120%. The method Limit of Detection (LOD) and Limit of Quantitation (LOQ) were 
estimated to be respectively, 0.8 mg/L and 2.6 mg/L. During method validation, 
parameters and acceptance criteria were defined for calibration slopes, correlation 
coefficients (≥0.995) internal standard peak areas and repeatability (RPD≤10%, 
CV≤15%). 
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3.3 RESULTS 
 
3.3.1 Formaldehyde air monitoring and exposure biomarker 
Analysis of air samples collected during FA-exposure allowed the calculation of the 8h-
TWA (time weighed average) level of exposure for each subject. Urinalysis of formic acid 
concentration in samples from exposed and control subjects were performed to 
investigate this assay as a potential exposure biomarker for FA occupational exposure. 
Results of the air level of exposure to FA and the level of formic acid in urine (FMU) by 
study group are reported in Table IV.  
 
Table IV. Results of FA-external exposure and biomarker of exposure 
  Controls  Exposed   
  N mean ± SE (range)  N 
mean ± SE 
(range)  p-value 
FA-level of exposure (air) 
ppm 
 
 __ ________  85 
0.38 ± 0.03 
(0.08-1.39) 
  
FMU (formic acid in urine) 
mg/g creatinine 
 
 70 
11.53 ± 0.95 
(0-44.01) 
 63 17.46 ± 1.33 
(1.16-52.79)  0.002 
 
The mean TWA-level of worker´s exposure to FA was 0.38 ± 0.03 ppm (range 0.08-1.39 
ppm). The peak emission of FA occurred mainly during two routine tasks, macroscopic 
examination of FA-preserved specimens (average FA concentration in air 1.4 ppm; range 
0.3-3.2 ppm) and disposal of specimens and waste solutions (average FA concentration in 
air 1.3 ppm; range 0.3-2.8 ppm). The current Portuguese occupational exposure limit is 
0.30 ppm (ceiling level), meaning the maximum safe FA concentration that should never 
be exceeded during any length of time in a worker’s breathing zone. Germany and the 
American Conference of Governmental Industrial Hygienists (ACGIH) also set for FA 
occupational exposure a maximum limit concentration of 0.30 ppm (TWA and ceiling, 
respectively). On the other hand, the Scientific Committee on Occupational Exposure 
Limit Values (SCOEL) appointed by European Commission has advised a 0.2 ppm (TWA) 
occupational exposure limit for FA in the workplace. The results obtained show that 
professionals of the anatomical pathology laboratories studied are exposed to levels of FA 
higher than admissible air standards and guidelines, both national and international. 
Regarding the levels of formic acid in urine the results obtained showed a significant 
increase of this compound in FA-exposed workers compared to controls.  
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3.3.1.1 Effect of exposure, lifestyle and work-related factors 
To understand the possible effect of recognised host factors such as gender, age and 
smoking habits on the dose biomarker concentration in urine (FMU) a multivariate 
analysis was applied. The influence of dietary habits described on chapter 2 (present 
study) was also evaluated but none of the parameters was found to be a confounder and 
therefore were not included in the final multivariable model. The data obtained is 
summarised in Table V. 
The significant effect of exposure on FMU was confirmed with exposed workers showing 
an increase of 43% on the levels of urinary formic acid compared to controls. In addition, a 
borderline significant (p=0.05) increase was found among subjects with more than 45 
years-old. In fact, a positive significant association was found between this biomarker and 
age (r=0.206, p=0.018) confirming this trend. No effect of gender or smoking habits were 
found.  
 
Table V. Effect of exposure, gender, age and smoking habits on 
the levels of FMU with estimates of mean ratios (MR) 
 FMU 
 N MR [95% CI] 
Exposure     
Controls 70 1.00  
Exposed 63 1.43** [1.12-1.83] 
Gender    
Females 101 1.00  
Males 32 0.73 [0.54-1.00] 
Age     
< 35 years 49 1.00  
35-45 years 48 1.26 [0.95-1.68] 
> 45 years 36 1.37 [1.00-1.86] 
Smoking Habits    
Non-smokers 95 1.00  
Smokers 38 1.01 [0.97-1.06] 
**p<0.01    
 
Concerning the exposed group no significant influence was observed on FMU levels of 
work related factors namely FA-levels of exposure (air), professional activity and time of 
exposure (data not showed). Further, no significant association was found between dose 
biomarker levels and work-related parameters. 
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3.4 DISCUSSION 
In anatomical pathology laboratories, FA is a well-known compound traditionally used as a 
fixative and tissue preservative for over 100 years. Numerous studies have consistently 
shown that the levels of airborne-FA in these settings are often higher than the 
recommended limit values (IARC, 2012). Indeed, indoor air analysis performed by Keil et 
al. (2001) in anatomy laboratories revealed average daily room concentrations of airborne 
FA ranging from 0.5 to 1.5 ppm. Because of its sensitising properties, irritating effects and 
cancer implication, FA accounts probably for the most important occupational chemical 
exposure hazard concerning this professional group. Inhaled FA primarily affects the 
upper airways; the severity and extent of physiological response depends on its 
concentration in the air.  
In the present study, the mean level of FA exposure found (0.38 ± 0.03 ppm) exceeds the 
current national recommended limit value of 0.3 ppm (ceiling).  Furthermore, 56% of the 
professionals had levels of exposure higher or equal to 0.30 ppm, half of which were 
exposed to FA-concentrations above 0.5 ppm. Therefore, the data obtained show that 
professionals were exposed to levels of FA superior to both national and international 
workplace limit values (Table III). The main FA vapour emissions occurred during 
macroscopic examination of FA-preserved specimens and during the disposal of 
specimens and waste solutions. In most cases during these tasks, the professionals were 
only using facemasks for biological hazard, not appropriate to protect from FA vapours. 
The main reason given by professionals for not using goggles and the appropriate 
respirators (when available) was the interference in the efficiency of the activities taken, 
namely communication difficulties, taking notes and handling the biologic material. 
Our finding is in accordance with previous studies reporting for these professionals high 
levels of exposure to FA, often above permissible exposure limit values. Shaham et al. 
(2002) reported for 14 pathology departments a mean low level and high level of FA 
exposure of 0.4 ppm and 2.2 ppm, respectively. Personal air sampling performed during a 
gross anatomy course by Akbar-Khanzadeh and Pulido (2003) revealed an individual FA-
exposure ranging from 0.6 to 1.3 ppm. Ohmichi et al. (2006) also evaluated personal 
exposure levels and indoor FA concentrations in a gross anatomy laboratory during 3 
lecture sessions, the average personal FA-exposure levels for instructors and students 
ranged between 0.4 and 1.1 ppm, while the room averages of FA concentrations varied 
from 0.4 to 0.7 ppm. Two recent Portuguese studies in anatomical pathology and 
histopathology laboratories reported a time-weighed FA level of exposure ranging from 
0.05 to 0.5 ppm, and a mean ceiling FA concentration of 1.1 ppm (Viegas et al., 2010; 
Ladeira et al., 2011).  
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Overall, our data, in agreement with other studies, shows anatomical pathology 
laboratories as one of the occupational settings where workers are regularly exposed to 
levels of FA near or higher than recommended limit values, which indicates a potential risk 
to worker’s health. 
Given the above, implementation of security and hygiene measures, such as periodic air 
sampling and biological monitoring, as well as good practice campaigns may be crucial to 
decrease the risk associated to FA occupational exposure in anatomical pathology 
laboratories. 
In this regard, the level of formic acid in urine was evaluated as a potential tool for 
biological monitoring of occupational exposure to FA.  
In fact, our results showed that the concentration of formic acid in urine increased 
significantly in FA-exposed workers compared to controls, although no significant 
correlation was found with the FA- level of exposure.  
Studies that monitor FA occupational exposure based on urinary formic acid shifts have 
also reported similar findings. In most studies, workers exposed to FA showed higher 
concentrations of urinary formic acid compared to controls (Boeniger, 1987; Mautempo et 
al, 2010) however, no consistent correlation was found between the formic acid 
concentrations in urine and FA exposure levels (Gottschling et al., 1984; Schmid et al, 
1994). Some authors suggested that other external or individual factors beyond FA-
exposure might influence the excretion of formic acid. Therefore, its suitability as a 
biological index for the biological monitoring of exposure to FA is a controversial topic. 
To determine possible influencing factors on the physiological excretion of formic acid a 
group of subjects not occupationally exposed to FA was investigated. Schmid et al (1994) 
found a considerable inter and intra-individual fluctuations on urinary formic acid levels 
among participants. One possible influencing factor highlighted by the authors, although 
not assessed, was food composition. The excessive intake of carbohydrates and proteins 
appears to increase formic acid excretion levels (Boeniger, 1987). However, Heinzow and 
Ellrott (1992) detected no influence of dietary habits on formic acid excretion among a 
group of healthy adults. 
In our study, the influence of dietary parameters in the level of urinary formic acid was 
also evaluated, but no effect was found, confirming previous results (Gottschling et al., 
1984; Heinzow and Ellrott, 1992).  
The metabolic activity is other plausible factor contributing to the fluctuations observed. 
FA is not the only chemical precursor to endogenous formic acid formation, other 
compounds include methanol, acetone and halomethanes (ATSDR, 1999, Shaham et al., 
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2003). However, it should be added that FA is a ubiquitous compound and metabolite of 
some common chemicals (e.g. methanol; ATSDR, 1999), therefore the variations obtained 
in non-occupational exposed subjects may still be influenced by FA. 
Further, polymorphic genes in major FA-metabolic enzymes namely FDH, ALDH2 and 
ADH1 may influence the kinetics of FA metabolism (Teng et al., 2001). A recent 
occupational study in China (Cheng et al., 2008b) found significant differences in urinary 
formic acid excretion among workers exposed to FA carrying different genotypes of 
ALDH2 polymorphic gene. Moreover, data showed that FA exposure concentration and 
ALDH2 genotypes may influence the urinary formic acid increment. This study clearly 
indicates an association between FA exposure levels in the workplace and formic acid 
excretion in urine, expressed by specific FA-enzymatic metabolism. 
Concerning the influence of gender, age and smoking habits on urinary formic acid 
concentrations, a positive association was found only with age. This effect was also 
observed in a previous study (Heinzow and Ellrott, 1992) and may be related to 
micronutrient status (e.g. folate) or disturbance on the tetrahydrofolic acid pathway 
(Boeniger, 1987) with increasing age. 
In summary, under the present state of knowledge, the level of formic acid in urine should 
be used to estimate occupational group exposures to FA, rather than individual 
exposures, since its measurement effectively indicated the exposure to FA, but was not 
correlated with the FA-level of exposure. 
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4. BIOMARKERS OF EFFECT  
 
4.1 OVERVIEW 
Biomarkers of effect are biological indicators of the body’s response to exposure and 
indicate early sub-clinical changes, which if sustained, may go on to have pathological 
consequences (Links et al., 1995). They either indicate early processes preceding disease 
or predict the development and presence of disease (by altered structure and/or function) 
(Kyrtopoulos, 2006). In terms of prevention, it is considered ideally if the biomarker is able 
to detect a biological alteration that is reversible. Therefore, although the early effect 
biomarkers are less associated with disease, their usage is much more useful in terms of 
disease prevention.  
Biomarkers of effect include several markers, such as, reported gene mutations (e.g. 
HPRT, TCR gene mutation assays), altered gene expression (e.g., protein expression of 
metabolizing genes, DNA repair genes or specific enzymes), DNA strand breaks 
(quantified by comet assay) or cytogenetic alterations, namely chromosomal aberrations 
(CAs), micronucleus (MN) and sister chromatid exchange (SCE) (Au, 2007). They may 
also involve immunological responses (Lutrell et al., 2008). 
Cytogenetic endpoints have long been applied in surveillance of human genotoxic 
exposure and early effects of genotoxic carcinogens. Assays measuring CAs, MN and 
SCEs in lymphocytes are well-established techniques used extensively in human 
biomonitoring studies to assess DNA damage at the chromosomal level. The relevance of 
cytogenetic alterations as a cancer risk biomarker is further supported by epidemiologic 
data linking CAs and MN with cancer risk in human populations (Hagmar et al., 1998; 
Bonassi et al., 2007). 
During the last years, the single cell gel electrophoresis assay or comet assay has been 
proven to be a very sensitive tool in human biomonitoring for the detection of different 
levels of DNA damage at the individual cell level (Collins, 2004). The simultaneous use of 
cytogenetic tests and comet assay in occupational studies allows a comparison of the 
presence of DNA strand breaks due to both acute and chronic exposure and of 
chromosome damage due to clastogenic and aneugenic events. In the case of chronic 
exposure, comparing the levels of damage from a cytogenetic technique with the comet 
assay could provide information about past versus current exposure (Albertini et al., 
2000). 
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Critical for using cellular phenotypes as biomarkers in human populations is the selection 
of biological specimens to be investigated (Mateuca et al., 2006). The general approach is 
assess these endpoints in readily available surrogate cells to estimate events occurring in 
target tissues and to provide early warning signals for adverse health outcome. The most 
frequently used sentinel cells in human studies are peripheral blood lymphocytes (PBLs). 
The main reason for using lymphocytes is that these cells circulate throughout the body 
and have reasonably long life-span; therefore, they can be damaged in any tissue/organ-
specific toxic environment (Au, 2007). Furthermore, assuming the mechanisms of 
chromosome damage formation are similar in the different tissues, the level of damage in 
PBLs can be expected to reflect the level of damage in cancer-prone tissues and to 
indicate cancer risk (Norppa et al., 2006). Their preference is also associated with the 
relatively easy harvest, the large number in the human body and resistance even after 
exposure to cytotoxic agents (Ramalho et al., 1995).  
In recent years, other non-blood cells obtained by non-invasive methods, such as buccal, 
nasal or urothelial cells have received a large interest by the scientific community. These 
cells are easily and rapidly collected and in some cases are better models than 
lymphocytes, since they are target tissues of some reactive chemicals. There has been 
some debate about whether the biological events observed in surrogate cells also occur in 
target cells and whether the observed events predict cancer or not. For particular 
exposures, when possible, using biomarkers of effect that can be evaluated both in target 
tissue as in surrogate tissue would help to clarify these questions (Salama et al., 1999). 
One of main issues concerning biomarkers of effect is the interpretation of altered levels 
of these indicators at individual level. Traditionally, risk predictions are only valid at a 
group level and therefore effect of inter-individual variability is removed (Bonassi and Au, 
2002). Also of note, the detection of a biomarker not necessarily indicate the presence of 
a disease, it may only indicate an effect of exposure of the organism to a substance. 
 
4.1.1 Chromosomal Aberrations 
Chromosomal aberrations (CAs) are changes in normal chromosome structure or number 
that can occur spontaneously or as a result of chemical or radiation exposure (Mateuca et 
al., 2006).  
The frequency of structural CAs in peripheral blood lymphocytes (PBLs) has been used 
for decades as a biomarker of the early effects of genotoxic carcinogens in occupational 
and environmental settings (Norppa et al., 2006).  
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Structural CAs may be induced by direct DNA breakage, replication on a damaged DNA 
template, inhibition of DNA synthesis or other mechanisms (e.g. topoisomerase II 
inhibitors) (Albertini et al., 2000). Usually, structural CAs are divided into two broad 
categories, chromosome-type aberrations and chromatid-type aberrations visible in 
metaphase-arrested cells (Savage, 1975). Although each class differs from each other 
morphologically and mechanistically, both include breaks and exchanges being breaks the 
more abundant CAs found in peripheral lymphocytes (Norppa et al., 2006), since they 
may also occur “spontaneously” at a low level (Savage, 2004) 
While morphologically chromosome-type aberrations (CSAs) involve the same locus on 
both sister chromatids on one or multiple chromosomes, chromatid-type aberrations 
(CTAs) affect only one of the sister chromatids on one or more chromosomes (Suspiro 
and Prista, 2011).  
Mechanistically, the formation of structural CAs requires one or several DNA double 
strand breaks (DSBs). The main differences between CSAs and CTAs formation is the 
timing and the type of initial lesion, and the DNA repair mechanisms (Hagmar et al., 
2004).  
Depending on the inducer agent, DSBs may result directly or indirectly by preexisting DNA 
lesions. Generally, the lesions are repaired by three main mechanisms: homologous 
recombination repair (HR), non-homologous end joining (NHEJ) repair and single-strand 
annealing (SSA). HR is an error-free repair process, highly accurate that precisely 
restores the original sequence at the break. NHEJ is an error-prone repair process that 
joins directly the two broken ends which usually leads to small-scale alterations at the 
break site. SSA mainly leads to the formation of interstitial deletions (Obe et al., 2002). 
CSAs are mostly generated in vivo in G0/G1 lymphocytes by S-phase independent 
clastogens and reflect DSBs which are incompletely repaired or unrepaired by the NHEJ 
repair and SSA mechanisms. After DNA synthesis and chromosome duplication, the CAs 
formed in G0/G1 are doubled and chromosome-type breaks and exchanges (e.g. dicentric 
and ring chromosomes) are seen in metaphase (Figure 6).  
CTAs arise predominantly in vitro during the S-phase of the cultured lymphocytes, in 
response to base modifications and single-strand breaks induced in vivo by S-phase- 
dependent clastogens. DSBs are formed from these initial lesions during DNA replication 
(Figure 7). Incomplete or failed repair of these lesions by conservative HR will trigger 
CTAs formation in a subsequent metaphase (Albertini et al., 2000; Hagmar et al., 2004).  
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 Figure 6. Example of formation of a Chromosome-type aberration (CSAs) (adapted from Mateuca et al., 
2012) 
 
The type of chromosomal aberration will be decisive for the fate of the cell. DSBs lesions 
are potential inducers of carcinogenesis through activation of proto-oncogenes, 
inactivation of tumor suppressor genes or loss of heterozygosity (Obe et al., 2002). Cells 
with unstable aberrations that can pose problems on transcription, replication and 
chromosome segregation are eliminated by apoptosis. Stable aberrations (e.g. deletions, 
translocations) on the other hand may have deleterious consequences for the organism 
since they are much less effective in causing apoptotic cell death. 
 
 
 
 
 
 
 
 
 
Figure 7. Example of formation of Chromatid-type aberration (CTAs) (adapted from Mateuca et al., 2012) 
 
In human biomonitoring studies, detection of structural CAs is performed in PBLs by the 
CA assay. Information on the type of aberrations induced (S-phase independent versus S-
phase dependent) following occupational and/or environmental exposure can be used to 
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identify into some extent the nature of the clastogenic damage produced via misrepair or 
misreplication (Palitti et al.,1998; Mateuca and Kirsch-Volders, 2007).  
However, the CAs assay does not allow the detection of symmetrical chromosome-type 
rearrangements such as translocations and inversions. CSAs scored in humans are 
mostly chromosome-type breaks and to a lesser extent dicentric chromosomes or rings. 
CTAs are practically chromatid breaks, since chromatid-type exchanges are very rare 
(Norppa et al., 2006). 
Among the biomarkers of early effect CAs is the most widely used and best validated 
biomarker (Bonassi and Au, 2002). This is because the mechanisms for CAs induction are 
better understood and because most environmental toxic substances have been shown to 
induce CAs (Au, 2007). CAs in PBLs are believed to represent a surrogate endpoint for 
more specific chromosome alterations in target tissues undergoing carcinogenesis. 
Due to their extensive use and accumulated data it was possible to examine the potential 
association between structural CAs frequency and subsequent cancer outcome (Bonassi 
and Au, 2002). Indeed, CAs in lymphocytes revealed to be predictive of overall cancer risk 
in human populations (Hagmar et al., 1998). Both CSAs and CTAs were considered to 
have similar predictive values yet in some studies CSAs showed a stronger association 
(Norppa et al., 2006). During the last two decades, a number of epidemiologic studies 
showing that high CAs frequencies in PBLs of healthy individuals are associated with 
increased cancer risk (Hagmar et al., 2004; Rossi et al., 2009) have enriched evidence 
concerning the role of CAs in carcinogenesis. The role of CAs on the etiology of cancer is 
further supported by the elevated frequencies of CAs found in most cancer cells and 
developmental abnormalities (Rossner et al., 2005; Au, 2007). 
Numerical CAs refers to changes in chromosome number that occur due to abnormal cell 
division. Cells are classified as aneuploid when they contain an extra (hyperploid) or 
missing (hypoploid) chromosome. Chemically induced aneuploidy may arise by a variety 
of mechanisms which may include damage to the mitotic spindle and associated 
elements, damage to chromosomal sub-structures, alterations in cellular physiology and 
mechanical disruption (Bourner et al., 1998; Albertini et al., 2000). Aneuploid cells can be 
scored in metaphase preparations prepared for structural CAs analysis, although possible 
technical errors may occur during slide preparation. Therefore, assessment of aneuploidy 
is often considered a minor component of structural CAs studies, so only limited attention 
has been given to developing the most appropriate study design for this endpoint 
(Albertini et al., 2000). 
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CAs assay has a key position in the test battery for genotoxic compounds and its protocol 
is defined by OECD guidelines (OECD 473). The combination with fluorescence in situ 
hybridization (FISH) chromosome painting methods can help to detect structural and 
numerical CAs and provide increased efficiency and specificity for identifying certain kinds 
of CAs induced in vivo (Albertini et al., 2000). 
 
4.1.2 Micronucleus assay 
Micronuclei arise from acentric chromosome/chromatid fragments or whole chromosomes 
that are not included in the daughter nuclei at the completion of telophase during mitosis 
because they fail to attach properly with the spindle, lagging behind during the 
segregation process at anaphase. The displaced DNA material is eventually enclosed by 
a nuclear membrane and except for its smaller size is morphologically similar to the nuclei 
after conventional nuclear staining (Fenech et al., 2011). Consequently, micronucleus 
(MN) contains either chromosomal fragments or whole chromosomes.  
Chromosomal fragments may result from direct double strand breakage, conversion of 
single strand breaks into DSBs after cell replication or inhibition of DNA synthesis 
(Albertini et al., 2000). In addition, misrepair of DSBs may lead to the production of a 
dicentric chromosome with an acentric fragment (Fenech et al., 2011). Frequently, at 
anaphase the acentric fragment results in a MN while the dicentric chromosome forms a 
nucleoplasmic bridge between the two daughter nuclei (Mateuca et al., 2006). Further 
evidence suggests that in these conditions some MN may also originate from the break of 
these anaphase bridges during cytokinesis (Fenech, 2006). Whole chromosomes are 
generally lag behind due to defects in the chromosome segregation machinery, such as 
deficiencies in the cell cycle checkpoint genes, failure of the mitotic spindle, kinetochore or 
other parts of the mitotic apparatus. Other causes may be associated to chromosomal 
substructures damage or hypomethylation of centromeric DNA (Albertini et al., 2000; 
Fenech, 2006).  
Once formed, a micronucleated cell may undergo apoptosis or may expel the MN, retain it 
in the cytoplasm or reincorporate it into the main nucleus. Nonetheless, the post-mitotic 
fate of MN and micronucleated cell is still a poorly understood event (Mateuca and Kirsch-
Volders, 2007).  
The use of MN as a biomarker of early genotoxic effects has become a standard assay in 
biomonitoring studies. In comparison with CA, the scoring of MN is simpler, requires 
shorter training and is less time consuming. MN assay is one of the best validated 
cytogenetic techniques for evaluating chromosomal damage in humans (Bolognesi and 
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Fenech, 2013). Since MN represents a measure of both chromosome breakage and 
chromosome loss, an increased frequency of micronucleated cells can reflect exposure to 
genotoxic agents with clastogenic or aneugenic modes of action (Albertini et al., 2000).  
Recently the in vitro mammalian cell MN test protocol for testing of chemicals was defined 
by OECD (OECD 487). 
The further combination of MN assay with FISH probes allows the distinction between MN 
containing a whole chromosome (centromere positive MN) or an acentric chromosome 
fragment (centromere negative MN) contributing to a higher sensitivity and specificity of 
the method.  
Besides its capacity to detect chromosome breakage/loss, the MN assay can provide 
additional parameters of genetic damage, namely nucleoplasmic bridges (NPB) and 
nuclear buds (Nbud). NPB generally results from dicentric chromosomes, when 
centromeres are pulled to the opposite poles of the cell at anaphase and are indicative of 
asymmetrical chromosome rearrangements and/or telomere end-fusions (Fenech, 2006). 
Nbud are characterised by having the same morphology as a MN, apart from being 
attached to the nucleus by a narrow or wide nucleoplasmic connection (Fenech, 2006). 
The process of nuclear budding occurs during S-phase and cells are sometimes referred 
as “broken egg” cells. Current evidence suggests that nuclear budding is the mechanism 
by which cells remove amplified and/or excess DNA and is therefore a marker of gene 
amplification and/or altered gene dosage (Fenech et al., 2011).  
MN frequency can be assessed in both peripheral blood lymphocytes (PBLs) or in 
exfoliated epithelial cells (buccal or nasal mucosa, or urine). MN can also be examined on 
erythrocytes but it is not a current practice (Albertini et al., 2000). Frequencies of this 
biomarker can be influenced by age, sex, nutritional status or smoking habits (Fenech, 
1998; Bonassi et al., 2001). In human studies, PBLs are usually the most frequently used 
tissue for MN test. In occupational studies, this endpoint has been used successfully to 
assess the genetic damage in subjects exposed to potential carcinogens in the workplace.  
 
4.1.2.1 Micronucleus assay in lymphocytes (CBMN) 
The cytokinesis-block micronucleus (CBMN) assay is the most extensively used method 
for measuring MN in cultured human lymphocytes because scoring is specifically 
restricted to cells in interphase that have divided once after mitogen stimulation. Since the 
induction of cytogenetic damage as MN can only be expressed in cells that have 
completed nuclear division, it is necessary to be able to distinguish these cells from 
resting cells (Mateuca et al., 2006). By adding cytochalasin-B (actin-polymerisation 
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inhibitor) into the culture medium before the first mitosis the cytokinesis is blocked and 
once-divided cells are able to be identified by their binucleate appearance. Hence, CBMN 
assay allows to distinguish between mononucleated lymphocytes, which did not divide, 
and binucleated lymphocytes, which completed one nuclear division during in vitro culture 
and are able to expressed the inflicted damage in vivo (Farmer and Emeny, 2006). 
Consequently, the assessment of MN frequencies on binucleated cells represents 
measure of the damage accumulated before cultivation plus mutations expressed during 
the first in vitro mitosis (Mateuca and Kirsh-Volders, 2006). CBMN method also provides 
the opportunity to rapidly measure the progression of nuclear division (nuclear division 
index) by registering the number of mono, bi, tri and tetranucleated cells. Obtained result 
offers useful information regarding cytostatic potential of chemicals under study, 
identifying compounds that stimulate or delay cell division (Fenech, 1997). 
Increased frequency of MN in lymphocytes of otherwise healthy subjects was recently 
associated to cancer risk (Bonassi et al., 2007), indicating that MN formation is associated 
with early events in carcinogenesis. MN may originate from CTAs formed during DNA 
replication on a damaged template or CSAs initiated before the mitosis and duplicated at 
replication (Albertini et al., 2000). Hence, considering the cancer risk predictivity of CAs 
and the mechanistic similarities between CAs and MN formation, an association between 
MN frequency and cancer risk was somewhat expected (Mateuca and Kirsch-Volders, 
2007). The link between MN induction in PBLs and cancer development is further 
confirmed by recent case control and meta-analysis studies (Iarmarcovai et al., 2008; 
Murgia et al., 2008). A significantly higher MN frequency was found in PBLs of subjects 
who developed cancer within 14 years after blood sampling (cases) as compared to those 
who were still cancer free at the end of the follow-up period (controls) (Murgia et al., 
2008). Moreover, the meta-analysis showed a 28–64% increase in the baseline MN level 
of untreated cancer patients compared to cancer-free referents (Iarmarcovai et al., 2008). 
All the recently accumulated data on the cancer predictive value of elevated MN 
frequencies makes the CBMN assay a good candidate for wide application in human 
biomonitoring studies, especially those populations more susceptible to exposure to 
hazard chemicals. Furthermore, recent scientific evidence suggests an association 
between elevated MN frequency in lymphocytes and age-related degenerative and 
neurodegenerative diseases (Petrozzi et al., 2002). Therefore, sensible biomarkers such 
as MN frequency that may identify individuals who are at an early stage of degenerative 
diseases would be useful since it would allow timely preventative intervention (Thomas et 
al., 2007). 
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4.1.2.2 Micronucleus assay in exfoliated buccal cells (BMCyt) 
Other increasingly popular cell type used to assess the formation of MN in biomonitoring 
studies are exfoliated epithelial cells (urothelial, buccal or nasal cells). Exfoliated epithelial 
cells have several advantages regarding PBLs, are easily collected, minimally invasive 
and therefore do not cause undue stress to the study subjects. In some cases, these cells 
are better models than lymphocytes, since they are target tissues of particular cancers. 
Furthermore, approximately 90% of all cancers appear to have an epithelial origin (Rosin, 
1992)  
Buccal cells are the first barrier to numerous potential hazard substances entering the 
body through ingestion and inhalation, and are capable of metabolizing carcinogens to 
reactive products (Vondracek et al., 2001; Spivack et al., 2004). Therefore, exfoliated 
buccal mucosa (BM) cells are ideal to monitor early genotoxic events resulting from the 
specific exposure to these agents. MN assay in BM cells have been successfully used to 
show the genotoxic effects of lifestyle factors such as tobacco smoking and diet,  medical 
treatments (radiotherapy) as well as occupational exposure to potential carcinogenic 
chemicals (Bloching et al., 2000; Burgaz et al., 2002; Holland et al., 2008).  
The mechanism of MN formation in BM cells is the same of lymphocytes but the buccal 
micronucleus cytome assay (BMCyt) has a few advantages. The MN assay in a rapidly 
dividing tissue, such as the buccal mucosa, allows the assessment of DNA damage 
without the need for an ex vivo cell replication step, so the establishment of cell cultures 
required for CBMN or for classical metaphase analyses, such as CA assay and SCE test 
are not needed (Bonassi et al., 2011). The collection of buccal exfoliated cells from the 
inner wall of the cheek is minimally invasive and therefore this assay is well suited for 
large biomonitoring studies.  
The buccal mucosa is composed of four layers of structural, progenitor and maturing cell 
populations,  namely the connective tissue (lamina propria), the basal cell layer of active 
dividing cells (stratum basale), the prickle cell layer containing differentiated, apoptotic 
and necrotic cells (stratum spinosum), and the keratinised layer at the surface (stratum 
corneum). Finger-like structures called ‘‘rete pegs’’ project up from the lamina propria into 
the epidermal layer produces an undulating basal cell layer effect (Holand et al., 2008; 
Thomas et al., 2009). A photomicrograph of a cross section of normal buccal mucosa 
along with a diagrammatic representation of the different cell layers are presented in 
Figure 8. 
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Figure 8. Photomicrograph (A) and a scheme (B) representation of a section of buccal mucosa showing 
the various cell layers (adapted from Holland et al. (2008) and Thomas et al. (2009)). 
 
The oral epithelium maintains itself by continuous cell renewal by migration of new cells 
from the basal layer to the surface. The basal layer contains the stem cells that may 
express genetic damage as MN (chromosome breakage or loss) during nuclear division. 
These cells may also exhibit Nbud. However, the MN in buccal exfoliated cells is a 
relatively rare event, with a mean background frequency of 1 micronucleated cells every 
1000 exfoliated cells (Ceppi et al., 2011). The daughter cells, which may or may not 
contain MN, in time differentiate into the prickle cell layer then into the keratinised 
superficial layer and finally exfoliate into the buccal cavity. Eventually, a few cells may be 
blocked in a binucleated stage and show two nucleus. Some cells may degenerate into 
cells with condensed chromatin, fragmented nuclei (karyorrhectic cells), pycnotic nuclei or 
completely lose their nuclear material (karyolitic cells). The molecular mechanisms leading 
to the various cell deaths events and their inter-relationships are unknown (Holland et al., 
2008). Figure 9 illustrates the sequential spatio-temporal origins of the various buccal cell 
stages and the different genetic damage that can occur induced by exogenous agents 
such as inhaled carcinogens. 
The evaluation of biomarkers of DNA damage (MN and Nbud) and cell death (condensed 
chromatin, karyorrhexis, pycnotic and karyolitic cells) provide a more comprehensive 
assessment of the cytogenetic damage induced by genotoxic agents. Therefore, the 
BMCyt assay may provide information on chromosome instability, cell proliferation (basal 
cell frequency), cytokinetic defects (binucleated cells) and cell death. 
As before mentioned, it was recently established a positive association between MN in 
human lymphocytes and cancer risk. Regarding MN in BM the extent of epidemiological 
data available is quite limited because of its relatively recent adoption. Whether an 
elevated MN frequency in BM is predictive of cancer risk, or whether the relationship is 
primarily site-specific (oral cavity), or extends to overall cancer risk, remains for the 
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moment unknown. Validation and prospective studies on the BMCyt assay (Holland et al., 
2008), as well as data on a strong correlation between MN in PBLs and BM, would help to 
evaluate this endpoint cancer predictability (Bonassi et al., 2011). Furthermore, similarly to 
MN in lymphocytes, recent scientific evidence suggests an association between BMCyt 
parameters and degenerative disorders, namely Alzheimer’s disease (Thomas et al., 
2007).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. Diagrammatic representation of the sequential spatio-temporal origins of the different buccal 
cell-stages (adapted from Thomas et al., 2009). 
 
4.1.3 Sister-chromatid exchanges 
Sister-chromatid exchanges (SCEs) result from the reciprocal exchanges of DNA regions 
between two sister chromatids of a duplicated chromosome in response to a damaged 
DNA template during the S-phase of the cell cycle. The interchange process involves DNA 
breakage and reunion at apparently identical loci of the sister chromatids (Latt and 
Schreck, 1980). This process is considered to be conservative and error-free, since no 
information is generally altered during reciprocal interchange by homologous 
recombination (HR) (Wilson and Thompson, 2007). Although, its biological meaning and 
mechanism has not been fully elucidated, SCEs appear to be the consequence of DNA 
replication errors on a damaged template, possibly at the replication fork (Albertini et al., 
2000). The mechanism by which SCEs are likely to occur involves the initial collapse of a 
replication fork when it encounters a pre-existing single-strand break (SSB) or gap in one 
parental strand (Wilson and Thompson, 2007). As a result, a replication-associated 
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double-strand break is formed with a 3’ free end, which initiates the repair process via HR 
pathway and the invasion of the intact sister strand to serve as template for DNA 
synthesis. Resolution of the resulting Holliday junction by non-crossing over results in 
SCEs formation (Helleday, 2003) (Figure 10). Another possible pathway of SCEs 
induction involves the initial stop of the replication fork due to obstacles on the DNA 
template (e.g. adducts). The repair process of the stalled replication fork gives rise to a 
double-strand break with one free end, which can be further repaired by HR and may 
result, as described above, in SCEs formation (Helleday, 2003). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. Mechanism of SCEs formation. A) Replication fork approaches a SSB. B) Collapsed 
replication fork; fork breaks; repair synthesis. C) 5’ to 3’ double-strand break resection. D) HR pathway, 
strand invasion. E) Resolution of the Holliday junction in the orientation shown by the green arrows 
results in SCE, as illustrated by the red/blue color junctions in the new “parental” strands. F) The 
replication fork is restored (adapted from Wilson and Thompson (2007) and Mateuca et al. (2012)). 
 
Currently, the standard fluorescence assay used to visualise SCEs is based on the 
differential staining of the sister chromatids after two rounds of replication in the presence 
of 5-bromo-2´-deoxyuridine (BrdU) (Natarajan et al., 1994). BrdU is an analogue of the 
DNA thymidine that is efficiently incorporated into the DNA strands during replication. 
Because replication of DNA is a semiconservative process, when cells are cultured 
through a single replication cycle in the presence of this thymidine analogue, one DNA 
strand in each daughter chromatid is substituted with BrdU (Wilson and Thompson, 2007). 
After a second round of replication in BrdU medium, one chromatid contains one 
substituted DNA strand, while both strands of its sister chromatid are substituted. The 
chromatids can be further differentiated by treatment with the Hoechst dye, which 
fluoresces at a lower intensity when bound to DNA substituted with BrdU than when 
bound to unsubstituted DNA (Perry and Wolff, 1974). Following Giemsa staining the 
asymmetric distribution of BrdU-substituted DNA in sister chromatids can be observed by 
light microscopy. BrdU has the effect of “bleaching” so that the chromatid with more BrdU 
is lighter in appearance (Wilson and Thompson, 2007). Any SCEs appears as a 
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discontinuity of the stain along the chromatid. The differential staining of the chromatids is  
related to the photosensitisation by UV light used in the methodology which seems to 
preferentially break the bonds present in non-histone proteins of the chromatid containing 
more BrdU, giving rise to a lighter staining intensity of this chromatid (Mateuca et al., 
2012). The SCE assay yields quantifiable data from every cell scored, which increases the 
efficiency of data collection and the identification of DNA damage resulting from exposure 
to genotoxic carcinogens (Albertini et al., 2000). In addition, scoring SCEs is more rapid 
compared to traditional chromosomal aberration analysis. 
Upon the advent of non-radiolabel detection methods for SCEs, these cytogenetic 
alterations were applied as genetic indicators for potential genotoxins/mutagens in 
laboratory toxicology tests, since most forms of DNA damage induce chromatid exchange 
upon replication fork collapse (Wilson and Thompson, 2007; Rodriguez-Reyes and 
Morales-Ramirez, 2003). Indeed, SCEs showed to be efficiently induced by numerous 
mutagenic or carcinogenic agents, especially those which form covalent adducts to the 
DNA or interfere directly or indirectly with DNA replication (Natarajan et al., 1994).  
This test has gained further popularity when it was noted that cells derived from patients 
with Bloom’s syndrome, characterised by a high propensity for cancer, exhibit a hallmark 
high occurrence of SCE (Chaganti et al., 1974) likely due to dysregulation of HR by a 
defective helicase function (Wilson and Thompson, 2007). It is believed that defects in HR 
process may presumably be responsible for the genetic instability, increased SCE and 
high incidence of cancer in early life associated with this disorder. In fact, markedly 
increased SCE is used clinically as a diagnostic marker for Bloom’s syndrome (Wilson 
and Thompson, 2007). 
The readily quantifiable nature of SCEs with high sensitivity for detecting toxicant-DNA 
interaction and the demonstrated ability of genotoxic chemicals to induce a significant 
increase in SCEs in cultured cells have resulted in the application of this endpoint in 
human studies as a biomarker of chromosomal damage in PBLs of individuals exposed to 
genotoxic agents (Albertini et al., 2000).  
This cytogenetic endpoint has revealed to be a highly sensitive tool for monitoring 
exposure to environmental contaminants in the workplace. Exposure to different chemical 
pollutants, including FA (Shaham et al., 2002; Costa et al., 2008), has been associated 
with increased frequency of SCEs (Teixeira et al., 2004 (styrene); Costa et al., 2006 
(pesticides); Wang et al., 2012 (polycyclic aromatic hydrocarbons)).  
Despite its good performance as a biomarker of effect to genotoxic/mutagenic chemicals, 
SCEs frequency does not appear to have cancer predictive value (Bonassi and Au 2002; 
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Norppa et al., 2006). A possible association between SCEs level and cancer  risk is more 
difficult to evaluate compared to chromosomal aberrations since the baseline levels of 
SCEs showed to differ among individuals and across studies, which may partly due to 
technical variation (Norppa et al., 2006). Therefore, a general classification of subjects 
into a high, medium, or low SCE group is difficult and needs further investigation.  
 
4.1.4 Single cell gel electrophoresis (Comet assay) 
Comet assay or single cell gel electrophoresis (SCGE) is a versatile and simple method 
for measuring DNA damage and repair at individual cell level. It is based on the ability of 
negative charged loops/fragments of DNA to be pulled through an agarose gel in 
response to an electric field, appearing like a 'comet'.  
During the last two decades, the comet assay became very popular and today is probably 
one of the most used tests for the assessment of DNA damage and repair. Although 
initially developed within a population of mammalian cells, comet assay applications now 
range from human and ecological biomonitoring (e.g., DNA damage in mussels living in 
polluted estuarine sites, earthworms in toxic waste sites or rodents near coal mines) to 
measurement of DNA damage in specific genomic sequences (Cotelle and Férard, 1999; 
Collins, 2004; Cortés-Gutiérrez et al., 2011). 
Comet assay combines the simplicity of biochemical techniques for detecting DNA strand 
breaks, alkali-labile sites, and cross-linking, with the single cell approach typical of 
cytogenetic assays. The assay has also a few limitations, for example it is not able to 
detect aneugenic effects and epigenetic mechanisms (indirect) of DNA (effects on cell-
cycle checkpoints) (Dhawan et al., 2009). 
The main advantages of the comet assay include: (a) sensitivity for detecting low levels of 
damage, (b) single cell data collection, allowing more robust statistical analyses, (c) 
requirement for a small number of cells per sample, (d) low cost, rapid and ease of 
application (e) flexibility to use fresh or frozen samples and (f) use of any eukaryote 
monodispersed cell population, proliferating as well as nonproliferating, e.g. cells from 
tissue biopsies that can be homogenised, buccal cells, and also yeast, plant and sperm 
cells (with few modifications) (Piperakis, 2009; Azevedo et al., 2011). For most purposes, 
however, well-characterised cell lines or primary cells (e.g. peripheral blood cells) used in 
classical genetic toxicology testing assays, are preferred.  
Several versions of the comet assay are currently in use being the most popular the 
alkaline version, first introduced by Singh and co-workers (1988). Briefly, cells embedded 
in agarose are placed on a microscope slide and lysed with detergent at high salt 
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concentration. During lysis, cellular membranes, cytoplasmic and nucleosplasmic 
constituents and most histones are removed. After lysis, what remains is the nucleoid 
containing RNA, proteins and negatively supercoiled DNA attached to the nuclear matrix. 
The immobilised nucleoid is then denaturated in an alkali buffer and electrophoresed in 
same buffer. Electrophoresis results in structures resembling comets, with a distinct head, 
comprising intact DNA and a tail of extended DNA loops and DNA fragments (Figure 11). 
 
 
The “comet” can be visualised with a fluorescence microscope after staining with a DNA 
staining dye (e.g: ethydium bromide, acridine orange). The size and shape of the comet 
and the distribution of DNA within the comet correlate with the extent of DNA damage 
present in the individual cell (Figure 12). 
Comets can be analysed by visual scoring, by computerised image analysis or by recently 
developed fully automatic computerised image analysis. There is a range of different 
software available to analyse comets. In visual scoring comets are divided into five 
categories (from class 0 to 4) representing increasing relative tail intensities and therefore 
increasing damaged cells (Collins, 2004). Computerised scoring is reported using a range 
of different parameters. The most frequently used endpoints are percentage DNA in tail 
(%TDNA), tail moment and tail length. The different ways of scoring cells have different 
advantages and limitations. Azqueta et al. (2011a) recently compared visual scoring, 
computerised scoring and automatic computerised scoring and concluded that all three 
scoring methods are reliable and results from the three methods are, to a certain extent, 
comparable.  
 
 
 
 
Figure 12. Comet assay images. (A) Untreated cell exhibiting intact DNA, without a tail. (B) Cells exhibiting 
increased DNA migration after treatment with a DNA damaging agent; images 1 to 4 represent different 
classes of DNA damage. 
 
 
 
 
Figure 11. Schematic picture representing a comet of a damaged cell and image. 
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Some technical sources of variability were detected in the assay that can have an impact 
on the results such as the agarose gel density, electrophoresis time or voltage across the 
gel. Several guidelines have been published (Azqueta et al., 2011a, 2011b), however a 
standardised protocol is still lacking.  
During the last decade, the comet assay was introduced as a useful biomarker for risk 
assessment in human biomonitoring studies as an indicator of carcinogen exposure. It has 
been shown to be a valuable tool for acquiring knowledge about current levels of 
exposure to toxicants agents and for identifying hot spots or trends in exposure risks of 
human populations. Applications include monitoring occupational exposure to genotoxic 
chemicals or radiation, environmental exposure (air pollutants) and detection of DNA 
damage associated with smoking. Recently the comet assay has been used to investigate 
DNA damage and repair efficiency in a wide range of tumour cells in response to a variety 
of DNA-damaging agents. These studies include both investigations on human tumour cell 
lines and on tumour cells extracted from cancer patients. In addition, the Comet assay has 
also the potential to be used to aid in clinical diagnosis (e.g. xeroderma pigmentosum and 
Nijmegen breakage syndrome). 
Besides is applicability to virtually any target tissue/cells, another reason for the increased 
use of the comet assay as a biomarker for risk assessment is the similarity of results 
between this assay and validated biomarkers extensively used in human studies (Kassie 
et al., 2000). Nevertheless, the usefulness of this assay depends on the toxicants 
involved, their molecular mechanisms of action, as well as the experimental design (e.g., 
use of control groups, timing of sample collection). 
The growing popularity of comet assay among researchers along with the increasing 
awareness of its versatility and potential use raised the need to validate this assay as a 
valuable tool in risk assessment. In this sense, several collaboration efforts were made 
and a number of international workgroups and networks (ICCVAM, ECVAG, JaCVAM, 
ComNet Project) were established to address this important issue, within the current 
OECD regulatory strategy for genotoxicity testing. Recent international inter-laboratory 
studies have contributed greatly to the validation of this assay (Forchhammer et al., 2010, 
2012; Ersson et al., 2013). The main objectives are to thoroughly evaluate the reliability 
and accuracy of the assay and to produce a standardised protocol with maximum 
acceptability by international regulatory agencies.  
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4.1.5 T Cell Receptor mutation assay 
The T Cell Receptor (TCR) mutation assay detects somatic mutations, unlike other 
biomarkers of effect here described that provide information on chromosomal alterations. 
These types of mutations reflect genomic instability induced by inherited or acquired 
changes (Balmain et al., 2003) that result in easily recognised cellular phenotypic 
alterations (Albertini et al., 1993). Somatic mutations are also considered to constitute a 
biomarker of carcinogenesis, since a number of mutational events are thought to be 
necessary to convert a normal cell into a malignant cancer cell (Compton et al., 1991).  
The TCR is a disulfide-linked heterodimer composed of two highly variable chains, α and 
β, that is expressed on the cell surface of the vast majority of peripheral blood T 
lymphocytes (Janeway et al., 2001). The genes coding for the two chains are located on 
chromosomes 14 and 7 respectively, and are phenotypically hemizygous. It is believed 
that only one of the two alleles is expressed actively as a result of allelic exclusion 
mechanism similar to that observed in the genes of immunoglobulins in B cells (Akiyama 
et al., 1995). Therefore, it is expected that a single mutation in the functional TCR genes 
results in the absence of phenotypic expression of the TCR on the cell surface. 
The α:β TCR can only be expressed on the cell surface in complex with CD3 (cluster of 
differentiation 3). TCR and CD3 play an important role in antigen (small surface peptides) 
recognition and signal transduction so that the junction of the two components is critical to 
these functions (Clevers et al., 1988). If the expression of any of the TCR genes (α or β) is 
inactivated, the α:β TCR/ CD3 complex cannot be transported to the surface of the cell 
membrane and defective complexes accumulate in the cytoplasm (Akiyama et al., 1995). 
In addition, most of the T cell mutants obtained in vitro lacking surface expression of TCR/ 
CD3 were found to have defects in TCR expression rather CD3 suggesting that TCR 
genes are more susceptible to mutagenesis than CD3 genes (Kyoizumi et al., 1990).  
TCR is essential to immune response. Through α:β TCR/CD3 complex T-cells specifically 
recognise protein antigens bound to the major histocompatibility complex (MHC) 
molecules at the surface of antigen-presenting cells. This ability to inspect degradation 
products of antigens creates a detection system that is intrinsically difficult for pathogens 
to avoid, as all proteins must eventually be degraded. It is also an extremely sensitive 
system, as very few peptide-MHC complexes on an antigen-presenting cell are needed to 
trigger a T cell response (Costa, 2012). The inactivation of a gene encoding a protein of 
the α:β TCR/CD3 complex should lead to loss of surface α:β TCR/CD3 expression and 
thereby result in defective antigen recognition and cell activation. 
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T cells, aside the α:β TCR/CD3 complex also express at the surface either CD4 or CD8 
antigens. The CD3+CD4+ α:β T cells constitute 60% of the α:β T cells and, in general , are 
T-helper cells recognizing peptides bound to MHC class II molecules. CD3+CD8+ α:β T 
cells represent 30%; they are able to identify peptides (generated by endogenous 
processing) bound to MHC class I molecules and are mostly cytotoxic T cells (Costa, 
2012).  
A minority of T cells bear an alternative, but structurally similar, receptor composed by 
different polypeptide chains, γ and δ chain. γ:δ T-cell receptors appear to have different 
antigen-recognition properties than the α:β T-cell receptors, including nonpeptide ligands. 
The biological function of γ:δ T cells in immune responses is not yet entirely clear 
(Janeway et al., 2001). 
The TCR mutation assay is a simple and quick method for evaluating the mutagenic 
effects in human populations requiring only a small volume of peripheral blood. The half-
life of the majority of mutated cells is around 2-3 years (Taooka et al., 2006). Mutations in 
the TCR genes can be detected by flow cytometry using antibodies against CD3 
molecules. The principle of the assay is to label lymphocytes with fluorescently tagged 
anti-CD3 and anti-CD4 antibodies to detect α:β TCR mutants in the population of T-helper 
cells expressing CD4; it measures the frequency of mutant cells CD4+CD3- among normal 
CD4+ T cells (Akiyama et al., 1995). This method considers the total number of mutations 
in the TCR chain genes, being unable to differentiate between mutations occurring in the 
α chain gene and occurred in the β chain gene. 
The TCR mutation assay has been employed in human biomonotoring studies to detect 
the genotoxic effects of environmental mutagens, namely radiation exposure (atomic 
bomb and accidental events), tobacco use, chemotherapeutic exposure and mining 
contamination (Kubota et al., 2000; Taooka et al., 2006; Coelho et al., 2011). 
Occupational exposure studies includes exposure to lead (García-Lestón et al., 2011), 
vincristine (Jiang et al., 2008) and pesticides (Costa, 2012), but none, to our knowledge, 
assessed formaldehyde (FA) exposure.  
 
4.1.6 Immune markers: Lymphocytes subpopulations 
Evaluation of potential adverse effects on the immune system is an important component 
of the overall evaluation of a compound toxicity. The immune response is a complex 
process involving the interaction of various components from anatomical barriers to 
specialised cells. The interaction among the various cellular components of the immune 
system (i.e., lymphocytes, macrophages, granulocytes, and natural killer cells) is 
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extremely advantageous for the organism and through the continuing dialogue between 
innate and acquired immune response, efficiency is ensured. The immune system cells 
continuously undergo proliferation and differentiation; its main responsibility is the 
organism defence against invasion by pathogenic microbial agents and spontaneously 
arising neoplasms. In doing so, the intensity and specificity of the immune response must 
be highly regulated and capable of discerning self from no self (Luster et al., 1989). 
A number of xenobiotic agents have the ability to alter the normal functionality of the 
immune system, potentially compromising the organism’s ability to recognise, control or 
eliminate infectious agents or neoplastic cells (Veraldi et al., 2006). The sensitivity of the 
immune system to chemicals relies both on the general properties of the xenobiotic (e.g. 
reactivity with macromolecules) and on the complex nature of the immune system, which 
encompasses antigen recognition and processing; cellular interactions involving 
cooperation, regulation, and amplification; cell activation, proliferation, and differentiation; 
and mediator production (Luster et al., 1989).  
Due to the structural and functional complexity of the immune system, the identification of 
substances that potentially modulate the human immune system requires the examination 
of multiple variables. To assess the immunotoxic effects in humans exposed to chemical 
agents, one of the most used approaches is the determination of lymphocyte phenotypic 
subsets. This includes the quantification of CD3+ (total T cells), CD4+ (T-helper cells), 
CD8+ (T-cytotoxic cells), CD19+ (B cells) and CD16+56+ (natural killer cells) subsets. The 
results obtained from this simple panel are sufficient to display the balance among 
lymphocyte subpopulations and highlight possible alterations (Colosio et al., 1999). 
Lymphocytes are the primary cells involved in acquired immunity and their number may 
vary from 20 to 40% of the total cells in human blood. They are highly specialised cells 
that interact with other cells (e.g. macrophage, dendritic cells) to initiate an immune 
response. The receptor specificity and functional heterogeneity allow them to respond to 
virtually any antigen (Descotes, 2004; Tryphonas et al., 2005). Furthermore, antigen-
specific response results in cell differentiation into memory cells, which remain in the 
organism and enables a quick response to further insults of that specific antigen, and in 
effector cells that act by destroying or inactivating the antigen.  
Lymphocytes are divided in T and B cells depending on whether cell maturation occurred 
in the thymus (T) or bone marrow (B).  
The use of monoclonal antibodies reacting with CD markers on the lymphocyte surface 
associated with flow cytometry, allows the identification of T and B cells subpopulations. 
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CD3 marker along with TCR is expressed on the cell surface of all T lymphocytes (or T 
cells). These cells are engaged in cell-mediated immune response. T cells are divided into 
two subpopulations, CD4+ and CD8+, differentiated by their surface marker and effector 
function. Presence of CD4+ allows the identification of T-helper (Th) cells while CD8+ 
expression indicates T-cytotoxic lymphocytes (Tc).  
These two types of T cells also differ in the class of MHC molecule they recognise; CD4 
binds to the MHC class II molecule and CD8 to the MHC class I molecule. MHC class II is 
only expressed in the cell surface of antigen-presenting cells (e.g. dendritic cells) whereas 
MHC class I is present on the cell surface of all nucleated cells. During antigen 
recognition, the TCR associated to either CD4 or CD8 molecules specifically binds to 
MHC/antigen complex, which activates T-cells leading to an effective response depending 
on the type of T-cell (Janeway et al., 2001).  
CD19 marker is present on the cell surface of all B lymphocytes (or B cells). B cells are 
precursors of antibody-secreting plasma cells and therefore are involved in the humoral 
immune response. These cells are activated directly when an antigen specifically binds to 
a surface immunoglobulin receptor (B-cell receptor) expressed on the cell membrane or 
indirectly by interaction with T-helper cells, through MHC II B cell, since they are also 
antigen-presenting cells. Upon activation, B cells differentiate into effector-B cells, called 
plasma cells, producing antibody molecules of the same antigen specificity as this 
receptor (Janeway et al., 2001). 
T cells and B cells play different roles in the adaptive immune response. Broadly, when a 
foreign substance enters the organism, it is recognised by professional antigen-presenting 
cells (e.g. dendritic cells) that internalise, degrade and present them as antigens in their 
surface bound to MHC II. T-helper cells identify that specific antigen in the surface of the 
antigen-presenting cells, which, as described above, trigger the Th cells to proliferate and 
differentiate into effector-Th cells. Effector-Th cells main function is to assist B cells 
activation by bounding to their antigen/MHCII complex or releasing cytokines stimulating 
cell proliferation. In turn activated effector-B cells (or plasma cells) produce and release 
antibodies in response to the antigenic attack; their function is to destroy (by tagging for 
phagocyte action) or inactivate the stimulating antigen (Janeway et al., 2001).  
T-cytotoxic (Tc) lymphocytes function is to destroy compromised or stressed cells, namely 
infected cells or tumour cells, by recognition on the cell surface of a specific antigen 
bound to MHC class I molecule (Janeway et al., 2001). Effector-Tc cell capture the target 
cell through mechanisms of adhesion and release the contents of their granules into it. 
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This induces apoptosis or disruption of the membrane and the death of the target cell 
(Abbas and Lichtman, 2004). 
A third class of lymphocytes involved in immune responses is natural killer (NK) cells. 
These cells are closely related to T cells, lacking their receptor and expressing CD16 and 
CD56 markers on their surface (Tryphonas et al., 2005).  
NK cells are effector lymphocytes of the innate immune system with cytotoxic and 
cytokine-production functions. The main role of NK cells is to kill compromised target cells, 
such as virus-infected cells or tumour cells (Vivier et al., 2008). NK cells are able to detect 
either antibody-coated target cells and exert antibody-dependent cell cytotoxicity by 
releasing cytotoxic mediators (Descotes , 2004) or “missing self” cells deficient in surface 
MHC I (Montaldo et al., 2013). In fact, the ability to recognise “missing self” cells underlies 
the mechanism by which NK cells are able to kill stressed cells, such as tumour cells, 
while sparing normal cells (Vivier et al., 2008). Furthermore, it is believed that NK cells are 
also regulatory cells engaged in reciprocal interactions with dendritic cells, macrophages, 
T cells and endothelial cells (Vivier et al., 2008).  
The importance of lymphocyte subpopulations assessment in human biomonitoring is 
highlighted by several studies linking the exposure to certain substances with 
immunotoxic properties with altered lymphocytes subsets and their effect on the immune 
response (Biró et al., 2002; Boscolo et al., 1999, Oh et al., 2005; Tulinska et al., 2004).  
Furthermore, it was recently demonstrated that an absent, increased or diminished 
function of immune system cells is clearly associated with autoimmune diseases, 
deregulation of the immune response, and defective immune response against neoplastic 
cells or different pathogens (Hernandez- Castro et al., 2009). Nevertheless, it should be 
carefully added that an immunotoxic effect does not always imply clinical consequences 
(Colosio et al., 1999). 
 
 
 
79 
PRESENT STUDY 
4.2 MATERIAL AND METHODS 
 
4.2.1 Lymphocytes culture 
For each cytogenetic assay in lymphocytes, aliquots of heparinised whole blood were 
cultured in 4.5 mL Hams F10 medium supplemented with 24% foetal bovine serum (FBS, 
Sigma), penicillin (100 IU/mL) (Sigma), streptomycin (100 μg/mL) (Sigma), 1% L-
glutamine (Sigma) and 1% heparin (50 IU/mL) (B. Braun). All cultures were established in 
duplicate. Lymphocytes were stimulated using 2% (v/v) of phytohaemaglutinin (Gibco 
BRL) and incubated at 37 ºC. 
 
4.2.2 Chromosomal Aberrations (CAs) Assay 
Aliquots of 0.5 mL of heparinised whole blood were cultured as described in 4.2.1. Each 
culture was established in duplicate and incubated at 37 ºC for 48h. To arrest cells at 
metaphase stage, demecolcine (Sigma) was added (0.11μg/mL) 3h before the cell 
harvest. Cells were collected by centrifugation, submitted to hypotonic treatment (KCl 
0.075 mol/L), 37 °C for 10 min, fixed twice with ice-cold methanol:acetic acid (3:1, v/v) 
freshly prepared (454xg, 5 min), dropped on coded slides and stained with 4% Giemsa 
(Merck) in phosphate buffer (PBS) (pH 6.8, Merck) for 10 min. Stained slides were then 
covered with coverslips and mounted with Entellan®. 
CAs analyses were performed on a Nikon Eclipse E400 light microscope, slides were 
scored blindly by the same reader. One hundred metaphases with well-spread 
chromosomes were analysed for each individual, fifty from each culture duplicate, using a 
500x and 1250x magnification. Gaps, chromosome-type aberrations (CSAs; e.g. 
chromosomal-type breaks and dicentric and ring chromosomes) and chromatid-type 
aberrations (CTAs; e.g. chromatid-type breaks, symmetrical homologous figures, radial 
figures) were identified and classified according to Savage et al. (1975). Gaps were not 
included in CAs parameters. The criteria for distinguishing chromatid-type breaks from 
gaps were the acentric piece displaced with respect to the chromosome axis and the size 
of the discontinuity exceeded the width of the chromatid. Acentric fragments were 
considered together with chromatid-type breaks. A dicentric with an acentric fragment was 
scored as one aberration. Numerical CAs was also scored and the number of aneuploid 
metaphases assessed (46 ± 1). Some of the CAs scored are collected in Figure 13.  
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Figure 13. Chromosomal aberrations observed in metaphase (1250x). A-C) dicentric chromosome with 
accompanying fragment; D) ring chromosome; E-G) break in one chromatid; H) tetraradial figure; I-K) 
symmetrical homologous figures and L) symmetrical interchange figure.  
 
In addition, known variables of chromosome fragility were also evaluated for each subject 
namely the number of aberrant and multiaberrant cells according to Castella et al. (2011) 
and Oostra et al. (2012). Exchanges (figures, dicentric and ring chromosomes) were 
converted into the number of breaks necessary to form each figure, two breaks. A 
metaphase exhibiting one break (corresponding to a chromatidic-break or a chromosomic-
break) was considered aberrant. A metaphase presenting exhanges or two or more 
fragments or breaks in different chromosomes were accounted as multiaberrant. 
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4.2.3 Lymphocyte Cytokinesis-Block Micronucleus Test (CBMN) 
The CBMN test was performed as described elsewhere (Teixeira et al., 2004). Briefly, 
aliquots of 0.5 mL of heparinised whole blood were used to establish duplicate lymphocyte 
cultures as outlined in 4.2.1. Cytochalasin B (Sigma), a cell-division inhibitor, was added 
after 44 h at a final concentration of 6 μg/mL. After a total of 72-h culture, cells were 
collected by centrifugation and treated twice with a mixture (pH 7.2) of RPMI 1640 
(Sigma) supplemented with 2% FBS (202xg, 7 min). Cells were then submitted to a mild 
hypotonic treatment in a mixture (pH 7.2) of RPMI:deionised water (1:4, v/v), 
supplemented with 2% FBS (202xg, 5 min). After centrifugation, a drop of the pellet was 
placed on dry slides and smears were performed. Air-dried slides were fixed (-20 ºC, 20 
min) with freshly prepared ice-cold methanol:acetic acid (3:1, v/v) and dried overnight. 
Slides were stained with 4% Giemsa in pH 6.8 PBS. Stained slides were then covered 
with coverslips and mounted with Entellan®. Microscopic analyses were performed on a 
Nikon Eclipse E400 light microscope. To determine the total number of micronucleus in 
binucleated (BN) cells, a total of 1000 BN cells (500 from each culture duplicate) with well-
preserved cytoplasm were scored for each subject. The % of mononucleated, binucleated, 
trinucleated and tetranucleated cells in 1000 cells was also registered. Micronucleus were 
scored blindly by the same reader and identified according to the criteria defined by Caria 
et al. (1995) and Fenech (2007) using a 500x and 1250x magnification. Figure 14 are 
showed some of the images of cells scored in the CBMN assay. 
 
 
Figure 14. Scored micronucleus (MN) images (500x). A) mononucleated and binucleated cells; and B-D) 
binucleated cells with micronucleus. 
 
4.2.4 Buccal Micronucleus Cytome Assay (BMCyt) 
BMCyt was performed as described by Thomas et al. (2009) with few modifications. 
Buccal sampling was performed separately inside of both cheeks, left and right, to 
eliminate any unknown bias that may be caused by sampling one cheek only. Samples 
collected were individually suspended in buccal cell buffer (0.01M Tris-HCl, 0.1M EDTA, 
0.02 NaCl, pH7). After cells centrifugation, supernatant was removed and replaced with 
fresh buffer and washed again two more times (728xg, 7 min). After the last wash, cells 
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were resuspended in the small volume of pellet and placed into clean coded slides (3 
slides for each cheek). After air-drying, slides were fixed (-20 ºC, 20 min) with cold 
absolute ethanol: acetic acid (3:1, v/v) freshly prepared. Air-dried fixed slides were treated 
in 5M HCl for 30 min and washed in running tap water for 3 min. Slides were then stained 
with Schiff’s reagent (Merck) at room temperature in the dark for 60-150 min. Stained 
slides were washed in running tap water for 5 min and 1 min in deionised water and left to 
dry in the dark, for 10 min. Slides were then counterstained for 5 sec in 1% Fast Green 
(Merck) solution, washed in absolute ethanol (3 times, 2 min each) and allowed to air dry. 
Afterwards, slides were covered with coverslips and mounted with Entellan®. Slides were 
scored blindly by the same reader on a Nikon Eclipse E400 light microscope using a 500x 
and 1250x magnification. For each subject the percentage of basal cells, differentiated 
cells, BN cells and cell death parameters such as condensed chromatin, karyorrhectic, 
pyknotic and karyolitic cells were scored in 1000 cells. Differentiated cells were scored for 
micronuclei, nuclear buds and nucleoplasmic bridges. Cells containing micronuclei were 
confirmed under fluorescence to eliminate false positives. The scoring criteria were based 
in Tolbert et al. (1992) and Thomas et al. (2009).  
 
4.2.5 Sister Chromatid Exchange (SCE) Test 
Aliquots of 0.5 mL of heparinised whole blood were cultured, in duplicate, as described 
above (4.2.1.) and 5 μL of 5-bromo-2´-deoxyuridine (BrdU, Sigma) were added into the 
culture medium at a final concentration of 10 μg/mL. Lymphocytes were incubated at       
37 ºC in the dark. At 56 h, demecolcine was added (0.11 μg/mL), to arrest cells at 
metaphase stage, and the cells were incubated for more 1h. Afterwards cells were 
submitted to a hypotonic treatment (KCl 0.075 mol/L) at 37°C for 10 min and fixed twice 
with ice-cold methanol:acetic acid (3:1, v/v) freshly prepared (454xg, 5 min). Cells were 
ressuspended in the small volume of pellet and dropped onto clean coded slides. Slides 
were stained with fluorescence-plus-Giemsa procedure (Perry and Wolff, 1974) for 
differential chromatid staining. Stained slides were then covered with coverslips and 
mounted with Entellan®. Microscopic analyses were performed on a Nikon Eclipse E400 
light microscope using a 500x and 1250x magnification. A single observer scored a total of 
50 well-spread second division metaphases for each subject (half from each duplicate) to 
determine the number of SCE per cell. Every switch of staining between the sister 
chromatids was scored as an SCE (Figure 15). 
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Figure 15. Images of cell metaphases scored for SCE (indicated by arrows) test (1250x).  
 
4.2.6 Comet assay 
Peripheral blood mononuclear cells were isolated using BD Vacutainer™ CPT™ Cell 
Preparation Tubes with sodium heparin (Becton Dickinson), following manufacturer's 
instructions. Cell viability, determined by trypan blue exclusion, was higher than 85% in all 
cases.  
The alkaline comet assay was performed as described by Singh et al. (1988) with minor 
modifications. Briefly, cells collected by centrifugation (4990xg for 3 min) and suspended 
in 100 μL of 0.6% low-melting-point agarose (LMA) in PBS (pH 7.4) were dropped onto a 
frosted slide precoated with a 1% layer of normal melting point agarose. Slides were 
placed on ice for 4 min and allowed to solidify. Coverslips were then removed and slides 
were immersed in freshly prepared lysis solution (2.5 M NaCl, 100 mM Na2EDTA, 10 mM 
Tris-base, 0.25 M NaOH, pH 10; 1% Triton X100) for 1 h at 4 °C, in the dark. After lysis, 
slides were placed on a horizontal electrophoresis tank in an ice bath. The tank was filled 
with freshly made alkaline electrophoresis solution (1 mM Na2EDTA, 300 mM NaOH, pH 
13) and left in the dark for 20 min to allow DNA unwinding. Electrophoresis was carried 
out for 20 min at 30 V and 300 mA (1.2 V/cm). Slides were then washed for 10 min with 
cold neutralizing solution (0.4 M TrisBase, pH 7.5) and 10 min with cold deionised water. 
After neutralisation, slides were left to air-dry in the dark, overnight. Gels were re-hydrated 
for 20 min with cold deionised water, stained with ethidium bromide solution (20 μg/mL), 
washed again for 20 min with cold deionised water and left in the dark for air-drying. For 
scoring 1 to 2 drops of water were dropped onto each gel and covered with coverslips. 
Two gels were prepared for each donor and a ‘blind’ scorer examined 50 randomly cells 
from each gel (100 cells/donor) using a magnification of x 400. Microscopic analyses were 
performed on a Nikon Eclipse E400 Epi-fluorescence microscope (G2A filter, Nikon C-
SH61). Image capture and analysis were performed with Comet Assay IV software 
(Perceptive Instruments). The percentage of DNA in the comet tail (%TDNA) was the DNA 
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damage parameter evaluated. A mix of lymphocytes preserved at -80 ºC, was introduced 
as an internal standard, the percentage coefficient variation (%CV) obtained was less than 
15%. 
 
4.2.7 TCR mutation assay  
Peripheral blood mononuclear leukocytes were isolated in BD VacutainerTM Cell 
Preparation Tubes (CPTTM) with sodium heparin according to manufacturer’s instructions. 
After centrifugation, cells were washed three times with ice-cold pH 7.4 phosphate buffer 
solution. TCR mutation assay was performed by a flow cytometric methodology following 
Akiyama et al. (1995) with minor modifications (García-Lestón et al., 2011). Cell 
suspensions were analysed by a FACScalibur flow cytometer with Cell Quest Pro 
software (Becton Dickinson). A minimum of 2.5×105 lymphocyte-gated events were 
acquired, and mutation frequencies of TCR (TCR-Mf) were calculated as the number of 
events in the mutant cell window (CD3−CD4+ cells) divided by the total number of events 
corresponding to CD4+ cells. 
 
4.2.8 Lymphocyte subpopulations assessment 
Cell percentages of total T lymphocytes (%CD3+), T-helper (Th) lymphocytes (%CD4+),   
T-cytotoxic (Tc)  lymphocytes (%CD8+), B lymphocytes (%CD19+) and natural killer (NK) 
cells (%CD16+56+) were determined by flow cytometric measurements using a three-color 
direct immunofluorescence surface marker methodology, as described by García-Lestón 
et al. (2011). The following antibodies were used: fluorescein isothiocyanate (FITC)-
labelled antiCD3, phycoerytrin (PE)-labelled antiCD4, phycoerytrin-cyanin 5 (PE-Cy5)-
labelled antiCD8, PECy5-labelled antiCD19, and PE-labelled CD16 and CD56. Analyses 
were carried out in a FACScalibur flow cytometer using Cell Quest Pro software (Becton 
Dickinson). After gating the lymphocytes based on forward/side scatter plots, fluorescence 
data from FL1 (FITC), FL2 (PE) and FL3 (PE-Cy5) were obtained. At least 104 events in 
the lymphocytes window were acquired. 
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4.3 RESULTS 
 
4.3.1 Biomarkers of genotoxicity 
Univariate comparisons of effect biomarkers by study group are reported in Table VI. All 
genotoxicity endpoints, with the exception of TCR-Mf, were significantly increased in the 
FA-exposed workers compared to control subjects. 
 
Table VI. Results of biomarkers of genotoxicity in the study groups. 
 Controls  Exposed   
 N mean ± SE 
(range)  N 
mean ± SE 
(range)  p-value 
CA-total 
 87 
2.09 ± 0.25  
(0-13)  
84 
3.96 ± 0.34  
(0-13) 
 <0.001 
CSAs  
CA-chromosome type 
87 
0.48 ± 0.10  
(0-4)  
84 
0.98 ± 0.14  
(0-5) 
 0.004 
CTAs  
CA-chromatid type 
87 
1.61 ± 0.19  
(0-10)  
84 
3.00 ± 0.28  
(0-12) 
 <0.001 
Gaps 
 87 
3.49 ± 0.32  
(0-14)  
84 
5.70 ± 0.31  
(0-13) 
 <0.001 
Aneuploidies 
 87 
2.13 ± 0.19  
(0-6) 
 84 
3.49 ± 0.19  
(0-8) 
 <0.001 
MNL (‰) 
MN in lymphocytes 
87 
2.79 ± 0.30  
(0-10) 
 84 
4.38 ± 0.38  
(0-18) 
 <0.001 
MNB (‰) 
MN in buccal cells 
69 
0.17 ± 0.05  
(0-2) 
 63 
0.65 ± 0.09  
(0-4) 
 <0.001 
BNbud (‰) 
Nbud in buccal cells 
69 
0.32 ± 0.06  
(0-2) 
 63 
0.94 ± 0.11  
(0-3) 
 <0.001 
SCE/cell 
 
87 
4.01 ± 0.11  
(1.82-6.16) 
 84 
5.08 ± 0.12  
(2.00-8.78) 
 <0.001 
%TDNA 
Comet assay  
87 
7.50 ± 0.47  
(0.86-24.40) 
 83 
11.67 ± 0.72  
(0.23-28.07) 
 <0.001 
TCR-Mf (x10-4) 
TCR mutation frequency 
64 
3.69 ± 0.43  
(1.08-27.95) 
 61 
3.90 ± 0.45  
(1.28-26.29)  0.733 
 
With regard to CAs types, both CSAs (chromosome-type aberrations) and CTAs 
(chromatid-type aberrations) were significantly higher in FA-exposed workers compared to 
controls. The latter was the most frequent type of aberration found in both groups, which 
is consistent to the fact that most of spontaneous aberrations are of chromatid-type, 
although with low frequency (Savage, 1975). In addition, other parameters regarding the 
CAs were assessed namely the frequency of aberrant (with one break) and multiaberrant 
cells (with two or more breaks). The results are showed in Table VII. Both variables were 
significantly higher in the exposed group than in the control group. 
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Table VII. Results of aberrant cells and multiaberrant cells in the study groups 
 Controls  Exposed   
 N mean ± SE (range)  N 
mean ± SE 
(range)  p-value 
Aberrant cells 
 
87 
1.90 ± 0.19  
(0-9) 
 84 
3.18 ± 0.28  
(0-11)  0.001
a 
Multiaberrant cells 
 
87 
0.14 ± 0.04  
(0-2) 
 84 
0.55 ± 0.09  
(0-3)  <0.001
a 
 
4.3.1.1 Effect of exposure, lifestyle factors and parameter-specific confounders 
To evaluate the genotoxic effect of exposure and the possible influence of some known 
confounders on the frequencies of the endpoints studied a multivariate modelling was 
carried out. All models included gender, age and smoking habits. A parameter-specific 
confounder was found for %TDNA, fruit consumption, and therefore it was included on the 
analysis. The influence of the level of formic acid in urine was also evaluated, however no 
significant effect was found in any of the considered biomarkers. Consequently, this 
variable was not included on the final statistical models. The result on genotoxicity 
biomarkers, adjusted for gender, age, smoking habits and actual parameter-specific 
confounders, are reported in Table VIII, Table IX and Table X.  
The significant effect of exposure was confirmed in all the cytogenetic biomarkers studied 
(CA-total, CSAs, CTAs, gaps, aneuploidies, MNL, MNB, BNbud and SCE; Tables VIII and 
IX) and in the DNA damage parameter (%TDNA; Table X) with FA-exposed workers 
showing increased frequencies compared to controls. No significant influence of gender 
was observed on the frequencies of the endpoints studied.  
Age was found to be a significant confounder but only for CSAs, MNL and MNB. CSAs 
frequency was significantly increased in subjects between ages 35-45 (Table VIII). It was 
also elevated in individuals above 45 years-old, but with a near significance (p= 0.06). 
Concerning MNL and MNB, both endpoint frequencies were significantly higher in 
subjects above 35 years old (Tables IX). Indeed, a significant positive correlation was 
found between age and MNL frequency (r=0.287, p<0.001) and MNB frequency (r=0.319, 
p<0.001).  
With regard to smoking habits, a significant effect was found for aneuploidies (decrease) 
and MNB (increase) frequencies. Significant associations found between these variables 
and packs/year further confirmed the influence of smoking on the frequencies of these 
endpoints. A negative correlation with aneuploidies (r=-0.270, p<0.001) and a positive with 
MNB (r=0.195, p=0.025). 
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Table VIII. Effect of exposure, gender, age and smoking habits on the frequencies of CA-total, CSAs, CTAs, gaps and aneuploidies with estimates of mean 
ratios (MR) 
   CA-total  CSAs  CTAs  Gaps  Aneuploidies 
 N  MR [95% CI]  MR [95% CI]  MR [95% CI]  MR [95% CI]  MR [95% CI] 
Exposure                  
Controls 85  1.00   1.00   1.00   1.00   1.00  
Exposed 87  1.91*** [1.44-2.53]  2.07** [1.27-3.38]  1.86*** [1.39-2.48]  1.65*** [1.34-2.03]  1.64*** [1.36-1.98] 
Gender                 
Females 133  1.00   1.00   1.00   1.00   1.00  
Males  39  0.85 [0.60-1.21]  0.53 [0.27-1.05]  0.98 [0.68-1.42]  1.03 [0.80-1.33]  0.89 [0.70-1.13] 
Age                  
<35 years 60  1.00   1.00   1.00   1.00   1.00  
35-45 years 63  1.11 [0.80-1.55]  1.89* [1.03-3.46]  0.97 [0.69-1.37]  0.98 [0.77-1.24]  0.89 [0.71-1.11] 
>45 years 49  1.20 [0.84-1.70]  1.84 [0.98-3.46]  1.08 [0.76-1.54]  0.96 [0.75-1.25]  0.99 [0.79-1.24] 
Smoking Habits                 
Non-smokers 129  1.00   1.00   1.00   1.00   1.00  
Smokers 43  0.82 [0.58-1.15]  0.88 [0.48-1.60]  0.79 [0.56-1.14]  0.81 [0.63-1.05]  0.67** [0.52-0.86] 
* p<0.05 
** p<0.01 
*** p<0.001 
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Table IX. Effect of exposure, gender, age and smoking habits on the frequencies of MNL, SCE, MNB and BNbud with estimates of mean ratios 
(MR) 
   MNL (‰)  SCE/cell    MNB (‰)   BNbud (‰) 
 N  MR [95% CI]  MR [95% CI]  N  MR [95% CI]  MR [95% CI] 
Exposure                 
Controls 85  1.00   1.00   69  1.00   1.00  
Exposed 87  1.55** [1.20-1.99]  1.27** [1.10-1.46]  63  4.08*** [2.12-7.87]  2.88*** [1.76-4.71] 
Gender                
Females 133  1.00   1.00    100  1.00   1.00  
Males  39  1.07 [0.77-1.48]  1.06 [0.89-1.26]  32  1.41 [0.76-2.63]  1.02 [0.58-1.76] 
Age                 
< 35 years 60  1.00   1.00   49  1.00   1.00  
35-45 years 63  1.40* [1.03-1.91]  1.11 [0.94-1.32]  47  2.32* [1.05-5.11]  1.00 [0.57-1.75] 
> 45 years 49  1.97*** [1.44-2.71]  1.10 [0.92-1.31]  36  3.54** [1.64-7.66]  1.61 [0.95-2.73] 
Smoking Habits                
Non-smokers 129  1.00   1.00   94  1.00   1.00  
Smokers 43  0.88 [0.64-1.20]  1.13 [0.96-1.34]  38  2.12** [1.22-3.69]  0.87 [0.52-1.46] 
* p<0.05 
** p<0.01 
*** p<0.001 
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Table X. Effect of exposure, gender, age and smoking habits on the frequencies of %TDNA and 
TCR-Mf with estimates of mean ratios (MR) 
   %TDNA    TCR-Mf (x10-4) 
 N  MR [95% CI]  N  MR [95% CI] 
Exposure           
Controls 85  1.00   69  1.00  
Exposed 87  1.50** [1.14-1.96]  61  1.03 [0.74-1.43] 
Gender          
Females 133  1.00   98  1.00  
Males  39  1.05 [0.75-1.47]  32  1.20 [0.81-1.77] 
Age           
< 35 years 60  1.00   48  1.00  
35-45 years 63  1.22 [0.88-1.67]  47  0.96 [0.65-1.42] 
> 45 years 49  1.10 [0.78-1.56]  35  1.02 [0.68-1.54] 
Smoking Habits          
Non-smokers 129  1.00   93  1.00  
Smokers 43  0.88 [0.64-1.20]  37  0.87 [0.59-1.28] 
Fruit consumption 
(no. pieces/day) 130  0.88* [0.78-0.99]  -  - - 
* p<0.05 
** p<0.01          
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In addition, fruit consumption was found to significantly decrease the DNA damage 
evaluated by comet assay (%TDNA) (Table X). Regarding aberrant and multiaberrant 
cells parameters no significant effect was obtained for gender, age or smoking habits 
(data not showed). 
 
4.3.2 Immune Markers: Lymphocytes subpopulations  
Data obtained for univariant analysis of lymphocyte subpopulations in FA-exposed 
subjects and controls are reported in Table XI. Statistically significant differences were 
found for %CD8+ (T-cytotoxic cells), %CD19+ (B lymphocytes) and %CD16+56+ (NK cells). 
The results found for CD4+/CD8+ ratio (Th/Tc) confirmed the effect on %CD8+. No 
significant differences were observed for %CD3+ (total T lymphocytes) and %CD4+ (T-
helper cells). 
 
Table XI. Results of lymphocyte subpopulations in the study groups. 
 Controls  Exposed   
 N mean ± SE (range)  N 
mean ± SE 
(range)  p-value 
Total T lymphocytes 
%CD3+ 64 
73.82 ± 0.96 
(49.99-88.6) 
 61 72.73 ± 1.10 (46.14-87.42)  0.455 
T-helper cells (Th) 
%CD4+ 
64 44.54 ± 1.10 (26.35-73.2) 
 61 45.03 ± 1.08 (23.76-63.48)  0.754 
T-cytotoxic cells (Tc) 
%CD8+ 64 
16.85 ± 0.90 
(5.49-39.33) 
 61 24.89 ± 1.11 (10.79-50.71)  <0.001 
B cells 
%CD19+ 
64 23.31 ± 1.13 (4.64-44.4) 
 61 
11.30 ± 0.47 
(3.02-20.08)  
<0.001 
Natural killer (NK) cells 
%CD16+56+ 64 
9.95 ± 0.78 
(1.66-39.17) 
 61 12.56 ± 0.95 (1.92-44.59)  0.035 
Th /Tc ratio 
CD4+ /CD8+ ratio 
64 3.34 ± 0.25 (1.04-8.74) 
 61 2.10 ± 0.13 (0.47-5.2)  <0.001 
 
4.3.2.1 Effect of exposure, lifestyle factors and parameter-specific confounders 
Table XII summarises the results obtained in the multivariant analysis of the immune 
markers taking into account gender, age and smoking habits in addition to exposure. The 
analysis was also adjusted for actual parameter-specific confounders, namely vitamin 
supplement intake for T-cytotoxic cells and fruit consumption for T-helper cells. Formic 
acid in urine was not included in the final multivariate models, since it proved not to be a 
modifying factor on the lymphocyte subsets.  
Significant effect of exposure were confirmed for percentages of T-cytotoxic cells 
(increase), B lymphocytes (decrease), NK cells (increase) and Th/Tc ratio (decrease). 
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Table XII. Effect of FA-exposure, gender, age and smoking habits on lymphocyte subpopulations with estimates of mean ratios (MR) 
   Total T lymphocytes %CD3+ 
 
T-helper cells 
%CD4+  
T-cytotoxic cells 
%CD8+  
B cells 
%CD19+ 
 NK cells 
%CD16+56+ 
 
Th/Tc 
CD4+ /CD8+ 
 N  MR [95% CI]  MR [95% CI]  MR [95% CI]  MR [95% CI]  MR [95% CI]  MR [95% CI] 
Exposure                     
Controls 64  1.00   1.00   1.00   1.00   1.00   1.00  
Exposed 61  0.98 [0.94-1.03]  1.02 [0.96-1.09]  1.47** [1.29-1.68]  0.51** [0.44-0.59]  1.30* [1.02-1.64]  0.69** [0.59-0.82] 
Gender                    
Females 95  1.00   1.00   1.00   1.00   1.00   1.00  
Males 30  1.01 [0.96-1.06]  1.01 [0.93-1.10]  0.81* [0.69-0.96]  1.11 [0.92-1.34]  1.20 [0.90-1.61]  1.22 [1.00-1.50] 
Age                     
< 35 years 43  1.00   1.00   1.00   1.00   1.00   1.00  
35-45 years 47  1.08** [1.03-1.13]  1.06 [0.98-1.14]  1.07 [0.92-1.26]  0.84 [0.70-1.00]  0.85 [0.64-1.12]  0.98 [0.81-1.20] 
> 45 years 35  1.06* [1.01-1.12]  1.19** [1.10-1.30]  0.77** [0.65-0.91]  0.90 [0.74-1.08]  0.82 [0.61-1.10]  1.56** [1.26-1.93] 
Smoking Habits                    
Non-smokers 90  1.00   1.00   1.00   1.00   1.00   1.00  
Smokers 35  1.01 [0.97-1.06]  1.04 [0.96-1.12]  0.95 [0.81-1.11]  1.02 [0.86-1.22]  1.05 [0.79-1.38]  1.11 [0.91-1.34] 
Fruit consumption 
(no. pieces/day) 125 
 
_ _  1.03 [1.00-1.06]  _ _  _ _  _ _  _ _ 
Vitamin suppl. intake 
(Yes/No) 125 
 
_ _  _ _  1.30* [1.05-1.60]  _ _  _ _  _ _ 
*p<0.05 
**p<0.01                   
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Regarding gender, males had a significantly lower percentage of T-cytotoxic cells 
compared with females.  
Furthermore, age significantly influenced total T lymphocyte, T-helper cells and               
T-cytotoxic cells subsets. Total T lymphocytes were higher in subjects above 35 years-old 
while T-helper cells were also significantly increased but only in individuals above age 45. 
A contrasting effect in the T-cytotoxic cells subset was found for that group age (> 45 
years-old) with a significant decrease. The effect of age in these endpoints was further 
confirmed by correlation analysis.  Indeed, a significant positive association was found for 
Total T lymphocytes (r=0.259, p=0.004) and T-helper cells (r=0.375, p<0.001), whereas 
for T-cytotoxic cells a negative association (r=-0.192, p=0.032) was found with age. 
No significant effect of smoking status was observed on lymphocyte subpopulations.  
Regarding actual parameter-specific confounders, vitamin supplement intake was found to 
significantly increase T-cytotoxic cells and fruit consumption was found to have a near 
significant increase on % T-helper cells (p=0.05). 
 
4.3.3 Effect of work-related factors  
In the exposed population the influence of FA-level of exposure corresponding to each 
exposed individual, time of exposure and professional activity on genotoxicity and immune 
markers was also evaluated by multivariate regression, results are described in Table XIII 
(only parameters for which at least one significant result was obtained are shown). 
With regard to genotoxicity biomarkers, MNL and BNbud frequencies were significantly 
increased with FA exposure level. Concerning lymphocyte subpopulations, NK cells 
(%CD16+56+) were significantly decreased with the FA-level of exposure. This effect was 
further confirmed with a nearly significant association between %NK cells and FA 
exposure level (r= -0.245, p=0.054).  
No significant effects were obtained with exposure duration or professional activities in 
any of the endpoints studied. However, a positive significant correlation was found 
between MNL frequencies and exposure duration (r=0.277, p=0.011).  
To better investigate the effect of the estimated FA-levels of exposure on the frequencies 
of MNL, BNbud and %NK cells, the variable was categorised into tertiles: T1, ranged 0.08-
0.22 ppm; T2, ranged 0.23-0.34 ppm; and T3 ranged 0.35-1.39 ppm, results are shown in 
Table XIV. Subjects in the categories T2 and T3, with higher exposure levels, had a 
significant increase in MNL frequency compared to reference category T1 (lowest 
exposure). 
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Table XIII. Influence of FA-exposure level, exposure duration and professional activity on micronuclei in lymphocytes (MNL), 
nuclear buds in buccal cells (BNbud) and %CD16+56+ cells, with estimates of mean ratios (MR) 
  MNL (‰)  BNbud (‰)  %CD16+56+  
  N MR [95% CI]  N MR [95% CI]  N MR [95% CI] 
             
FA-level of exposure 
(ppm)  84 2.71* [1.18-6.23]  63 5.27* [1.27-21.90]  61 0.32* [0.12-0.84] 
Exposure duration              
<8 years  28 1.00   25 1.00   24 1.00  
8-14 years  28 0.78 [0.51-1.23]  18 0.74 [0.30-1.78]  17 1.00 [0.63-1.60] 
>14 years  28 0.68 [0.40-1.15]  20 1.00 [0.37-2.74]  20 1.31 [0.75-2.28] 
Professional activity             
Physician  30 1.00   23 1.00   21 1.00  
Technician  40 0.91 [0.61-1.35]  30 1.90 [0.94-3.86]  30 0.92 [0.60-1.41] 
Hospital orderlies  10 0.78 [0.43-1.42]  7 1.07 [0.35-3.20]  7 1.76 [0.96-3.23] 
Administrative  4 0.95 [0.44-2.07]  3 - -  3 0.89 [0.39-2.03] 
*p<0.05                
 
Table XIV. Influence of FA-exposure level of exposure categorized by tertiles on micronuclei in lymphocytes (MNL), 
nuclear buds in buccal cells (BNbud) and %CD16+56+ cells, with estimates of mean ratios (MR) 
  MNL (‰)  BNbud (‰)  %CD16+56+  
  N MR [95% CI]  N MR [95% CI]  N MR [95% CI] 
             
FA-level of exposure             
T1 (0.08-0.22 ppm)  27 1.00   20 1.00   20 1.00  
T2 (0.23-0.34 ppm)  29 1.50** [1.12-2.00]  16 1.42 [0.64-3.14]  25 1.05 [0.69-1.60] 
T3 (0.35-1.39 ppm)  28 1.37* [1.04-1.81]  17 1.96 [0.91-4.24]  16 0.50** [0.32-0.79] 
*p<0.05 
**p<0.01             
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The same effect was observed for BNbud, but it did not reach significance. For %NK cells, 
no significant difference was observed between T1 and T2. In contrast, a marked and 
significant decrease in %NK cells was found in the highest tertile, T3, corresponding to 
workers exposed to estimated levels of FA equal or higher than 0.35 ppm. This trend is 
further confirmed by the mean %NK values found in these three groups: T1, 12.78%; T2, 
15.22% and T3, 8.12% (this last value even lower than the observed for the control group, 
9.95%). 
 
4.3.4 Correlations between biomarkers  
The associations between the different studied biomarkers were evaluated and some 
were found to be significant. As expected, CA-total parameter was significantly well 
correlated with CSAs (r=0.632 p<0.001), CTAs (r=0.930 p<0.001), aberrant (r=0.953 
p<0.001) and multi-aberrant cells (r=0.580 p<0.001). A significant positive association was 
also found between gaps and CA-total (r=0.521 p<0.001), CSAs (r=0.291 p<0.001), CTAs 
(r=0.498 p<0.001), aberrant (r=0.511 p<0.001) and multi-aberrant cells (r=0.315 p<0.001). 
In contrast, no significant correlations were found for aneuploidies and TCR-Mf with any of 
the biomarkers. Further associations found between the genotoxicity endpoints are 
gathered in Table XV. 
 
Table XV. Associations between biomarkers of genotoxicity 
Endpoint 1 Endpoint 2 Correlation coefficient (r) 
CTAs CSAs 0.343*** 
Gaps 
MNL 0.233** 
%TDNA 0.273*** 
MNL 
Total-CAs 0.299*** 
CSAs 0.162* 
CTAs 0.295*** 
MNB 0.359*** 
MNB BNbud 0.261** 
SCE 
Total-CAs 0.172* 
CTAs 0.159* 
Gaps 0.156* 
%TDNA CSAs 0.174* 
* p<0.05 
** p<0.01 
*** p<0.001 
  
 
Concerning lymphocyte subpopulations a significant inverse association was found 
between T-cytotoxic cells and B cells (r=-0.577 p<0.001). Analysis of correlations between 
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the different biomarkers of genotoxicity and lymphocyte subpopulations showed that these 
were significant for CA-total and T-cytotoxic cells (r=0.376, p<0.001) and B cells (r=-0.313 
p<0.001). Similarly, between SCE frequency and T-cytotoxic cells (r=0.204 p<0.05) and B 
cells (r=-0.352 p<0.001). And lastly for %TDNA and T-cytotoxic cells (r=0.296 p<0.001) 
and B cells (r=-0.350, p<0.001). 
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4.4 DISCUSSION  
As observed, occupational exposure to Formaldehyde (FA) is common in pathological 
anatomy laboratories, where professionals are often exposed to FA-airborne 
concentrations near or superior to recommended limit values. FA was recently classified 
carcinogenic to humans. Consisting findings of increased risks of rare cancers, such as 
nasopharyngeal and sinonasal cancer were found among workers with higher measures 
of exposure to FA (exposure level or duration).  
In addition, an excess of mortality from leukaemia was observed in epidemiological 
studies involving embalmers, funeral directors and healthcare professionals, namely, 
pathologists and anatomists. It has been speculated that these findings might be 
explained by concurrent exposure to other chemicals (Golden, 2011), however none of 
the compounds used in these settings have established leukaemogenic properties 
(Hauptmann et al., 2009). Moreover, the exposure to other chemicals would differ 
between professional groups, which reduce the likelihood that such exposures could 
explain the observed increases in risk (IARC, 2006). Furthermore, in a meta-analysis that 
included 18 studies, it was reported that the overall increase of relative risk for leukaemia 
among embalmers, pathologists and anatomists did not vary significantly between studies, 
and the results were found to be homogeneous (Collins and Lineker, 2004). 
The mechanisms by which FA causes cancer are not completely understood but most 
likely involve multiple modes of action, including genotoxicity by DNA reactivity, 
chromosomal breakage, aneuploidy or oxidative stress (Zhang et al., 2010a; NTP, 2011). 
Although, FA genotoxicity has been demonstrated in vitro experiments on cell lines and 
laboratory animals, data regarding occupationally exposed individuals are often 
inconsistent and controversial, particularly in what concerns FA-induced genotoxic effects 
in circulating peripheral blood lymphocytes (PBLs).  
 
4.4.1 Biomarkers of genotoxicity 
Genotoxicity evaluation constitutes a valuable tool for studying the most important 
occupational hazards to public health occurring in the past few decades and allows a 
reasonable epidemiological evaluation of cancer predictivity (Bonassi et al., 2005; Laffon 
et al., 2006). Cytogenetic biomarkers such as chromosomal aberrations (CAs), 
micronucleus (MN) and sister chromatid exchanges (SCE) are well-established endpoints 
that have been extensively used for assessing DNA damage at the chromosomal level in 
human biomonitoring studies (Carrano and Natarajan, 1988; Fenech, 1993).  
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In this study, all cytogenetic parameters evaluated (Total-CA, CSAs, CTAs, gaps, 
aneuplodies, MNL, MNB, BNbud and SCE) were significantly elevated in pathological 
anatomy professionals exposed to FA (0.38 ppm) compared with control subjects (Table 
VI).  
In fact, FA-exposed individuals showed an increase of 91% on Total-CAs frequency 
compared to controls (Table VIII). Furthermore, mean frequencies of both CAs types, 
CSAs (chromosome-type aberrations) and CTAs (chromatid-type aberrations) were 
significantly higher in exposed workers than controls (Table VI). Although there is a 
paucity of studies assessing CAs in FA occupational exposed subjects, our findings are in 
agreement with most of the published literature. Indeed, increased frequencies of CAs 
were found in PBLs of anatomy students exposed to FA (mean level, 2.37 ppm) during a 
12-week (10h per week) anatomy class (He et al., 1998). Similarly, in a recent study 
involving FA-exposed personnel working in pathology departments (n=21; mean 
level=0.72 ppm) Total-CA and CTAs were significantly elevated compared to controls, no 
significant differences were found for CSAs (Jakab et al., 2010). Moreover, in vitro 
experiments of Schmid et al. (1986) with human lymphocytes showed that FA induces 
CAs, mostly of chromatid-type and gaps, as observed in occupational exposed subjects. A 
significant increase on CAs frequencies were also observed in industrial workers, namely 
in a group of paper factory workers, i.e. dicentric and rings chromosomes (Bauchinger and 
Schmid, 1985), and among workers manufacturing nitrogen fertiliser and exposed to FA 
concentrations exceeding permissible levels (Kitaeva et al., 1996). In addition, a study in 
former Czechoslovakia reported increased levels of CAs in PBLs of children exposed to 
FA in prefabricated schools (Neri et al., 2006).  
In opposition, Thomson et al. (1984) found no significant differences in the incidences of 
CAs in a group of six pathology workers compared to unexposed controls. The same 
result was obtained among FA-exposed medical students working in an anatomy 
dissection laboratory (Vasudeva and Anand, 1996). Further, no significant differences 
were found on CAs frequencies between individuals working in different laboratories of a 
Cancer Research Institute including an anatomical pathology laboratory (Pala et al., 
2008), however the results obtained may be attributed to the low level of FA exposure 
(range, 0.01-0.05 ppm) and  the reduced number of subjects evaluated. 
In the present study, both CAs sub-types were statistically elevated in PBLs of FA- 
exposed workers. As referred earlier, the generation of structural CAs requires one or 
several DNA double-strand breaks (DSBs), CSAs and CTAs formation appear to occur in 
different cellular phases, involve specific DNA repair mechanisms and induce by different 
agents. While CSAs are thought to be formed by direct double stranded breakage in vivo 
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in G0/G1 lymphocytes (being duplicated during replication), CTAs formation requires 
DNA-replication and arise in vitro from other lesions pre-existing in DNA. However, CTAs 
that survive to an earlier division can be converted by duplication into secondary 
chromosome-types, and in next cell generation appear as CSAs (Savage, 1975; Musak et 
al., 2013). Indeed the significant positive association found in our study between CTAs 
and CSAs (r=0.343, p<0.001) may confirm this association and explain our results. 
Nevertheless, it should be noted that mechanistically, for instance, two close single-strand 
breaks in vivo, not repaired in G1, might produce in metaphase a chromosome type 
break. 
Hence, our findings indicates that FA- exposure is able to induce lesions in chromosomal 
DNA which during repair or DNA synthesis generates DSBs and CAs formation. In 
addition, some stable forms of CTAs seem to survive division and pass in a modified form 
to next cell generation.  
Other variables were analysed in order to obtain more information about the biological 
impact of our results. Therefore, we assessed the number of aberrant cells (cells with one 
CSAs or CTAs break) and multiaberrant cells (cells with CSAs or CTAs type exchanges or 
with more of two breaks/fragments). Significant differences were obtained in both 
variables, with FA-exposed subjects showing elevated number of aberrant and 
multiaberrant cells compared to controls.  
While the majority of CAs are lethal to the cell, others may lead to oncogenic 
transformation, for instance by inactivation of a tumour suppressor gene or activation of 
an oncogene by generating novel fusion proteins capable of initiating carcinogenesis 
(Pfeiffer et al., 2000). Indeed, accumulated data confirms that high CAs frequencies in 
lymphocytes of healthy individuals are predictive of cancer risk (Hagmar et al., 1998). A 
number of factors may collectively influence the association between CAs and cancer 
including exposure to genotoxic carcinogens and internal generation of genotoxic species 
(e.g. oxidative stress) (Norppa et al., 2006). In fact, a significant association was found 
between cancer incidence and CAs (chromatid breaks) and aberrant cells frequency in a 
group of miners exposed to radon – the authors estimated that an increase of 1% in the 
frequency of CAs was associated with an increased cancer incidence of 64% 
(Smerhovsky et al., 2001, 2002). 
 
Our results also showed that FA-exposed workers had significantly higher frequencies of 
gaps (a 65% increase) than controls (Table VIII). Schmid et al. (1986) and Jakab et al. 
(2010) found similar results in vitro experiments and in PBLs of pathologists exposed to 
FA, respectively. Previous reports of individuals occupationally exposed to other 
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chemicals also found significant increases on gaps compared to referents (Tunca and 
Egeli, 1996; Lander et al., 2000; Goud et al., 2004; Almeida-Santos et al., 2005; Skjelbred 
et al., 2011). The validity of scoring and analysing gaps in human biomonitoring studies 
has been the subject of much discussion. One reason is the visual distinction of a gap 
from a break. Although a consensus was reach on scoring criteria their inclusion in studies 
remain controversial (Oostra et al., 2012). Other point of discussion is whether a gap 
represents a true double-stranded break in the DNA of a chromatid, a staining 
discontinuity or an error in chromosome condensation process (“folding defect”) (Savage, 
2004). Our findings, revealed significant positive correlations between gaps and all 
structural CAs endpoints, showing an association with established CAs parameters, and 
confirming this parameter sensitivity for FA genotoxicity evaluation. In fact, results from a 
recent comparative analysis of different types of CAs observed under light microscopy 
and by means of atomic force microscopy showed that most gaps are chromosome 
alterations and should be included in genotoxicity studies (Koleva et al., 2013). This 
statement is further supported by evidence that DNA lesions such as DSBs may affect 
chromatin condensation (Savage, 2004), and by the observation that chromatin relaxation 
is a fundamental pathway in the DNA-damage response (Ziv et al., 2006). Therefore, the 
increase of gaps in FA-exposed subjects may occur as a response to double-stranded 
breakage. Also of note, in opposition to CAs, gaps are reparable, and produce no further 
structural damage on transmission (Savage, 2004), so by being a reversible form of 
damage it may reflect relatively recent genotoxic exposure (Lander et al., 2000). Paz-y-
Miño et al. (2002) tested the correlation between gaps and comet assay, a biomarker of 
recent damage, with positive results. Indeed, we also found a significant positive 
association between gaps and the comet assay parameter (r=0.273; p<0.001), which 
confirm the above hypothesis of the possible biological significance of gaps, and 
reinforces the inclusion of this event as a parameter in biomonitoring studies.  
 
In our study, a significant increase in aneuploid PBLs was found among FA-exposed 
workers compared to controls (Table VI). However, there are limited data available 
evaluating the frequency of numerical CAs in occupational subjects exposed to FA and 
published results are conflicting (Zhang et al. 2010b, Speit et al., 2011). An earlier study 
reported an increase in aneuploid cells in a group of pathologists compared to controls, 
but it did not reach significance (Thomson et al., 1984).  Conversely, a significant 
decrease in aneuploidy was found among workers exposed to FA (0.72 ppm) in a 
pathology department, but the observed lower frequency of aneuploid cells may be 
attributed to the significant increase of apoptotic cells found in the FA-exposed workers 
investigated (Jakab et al., 2010). In fact, in vitro experiments on cell lines showed that at 
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concentrations around 1mM, FA enhanced apoptosis and decreased cell proliferation, 
whereas at lower doses (0.1 mM) it decreased apoptosis and increased cell proliferation 
(Tyihák et al., 2001). Although apoptosis induction was not evaluated in our study, this 
finding may explain the different outcome found in our group of workers exposed to 0.38 
ppm compared to Jakab et al. (2010) study (0.72 ppm). Furthermore, in a recent study FA 
showed to deregulate the expression of miRNAs involved in apoptosis signalling within the 
nasal rats epithelium exposed to FA (Rager et al., 2013), which was in accordance with 
previous findings in pulmonary cells of rats also exposed to FA (Sul et al., 2007).  
Other studies based on a different assay (e.g. fluorescence in situ hybridisation) have also 
yielded mixed results, with cells of professionals exposed to FA showing a significant 
increase of chromosome loss in one study (Orsière et al., 2006) and no significant effect 
in another (Titenko-Holland et al., 1996). 
Nevertheless, it should be noted that aneuploidy is a natural event occurring in healthy 
subjects. Indeed, different studies have showed that in humans about 3% of lymphocytes 
are aneuploid (Fang and Zhang, 2011). It is possible that aneuploid cells are present in all 
tissue types and because of their presence in low percentages they do not post any 
significant pathological danger including oncogenic transformation. On the other hand, 
aneuploidy is a prominent phenotype of cancer, and it has been discussed whether 
aneuploidy is only a byproduct of the oncogenic processes or if it can induce 
tumorigenesis (Fang and Zhang, 2011). Zhang et al. (2010b) reported leukaemia-specific 
chromosome changes (monosomy 7 and trisomy 8) in cultured peripheral blood myeloid 
progenitor cells of workers exposed to FA, this finding suggest that FA- exposure may 
have an adverse impact through an aneugenic effect on the hematopoietic system. 
However, the mechanisms behind aneuploidy are difficult to dissect due to countless 
factors that may be involved. Therefore, taking in consideration the above mentioned 
further studies on the FA potential aneugenic activity are needed before reaching to any 
conclusion. 
 
The results of micronucleus (MN) frequency in PBLs and buccal cells are shown in Table 
VI. Compared to controls, MN frequency was significantly increased in FA-exposed 
workers in both PBLs and exfoliated buccal cells. MN frequency in PBLs was found to be 
approximately 1.6-times higher in the exposed workers compared to control subjects, 
whereas in buccal cells an around 3.8-fold increase was observed. Furthermore, a 
significant higher frequency of nuclear buds (BNbud) in exfoliated buccal cells was also 
found among workers in comparison to controls (2.9-times higher). The increase of 
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damage was higher in buccal cells, which is not surprising since the oral mucosa 
constitutes a site of first contact for inhaled FA. 
Our findings comply with others that reported an increased frequency of MN in PBLs 
and/or epithelial cells among mortuary students and, more recently, in hospital staff 
exposed to FA. Indeed, Suruda et al. (1993) found significant increased frequencies of 
MN in lymphocytes (26%) and buccal mucosa cells (12-fold) in a group of mortician 
students exposed to FA (8h-TWA level, 0.33 ppm) before and after attending to an 
embalming course. A dose-response relationship was observed with cumulative exposure, 
but only for buccal micronuclei. Ying et al. (1997) also reported a significant higher 
frequency of MN in nasal and oral exfoliated cells in anatomy students exposed to FA 
after an 8-week course (8h-TWA level, 0.41 ppm), but no significant difference was found 
for lymphocytes. However, a significant elevated frequency in micronucleated 
lymphocytes was found among 59 pathology and anatomy laboratory workers in a study 
conducted by Orsière et al. (2006). Burgaz et al. (2001, 2002) evaluated MN induction in 
buccal and nasal epithelium from pathology and anatomy workers exposed to FA, an 
increased frequency in both epithelial cells was found in exposed subjects. More recently 
in a group of Portuguese histopathology professionals Ladeira et al. (2011)  reported 
elevated MN frequencies in PBLs and buccal epithelial cells, confirming previous reports 
by Costa et al. (2008, 2011) and Viegas et al. (2010). Ladeira et al. (2011) also evaluated 
the frequency of BNbud, finding a significant increase in FA- exposed workers compared 
to controls. BNbud formation in cells is associated to the elimination of amplified DNA 
and/or DNA-repair complexes (Fenech et al., 2011). Indeed, a recent study showed a 
significant association between a polymorphic gene in repair pathway and nuclear buds 
formation (Ladeira et al., 2013). Elevated frequencies of MN were also found among FA-
exposed workers from industrial units both in PBLs (Jiang et al., 2010) and in nasal 
mucosa cells (Ballarin et al. 1992; Ye et al., 2005).  
In the present work the correlation between MN frequencies in buccal cells and PBLs 
showed to be highly significant (r=0.359, p<0.001). The concomitant increase of MN 
formation in buccal cells (a FA-target tissue) and in PBLs indicates not only that inhaled 
FA is able to induce cytogenetic alterations in circulating systemic cells (distal tissue) but 
also that the damage between this two tissues may be associated, reinforcing the 
biological plausibility of inhaled FA to induce systemic genotoxic effects.  
Finally, in our study, a positive significant correlation was observed between MNL 
frequencies and FA exposure duration (r=0.277, p=0.011). Also, by correlation testing a 
significant positive association was found between FA-level and MNB (r=0.407, p=0.001). 
Moreover, MNL and BNbud frequencies were increased with increasing FA-level of 
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exposure classes (Table XIV), confirming MN as a sensible bioindicator for the evaluation 
of the genotoxic action of FA. 
 
SCEs are known to be increased by exposure to various genotoxic carcinogens (Albertini 
et al., 2000). Our results on SCE frequency (Table VI) agrees with data from other studies 
which reported a higher frequency of this cytogenetic biomarker in FA exposed workers 
compared to referents. Yager et al. (1986) were the first to observe an increase of SCE in 
subjects exposed to FA (mean level, 1.2 ppm) after a 10 week anatomy class compared 
to samples obtained from the same individuals immediately before FA exposure began.  
Shaham et al. (1997, 2002) reported similar findings in two studies involving pathology 
workers exposed to FA, both groups of workers showed significantly higher SCE 
frequencies compared to controls. In the larger study that enrolled 90 professionals, 
workers were divided into a “low exposure group” (mean level, 0.40 ppm) and a “high-
exposure group” (mean level, 2.24 ppm); no significant differences on SCE frequencies 
were found between the two FA-exposed groups. More recently, Ye et al. (2005) 
examined two different types of workers exposed to FA, with different outcomes. One 
group was composed of 18 workers of a FA manufacturing facility (8h-TWA level, 0.82 
ppm) whereas the second group included 16 waiters who were exposed to low levels of 
FA while working in a new ballroom for 12 weeks (5h TWA level, 0.09 ppm). The first 
group showed a significantly increased frequency of SCE in lymphocytes when compared 
to controls, whereas no significant difference was found in waiters, probably due to the 
low level of exposure to FA. Nevertheless, other studies also did not find increased SCE 
rates in workers exposed to FA (Thomsom et al., 1984; Suruda et al., 1993; Ying et al., 
1999). Despite some negative findings, most of the studies have reported positive results, 
confirming this biomarker sensitivity to evaluate occupational exposure to FA (IARC, 
2012). 
The increase of SCE in PBLs of FA-exposed individuals may indicate the inability of the 
cell to efficiently repair replication-blocking lesions induced by the exposure, which results 
in fork collapse and the initiation of homologous recombination (HR) for repair. Moreover, 
there is some evidence that implicates the presence of single-strand breaks (SSBs) in 
DNA as the primary lesion that leads to SCE formation. The mechanism is likely to 
involved an unrepaired SSB, a DSB formation upon replication fork collapse, and HR (with 
the sister chromatid) to facilitate accurate repair (Wilson and Thompson, 2007). An 
increase of repair activity leads to an increase of SCE, which may explain the elevated 
frequency of this biomarker in PBLs of FA-exposed workers. Interestingly, we found 
significant positive associations, although weak, between this endpoint and double-strand 
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breakage parameters, namely Total-CAs (r=0.172; p<0.05), CTAs (r=0.159; p<0.05) and 
gaps (r=0.156; p<0.05). In conclusion, the increase on SCEs frequency found in the 
present study and previous reports may reflect the repair of FA- induced DNA lesions by 
HR.  
 
Compared to the cytogenetic endpoints above described, the comet assay was recently 
introduced as a useful technique in human biomonitoring studies, allowing the evaluation 
of DNA damage (single and double strand breaks and abasic sites) at the single cell level. 
Hence, there are only a few studies published on FA occupational exposure in which this 
biomarker is used. In our study, the levels of DNA damage measured as percentage of tail 
DNA (%TDNA) were significantly increased in PBLs of FA-exposed professionals 
compared to controls (Table VI). This result agrees with Yu et al. (2005) and Jiang et al. 
(2010) who reported a significantly increase in comet assay parameters, comet tail length 
and olive tail moment, in workers exposed to FA (mean level, 0. 83 ppm) from two 
plywood factories. In contrast, no significant differences in comet assay endpoints was 
found in PBLs of workers from fiberboard plants compared to controls, however the 
results obtained in this study may be attributed to the low level of exposure to FA, 0.2 ppm 
(Aydin et al., 2013).  
Comet assay has also proved to be a sensitive biological indicator in the evaluation of the 
genotoxic effect of FA in several in vitro experiments using cell lines or cells from FA-
exposed rodent or humans (Frenzilli et al., 2000; Emri et al., 2004; Im et al., 2006; Liu et 
al., 2006; Sul et al., 2007). Interestingly, in most of these studies FA showed a “two-
phase” dose-response relationship. At low doses, FA induced an increase in DNA 
migration whereas at higher doses a decrease in DNA migration was observed.  
The DNA damaging and crosslinking effects of FA may explain this finding. Hence, at low 
concentrations, it induces strand breaks whilst at higher concentrations crosslinking 
activity seems to become the dominant lesion (Frenzilli et al., 2000). This is further 
explained by excess of FA-induced lesions at high concentrations which may overwhelm 
the cell repair capacity and result in the accumulation of cross-link lesions and the 
decrease in DNA migration; while the strand breaks observed at low concentrations are 
indicative of repair processes in progress or incomplete. Indeed, SSBs are often 
intermediates during repair of other DNA lesions. In fact, Saccharomyces cerevisiae 
strains defective in excision-repair of pyrimidine dimers showed to be more susceptible to 
the lethal effects of FA and a reduced capacity to undergo single-strand breaks compared 
to the wild type, which seems to suggest that SSBs are a step in the repair process of FA-
induced lesions (Magaña-Schwencke et al., 1978; IARC, 2006). 
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In the present study, no significant differences were found regarding TCR-Mf (Table VI). 
To our knowledge, this is the first study in which TCR-Mf was evaluated in workers 
exposed to FA. Although this assay has shown to be a sensitive indicator for exposure to 
radiation and chemicals in some studies (Kubota et al., 2000; García-Lestón et al., 2012) 
others did not find the same result (Chen et al., 2006). 
 
4.4.2 Immune-markers: Lymphocytes subpopulations  
The percentages of the different lymphocyte subsets in peripheral blood of exposed and 
control subjects were assessed as indicators of possible FA exposure-related 
immunotoxicity. The reference ranges for lymphocyte subsets in Caucasian population are 
approximately, 60-87% for total T lymphocytes (CD3)+, 32-61% for T-helper cells (CD4+), 
14-43% for T-cytotoxic cells (%CD8+), 5-20% for B cells (%CD19+) and 4-28% for NK cells 
(CD16+-56+) (Santagostino et al., 1999). Our results in both groups fall within these 
expected ranges and are also in accordance with recent data published for a Portuguese 
population by García-Lestón et al. (2011).  
Regarding the FA exposure effect when comparing both groups, no statistically significant 
differences were observed for total T lymphocyte and T-helper cells (Table XI). However, 
in the exposed group a significant increase in the percentages of T-cytotoxic cells and NK 
cells were found along with a significant decrease of percentage of B cells (Table XI). A 
lower ratio of CD4+/CD8+ (Th/Tc) was also observed with statistical significance, due to 
increase of T-cytotoxic cell subpopulation in the exposed group. 
Our findings are in agreement with other studies, which showed that FA exposure may 
affect immunological parameters. Tang et al. (2009) summarised eight studies concerning 
FA-induced immunotoxicity and hematotoxicity. In one of the studies regarding clinical 
pathology personnel (FA exposure-levels between 0.2 and 0.8 ppm) a significantly higher 
proportion of the exposed subjects (14%) showed abnormal white blood cell (WBC) 
counts compared to controls (5%). Moreover, an investigation by Zhang et al. (2010b) on 
the ability of FA to disrupt haematopoiesis revealed a significant decrease in total WBC 
counts, granulocytes and lymphocytes in a group of FA-exposed workers (mean FA 
exposure-level, 1.28 ppm). In a recent study involving fibreboard plant workers exposed to 
low-levels of FA (mean level, 0.2 ppm) no significant differences in peripheral blood cells 
in terms of total WBC, red blood cells, neutrophils, and monocytes were found; 
nevertheless significant alterations in total lymphocyte and lymphocyte subpopulations 
were detect between workers and controls (Aydin et al., 2013). Conversely, in other 
studies lymphocyte subsets and WBC counts were not significantly influenced by FA 
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exposure (Tang et al., 2009). It should be noted, however, that the available data on 
immunotoxicity and hematotoxicity in FA-exposed populations are still sparse, which may 
contribute to the inconsistent data.  
In our study, the increased percentages of T-cytotoxic cells and NK cells may indicate an 
activation of the immune response in workers exposed to FA at a mean level of 0.38 ppm. 
T-cytotoxic lymphocytes are cells enrolled in cell-mediated immune responses. Their 
function is to destroy compromised or stressed cells (e.g. infected cells or tumour cells) by 
recognition on the cell surface of a specific antigen presented by MHC class I (present in 
all nucleated cells).  NK cells are effector lymphocytes of the innate immune system that 
have also cytotoxic function but do not form immune memory. NK cells are able to detect 
compromised cells tagged by antibodies or deficient in MHC class I surface marker. 
Recent research highlights the fact that NK cells are also regulatory cells engaged in 
reciprocal interactions with dendritic cells, macrophages, T cells and endothelial cells 
(Viver et al., 2008). Upon activation, T-cytotoxic lymphocytes and NK cells migrate to the 
site of inflammation or injury where they may exert their cytolytic function depending on 
the combination of inhibitory and activating signals conveyed by the target. 
In fact, mild nasal epithelium lesions and a decrease in nasal epithelial cells have been 
consistently reported in workers exposed to FA (Edling et al., 1988; IARC, 2006). 
Moreover, FA is a mucous membrane irritant as demonstrated in experimental and human 
studies (IARC, 2006). A non-specific, non-allergic pro-inflammatory effect of inhaled FA 
was suggested (Pazdrak et al., 1993), and clinical findings of upper respiratory tract 
inflammation were reported in workers exposed to FA (Lyapina et al., 2004). Substances 
that elicit inflammatory events may provide a ‘danger’ signal to the immune system 
leading to activation of lymphocytes and other cells involved in immune response. 
Therefore, it is possible to speculate that the observed increase of T-cytotoxic 
lymphocytes and NK cells in exposed subjects may occur in response to the irritant 
properties of FA in the upper respiratory tract mucosa and tissue inflammation. Similarly, a 
significant increase on percentages of total T lymphocytes and NK cells were recently 
reported in workers exposed to 0.2 ppm, confirming our findings (Aydin et al., 2013). 
Our data also show a significant decrease of %B cells in the exposed individuals 
compared to controls. In workers exposed to benzene and polycyclic aromatic 
hydrocarbons, B cells revealed to be more sensitive than T cells to the genotoxic effects 
of these compounds (Sul et al., 2002, 2003), which may probably be the case of FA and 
would explain our findings. 
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Further, the observed decrease in B cells suggests immunosuppression and decreased 
ability to respond to exogenous aggressions (e.g. virus, bacteria) in FA-exposed 
individuals. B cells are involved in organism’s humoral response against antigens and 
engaged in the adaptive immune response system that enables a quick response of the 
organism to a relapsed infection. Upon activation, B cells differentiate into plasma cells 
producing specific molecules, antibodies, which eliminate targeted antigens (Janeway et 
al., 2001).  
Although FA-exposed subjects showed as a whole increased %NK cells with regard to the 
controls, when analysing the effect of work-related factors on the endpoints studied, we 
found a clear decrease in these cells associated with the highest FA-levels of exposure 
(Table XIV), specifically at levels equal or above 0.35 ppm, showing percentages lower 
than the control population, which may indicate that at high exposure levels FA induce a 
decrease in immune response. 
Indeed, a decrease in NK cells was reported for workers exposed to mean-airborne 
concentrations of 1.28 ppm (Hosgood et al., 2012). In a recent study, FA exposure in mice 
(10 ppm for 6h/day and 5 days/week) caused a selective NK cell deficiency, without any 
defect in other lymphocytes, by impairing NK cell differentiation (Kim et al., 2013). 
NK cells function comprises the control of several types of tumours and microbial 
infections by limiting their spread and subsequent tissue damage (Vivier et al., 2008).   
Our findings suggest that workers exposed to FA are potentially more susceptible to 
infectious agents. Indeed, several studies describe a reduced resistance to infections 
(upper respiratory tract infections, recurrent rhinitis and pneumonitis) in individuals 
occupationally exposed to FA (IARC, 2006). In the study of Zhang et al. (2010b), 40% of 
the exposed subjects had recent respiratory infections. Lyapina et al. (2004) measured 
neutrophil respiratory burst activity (NRBA) in 29 workers exposed to FA (mean level, 0.71 
ppm). Exposed workers showed a significant increase in upper respiratory tract 
inflammations compared to controls, but no significant differences in spontaneous or 
stimulated NRBA assays were found between them.  
Further, viral associated cancers are increased in immunosuppressed individuals, most 
likely due to the inability of the organism to limit viral replication and/or expansion of 
infected cells (Schulz, 2009; Hosgood et al., 2012). The Epstein-Barr virus (EBV) is 
strongly implicated in the aetiology of nasopharyngeal carcinoma (Gullo et al., 2008). In 
fact, the risk of nasopharyngeal carcinoma in workers exposed to FA was more 
pronounced among EBV seropositive individuals than non-seropositive (Hildesheim et al., 
2001). 
107 
PRESENT STUDY 
 
Although our results are in agreement with published data, lymphocyte subpopulations 
were differently affected in few other studies. For example, in a group of 23 medical 
students exposed to FA (mean FA-level of exposure, 0.41ppm) during an 8-week anatomy 
class, Ying et al. (1999) found a significant increase in B cells and a significant decrease 
in total T cells, T-helper-inducer cells and T-cytotoxic-suppressor cells. Similarly, Ye et al. 
(2005) reported a significant increase in B cells and decrease in total T cells and T-
cytotoxic-suppressor cells in 18 workers from a FA manufacturing facility (mean FA-level 
of exposure, 0.98 ppm). Interestingly in both studies, the pattern of immune alteration was 
the same at lower (0.41 ppm) and higher (0.98 ppm) levels of FA exposure. The small 
sample size or/and the FA level of exposure may have contributed to the different 
outcomes observed between these studies and the present work. Another factor that may 
also contribute to explain the different results is individual susceptibility. One of the 
enzymes involved in FA detoxification is the mitochondrial aldehyde dehydrogenase-2 
(ALDH2) (Teng et al., 2001). ALDH2 gene has an inactive ALDH2*2 allele; the presence 
of the mutant allele leads to the decrease or absence of ALDH2 catalytic activity (Wang et 
al., 2002; Brennam et al., 2004). Approximately 50% of East Asians carry the mutant 
inactive ALDH2*2 allele (Brennam et al., 2004; Oota et al., 2004), whereas nearly all 
Caucasians carry the functional ALDH2*1/1 genotype (Chambers et al., 2002; Brennam et 
al., 2004). Furthermore, in a recent Chinese study FA-exposed workers carrying the wild-
type genotype had a significant increment in formic acid in urine compared with workers 
carrying the mutant genotype, confirming that ALDH2 genotypes may influence FA 
metabolism (Cheng et al., 2008b). Therefore, genetic variables may modulate the 
response to FA exposure and affect differently the populations exposed. 
Overall, our findings indicate that inhaled FA may induce alterations in lymphocyte 
subsets in exposed workers.  
These results should be carefully interpreted until confirmation in further studies. Although 
study population was homogenous regarding major confounding factors, and the 
statistical analysis took them into account, it is known that the lymphocyte subpopulations 
can vary depending on different life situations (Moszczynski et al. 2001).  
Also of note, modifications in the immune parameters do not always give measurable 
effects. Moreover, even if an immunotoxic effect is shown, it does not always imply clinical 
consequences (Vial et al., 1996).  
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4.4.3 Effect of lifestyle factors and parameter-specific confounders on the 
biomarkers studied 
In human biomonitoring studies is important to assess the influence of major potential 
confounding factors such as gender, age and smoking habits in the biomarkers studied.  
 
4.4.3.1 Biomarkers of genotoxicity 
In the present study, age was found to be a confounder for CSAs, MNL and MNB, with 
frequencies increasing significantly with aging (Tables VIII and IX). This influence was 
further confirmed by the significant positive correlation found between age and MNL and 
MNB frequency. Our data is in accordance with previous studies (Carbonell et al., 1996; 
Bolognesi et al., 1997; Bonassi et al., 2001, 2011) reporting a positive association 
between age and cytogenetic biomarkers. The observed age-related effect is probably 
associated with a progressive increase in spontaneous chromosome instability and the 
loss of efficiency in DNA repair mechanisms, which may result in the accumulation of 
genetic lesions with increasing age (Bolognesi et al., 1999). 
Cigarette smoking had a significant influence on aneuploidy in PBLs (decrease) and MNB 
frequencies in oral mucosa (increase) (Table IX). Further, the significant correlations 
found between these biomarkers and packs/year confirmed the observed effect of tobacco 
smoking on these endpoints.  
Tobacco smoke contains a high number of mutagenic and carcinogenic substances, such 
as benzene, arsenic and FA. Epidemiologically it has been associated with a higher risk 
for cancer development, especially in the oral cavity, larynx, and lungs, as these are 
places of direct contact with the carcinogenic tobacco compounds (IARC, 2004). 
With regard to our data, the significant decrease of aneuploid PBLs found in smokers 
might be related with a higher apoptotic activity in these subjects induced by the increased 
levels of DNA damage resulting from tobacco smoking. Indeed, exposure of rats to 
mainstream cigarette smoke produced a significant and time-dependent increase in the 
proportion of apoptotic cells in the bronchial and bronchiolar epithelium (D’Agostini et al., 
2000). Some authors have reported lower damage in PBLs of healthy smokers compared 
to never-smokers (Wang et al., 2003; Lao et al., 2008). Furthermore, smokers have 
showed an increase on baseline repair capacity (Wei et al., 2000a), probably as an 
adaptation resulting from the increased demand for repair stimulated by the continuous 
damage caused by tobacco carcinogens. The genotoxicity of mainstream tobacco smoke 
and cigarette smoke condensate has been demonstrated in vitro and in vivo experiments, 
although human studies have produced mixed results (DeMarini, 2004). Nevertheless, it is 
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important to note that the unbalanced number of smokers and non-smokers in our study 
limits the value of the data obtained and restricts possible conclusions, so larger studies 
are necessary to confirm this result. 
Several studies have described an increase on MN formation in exfoliated buccal cells of 
smokers (Goud et al., 2004; Gabriel et al., 2006; Proia et al., 2006; Nersesyan et al., 
2011). In fact, smoking was the only lifestyle variable that significantly influenced the level 
of micronuclei in the oral mucosa of 120 healthy individuals, with smokers showing higher 
frequency of MNB compared to controls (Konopacka et al., 2003). Furthermore, our 
results showed a significant positive association with packs/year. Similarly, among a 
group of tobacco smokers Wu et al. (2004) found a significant positive trend between 
MNB frequency and either daily cigarette consumption or cumulative smoking pack-years. 
Yet other publications report no difference between smokers and non-smokers (Karahalil 
et al., 1999; Nersesyan et al., 2006; Holland et al., 2008). Nevertheless, a recent meta-
analysis found significant increases in the MNB frequency but only in heavy smokers (40 
cigarettes/day) (Bonassi et al., 2011). 
In our study, fruit consumption was found to significantly decrease the DNA damage 
measured by comet assay %TDNA parameter (Table X). Epidemiological studies 
consistently report that a balanced diet rich in fruit and vegetables is associated with a 
reduced risk of cancer and heart disease (Duthie et al., 2006). Indeed, fruits are rich in 
several phytochemicals and antioxidants such as vitamin C and flavonoids that inactivate 
reactive oxygen species (ROS) involved in the initiation or progression of these chronic 
diseases (Brevik et al., 2011a). Therefore regular fruit consumption protects against the 
oxidative damage of DNA and thus might prevent mutation and cancer. Human 
supplementation trials investigating the anti-oxidant effect of fruit consumption measured 
by comet assay (classical and modified versions) have, however, given ambiguous results 
(Hoelzl et al., 2009). In some studies, kiwifruit (juice or whole fruit) consumption showed to 
significantly decrease the levels of DNA breakage in lymphocytes (induced by H2O2) and 
formation of endogenous oxidised bases (measured by incubation with lesion-specific 
enzymes) indicating an increased antioxidant capacity with fruit intake (Collins et al., 
2001; Collins et al., 2003; Brevik et al., 2011b). Conversely, in other trials, no effect in 
oxidative damage or repair in PBLs was observed after fruit consumption (Duthie et al., 
2006; Yuan et al., 2011). Our data suggest that regular consumption of fruit may actually 
protect against DNA damage, however, one shortcoming of our study was the lack of 
information concerning the type of fruit consumed which would enable further conclusions.  
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4.4.3.2 Lymphocyte subpopulations 
In the present study significant influence of the major confounding factors, gender and 
age, were observed for some lymphocyte subpopulations (Table XII).  
Previous studies have demonstrated gender-related differences in immune cell 
percentages (Santagostino et al., 1999; Jentsch-Ullrich et al., 2005; Yan et al., 2010). The 
total lymphocyte count is generally similar in males and females, but the percentage of T 
cells within the lymphocyte population tends to be lower in males (Yan et al., 2010) mostly 
because of total T lymphocyte and T-helper cells decreases (García-Dabrio et al., 2012). 
Percentage of T-cytotoxic cells usually does not differ between males and females 
(Jentsch-Ullrich et al., 2005). However, in our study males had a significantly lower 
percentage of T-cytotoxic cells compared to females. No significant differences were 
found between genders for T lymphocytes and T-helper cells.  Some evidence suggests 
that the influence of gender on T lymphocyte subsets is related to sex hormones, although 
the processes involved are not well understood. Two different mechanisms have been 
proposed: acceleration of thymocyte apoptosis by androgens, which may mediate 
processes of thymocyte selection and shape the peripheral T cell repertoire (Olsen et al., 
1998) or the effect of binding to cell receptors for the sex steroids present on T cells 
(Chng et al., 2004, Pierdominic et al., 2010).  
The influence of age in the immune system has been described in several studies 
(Jentsch-Ullrich et al., 2005; Saule et al., 2006; Andreu-Ballestar et al., 2012). Age is 
known to affect the immune function and the percentages of circulating lymphocytes in a 
process often designated as "immunosenescence" (Yan et al., 2010). Aging of the 
immune system is characterised by a decrease in immunocompetence. Hence, it may 
lead to infections or autoimmune diseases and be involved in the pathogenesis of several 
age-related disorders, such as cardiovascular or neurodegenerative disorders (Laffon et 
al., 2013). In our study, a significant decrease with age was found for T-cytotoxic cells 
whereas total T lymphocytes and T-helper cells were significantly increased (Table XII). 
The effect of age in these endpoints was further confirmed by correlation analysis. Other 
authors (Tollerud et al., 1990; Chng et al., 2004) found similar results. Moreover, in a 
recent study carried out in a Mediterranean population (Spain) a significant positive 
correlation with age was found for T-helper cells, in addition, an inverse trend was 
observed for T-cytotoxic cells, but it did not reach statistical significance (García-Dabrio et 
al., 2012). The impact of age on lymphocyte subsets is not well established with different 
studies reporting contrasting results (Bisset et al., 2004; Coelho et al., 2011; García-
Lestón et al., 2011; Andreu-Ballester et al., 2012). T lymphocyte generation in aging is 
known to result from dynamic changes in thymic as well as extrathymic functions, along 
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with sequential developmental steps from stem cells to ultimately mature cells (Jentsch-
Ullrich et al., 2005). Therefore, the age range of subjects studied, methodological 
features, environmental and genetic factors may influence the results and account for the 
differences (Jentsch-Ullrich et al., 2005; Andreu-Ballester et al., 2012).  
 
In our study, multivitamin supplement intake was found to significantly increase               
T-cytotoxic cells percentage (Table XII).  Furthermore, fruit consumption was also found to 
increase T-helper cells percentage, but it did not reach significance. The link between diet 
and immunity has long been established. Systematic studies have consistently shown that 
nutritional deficiency impairs immune response, particularly cell-mediated immunity by 
reducing number and functions of T-cells, phagocyte function, cytokine production, 
secretory antibody response, antibody affinity and complement system (Chandra, 1999). 
Similar findings have been reported for moderate deficiencies of individual nutrients such 
as trace minerals and vitamins, particularly Zn, Fe, Se, vitamins A, B6, C and E (Chandra, 
1999; Liu et al., 2011). The use of nutrient supplements, singly or in combination, 
stimulates immune response and may lower the incidence of infection or reverse some of 
the changes associated with impaired immune responses in some chronic diseases 
(Grzegorzewska and Leander, 2005) and in elderly people (High, 2001). In a randomised 
placebo-controlled intervention study, healthy volunteers consumed probiotic multivitamin 
and mineral supplement for 3-5 months during winter/spring period. Leukocytes, 
lymphocytes, in particular T-lymphocytes including T-cytotoxic cells and T-helper cells, as 
well as monocytes were significantly increased in the “supplementation” group, during the 
first two weeks of supplementation compared to placebo. Additionally, in the 
“supplementation” group the incidence and severity of symptoms related to common cold, 
frequent at that time of year, were reduced. Overall, according to published data, 
multivitamin supplementation intake and a balanced diet (rich in vitamins and anti-
oxidants) improve the immune status, which is in agreement with our findings. 
 
4.4.3 Correlations between biomarkers studied  
The association found between MNL frequencies with CAs parameters and gaps is 
related to the fact that both endpoints are able to indicate chromosomal and chromatidic 
breaks, which suggests chromosome breakage as the primary mechanism of FA-related 
micronuclei formation. In fact, in an earlier study by Titenko-Holland et al. (1996) it was 
detected a greater increase in centromere-negative micronuclei content in buccal and 
nasal tissues of FA-exposed students, however Orsière et al. (2006) found higher 
frequencies of centromere-positive micronuclei (monocentric) in health professionals 
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exposed to FA. Our findings, comply with recent studies by Speit et al. (2011) 
(mammalian cell lines) and Costa et al. (2011) (FA-exposed pathology anatomy workers) 
indicating a clastogenic action of FA, thus confirming previous results from Titenko-
Holland et al. (1996). A significant association was found between CSAs and %TDNA, but 
the coefficient was relatively low. This association is not surprising since %TDNA detects 
DNA strand breaks, including double-strand breaks.  
Concerning the immune markers, T-cytotoxic lymphocytes were inversely correlated with 
B cells (r=-0.577, p<0.001). As mentioned earlier, B lymphocytes seem to be more 
sensitive to genotoxicity induced by organic compounds exposure than T lymphocytes 
(Sul et al., 2002, 2003). The primary function of T-cytotoxic lymphocytes is to remove 
compromised or stressed cells. The inverse correlation found may result as a response to 
stressed B cells. Further, T-cytotoxic lymphocytes were positively associated with 
genotoxicity endpoints, while B cells were inversely correlated. Genotoxicity events have 
been shown to alter immune responses (Gasser and Raulet, 2006). No previous studies 
were found reporting similar results. Nevertheless, our findings indicate that increased 
levels of DNA damage are associated with alterations in immune system. 
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5. BIOMARKERS OF SUSCEPTIBILITY 
 
5.1 OVERVIEW 
 
5.1.1. Genetic polymorphisms as susceptibility biomarkers 
About 99.9% of the DNA is identical in every human genome (Hirvonen et al., 2008). The 
0.1% difference is responsible for the inter-individual variation and the unique phenotype 
of each individual. These minor differences correspond to genetic variations in the DNA 
sequence, known as polymorphisms. The majority of polymorphisms are single nucleotide 
polymorphisms (SNPs), changes at a single DNA base, which occur with a frequency of 
10-6 throughout the human genome (Rueff et al., 2002). SNPs play an important role in 
modulating susceptibility to diseases as well as in the individual response to various drugs 
and environmental carcinogens (Hemminki and Shields, 2002).  
In simple terms, SNP’s can alter an individual’s response to a chemical exposure by 
interfering with the expression or function of proteins involved in their metabolism or in the 
repair of the chemical-induced DNA lesions. SNPs in gene coding regions can lead to 
changes in the biological properties of the encoded protein. In fact, about 50% of the 
SNPs in the coding regions results in a change in the amino acid protein sequence 
(Hirvonen et al., 2008). On the other hand, SNPs in non-coding regulatory regions may 
affect gene expression levels in an allele-specific manner (Wang et al., 2005). 
Altered function of low penetrance genes due to SNPs may affect the gene-environment 
and gene-gene interaction, thereby increasing the risk of cancer development (Hirvonen 
et al., 2008). Therefore, the identification of sequence polymorphisms that modulate gene 
expression or function is crucial for understanding human genetic differences and 
diseases (Pastinen et al., 2004) and to recognise susceptible groups in the population. 
Genetic polymorphisms are thus considered to play a primary role in individual response 
to carcinogen-induced disease (Teixeira et al., 2004). Therefore, in recent years, they 
have been used as susceptibility biomarkers in human biomonitoring studies to assess the 
risk of exposure to genotoxic chemicals. 
 
5.1.2. Genetic Polymorphisms, DNA damage and Cancer Risk 
Cancer is a multifactorial disease that results from complex interactions between genetic 
and environmental factors (Hirvonen, 2008). This means that with few exceptions (e.g. 
Mendelian cancer syndromes such as retinoblastoma) the cause is not entirely genetic or 
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entirely environmental (Rueff et al., 2002) and is not a single gene or single environmental 
factor that has large effects on cancer susceptibility (Kiyohara et al., 2007). Instead, 
various genetic and biologic aspects (e.g. gender, ethnicity) and exogenous factors (e.g. 
environmental/occupational exposure to carcinogenic compounds, lifestyle factors, 
nutritional status) play a joint role in the process of carcinogenesis (Rueff et al., 2002) 
(Figure 16).  
 
 
 
 
 
 
 
 
 
Figure 16. Both environmental and host factors acts in concert in individual susceptibility (genetic and 
acquired) for disease development (retrieved from Perera, 1997) 
 
Biologically, cancer is considered to be a genetic disease, caused by genetic alterations at 
either chromosomal or gene levels, as identified in most cancers (Wei et al., 2000b). It is 
also agreed, that genetic polymorphisms are associated with most common disorders with 
a genetic component (Rueff et al., 2002). Nevertheless, as mentioned before, 
susceptibility-conferring alleles are not sufficient to cause disease, but modulate the risk in 
combination with other alleles and environmental exposures. 
It is known that environmental carcinogens, as a result of complex metabolism, are able to 
interact with DNA and produce measurable alterations evaluated by several biomarkers of 
lesion (e.g. DNA adducts, chromosomal aberrations, micronucleus) (Rueff et al., 2002; 
Mateuca et al., 2008). Interestingly, it has also been observed that the correlation between 
the levels of the different biomarkers and levels of exposure are not always linear, 
suggesting that intra-individual susceptibility play an important role in processing the 
damage (Rueff et al., 2002). Indeed, several studies have shown that the level of 
biomarkers arising from environmental and/or occupational exposure may be influenced 
by polymorphic genes coding for enzymes engaged in metabolic or repair processes 
(Pavanello and Clonfero, 2000; Hung et al., 2005; Mateuca et al., 2008). Therefore, the 
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complex metabolism of carcinogens, involving different polymorphic genes, as well as 
gene variants of DNA repair mechanisms, can modulate the individual susceptibility for 
cancer (Pavanello and Clonfero, 2000). This is best exemplified by tobacco smoking; 
cigarette smoking is one main cause of lung cancer but only a relative minority of smokers 
develop pulmonary cancers.  
 
5.1.3. Xenobiotic-metabolising enzymes 
The balance between phase I and phase II metabolic enzymes is an important 
determinant of whether exposure to carcinogens will result in toxicity or increased levels of 
genetic damage (Talalay et al., 1990).  
Most carcinogens undergo activation by phase I enzymes, often as an oxidation reaction, 
and detoxification by phase II enzymes. The cytochrome P450 enzyme superfamily 
constitutes the majority of phase I enzymes, whilst the glutathione S-transferases (GSTs) 
and N-acetyltransferases (NATs) are primarily responsible for detoxification of xenobiotics 
in phase II. 
Phase I enzymes are generally involved in the metabolism of xenobiotic compounds with 
hydrophobic character, producing more polar intermediates that are easily excreted from 
the cell. However, phase I metabolism may also result in the activation of carcinogenic 
compounds, yielding reactive electrophilic metabolites that can react with cellular 
macromolecules, like DNA. The action of phase II enzymes, generally contributes to 
detoxifying metabolism of more hydrophilic carcinogens. Phase II enzymes, also act on 
phase I carcinogenic metabolites, transforming them into inactivated compounds that are 
then excreted. Less frequently, GSTs and NATs can also mediate activating steps for 
some carcinogen metabolites. 
Genetic polymorphisms exist in a number of phase I (activating) and phase II (inactivating) 
enzymes. Hence, it is plausible that individuals with genotypes associated with a more 
efficient activating enzyme and/or a less efficient inactivating enzyme might be at 
particularly high risk of adverse health effects, if exposed to toxicants. Indeed, 
accumulated data suggest that polymorphisms in genes controlling carcinogen 
metabolism and thus the metabolic capacity may in fact play a primary role in 
susceptibility to environmentally induced diseases, such as cancer.  
 
5.1.3.1. Polymorphisms of phase I enzymes studied: Cytochrome P450 family 
The Cytochrome P450 (CYPs) system is the most important enzymatic system involved in 
phase I of human metabolism (Rueff et al., 2002). CYPs constitute a superfamily of a 
116 
PRESENT STUDY 
highly diverse group of haem-containing enzymes responsible for the oxidative 
metabolism of a wide range of drugs and toxic hydrocarbons. All CYPs exhibit similarity in 
their structure and general mechanism of action; NADPH is required as a coenzyme and 
O2 is used as a substrate. However, there are significant differences in substrate 
specificity due to structural variations at the active site. Based on sequence homologies, 
human CYPs are divided into families and subfamilies.  
The highest concentration of CYPs is in the liver, where it determines the intensity and 
duration of drug action and promotes the detoxication of some xenobiotics. Extrahepatic 
tissues, especially those that are portals of entry for foreign compounds, such as the 
respiratory tract, also express xenobiotic-metabolising CYPs. In these tissues, CYPs not 
only contribute to the first-pass clearance but may also influence the tissue burden of 
foreign compounds or bioavailability of therapeutic agents. In the cell, these enzymes are 
primarily located in the membrane of the endoplasmatic reticulum (microsomes), but they 
are also found in the mitochondrial membrane. 
During biotransformation, xenobiotics are either detoxified or activated into reactive 
intermediate substances that might be more toxic than the parent compounds. However, 
not all xenobiotic-metabolising CYPs subfamilies show the same propensity in the 
bioactivation of chemicals. For example, the CYP2B, 2C and 2D subfamilies play virtually 
no role in the bioactivation of toxic and carcinogenic chemicals, whereas the CYP1A, 1B 
and 2E subfamilies are responsible for the bioactivation of the majority of xenobiotics 
(Ioannides C, 2007).  
These reactions can also result in the transfer of electrons to produce oxygen radicals. 
Cytochrome P450‐catalysed reactions can thus produce xenobiotic metabolites and 
oxygen species capable of interfering with cell homeostasis. Over 60 key forms of CYPs 
are known, with hundreds of genetic variations that correspond to different metabolic 
activities and therefore to a wide variety of susceptibility to potential deleterious effects 
induced by toxicants (Autrup H, 2000; Godschalk and Schooten, 2008).  
 
CYP2E1 gene (CYP2E subfamily) 
The CYP2E subfamily has only be described in mammals, and only one CYP2E gene, 
CYP2E1 has been identified in humans (Godschalk and Schooten, 2008).  
CYP2E1 gene encodes the enzyme N,N-dimethylnitrosamino-N-dimethylase, which 
catalyses the metabolism of a wide variety of therapeutic agents, toxicants and low 
molecular weight pro-carcinogens, including benzene, N-nitrosamines and vinyl chloride 
(Anzenbacher et al., 2001). It has a clear toxicological role, since it may activate pro-
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carcinogens, organic solvents and drugs, and potentiate their toxicity by converting them 
into cytotoxic or carcinogenic products (Nedelcheva et al., 1996). 
For instance, this enzyme is involved in the oxidation of compounds, such as ethanol, 
producing reactive oxygen species (ROS), which can affect target tissue and ultimately 
lead to carcinogenesis (Guo et al., 2008). Indeed, a number of studies in cells lines have 
established the importance of this enzyme in oxidative stress (Cederbaum, 2006). During 
ethanol oxidation, the CYP2E1 enzyme produces ROS (O2– and H2O2) that can deplete 
glutathione and cause cellular damage (Gonzalez, 2007). In addition, ROS can further 
react and produce oxidants or result in elevated lipid peroxides that can form adducts with 
cellular nucleophiles such as proteins and nucleic acids (Gonzalez, 2007). 
The enzyme is mostly expressed in the hepatic tissue and can be induced by xenobiotics 
such as ethanol, acetone or isoniazid (Novak and Woodcroft, 2000) all of which are 
substrates. It was also detected, at low levels in human lung and oesophagus (Ding and 
Kaminsky, 2003), and evidence suggests that it can be present in kidney and nasal 
mucosa (Lucas et al., 2001). 
CYP2E1 enzyme was detected by immunochemistry in the white cell fraction of human 
peripheral blood (Lucas et al., 2001). Expression of the CYP2E1 enzyme in lymphocytes 
appears to be influenced by the same factors that affect the concentration of the hepatic 
enzyme, including xenobiotics and physiological status (Raucy et al., 1995; 1997). 
The CYP2E1 gene is present in the human population in various polymorphic forms. 
Although there are a number of SNPs in the CYP2E1 sequence, no known variant results 
in the complete inactivation of the gene, suggesting that the enzyme is essential for 
humans (Gonzalez, 2007).The gene is located in the 10q24.3-qter region of the 
chromosome 10 (Shahriary et al., 2012). It spans 11,413 base pairs and contains 9 exons, 
8 introns, and a typical TATA box (Shahriary et al., 2012). The first alleles were identified 
by restriction fragment length polymorphism (RFPL) analysis. The best studied CYP2E1 
polymorphisms were detected by PstI/RsaI and DraI restriction enzymes, which 
corresponds to SNPs in the 5'-flanking region and in the intron 6 of the CYP2E1 gene. It 
has been shown that polymorphisms detectable by PstI/RsaI can affect the transcription of 
CYP2E1 in vitro. In contrast, DraI polymorphism does not appear to affect gene 
transcription, but rather the CYP2E1 enzyme catalytic activity (Shahriary et al., 2012). 
The allele frequencies of CYP2E1 polymorphisms may differ remarkably among different 
human populations (Garte et al., 2001; Bolt et al., 2003). For instance, the DraI 
polymorphism occurs at a higher frequency in Taiwanese when compared with European 
and African-Americans (Stephens et al., 1994). Additional information on genotype 
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frequency distribution of the polymorphism studied is shown in Annex III. Polymorphisms 
in the CYP2E1 gene have been associated with increased risk of cancer in different sites, 
including breast cancer (Anderson et al., 2012; CYP2E1 intron, allele A), lung cancer (Wu 
et al., 1997; RsaI, allele), nasopharyngeal carcinoma (Kongruttanachok et al., 2001; RsaI, 
allele C) and gastric cancer (Boccia et al., 2007; PsI/RsaI, allele C). 
 
5.1.3.2 Polymorphisms of Phase II enzymes studied: Glutathione S-transferases  
The glutathione S-transferases (GSTs) play a critical role in providing protection against 
electrophiles and products of oxidative stress (Hayes and Pulford, 1995).  
The GSTs are a superfamily of phase II enzymes which catalyse the conjugation of 
reduced glutathione (GSH) with different species of electrophilic compounds, including 
many environmental mutagens and carcinogens and their reactive metabolites (Strange et 
al., 2001). In addition to their role in phase II detoxification, GSTs also play an important 
role in modulating the induction of other enzymes and proteins for cellular functions, such 
as DNA repair (Hayes and Pulford, 1995). Because of their role in the detoxification of 
potentially carcinogenic compounds, these enzymes and the genes encoding them may 
play an important role in cancer susceptibility. 
GST enzymes are present in the cytosol of all eukaryotic cells, but are also bound to 
membranes (Landi, 2000). The human cytosolic GSTs are grouped into eight families of 
GST isoenzymes, including: GSTA (α), GSTM (μ), GSTP (π), GSTS (σ), and GSTT (θ) 
(Raimondi et al., 2006; Hirvonen, 2008). The classification is in accordance with the 
substrate specificity, chemical affinity, structure, aminoacid sequence and kinetic behavior 
of the enzyme (Hayes and Pulford, 1995). Because GSTs have overlapping substrate 
specificities, the deficiencies of a given GST isoenzyme may be compensated by other 
isoenzyme and use of alternative metabolic pathways is possible (Hirvonen, 2008). 
Polymorphisms have been identified in the GSTM1, GSTT1 and GSTP1 genes coding for 
GSTs enzymes in the mu (μ), theta (θ), and pi (π) classes, respectively. These enzymes 
detoxify a wide variety of chemicals, such as reactive epoxides and carcinogens produced 
by tobacco smoke. Genetic polymorphisms in GSTs encoding genes have been 
associated with susceptibility to genetic lesions in populations exposed to several 
environmental carcinogens, including polycyclic aromatic hydrocarbons (PAHs; Butkiewicz 
et al., 2000), styrene (Teixeira et al., 2004) and hydroquinone (Silva et al., 2004). 
Many studies have suggested a predisposing role of GSTs polymorphisms for various 
cancers in different tissues, such as lung, breast and colon (Hirvonen, 2008). However, 
there are also various reports contradicting these findings (Raimondi et al., 2006). One of 
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the reasons of the controversial data may be the overlapping substrate specificities of the 
GSTs enzymes. Therefore, simultaneous determination of different GSTs genotypes 
relevant for a given exposure may be crucial for a reliable interpretation of the role of the 
GST gene family in cancer development (Hirvonen, 2008). Indeed, meta-analyses studies 
have indicated that carriers of both GSTM1 and GSTT1 null alleles have a slightly higher 
risk of developing lung cancer compared to carriers of at least one functional allele 
(Benhamou et al., 2002; Raimondi et al., 2006).  
Additional information on frequency distribution of the GSTs studied among different racial 
groups is available in Annex III. 
 
Glutathione S-transferase T1 gene (GSTT1) 
The encoded GSTT1 enzyme (θ subfamily) is involved in the detoxification of 
monohalomethanes and reactive epoxide metabolites of butadiene, both of which are 
constituents of tobacco smoke (Landi et al., 2000; Hirvonen, 2008).  
GSTT1 gene is located on 22q11.23 region of the chromosome 22; it spans 8092 base 
pairs and contains 5 exons and 4 introns (Yang et al., 2013). The most common 
polymorphism in GSTT1 consists of a deletion of the whole gene (GSTT1*0, null 
genotype) resulting in the lack of active enzyme (Raimondi et al., 2006). The risk 
associated with the null genotype is difficult to predict since the enzyme may have both 
detoxification and toxification activities toward different industrial and environmental 
chemicals. The enzyme in human erythrocytes detoxifies the carcinogen ethylene oxide 
but may enhance the formation of the genotoxic metabolites from dichloromethane (To-
Figueiras et al., 1997). 
The prevalence of GSTT1 null genotype shows a wide variation among different racial 
populations and ethnic groups. For instance, in Caucasians the prevalence is 10–20% 
(Hirvonen, 2008) and in Asians it can vary between 45-60% (Cho et al., 2005). 
The null genotype has been correlated with increased risk of several types of 
malignancies including lung and larynx cancers (Yang et al., 2013, Sørensen et al., 2004; 
Russo et al., 2013). A modest increase in the risk of haematological malignancies 
(lymphoma, leukaemia) was also observed (Ye and Song, 2005; Bin and Luo, 2013). 
However, other studies have reported negative results (López-Cima et al., 2012; 
Sørensen et al., 2007). Some of the observed heterogeneity may be partly due to ethnicity 
(Raimondi et al., 2006).  
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Glutathione S-transferase M1 gene (GSTM1) 
A gene cluster at 1p13.3 region of chromosome 1 encodes the GST µ subfamily 
(Hirvonen, 2008). One of the gene variants includes a deletion and homozygotes 
(GSTM1*0, null genotype) do not express the protein, thus lacking the enzyme activity 
(Hayes and Pulford et al., 1995). GSTM1 enzyme is involved in the detoxification of large 
hydrophobic electrophiles, such as benzo(a)pyrene and other PAHs found in tobacco 
smoke. 
Several epidemiological studies on GSTM1 null genotype have suggested, although 
moderate, an association between this genotype and cancer risk, namely bladder cancer, 
lung cancer, prostate cancer and head and neck cancer (Hirvonen, 2008). Moreover, this 
genotype appears to be associated with a modest increase in the risk of acute 
lymphoblastic leukaemia (Ye and Song, 2005). Some conflicting reports also exist (López-
Cima et al., 2012; Bin and Luo, 2013). However, recent pooled and meta-analyses 
support previous findings suggesting that GSTM1 deficiency can contribute substantially 
to the incidence of cancer at the population level (Engel et al., 2002; Hiyama et al., 2008; 
Mo et al., 2009). 
The distribution of the GSTM1 null genotype varies among racial and ethnic groups. For 
instance the mean reported frequency for the null genotype among Caucasians is about 
50%, while for African descendants is 29 % (Hirvonen, 2008). 
 
Glutathione S-transferase P1 gene (GSTP1) 
The glutathione S-transferase P1 (GSTP1) belongs to GSTP (π) subfamily. A single 2.8 
kb long GSTP1 gene at 11q13 region of chromosome 11, encodes an isoform that is 
known to metabolise many carcinogenic compounds, including polycyclic aromatic 
hydrocarbons (PAHs). GSTP1 is the most abundant glutathione S-transferase in the lungs 
(Cote et al., 2009) and therefore it is thought to be of particular importance in the 
detoxification of inhaled carcinogens (Hirvonen, 2008). 
An A>G transition at nucleotide 313 of the GSTP1 gene results in an isoleucine (Ile) to 
valine (Val) amino acid change at codon 105 (Ile105Val). This produces a variant enzyme, 
which differs in enzymatic activity (more or less effective detoxification) depending on the 
substrate and alters their thermo stability (Mo et al, 2009). The presence of the GSTP1 
Val variant (GG or GA genotypes) is associated with a lower conjugating activity when 
compared to the homozygous GSTP1 Ile variant (AA genotype) (Cote et al., 2009). 
Moreover, having at least one copy of the G allele at this locus is also associated with 
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increased levels of hydrophobic adducts in the lung and higher levels of PAH-DNA 
adducts in human lymphocytes (Butkiewicz et al., 2000). 
The GSTP1 Ile105Val polymorphism has been investigated for associations with breast, 
head and neck cancers, with both positive and negative outcomes (Egan et al., 2004; 
Ruwali et al., 2011). In addition, epidemiological studies of the impact of the            
GSTP1 Ile105Val polymorphism on lung cancer risk including two meta-analyses show 
inconsistent results (Cote et al., 2009; López-Cima et al., 2012).  
 
5.1.4. DNA Repair 
DNA repair is a ubiquitous process throughout the living world and is essential for the 
maintenance of genome integrity. Several identified genes and sequence variants are 
involved in human DNA repair (Au et al., 2003; Rueff et al., 2002). These genes function 
in a complex diverse set of pathways that involve recognition and removal of DNA lesions 
caused by endogenous or exogenous agents and/or correction of DNA errors occurred 
during DNA replication or DNA repair (Ronem and Glickman, 2001). Other genes are 
indirectly involved in DNA repair, by regulating the cell cycle, providing an opportunity for 
repair or controlling apoptosis mechanisms (Moses et al., 2001; Ronem and Glickman, 
2001). 
Both endogenous and exogenous agents are continually inducing cellular DNA damage. If 
unrepaired, the damage can interfere with important cellular functions potentially leading 
to genetic instability, unregulated cell growth and cancer (Au et al., 2003). On the 
contrary, if damage is recognised by cell machinery it can be repaired enabling the cell to 
replicate as planned. At cell level, several responses may occur to prevent replication in 
the presence of genetic errors: checkpoints can be activated to arrest the cell cycle, 
transcription can be up-regulated to compensate for the damage or cell can trigger 
apoptosis (Goode et al., 2002).  
Polymorphisms in DNA repair genes may be innocuous or may change protein function 
and therefore alter individual’s capacity to repair DNA lesions caused by exogenous or 
endogenous agents (Au et al., 2003). A deficient or unrepaired damage can ultimately 
lead to cancer (Ronem and Glickman, 2001).  
Mutations that affect the function of DNA repair enzymes are rare in the human population 
because they cause severe health consequences including higher proneness for cancer 
development (Au et al., 2003). Examples of cancer syndromes where the disease-causing 
mutations occur in DNA repair genes include xeroderma pigmentosum, Fanconi anaemia 
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and Bloom’s syndrome; each disorder shows specific damage sensitivities at the cellular 
level and specific disease phenotypes (Moses et al., 2001).  
The etiologic association between deficient DNA repair and increased cancer risk is also 
supported by evidence from epidemiologic studies of sporadic cancers of the lung (Goode 
et al., 2002), head and neck (Gresner et al., 2012), bladder (Stern et al., 2002) and skin 
(Mocellin et al., 2009). These data strongly suggest that it is important for normal tissues 
to have efficient DNA repair in order to eradicate DNA lesions caused by carcinogens, 
thereby reducing the risk of mutation fixation and subsequent development of cancer (Wei 
et al., 2000b). 
 
5.1.4.1 DNA Repair pathways 
A variety of complex pathways have evolved to perform the critical repair functions. The 
main classic pathways of DNA repair are base excision repair (BER), nucleotide excision 
repair (NER), mismatch repair (MMR) and double-strand break repair (Jeppesen et al., 
2011). Each pathway operates on specific types of DNA lesion and involves numerous 
molecules in the repair processes (Goode et al., 2002) (Figure 17). 
BER (Figure 17A) operates on small lesions (e.g. oxidised or reduced bases; fragmented 
or nonbulky adducts) caused by a variety of factors including ionising radiation and 
alkylating agents (Goode et al., 2002). The process  which aims to remove and replace a 
damaged nucleotide, is typically initiated by one of several substrate-selective DNA 
glycosylases, which recognise and excise base modifications, such 8-oxo-7,8-dihydro-2'-
deoxyguanosine (8-oxo-dG), among others (Wilson et al., 2011). The resulting abasic site 
is incised by an AP endonuclease (APE1). The baseless phosphodiester backbone and 
adjacent nucleotides are then removed and the gap is filled by DNA polymerase β that 
uses the other strand as a template for the DNA synthesis (Collins, 1996). The final step is 
ligation of repair patch into the pre-existing DNA strand by a DNA ligase, which in 
mammals is typically ligase III in complex with x-ray cross-complementing protein 1 
(XRCC1) (Almeida and Sobol, 2007).  
NER (Figure 17B) is the major pathway in humans for the repair of bulky lesions, such as 
UV-induced pyrimidine dimers and chemical adducts, induced by environmental 
carcinogens (Au et al., 2003). In the NER repair process, the distortion of the double helix 
(e.g. bulky adduct) is recognised by a complex of bound proteins including XPC; the 
formation of the transcription factor complex, TFIIH, allows the unwinding of the DNA and 
the removal of the damaged single-stranded fragment (usually about 27–30 nucleotides); 
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the DNA synthesis is carried out by DNA polymerase δ using the other strand as a 
template (Goode et al., 2002).  
The MMR (Figure 17C) maintains genomic stability by correcting replication errors, such 
as mispairings (base-base or insertion-deletion mismatched) caused by DNA polymerase 
during replication (Aquilina and Bignami, 2001; Goode et al., 2001). The process begins 
with specific repair proteins recognising and binding to the mismatched bases, further 
enzymatic action proceeds to exonucleolytic degradation, DNA resynthesis and ligation 
(Aquilina and Bignami, 2001). 
Double-strand breaks, DSBs, (Figure 17D) can be produced by replication errors and by 
exogenous agents (e.g. ionising radiation) (Goode et al., 2002). DSBs are the most 
serious form of DNA damage because they pose problems for transcription, replication, 
and chromosome segregation. DSBs affect both strands of the DNA duplex and therefore 
prevent the use of the complementary strand as a template for repair. Cells have evolved 
at least two different mechanisms of DSBs repair: Homologous recombination (HR) and 
Non-homologous end-joining (NHEJ). The first is a highly accurate repair process that 
corrects DSBs defects in an error-free manner using a mechanism that retrieves genetic 
information from the homologous, undamaged DNA molecule. The majority of HR-based 
repair takes place in late S- and G2-phases of the cell cycle when an undamaged sister 
chromatid is available for use as repair template (Khanna and Jackson, 2001). 
Conversely, the NHEJ repair mechanism is error prone, since it  re-joins the two broken 
ends of DNA directly, which frequently can lead to small alterations (base pair 
substitutions, insertions and deletions) in the DNA sequence (Khanna and Jackson, 
2001).  
 
The Fanconi Anaemia (FANC) pathway has emerged recently as an important model for 
studying the mechanisms surrounding DNA damage response/DNA repair, genomic 
instability and ubiquitin signalling (Moldovan and D'Andrea, 2009; Kottemann and 
Smogorzewska, 2013).  
FANC repair pathway coordinates the action of multiple distinct repair processes, in 
particular, NER, HR and translesion synthesis (TLS; a mode of damage tolerance that 
uses specialised polymerases to insert a base across from a lesion or abasic site) 
(Moldovan and D'Andrea, 2009). Studying the FANC repair pathway provides a unique 
window into the elaborate interplay of multiple cellular networks involved in DNA repair. 
The FANC proteins work together to maintain genomic stability during DNA replication 
and to repair DNA interstrand crosslinks (ICLs), a severe lesion that blocks both DNA 
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A. Base excision repair (BER) B. Nucleotide excision repair (NER) C. Mismatch repair (MMR) 
D. Double-strand break (DSBs) repair 
Non-homologous end-joining Homologous recombination 
replication and transcription (Moldovan and D'Andrea, 2009; Kottemann and 
Smogorzewska, 2013).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17. DNA Repair pathways. A) BER mediates the removal and replacement of small lesions, such 
as, damaged bases and uracil residues caused by reactive oxygen species (UNG for uracil is shown in 
the figure); the resulting abasic site is incised by an AP endonuclease (APEX1); the baseless 
phosphodiester backbone is removed and the gap filled by DNA polymerase β (Pol β). B) NER acts on 
larger lesions or adducts and involves lesion recognition, formation of the TFIIH complex, removal of 25–
30 nucleotides and gap filling by a DNA polymerase. C) MMR removes mismatched bases; after 
recognition of specific proteins, a segment of DNA is excised between the mismatch and a nearby nick, 
the gap left is filled by DNA polymerase δ. D) DSBs can be repaired by Non-homologous end joining 
(NHEJ), a error prone process that joins directly the DNA ends or Homologous recombination (HR), a 
error free repair processes that operates when a double-stranded copy of the sequence is available 
(adapted from Lange et al., 2011) 
 
FANC is a rare genetic disease caused by germline mutations that disrupt the FANC 
pathway leading to a deficient repair function (Moldovan and D'Andrea, 2009). 
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FANC patients manifest a high propensity for cancer, namely squamous cell carcinomas 
(e.g. head and neck, gynecologic system) and acute myeloide leukaemia (AML) (Alan and 
D'Andrea A, 2010). This phenotype has launched the question as to whether inherited or 
acquired mutations in FANC genes might be involved in the development of sporadic 
cancers (Tischkowitz et al., 2004). Moreover, several genes involved in the FANC 
pathway also predispose individuals to breast and ovarian cancer, which, together with 
the cancer susceptibility of patients with FANC, suggests FANC proteins have an 
important role in suppressing tumorigenesis (Kottemann and Smogorzewska, 2013). 
The association between a chromosomal instability syndrome and cancer predisposition is 
not surprising since excessive chromosome breakage might be expected to lead to 
unrepaired DNA damage and apoptosis, or to mutations which could confer a selective 
growth advantage to certain cells (Mathew, 2006). However, the reason why cells of 
myeloid origin are particularly affected in FANC case leading to AML is not known 
(Mathew, 2006; Moldovan and D'Andrea, 2009). Recent work has begun to gain 
tantalising insight into not only FANC pathogenesis, but also the intersection between 
DNA repair and stem-cell maintenance and the general role of FANC repair pathway 
genes (Kottemann and Smogorzewska, 2013). One explanation is that the myeloid 
precursors are particularly susceptible to forms of DNA damage (e.g. crosslinks), that are 
recognised or repaired by the FANC pathway. It is likely that the cellular endogenous 
metabolism might specifically yield agents that cause DNA lesions (Moldovan and 
D'Andrea, 2009), and circulating metabolites such as formaldehyde (FA) may account for 
the sensitivity of FANC hematopoietic stem cells (Ridpath et al., 2007). Indeed, recent 
advances have identified endogenous aldehydes, such as acetaldehyde and FA, as 
possible inducers of the DNA damage that may lead to the chromosomal instability seen 
in FANC pathway deficient cells (Rosado et al., 2011; Kottemann and Smogorzewska, 
2013). More importantly, there is also recent evidence that genes in the FANC repair 
pathway have a crucial role in counteracting acetaldehyde-induced genotoxicity in mice, 
furthermore, mice mutant in both FANC repair genes and aldehyde-catabolism gene 
spontaneously developed acute leukaemia (Langevin et al., 2011). 
Taking into account the above, it is reasonable to speculate the existence of polymorphic 
FANC genes that may modulate individual susceptibility to the effects of exposure to FA, 
particularly in the workplace. This association would also agree with Zhang et al. (2010) 
hypothesis of FA ability to affect haemotopoietic system in exposed individuals and help to 
elucidate the increase of AML cases among FA-exposed workers. Therefore, it was 
relevant in our study a screening of polymorphic genes associated with FANC repair 
pathway.  
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At least fifteen FANC complementation groups of proteins/genes (FANC-A, -B, -C, -
D1/BRCA2, -D2, -E, -F, -G, -I, -J/BRIP1, -L -M, -N/PALB2, -P and -O/RAD51C) were 
found to constitute the FANC pathway (Kim and D'Andrea, 2012).  
The FANC pathway is turned on during the S phase of the cell cycle or following DNA 
damage, by FANC protein monoubiquination (the addition of one ubiquitin, an amino acid 
tag, to the internal lysine residue of a protein). During activation, multiple FANC proteins 
undergo phosphorylation by checkpoint kinases (ATR-CHK1) (Kim and D’Andrea, 2012). 
Once active, the FANC proteins work in concert to regulate the monoubiquitinated state of 
the FANCD2 and FANCI proteins and the downstream functions of the repair process 
(Alan and D'Andrea, 2010).  
A few models on the FANC-mediated crosslink mechanism have been proposed, but 
generally it is described as follows. During replication, the presence of an ICL that 
covalently links both strands of a DNA duplex, blocks the DNA unwinding and stops the 
progression of the replication fork. A complex formed by FANCM and FAAP24 proteins 
recognises the stalled replication fork structure and recruits the FANC core complex to the 
damaged DNA region initiating the FANC pathway (Kim and D'Andrea, 2012) (Figure 18).  
 
 
 
 
 
Figure 18. Interaction of the FANC proteins in the recognition of an ICL in S phase. A) Two replication forks converge 
on the DNA. B) The FANCM–FAAP24 complex recognises the stalled replication fork structure. FANCM stabilises the 
stalled replication fork, and initiates the ATR-CHK1-dependent checkpoint response, which in turn phosphorylates 
multiple FANC proteins, including proteins in the FANC core complex and FANCD2/FANCI unit. C) The FANC core 
complex monoubiquitinates FANCD2/FANCI complex, and it is recruited to the DNA lesion (adapted from Kim and 
D’Andrea, 2012) 
 
FANCM prevents the collapse of replication fork, independently of FANC pathway 
activation. The FANC core complex is an ubiquitin ligase multi-subunit composed by eight 
FANC proteins (FANCA,-B,-C,-E,-F,-G,-L,-M) that monoubiquitinates the FANCD2/FANCI 
unit (Alan and D'Andrea A, 2010). Lastly, the ubiquitin-tagged FANCD2/FANCI complex 
interacts with other downstream FANC proteins (FANCD1, FANCN, and BRIP1) and other 
DNA repair proteins to resolve the ICL and the stalled replication fork (Kim and D’Andrea, 
2012). 
A. B. C. 
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In the DNA, two nucleolytic incisions flanking the ICL region release it from one of the 
DNA strands. The unhooking process forms a double-strand break and leaves cross-
linked oligonucleotides in the complementary strand. The latter is bypassed by TLS 
restoring the strand and NER removes the remaining adduct and fills the gap. The double-
strand break is repaired by HR mechanism. An ubiquitin-specific protease removes the 
ubiquitin from the FANCD2/FANCI complex, and completes the FANC repair pathway 
(Kim and D’Andrea, 2012) (Figure 19). 
 
 
Figure 19. Simplified model of the mechanism of ICL repair process involving NER, TLS and HR. A) An 
ICL blocks the DNA unwinding and stops the progression of the replication fork; FANC complex stabilises 
the staled fork. B) The crosslink unhooking from one of the DNA strands forms a DSB and leaves a 
monoadduct in the complementary strand. C) FANC recruits TLS to bypass the remaining monoadduct. 
D) NER excises the monoadduct and repairs the strand. E) The DSB is repaired by HR mechanism.       
F) Intermediate DNA crossover structures are resolved and the replication fork is re-established (adapted 
from Kennedy and D'Andrea, 2005) 
 
5.1.4.2. Polymorphisms of the BER pathway studied 
BER (base excision repair) repairs DNA lesions such as non-bulky base modifications, 
abasic sites and a range of chemically distinct single-strand breaks (Wilson et al., 2011). 
Genetic polymorphisms in BER pathway have been associated with cancer risk at several 
sites (Wilson et al., 2011; Hung et al., 2005). Further, deficiencies in BER gene products 
have been linked to neurodegenerative disorders and immunodeficiency (Doseth et al., 
2011; Wilson et al., 2011). Because polymorphisms of BER genes may affect the level of 
DNA repair induced by chemicals, leading to carcinogenesis, it is important to establish 
the molecular causes of the carcinogenetic process. The major genes involved in the BER 
pathway include, among others, XRCC1, PARP1 and MUTYH (Almeida and Sobol et al., 
2007). Genotype frequencies may vary markedly across race, supplementary information 
on the frequency distribution of the studied polymorphisms is available in Annex III. 
 
XRCC1 
The XRCC1 (x-ray repair cross-complementing group 1) protein forms complexes with 
DNA polymerase β, DNA ligase III and poly-ADP-ribose-polymerase (PARP) in the repair 
A. B. C. D. F. 
   
   
E. 
NER HR TLS 
128 
PRESENT STUDY 
of nicks or gaps left in BER pathway and in the repair of single-strand breaks, SSBs (Aka 
et al., 2008). It is an important protein for co-ordination of DNA damage repair (Thaker 
and Zdzienickab, 2003). 
The XRCC1 gene has been located at 19q13.2–13.3 region of human chromosome 19. 
The importance of this gene is highlighted by the description of its null mutant mice, 
whose embryonic development is arrested (Aka et al., 2008). Cell lines defective in this 
nonenzymatic scaffold protein show reduced SSBs repair, increased sensitivity to DNA-
damaging agents that produce SSBs (Kulkarni et al., 2008), and elevated chromosomal 
aberrations and sister chromatid exchanges frequencies  (Thompson and West et al., 
2000). 
Two common polymorphisms of XRCC1 that lead to amino acid substitutions are located 
in exon 10 (G to A, arginine to glutamine, Arg399Gln) and in exon 6 (C to T, arginine to 
tryptophane, Arg194Trp).  
In humans, while the XRCC1 Arg399Gln substitution is associated with increased genetic 
instability the XRCC1 Arg194Trp substitution is suggested to enhance individual DNA 
repair capability (Tuimala et al., 2004; Aka et al., 2008; Chang et al., 2009). 
Indeed, published data on XRCC1 gene and cancer risk show associations between: a) 
the XRCC1 399Gln/Gln genotype and increased risk of tobacco-related cancers among 
light smokers, but decreased risk among heavy smokers (Hung et al., 2005); b) the 
XRCC1 Arg194Trp substitution and reduced risk of various types of cancer, including 
breast and lung cancer (Goode et al., 2002). Nonetheless, recent data from a Polish study 
suggest that XRCC1 399Gln allele is a potential risk factor for breast cancer (Romanowicz 
et al., 2010). Yet, there are other studies with contradictory findings (Hirvonem et al., 
2008). The XRCC1 Arg194Trp substitution is more prevalent among Asians (2.6-13.2%) 
than among Caucasians (≤ 2.3 %) (Hung et al., 2005). Regarding XRCC1 Arg399Gln 
genotype frequencies, there is no major variation across race and ethnicity (Hung et al., 
2005; Chang et al., 2009).  
 
PARP1  
Human Poly(ADP-ribose) polymerase-1 (PARP1) is  a major member of the PARP family 
proteins. PARP1 functions as a DNA damage sensor in the DNA repair process. 
Generally, in response to DNA damage caused by exogenous or endogenous agents, 
PARP1 binds to the DNA lesion through its DNA-binding domain. This activates the 
poly(ADP-ribosyl)ation of target proteins involved in the DNA repair pathways, including 
BER and DSBs systems, and recruits the repair proteins to the sites of DNA damage (Yu 
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et al., 2012). PARP1 complex interacts preferentially with XRCC1, triggering the BER 
repair machinery (Masutani et al., 2003). 
PARP1 is also involved in other cellular processes, such as modulation of gene 
transcription, cell proliferation and death. Accumulated data from in vitro and in vivo 
studies indicates that PARP1 deficiency leads to DNA repair defects, genomic instability 
and failure to induce cell apoptosis, which may contribute to cancer development (Yu et 
al., 2012). 
The human PARP1 gene is located on 1q41-42; it spans 47.3 kb and comprises 23 exons. 
PARP1 Val762Ala is a polymorphism in exon 17 (T to C transition) that may result in 
altered activity of PARP1, due to an amino acid substitution, alanine (Ala) for valine (Val), 
in the protein catalytic domain. PARP1 Val762Ala has been implicated in human 
carcinogenesis, but with inconclusive results. Nevertheless, data of a recent meta-
analysis suggest that this polymorphism may modulate cancer risk differently depending 
on ethnicity and type of cancers. The study found an association between PARP1 
Val762Ala and increased risk of cancer among Asians but a decreased risk among 
Caucasians, particularly of glioma (Yu et al., 2012).  
 
MUTYH 
The MUTYH gene encodes a DNA glycosylase involved in the repair of oxidative DNA 
lesions such as 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxo-dG), a stable oxidation 
product of guanine. If left unrepaired, 8-oxo-dG can mispair with adenine during DNA 
replication, leading to a G:C>T:A transversion (Santos et al., 2012). The MUTYH protein 
prevents these transversions by excising any adenine residue misincorporated in the 
newly synthesized DNA strand opposite to 8-oxo-dG, thus allowing the repair process to 
be continued by downstream BER enzymes (Mazzei et al., 2013). MUTYH dysfunction 
may, therefore, be especially problematic for tumorigenesis in humans since there are no 
other mechanisms for repairing 8-oxo-dG/adenine mismatches (Santos et al., 2012). 
Mutations in this gene strongly predispose humans to a rare hereditary form of colorectal 
cancer (MAP) (Out et al., 2012). MAP tumours display an unusually high proportion of 
somatic G:C>T:A transversion mutations in certain genes, probably reflecting defective 
MUTYH protein activity and consequent failure to correct A:8-oxo-dG mispair (Santos et 
al., 2012). Several MUTYH germline mutations and SNPs have been identified (Wilson et 
al., 2001). MUTYH is located on the short arm of the chromosome 1 at 1p34. It spans a 
region of 11,147 base pairs with 16 exons. 
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MUTYH Gln335His (rs3219489) is a common polymorphism located on exon 12. The 
variant genotype implicates a G> C transition and a substitution of the amino acid 
glutamine (Gln) for histidine (His) at the 335 codon of the MUTYH protein. The enzyme 
encoded by this variant has been demonstrated to have partially impaired glycosylase 
activity in vitro (compared to the wild-type, the variant enzyme was 34% less active in 
removing adenine from substrates containing an A:GO mismatch) and could therefore 
contribute to cancer susceptibility (Santos et al., 2012). 
The 335His variant allele has been suggested to be associated with increased risk of 
colorectal cancer in some studies (Picelli et al., 2010; Santos et al., 2012). A positive 
association was also found for lung cancer, but only when gene-gene interactions were 
considered (Qian et al., 2011). Also, in a bladder cancer susceptibility study, gene-gene 
interactions among BER polymorphisms (including MUTYH Gln335His) were observed in 
ever smokers (Huang et al., 2007), suggesting that BER genetic variation might contribute 
to cancer risk through gene-gene and gene-environmental interactions (Santos et al., 
2012). 
 
5.1.4.3. Polymorphisms of the DSBs repair pathway studied 
Unrepaired or misrepaired, double-strand breaks (DSBs) may result in cell death, 
chromosome rearrangements and genome instability, all processes involved in 
carcinogenesis. The DSBs repair by homologous recombination (HR) is a key pathway for 
the maintenance of genetic stability in mammalian cells (Tambini et al., 2010). HR is a 
high fidelity process that uses homologous sequence as a template to synthesise new 
error-free DNA. It acts in coordination with the S and G2 checkpoint machinery to 
eliminate chromosomal breaks before the cell division occurs (Thompson and Schild, 
2001). Two major cancer genes, BRCA1 and BRCA2, associated with breast cancer are 
involved in HR pathway. Gene variants of other participants in HR have showed to be 
associated with cancer risk at several sites, pointing out the relevance of HR and DSBs in 
cancer susceptibility. The frequency distribution of DSBs repair genotypes varies across 
racial groups, supplementary information for each polymorphic gene studied is available in 
Annex III. 
 
Rad51 
The RAD51 protein is responsible for the central activity of the HR repair pathway, in 
which it catalyses the invasion of the broken ends of the DSBs into the intact sister 
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chromatid, that will serve as template to reconstruct the missing part of the damaged 
strand (Gresner et al., 2012).  
In this process, the generated single-stranded DNA ends are bound by Rad51 to form a 
nucleoprotein filament that searches the undamaged DNA on the sister chromatid for a 
homologous repair template. Other proteins including the breast cancer predisposition 
proteins (BRCA1 and BRCA2), and several additional Rad51-related proteins (e.g. 
XRCC2, XRCC3) serve as accessory factors in filament assembly and subsequent Rad51 
activities (Richardson, 2005; Thacker, 2005). Furthermore, BRCA2 is shown to regulate 
both the intracellular localisation and the DNA-binding ability of this protein (Davies et al., 
2001). Several studies of Rad51 among BRCA1/2 mutation carriers have found 
associations with breast cancer risk (Thacker, 2005; Ricks-Santi et al., 2011). In addition, 
several genetic assays have also demonstrated that p53 can down-regulate Rad51-
mediated HR events; however, the process by which it occurs remains unclear 
(Richardson, 2005) 
The role of Rad51 in genomic integrity is strongly supported by Rad51 mouse knockouts 
which result in early embryonic lethality (Richardson, 2005). Experimental studies have 
also show that the loss of Rad51 may drive to genetic instability, chromosomal 
aberrations, and carcinogenesis by facilitating an accumulation of genetic changes 
(Richardson, 2005). A recent case control found evidence that Rad51 gene variability may 
be of relevance with respect to head and neck cancer risk modulation (Gresner et al., 
2012) 
The RAD51 gene is located at 15q15.1 in chromosome 15. Multiple transcript variants 
encoding different isoforms have been found for this gene (Thacker, 2005).  
The RAD51 SNP in the 5′ untranslated region (G > T, rs1801321, RAD51 5’UTR) is a 
polymorphism whose association with cancer risk is scarcely explored. The few available 
epidemiological data concerns breast cancer risk, but no association was found (Silva et 
al., 2010). 
 
XRCC2  
The X-ray repair cross-complementing protein group 2 (XRCC2) is a RAD51-related 
protein, essential for efficient HR repair process of DSBs (Tambini et al., 2010). The 
degree of sequence homology to RAD51 or to other RAD51-like proteins is relatively 
small, around 45% similarity and 25% identity (Thaker and Zdzienickab, 2003). 
XRCC2 role is still not clear, but there are indications that it acts as a cofactor for the 
RAD51 in strand invasion and exchange activities and also in late stages of the HR repair 
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pathway (Richardson, 2005; Silva et al., 2010). The loss of XRCC2 has showed to result 
in a severe delay in the early response of RAD51 to DNA damage (Tambini et al., 2010). 
In addition, XRCC2-deficient cell lines have chromosome missegregation associated with 
fragmentation of the centrosome, indicating that the protein is also required for correct 
chromosome segregation (Griffin et al., 2000). 
The disruption of XRCC2 gene in mice resulted in early embryonic lethality (Thaker and 
Zdzienickab, 2003). 
Human XRCC2  gene was first identified by the ability to complement the irs1 mutated 
hamster cell line phenotype, which is highly sensitive to mitomycin C, a DNA cross-linking 
agent, and suffer increased frequency of chromosomal aberrations, i.e., breaks (Cui et al., 
1999). Further studies showed that XRCC2 is highly conserved, and most truncations of 
the protein destroy its ability to protect cells from the effects of the DNA cross-liking 
agents (Park et al., 2012). 
XRCC2 gene is localised on chromosome 7q36.1. The XRCC2 Arg188His polymorphism 
(G > A, substitution of arginine to histidine, rs3218536) has been linked to small but 
significant increased risk to breast (Thompson and Schild, 2002; Silva et al., 2010), 
colorectal (Vineis et al., 2009) and cervical cancer (Pérez et al., 2013). Other studies 
reported null results (Yu et al., 2010; Park et al., 2012). Therefore, additional studies with 
larger sample size are required to confirm the role of this polymorphism in cancer 
susceptibility.  
 
XRCC3 
The XRCC3 (x-ray repair cross-complementing group 3) protein plays a critical role in 
repair of DSBs in homologous recombination pathway. It is involved in the assembly and 
direct stabilisation of RAD51 protein multimers at DSBs sites (Aka et al., 2008, Tambini et 
al., 2010); however the precise function of XRCC3 is not fully understood (Richardson, 
2005). Additionally, there is evidence that XRCC3 protein is required for correct 
chromosome segregation (Griffin et al., 2000). Analysis of sequence similarities showed 
that XRCC3 is a RAD51-like protein, but it only shares around 25% sequence identity to 
RAD51 and to other RAD51-related proteins (Thaker and Zdzienickab, 2003). 
As in XRCC2, the human XRCC3 gene was originally identified by the ability to correct the 
phenotype of mutated rodent cell lines (irs1SF) for sensitivity to ionising radiation and 
other DNA damaging agents (e.g. cisplatin, mitomycin C) (Thaker and Zdzienickab, 2003). 
Without XRCC3 activity, the irs1SF cells displayed highly elevated levels of deletions, 
breaks, and translocations (Cui et al., 1999). 
133 
PRESENT STUDY 
The human XRCC3 gene is located at 14q32.3 region of chromosome 14. Rare 
microsatellite polymorphism in the XRCC3 have been reported, including a C>T non-
conservative change (Thr241Met, rs861539) in exon 8, which gives rise to an amino acid 
substitution (threonine for methionine) (Aka et al., 2008). The XRCC3 241Met allele was 
associated with significant increases in chromosome deletions in x-ray-challenged blood 
lymphocytes (Manuguerra et al., 2006). Several studies have evaluated the influence of 
XRCC3 Thr241Met on cancer risk in different tissues (Goode et al., 2002). Positive 
associations were obtained for bladder cancer (Matullo et al., 2001), breast cancer (Silva 
et al., 2010), lung cancer and colorectal cancer (Aka et al., 2008). In some studies, it was 
found a potential gene-gene interaction with genes of metabolic enzymes (Matullo et al., 
2001) and other DNA repair pathways (Aka et al., 2008). Nevertheless, other studies have 
reported contrasting results (Manuguerra et al., 2006; Aka et al., 2008). The prevalence of 
Met/Met homozygosis is around 4.6 % in African Americans, 0.2 % in Asians, and 12.4 % 
in Caucasians (Manuguerra et al., 2006). 
 
5.1.4.4 Polymorphisms of the FANC repair pathway studied 
FANC (Fanconi anaemia) is a genetic recessive disorder, caused by mutations in genes 
regulating replication-dependent removal of DNA crosslinks (Moldovan and D’Andrea, 
2009).  
At least fifteen FANC complementation groups (FANC-A, -B, -C, -D1/BRCA2, -D2, -E, -F, 
-G, -I, -J/BRIP1, -L -M, -N/PALB2, -P and -O/RAD51C) and their corresponding genes 
have been identified to cooperate in the FANC pathway (Su and Huang, 2011).  
The members of the FANC complementation group do not share sequence similarity. Four 
of the FANC pathway genes (FANCD1/BRCA2, -J/BRIP1, -N/PALB2, and -O/RAD51C) 
are known breast cancer susceptibility genes and other gene products, that connects 
FANC proteins to HR (homologous recombination) of DSBs repair pathway (Castella et 
al., 2011). Proteins encoded by these genes participate in the repair of ICLs during 
replication and are essential for accurate processing of stalled replication forks (Castella 
et al., 2011). 
Mutations in FANC-A, -C and -G are the most common and account for approximately 
85% of patients with FANC (Su and Huang et al., 2011). FANC individuals have greatly 
increased risks of cancer, including acute myeloid leukaemia (AML). 
It has long been hypothesized that heterozygotes for autosomal recessive DNA repair 
disorders may have reduced efficiency of their DNA repair systems that could cause an 
increased risk of cancer (Tischkowitz et al., 2008). Epidemiological studies assessing 
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incidence of malignancies (including AML) in FANC families have failed to demonstrate an 
increased incidence in heterozygous individuals (Mathew, 2006; Tischkowitz et al., 2008). 
However, this raises the question as to whether inherited or acquired mutations in FANC 
genes might be involved in the development of sporadic cancers, e.g. AML (Tischkowitz et 
al., 2004).  The major role of BRCA2/FANCD1 in susceptibility to breast and other 
cancers, such as cancer of the ovarian , prostate and pancreas, is well established 
(Mathew, 2006). There have been several studies of the other known FANC genes in 
relation to breast cancer susceptibility, some of which found an association with 
FANCN/PALB2, FANCJ/BRIP1 and FANCD2 (Mathew, 2006; Barroso et al., 2009). There 
is also some limited data suggesting an association with sporadic hematological 
malignancies (Tischkowitz et al., 2004). It is important to point out that these studies had 
some limitations and therefore replication in larger studies is needed to confirm these 
findings (Mathew, 2006). Additional information on frequency distribution of the 
polymorphisms studied among different racial groups is available in Annex III. 
 
FANCA 
FANCA (or Fanconi anemia complementation group A) protein is one of the eight FANC 
proteins that comprise the FANC core complex, a multisubunit complex required for 
FANCD2 ubiquitination, essential for resolving ICL and stalled replication fork, during 
replication. 
Furthermore, evidence suggests that FANCA phosphorylation is DNA damage–inducible 
and essential to the function of the FANC pathway (Collins et al., 2008).  
Mutation in FANCA gene accounts for more than 60% of all cases of FANC (Moldovan 
and D'Andrea, 2009). The mutation profile of FANCA is highly heterogeneous with over 
100 different mutations described, a large part being deletions (Castella et al., 2011). 
Hence is one of the most studied genes in the FANC family in relation to cancer 
proneness. 
Human FANCA gene is located at 16q24.3 in chromosome 16. The FANCA Thr266Ala 
polymorphism (rs7190823) results in a aminoacid substitution, in codon 266, of threonine 
to alanine. The current evidence regarding the role of FANCA mutations in sporadic 
malignancies is limited. Nonetheless, some findings suggest that acquired FANCA 
dysfunction and/or FANCA variants may be involved in the promotion of genetic instability 
in cases of sporadic AML (Lensch et al., 2003; Tischkowitz et al., 2004). Additionally, a 
recent epidemiologic study have found an increased risk of cervical cancer associated 
with FANCA variants (Wang et al., 2009b). 
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BRIP1 
BRIP1 (BRCA1-interacting protein 1) also known as BACH1 (BRCA1-associated C-
terminal helicase-1) or FANCJ (for Fanconi anemia complementation group J) is a DNA 
helicase that interacts directly with BRCA1 and thus is essential for DNA repair and 
genomic stability (Cantor and Guillemette, 2011). It is universally expressed and co-
localised with BRCA1 in the nuclear foci (Ma et al., 2013). 
Phosphorylated BRIP1 functions together with BRCA1 protein to mediate proper and 
efficient repair of DNA double-strand break via HR repair subpathway (Cantor et al., 
2001). BRIP1 interacts with BRCA1, unwinds DNA structures that block replication forks 
and facilitates checkpoint signalling (Constantinou, 2012). The complex formed by BRIP1 
and BRCA1 is important not only for HR-mediated double-strand break repair but also for 
tumour suppressor function (Ma et al., 2013).  
This specific interaction between BRIP1 and BRCA1 is regulated by the cell cycle and is 
essential for execution of the G2/M cell cycle checkpoint and for normal progression 
through S phase by assisting in the resolution of stalled replication forks (Kumaraswamy 
and Shiekhattar, 2007) 
It is well established that a deficient DNA helicase function can result in human genetic 
disorders in which genomic instability and predisposition to cancer are common features 
(e.g. Bloom Syndrome) (Cantor et al., 2004). Accumulating data suggests an anti-
oncogenic role of BRIP1, and downregulation of BRIP1 gene has been reported in 
multiple cancers (Cantor et al., 2001; Ma et al., 2013). 
The BRIP1 gene is located on chromosome 17q22, it spans 180 kb and comprises 20 
exons (Cantor et al., 2001). In the last few years, common SNPs in the BRIP1 gene have 
been associated with susceptibility to breast cancer (Cantor et al., 2004), ovarian cancer 
(Pennington and Swisher, 2012) cervical cancer (Ma et al., 2013) and prostate cancer 
(Kote-Jarai et al., 2009). 
Recently, the rare polymorphism BRIP1 Ser919Pro (substitution of serine to proline, 
rs4986764) was reported to be a risk factor of breast cancer (Sigurdson et al., 2004) 
especially in women up to age 50, however contrasting results was also found (Vahteristo 
et al., 2006) and therefore this association needs further research. 
A final model linking the various factors involved in individual’s response to an exogenous 
insult and potential biologic effects is outlined in Figure 20.  
In short, most of the carcinogens present in the environment undergo bio-activation into 
ultimately reactive metabolites, and this transformation is modulated by the individual 
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genetic profile of metabolic genes. In addition, common polymorphisms in DNA repair 
genes may alter protein function and eventually the individual ability to repair DNA 
damage (Iarmacovai et al., 2007). 
Therefore, the study of the interaction of different genetic polymorphisms involved both in 
the metabolism of environmental carcinogens and in the DNA repair is crucial to evaluate 
the possible combined effect of several genetic variants in relation to a specific chemical 
exposure (Mateuca et al., 2008). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20. Association among the various factors involved in individual’s response to an exogenous 
insult and potential biologic effects (retrieved from Iarmacovai et al. (2007) 
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5.2 MATERIAL AND METHODS 
 
5.2.1 DNA extraction 
Genomic DNA was obtained from heparinised whole blood samples (350 μL) using a 
commercially available kit (Qiagen EZ1 DNA Blood kit; Qiagen BioRobot EZ1 System) 
according to the manufacturer’s instructions. DNA samples were stored at -20 ºC until 
analysis.  
 
5.2.2 Genotyping of polymorphisms in gene involved in the metabolism 
Detailed information regarding selected SNP’s and corresponding amino acid exchanges 
are presented in Table XVI. Genotype determinations were carried out twice in 
independent experiments and all the inconclusive samples were reanalysed. 
 
5.2.2.1 CYP2E1  
The CYP2E1 intronic polymorphism (rs6413432) was determined by PCR-RFLP as 
described elsewhere (Lin, 1998; Teixeira, 2004) with minor modifications. Primer design 
and PCR conditions were optimised in order to achieve the best possible results: 
OligoAnalyzer 3.1 (http://eu.idtdna.com/analyzer/Applications/OligoAnalyzer/) was used to 
determine melting temperatures, GC contents, hairpins, and dimmer formation. Basic 
Local Alignment Search Tool (BLAST) resource (http://blast.ncbi.nlm.nih.gov/Blast.cgi) 
was used to confirm low similarity with other human sequences. This polymorphism 
results in the loss of a restriction site, which allows the common and variant alleles to be 
discriminated by RFLP after appropriate restriction enzyme digestion. Specific primers, 
restriction enzyme site details and restriction patterns for each of these SNPs are shown 
in Table XVII. PCR was performed in a 50 µL reaction volume containing: 100 ng of 
genomic DNA, 1 µM of each primer, MgCl2 5 mM, 0.5 U of Immolase (Bioline), 0.2 mM of 
each dNTP (Bioline) and 2% dimethyl sulfoxide (DMSO), in 1x PCR buffer. The 
amplification was accomplished in a GeneAmp® PCR System 9700 thermal cycler 
(Applied Biosystems) and consisted of an initial activation step (7 min at 95 ºC); 35 cycles 
of denaturation (30 sec at 94 ºC), annealing (30 sec at 62 ºC) and extension (30 sec at   
72 ºC); and a final extension step (10 min at 72 ºC). For restriction analysis, 10 µL of the 
PCR product were digested with 5 units of the SexAI (Fermentas) restriction enzyme  
(12.5 µl final reaction volume), during 210 min at 37 ºC. After restriction enzyme 
inactivation (20 min at 65 ºC), restriction fragments were subjected to electrophoresis in 
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2% agarose gel with ethidium bromide (1 μg/mL) for visualisation under ultraviolet light. 
HyperLadder IV (Bioline) was used as molecular marker. 
 
5.2.2.2 GSTM1 and GSTT1 
GSTM1 and GSTT1 genotyping for gene deletions were carried out through a multiplex 
PCR technique described elsewhere (Lin et al., 1998; Teixeira et al., 2004) with minor 
modifications. DNA samples were amplified for GSTM1 with the primers: 5´-GAA CTC 
CCT GAA AAG CTA AAG C-3´ (forward) and 5´-GTT GGG CTC AAA TAT ACG GTG G-
3´ (reverse) which produced a 219-bp product. For GSTT1, DNA samples were amplified 
with the primers 5´-TCA CCG GAT CAT GGC CAG CA-3´ (forward) and 5´-TTC CTT ACT 
GGT CCT CAC ATC TC-3´ (reverse) which produced a 459-bp product. For either gene, 
the success of the amplification procedure depended on the absence of the polymorphic 
deletion. The amplification of the albumin gene with the primers 5′-GCC CTC TGC TAA 
CAA GTC CTA C-3′ (forward) and 5′-GCC CTA AAA AGA AAA TCC CCA ATC-3′ 
(reverse) was used as an internal control and produced a 350-bp product. PCR was 
performed in a final volume of 50 μL, consisting of 100 ng of genomic DNA, 0.2 mM of 
each dNTP (Bioline), MgCl2 5 mM, 0.5 μM of each GSTM1 primer, 0.15 μM of each 
GSTT1 primer, 0.1 μM of each albumin primer, 0.5 U of Immolase (Bioline), 1x PCR buffer 
and 2% dimethyl sulfoxide (DMSO). Amplification was performed with an initial 
denaturation at 95 ºC for 7 min, followed by 35 cycles of amplification performed at 94 ºC 
for 1 min, 62 ºC for 1 min, 72 ºC for 2 min, and a final extension at 72 ºC for 10 min using 
a GeneAmp® PCR System 9700 thermal cycler (Applied Biosystems). After 
electrophoretic separation in 2% agarose gel stained with ethidium bromide (1µg/mL), the 
amplified products were visualised under ultraviolet light.  
 
5.2.2.3 GSTP1  
The GSTP1 (rs1695) polymorphism was determined by PCR-RFLP as described 
elsewhere (Harries, 1997; Teixeira, 2004), with minor modifications. PCR was performed 
in a 50 µL reaction volumes containing: 100 ng of genomic DNA, 1 µM of each primer, 
MgCl2 10 mM, 0.5 U of Immolase (Bioline), 0.2 mM of each dNTP (Bioline) and 2% 
dimethyl sulfoxide (DMSO), in 1x PCR buffer. The amplification was accomplished in a 
GeneAmp® PCR System 9700 thermal cycler (Applied Biosystems) and consisted of an 
initial activation step (7 min at 95 ºC); 35 cycles of denaturation (1 min at 94 ºC), 
annealing (1 min at 62 ºC) and extension (1 min at 72 ºC); and a final extension step (10 
min at 72 ºC). For restriction analysis, 10 µL of the PCR product were digested with 5 
units of the BsmAI (Fermentas) restriction enzyme (12.5 µL final reaction volume), 
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overnight (16-18 hours) at 37 ºC. After restriction enzyme inactivation (20 min at 65 ºC), 
restriction fragments were subjected to eletrophoresis in 4% agarose gel with ethidium 
bromide (1 μg/mL) for visualisation under ultraviolet light. HyperLadder V (Bioline) was 
used as molecular marker. Primer design and PCR conditions were optimised in order to 
achieve the best possible results: OligoAnalyzer 3.1 
(http://eu.idtdna.com/analyzer/Applications/ OligoAnalyzer/) was used to determine 
melting temperatures, GC contents, hairpins, and dimmer formation. Basic Local 
Alignment Search Tool (BLAST) resource (http://blast.ncbi.nlm.nih.gov/Blast.cgi) was 
used to confirm low similarity with other human sequences. For GSTP1 polymorphism the 
nucleotide change resulted in gain of a restriction site, which therefore allowed the 
common and variant alleles to be discriminated by RFLP after appropriate restriction 
enzyme digestion. Detailed information and expected products for each genotype of the 
tested gene are shown in Table XVII.  
 
5.2.3 Genotyping of polymorphisms in genes involved in DNA repair 
Detailed information regarding selected SNP’s and corresponding base and amino acid 
exchanges are presented in Table XVI.  
 
5.2.3.1 XRCC1, PARP1, MUTYH, RAD51, BRIP1 and FANCA 
XRCC1 (rs1799782 and rs25487), PARP1 (rs1136410), MUTYH (rs3219489), RAD51 
(rs1801321), BRIP1 (rs4986764) and FANCA (rs7190823) were genotyped by real-time 
PCR, using TaqMan SNP Genotyping Assays (Applied Biosystems). In order to assure 
uniformity in genomic DNA content (2.5 ng/µL) in all samples, DNA was quantified using 
the fluorimetric Quant-iT™ Picogreen® dsDNA Assay Kit (Invitrogen) and a Zenyth 3100 
plate reader (Anthos Labtech Instruments), according to the manufacturer’s 
recommendations. The PCR amplification was performed in a 7300 Real-Time PCR 
System thermal cycler (Applied Biosystems), with 96-well microplates containing 10 ng of 
genomic DNA, 1x SNP Genotyping Assay mix (Applied Biosystems) and 1x TaqMan 
Universal PCR Master Mix (Applied Biosystems) per well (final volume, 10 µL/well). The 
specific Genotyping Assay mix used for each polymorphism is identified in Table XVI.  
The amplification conditions consisted of an initial enzyme activation step (10 min at       
95 ºC), followed by 40 or more amplification cycles consisting of denaturation (15 sec at 
92 ºC) and annealing/extension (1 min at 60 ºC). Allelic discrimination was then performed 
by measuring fluorescence emitted by both VIC and FAM dyes in each well (60 sec) and 
computing the results into the System SDS software version 1.3.1. The procedure was 
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repeated for all inconclusive samples. Also, 10-15% of the genotype determinations were 
carried out twice in independent experiments with 100% of concordance between 
experiments. 
 
Table XVI. Detailed information on selected SNPs 
Gene a Location db SNP cluster ID (rs no.) Amino acid change AB Assay ID 
CYP2E1 10q26.3 rs6413432 -- c -- d 
GSTP1 11q13.2 rs1695 Ile105Val -- d 
XRCC1 19q13.2 rs1799782 Arg194Trp C__11463404_10 
XRCC1 19q13.2 rs25487 Gln399Arg C____622564_10 
PARP1 1q41-q42 rs1136410 Val762Ala C___1515368_1_ 
MUTYH 1p34.1 rs3219489 Gln335His C__27504565_10 
RAD51 15q15.1 rs1801321 -- b C___7482700_10 
XRCC2 7q36 rs3218536 Arg188His -- d 
XRCC3 14q32.3 rs861539 Thr241Met -- d 
FANCA 16q24.3 rs7190823 Thr266Ala C__30590701_10 
BRIP1 17q22.2 rs4986764 Ser919Pro C___2547422_10 
a Deletions at GSTM1 (1p13.3) and GSTT1 (22q11.23) were also analysed but are not considered here, as this table pertains 
only to SNPs. b SNP located on 5’ UTR. c Intronic SNP. d not applicable (genotyping performed by PCR-RFLP). 
 
5.2.3.2 XRCC2 and XRCC3 
XRCC2 (rs3218536) and XRCC3 (rs861539) polymorphisms were determined by PCR-
RFLP as described previously (Bastos et al., 2009; Silva et al., 2010) with slight 
modifications. Primer design and PCR conditions were optimised in order to achieve the 
best possible results: OligoAnalyzer 3.1 (http://eu.idtdna.com/analyzer/Applications/ 
OligoAnalyzer/) was used to determine melting temperatures, GC contents, hairpins, and 
dimmer formation. Basic Local Alignment Search Tool (BLAST) resource 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) was used to confirm low similarity with other human 
sequences. For these polymorphisms the nucleotide change resulted in the gain of a 
restriction site, which therefore allowed the common and variant alleles to be 
discriminated by RFLP after appropriate restriction enzyme digestion. Specific primers, 
restriction enzyme site details and restriction patterns for each of these SNPs are shown 
in Table XVII. PCR was performed in a 50 µL reaction volumes containing: 100 ng of 
genomic DNA, 0.6 µM of each primer (Stabvida), MgCl2 2.5 mM, 0.75 U of Immolase 
(Bioline) and 0.2 mM of each dNTP (Bioline), in 1.3x PCR buffer. The amplification was 
accomplished in a GeneAmp® PCR System 9700 thermal cycler (Applied Biosystems) 
and consisted of an initial activation step (7 min at 95 ºC); 32 (XRCC2) or 35 (XRCC3) 
cycles of denaturation (30 sec at 94 ºC), annealing (30 sec at 62 ºC or 64 ºC for XRCC2 
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or XRCC3, respectively) and extension (30 sec at 72 ºC); and a final extension step      
(10 min at 72 ºC). For restriction analysis of the XRCC2 (rs3218536) polymorphism, 10 µL 
of the PCR product were digested with 2 units of the SexAI (Fermentas) restriction 
enzyme (12.5 µL final reaction volume), overnight (16-18 hours) at 37 ºC. For restriction 
analysis of the XRCC3 (rs861539) polymorphism, 10 µL of the PCR product were 
digested with 2.5 units of the NlaIII (Fermentas) restriction enzyme (12.5 µL final reaction 
volume), during 180 min at 37 ºC. After restriction enzyme inactivation (20 min at 65 ºC), 
restriction fragments were subjected to eletrophoresis in 4% agarose gel with ethidium 
bromide (1 μg/mL) for visualisation under ultraviolet light. HyperLadder V (Bioline) was 
used as molecular marker. Genotype determinations were carried out twice in 
independent experiments and all the inconclusive samples were reanalysed. 
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Table XVII. PCR-RFLP details for the XRCC2 (rs3218536), XRCC3 (rs861539), GSTP1 (rs1695) and CYP2E1 (rs6413432) polymorphisms 
SNPs Primers PCR product (bp) 
SNP effect on restriction 
enzyme site 
Restriction patterns after 
enzyme digestion 
XRCC2  5’-GGT GTA CTG CAG TAG TAG CAC CCA CTT AC-3’ (forward) 307 creates a SexAI site G/G: 307 bp;  
G/A: 307, 214, 93 bp; 
 A/A: 214, 93 bp.  5’-CAC ATC ACA CAG TCG TCG AGA GGC-3’ (reverse)   
XRCC3  5’-GTA CTG CTG TCT CGG GGC ATG-3’ (forward) 315 creates a NlaIII site C/C: 22, 293 bp;  
C/T: 22, 105, 188, 293 bp;  
T/T: 22, 105, 188 bp.  5’-CGA TGG TTA GGC ACA GGC TGC-3’ (reverse)   
GSTP1  5’-ACC CCA GGG CTC TAT GGG AA-3’ (forward) 176 creates a BsmAI site A/A: 176 bp;  
A/G: 85, 91, 176 bp;  
G/G: 85, 91 bp.  5’-TGA GGG CAC AAG AAG CCC CT-3’ (reverse)   
CYP2E1  5’-CTG CTG CTA ATG GTC ACT TG-3’ (forward) 688 eliminates a DraI site T/T: 338, 350 bp;  
T/A: 338, 350, 688 bp;  
A/A: 688 bp.  5’-GGA GTT CAA GAC CAG CCT AC-3’ (reverse)   
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5.3 RESULTS 
 
5.3.1 Genotype distribution of polymorphisms in the study population  
The genotypic frequencies of polymorphisms in genes involved in the metabolism and 
DNA repair pathways for sets of exposed workers, controls, and whole population are 
presented in Tables XVIII and XIX. Moreover, the distribution frequencies of the 
genotyped polymorphisms in the study population were in agreement with Hardy-
Weinberg equilibrium. 
 
Table XVIII. Frequency of genotypes involved in xenobiotic metabolism in the study population 
   All  Controls  Exposed   
Gene Allele  N %  N %  N %  p-value 
CYP2E1 intron           0.552 
T/T  132 82.0  68 79.1  64 85.3   
T/A  27 16.8  17 19.8  10 13.3   
A/A  2 1.2  1 1.2  1 1.3   
GSTM1 deletion           0.923 
Present  78 45.6  40 46.0  38 45.2   
Null  93 54.4  47 54.0  46 54.8   
GSTT1 deletion           0.626 
Present  140 81.9  70 80.5  70 83.3   
Null  31 18.1  17 19.5  14 16.7   
GSTP1 Ile105Val           0.499 
Ile/ Ile  69 40.4  32 36.8  37 44.0   
Ile/Val  84 49.1  44 50.6  40 47.6   
Val/Val  18 10.5  11 12.6  7 8.3   
 
Between the groups studied, there was no significant difference in the frequency of the 
genetic polymorphisms of xenobiotic metabolising enzymes. The frequencies of the 
metabolic polymorphisms found herein are in accordance with previous studies carried out 
in Caucasians (Garte et al., 2001; Laffon et al., 2006; López-Cima et al., 2012) and 
related to those already described by other authors on Portuguese populations (Gaspar et 
al., 2004; Teixeira et al., 2004; Costa et al., 2012).  
Regarding the DNA repair genes, there was no significant difference between study 
groups in the frequency of studied polymorphisms except for RAD51 5'UTR and XRCC2 
Arg188His (Table XIX).  
The differences observed on genotypic distribution of RAD51 5'UTR may be associated to 
the total number of exposed subjects genotyped compared to controls, whereas for 
XRCC2 Arg188His the reason is possibly the rare incidence of the homozygous variant 
genotype among Caucasians.  
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The distribution in the study population of the genotypes involved in DNA repair pathways 
are consistent with those reported by other authors for Caucasian (Figueiroa et al., 2007; 
Frank et al., 2007; Wang et al., 2009b; Santonocito et al., 2012) and more specifically for 
Portuguese populations (Garcia-Léston et al., 2012; Silva et al., 2010). Regarding 
XRCC1, statistical analysis revealed that the two studied genotypes are not in linkage 
disequilibrium. In another study conducted in a Portuguese population the XRCC1 
polymorphisms (Arg194Trp and Gln399Arg) also showed that these loci were not in 
linkage disequilibrium. 
 
Table XIX. Genotype frequency of genes involved in DNA repair in the study population 
   All  Controls  Exposed   
Gene Allele  N %  N %  N %  p-value 
XRCC1 Arg194Trpa           0.058 
Arg/Arg  151 91.5  83 95.4  68 87.2   
Arg/Trp  14 8.5  4 4.6  10 12.8   
XRCC1 Gln399Arg           0.917 
Gln/Gln  63 38.2  32 36.8  31 39.7   
Gln/Arg  68 41.2  37 42.5  31 397   
Arg/Arg  34 20.6  18 20.7  16 20.5   
PARP1 Val762Alaa           0.505 
Val/Val  141 85.5  75 87.2  66 83.5   
Val/Ala  24 14.5  11 12.8  13 16.5   
MUTYH Gln335His           0.992 
Gln/Gln  81 54.0  45 53.6  36 54.5   
Gln/His  55 36.7  31 36.9  24 36.4   
His/His  14 9.3  8 9.5  6 9.1   
RAD51 5'UTR           0.003b 
G/G  44 27.2  22 25.6  22 28.9   
G/T  82 50.6  36 41.9  46 60.5   
T/T  36 22.2  28 32.6  8 10.5   
XRCC2 Arg188His           0.030b 
Arg/Arg  126 73.7  57 65.5  69 82.1   
Arg/His  43 25.0  28 32.2  15 47.9   
His/His  2 1.2  2 2.3  0 0   
XRCC3 Thr241Met           0.051 
Thr/Thr  49 28.8  24 27.9  25 29.8   
Thr/Met  93 54.1  42 48.8  51 60.7   
Met/Met  28 16.3  20 23.3  8 9.5   
FANCA Thr266Ala           0.498 
Thr/Thr  21 12.5  9 10.5  12 14.6   
Thr/Al  66 38.4  32 37.2  34 41.5   
Ala/Ala  81 47.1  45 52.3  36 43.9   
BRIP1 Ser919Pro           0.146 
Ser/Ser  16 9.7  6 7.0  10 12.7    
Ser/Pro  77 46.7  46 53.5  31 39.2   
Pro/Pro  72 43.6  34 39.5  38 48.1   
a no variant homozygous  
b between controls and exposed 
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5.3.1 Analysis of association between the genetic polymorphisms and 
biomarkers studied 
The influence of genetic polymorphisms coding for metabolic and DNA repair enzymes on 
the level of genotoxicity and lymphocyte subsets are reported in Table XX (only the data 
with statistically significant or near to significance are shown). 
Nuclear buds (BNbud) formation was significantly higher in buccal cells of exposed 
individuals carrying the CYP2E1 intron variant allele (A) compared to homozygous wild 
type individuals. Amongst controls, CYP2E1 intron genotypes had no effect in the 
frequency of this biomarker.  
 
Table XX. Influence of biomarkers of susceptibility on genotoxicity parameters (only significant 
effect are included) 
   Controls   Exposed 
  N Mean ± SE p-value  N Mean ± SE p-value 
CYP2E1 intron         
BNbud         
T/T  53 0.36 ± 0.077 0.542  51 0.80 ± 0.12 0.022 
T/A+A/A  15 0.20 ± 0.11   7 1.57 ± 0.20  
GSTM1 deletion         
%TDNA         
Null  47 7.66 ± 0.71 0.923  45 13.23 ± 0.99 0.011 
Present  40 7.33 ± 0.61   38 10.36 ± 0.98  
GSTT1 deletion         
Aberrants         
Null  17 1.12 ± 0.30 0.050  14 2.79 ± 0.60 0.649 
Present  70 2.09 ± 0.22   70 3.26 ± 0.32  
GSTP1 Ile105Val         
MNB         
Ile/ Ile  28 0.14 ± 0.07 0.729  29 0.45 ± 0.11 0.050 
Ile/Val+Val/Val  41 0.20 ± 0.07   33 0.82 ± 0.15  
FANCA Thr266Ala         
MNL         
Thr/Thr  9 2.33 ± 0.93 0.577  12 2.33 ± 0.57 0.019 
Thr/Ala+ Ala/Ala  77 2.84 ± 0.32   70 4.74 ± 0.44  
 
Further differences were found in genotoxicity biomarkers frequencies among exposed 
workers and control individuals carriers of GSTM1 and GSTT1 null alleles, respectively. 
Indeed, exposed individuals carrying the null GSTM1 genotype had a significant increase 
on the percentage of tail DNA (%TDNA) compared to referents expressing the enzyme. In 
the control group, subjects with the active GSTT1 genotype showed a near significant 
increase on aberrant cells frequency compared to null subjects. 
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The frequency of micronucleus on buccal cells (MNB) was higher in exposed subjects 
carrying the GSTP1 Val allele compared to homozygous wild type; however, the increase 
was near statistical significance.  
Moreover, exposed subjects carrying the FANCA Ala variant allele showed a significant 
increase on micronucleus frequency in peripheral blood lymphocytes (MNL) compared to 
carriers of the wild type genotype (Thr/Thr). No significant differences were found for 
FANCA genotypes among individuals from the control group. 
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5.4 DISCUSSION 
It is generally agreed that exposure assessment and biomonitoring also requires 
information on the genetic make-up of each individual. Given the fact that genetic 
polymorphisms in metabolic enzymes may cause inter-individual variability in the 
genotoxic damage induced by xenobiotics, individual risk assessment has to be evaluated 
by taking into account individual genetics. Hence, genotyping xenobiotic metabolising 
enzymes, such as cytochrome P450 (CYPs) and glutathione S-transferases (GSTs) is of 
particular importance in risk assessment to hazardous chemicals. 
In the present study, we evaluated the impact of major polymorphic metabolising enzymes 
on the different biomarkers of genotoxicity. Our results showed that metabolic 
polymorphisms in CYP2E1, GSTP1 and GSTM1 genes were able to influence the level of 
DNA damage induced by FA-exposure (Table XX). 
Concerning CYP2E1 intronic polymorphism, a significant increase on the frequency of 
BNbud was found in carriers of the variant A allele compared to homozygous wild type 
individuals, suggesting a possible protective effect of the wild-type genotype with regard to 
genotoxic effects induced by FA inhalation.  
As mentioned earlier, the CYP2E1 enzyme is responsible for the oxidation of various 
compounds, producing reactive oxygen species (ROS) that can deplete glutathione 
(Gonzalez, 2007). Buccal mucosa is the first tissue of contact to several agents and 
probably more susceptible to oxidative stress. The cellular glutathione content is 
determinant for FA-detoxification since it is the co-factor of the most important enzyme in 
the metabolic inactivation of FA. Therefore, glutathione depletion may lead to a decrease 
on FA detoxication and an increase on FA toxicity.  
Indeed, in vitro experiments showed an increment of FA cytotoxicity with glutathione 
depletion (Saito et al., 2005; Teng et al., 2001). Curiously, in glutathione-depleted rat 
hepatocytes, also inhibited for ADH1 activity, the CYP2E1 inhibitor isoniazid was effective 
at inhibiting FA metabolism and increasing cytotoxicity, showing that FA can also be a 
subtract for CYP2E1 enzyme (Teng et al., 2001). Data also described ROS formation 
during cellular treatment with several FA concentrations. Saito et al. (2005) reported that 
FA together with free radicals induced a synergistic increment of the cellular ROS by 
glutathione depletion that led to an increased cell death, but FA cytotoxicity was 
associated to cross-link formation. 
In conclusion, the increase on cytogenetic damage found in buccal cells of FA-exposed 
individuals carrying the variant allele may be related to the activity of the encoded 
CYP2E1 enzyme, probably more effective than the protein expressed by wild type 
148 
PRESENT STUDY 
 
individuals. The consequent increase of intracellular ROS due to enzyme activity causes 
glutathione decrease as a result FA detoxication may decrease, thus increasing FA-
induced genotoxicity. To our knowledge, this is the first study investigating the influence of 
CYP2E1 polymorphism on genotoxicity biomarkers induced by FA-exposure. Therefore, 
these findings must be cautiously interpreted, as further studies are needed to confirm our 
results.  
With regard to GSTs polymorphic genes, our results showed a significant increase of DNA 
damage, %TDNA, associated with GSTM1 null allele among FA-exposed workers. This 
result is not surprising since null individuals, do not express the protein and therefore 
lacks the enzyme activity. Similarly, subjects carrying GSTP1 variant Val allele had higher 
frequency of MNB compared to homozygous wild type (p=0.05). The GSTP1 Val allele is 
associated to an enzyme with a lower conjugating activity when compared to the GSTP1 
Ile allele phenotype (Cote et al., 2009). Moreover, GSTP1 gene polymorphism is 
associated with bronchial asthma and airway hypersensitivities (Mapp et al., 2002; Lee et 
al., 2004), which implicate that GSTP1 genotypes may be a risk factor for FA exposure. 
Our results are in accordance with a recent study by Jiang et al. (2010) who found non-
significant increases on tail moment (comet assay) in FA-exposed subjects carrying the 
GSTM1 null genotype and on MNL frequency in GSTP1 Val allele carriers. 
The results found seem to indicate an important role of GSTs enzymes on the genotoxic 
effect induced by FA exposure, since the lack or diminished function of the enzymes led to 
an increase of genetic damage in exposed individuals.  
GSTs constitute the major defensive antioxidant system against oxidative stress, 
catalysing the conjugation of glutathione with different species of reactive molecules; their 
activity, as FA detoxication process is dependent of cell’s glutathione content. Some in 
vitro studies indicates that FA can decrease glutathione cellular levels (Teng et al., 2001; 
Zhou et al., 2006) suggesting that it may disrupt the intracellular balance between 
oxidants and antioxidants and cause oxidative stress (Sul et al., 2007) through the build-
up of ROS levels, observed by Saito et al. (2005) and Teng et al. (2001). On the other 
hand, the increase of oxidative stress may activate intracellular signalling pathways 
leading to increased production of detoxification enzymes such as GSTs. 
Our findings together with other authors seems to indicate that the DNA damaged found in 
null GSTM1 individuals and carriers of GSTP1 variant Val allele are not only related to a 
decrease in the effectiveness of antioxidant defenses but also to oxidative stress induced 
indirectly by FA exposure, since both processes are glutathione-dependent. 
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The increase of intracellular ROS may induce oxidative damage to lipids, proteins and 
DNA (Dalle-Donne et al., 2003). Increased levels of malondialdehyde, a biomarker of 
oxidative stress and lipid peroxidation, was found in the lung tissues of rats exposed to FA 
(Sul et al., 2007). Moreover, in a group of FA- exposed pathologists Bono et al. (2010) 
reported an increase on leukocyte malondialdehyde-deoxyguanosine adducts compared 
to controls.   
A borderline significant increase on aberrant frequencies was found in controls among 
GSTT1 positive subjects. This finding is consistent to data indicating that GSTT1 enzyme 
have both detoxification and activating activities toward different environmental chemicals 
(To-Figueiras et al., 1997; Raimondi et al., 2006), therefore the effect associated with 
GSTT1 null allele is difficult to predict. 
 
DNA repair is a very important mechanism in the protection against multiple types of DNA 
damage, specifically those induced by endogenous and exogenous agents. Common 
polymorphisms in DNA repair genes may alter protein function and an individual’s 
capacity to repair damaged DNA. A deficient repair capacity may lead to genetic instability 
and ultimately to cancer initiation. 
In the present study, the level of genetic damage induced by FA exposure was 
significantly affected by FANCA genotypes. Subjects carrying the Ala variant allele 
showed a significant increase on MNL frequency compared to those carrying the wild type 
genotype. This finding suggests that wild-type homozygotes for FANCA polymorphism are 
more proficient to repair efficiently the DNA damage induced by the exposure to FA than 
the variant allele carriers do.  
Our results are in accordance with recent in vitro data suggesting a role of FANC repair 
pathway genes in counteracting FA-induced DNA damage. Chicken DT40 cells deficient 
in FANC genes show a hypersensitive response to treatment with FA (Ridpath et al., 
2007). Moreover, Rosado et al. (2011) reported that DT40 cells with FANC knockouts are 
synthetic lethal with mutations in the FA-catabolism ADH5 gene, suggesting that FA-
cytotoxicity, evidenced by increased CAs, is generated when it is accumulated in the cell.  
FANCA integrates the FANC repair pathway as a subunit of the FANC core complex. This 
complex comprises eight FANC proteins required to activate the FANC repair system, to 
resolve DNA crosslinks and to stabilise stalled replication forks. The phosphorylation of 
the FANCA protein seems to be an important step in the response of the FANC pathway 
to damaged DNA (Collins et al., 2009). Additionally, recent in vitro data indicates FANCA 
as one of the proteins involved in the stabilisation of stalled replication forks induced by 
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hydroxyurea treatment. The absence of functional protein led to an increase in 
chromosomal instability, evidenced by chromosomal aberrations (Schlacher et al., 2012).  
In addition to the present investigation, only a few studies were carried on FA exposed 
populations to understand the influence of genetic polymorphisms of DNA repair and 
xenobiotic-metabolising enzymes on observed genetic damage. Some studies have 
reported positive outcomes, while others have not. A recent study found a significant 
association between carriers of the variant allele Met for XRCC3 Thr241Met and BNbud 
(Ladeira et al., 2013). However, in our study this effect was only observed for metabolic 
genes and not for XRCC3 Thr241Met. Jiang et al. (2006) reported significant differences 
on DNA damage for XRCC1 Arg280His; subjects with the variant genotype showed an 
increase on comet tail length compared to wild-type homozygotes. In contrast, the 
increase on CAs found in a group of pathologists was not affected by GSTM1 or GSTT1 
null genotypes (Santovito et al., 2011). However, the result may have been influenced by 
the low number of individuals included in the study, since in a previous study, with a 
smaller population, we also did not find any association between GSTM1, GSTT1 and the 
damage induced by FA-exposure (Costa et al., 2008). 
Lastly, our results indicate that polymorphisms in DNA repair and xenobiotic metabolising 
enzymes may affect an individual response to the DNA damage induced by occupational 
exposure to FA, evidenced in both buccal cells and lymphocytes. An important association 
was found for CYP2E1, GSTM1, GSTP1 and FANCA polymorphic genes. It is likely that a 
combined action of enzymatic detoxication and DNA repair is needed to protect cells 
against FA effects. 
Variability in the expression and/or activity of enzymes is attributed to a number of 
sources, including genetic variation. Nevertheless, the contributions of genetics are 
controversial. In many cases, genotype does not correlate well with phenotype, a 
phenomenon which is likely due to the fact that these enzymes are also induced to 
varying degrees by external factors (lifestyle factors, drugs, stress) (Peck and Eaton, 
2010). 
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“All substances are poisons; there is none which is not a poison. 
The right dose differentiates a poison from a remedy.”  
Paracelsus (1493–1541)  
 
The current labour force stands about 45% of the world’s population. Their work sustains 
the economic and material basis of society which is critically dependent on their working 
capacity. Thus, health at work and healthy work environments are one of the most 
valuable assets of individuals, communities and countries. Hence, a policy-oriented 
research focused on the development of integrated approaches regarding the health risk 
assessment of populations occupationally exposed to hazard compounds is of paramount 
importance. 
In anatomical pathology laboratories, Formaldehyde (FA) is a well-known compound 
routinely used for over 100 years as a fixative and tissue preservative. Because of its 
sensitizing properties, irritating effects and cancer implication, FA accounts probably for 
the most important chemical-exposure hazard concerning this professional group.  
Indeed data from the present study shows that subjects working in anatomical pathology 
laboratories are regularly exposed to average levels of FA higher (0.38 ppm) than national 
and international limit values, which indicates a potential risk to worker’s health. 
Our findings also suggest that the level of formic acid in urine can be used to estimate the 
occupational exposure to FA in a group of workers, since its measurement effectively 
indicates the exposure to FA. 
Regarding the genotoxicity evaluation, all cytogenetic and DNA damage endpoints were 
significantly elevated in the peripheral blood lymphocytes (PBLs) of pathological anatomy 
professionals exposed to FA (0.38 ppm) compared to control subjects. Our findings 
reinforce recent data indicating the biological plausibility of inhaled FA to induce genotoxic 
damage on circulating blood cells and potentially on other distant-site cells. Furthermore, 
the same biological effect, higher frequency of micronucleus formation, observed in these 
surrogate cells also occurs in FA-target cells from buccal mucosa. The association found 
between the micronucleus formation in these two tissues and FA-levels of exposure and 
duration, confirms this biomarker sensitivity to evaluate the genotoxic action of FA in 
occupational exposed subjects.  
Chromosome breakage (measured by CAs and comet assay) in PBLs was significantly 
higher in FA-exposed workers compared to controls, which may suggest a clastogenic 
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mode of action of FA, and the primary mechanism of micronucleus formation. Moreover, 
the increase on SCEs frequency among workers seems to reflect the repair of FA-induced 
DNA lesions by homologous repair (HR) pathway. 
Concerning the immunological markers, our findings indicate that FA exposure may affect 
the percentage of lymphocyte subpopulations. Moreover, this influence seems to be 
associated with immunosuppression. To our knowledge, this is the first European study 
evaluating these indicators in FA-exposed professionals from anatomical pathology 
laboratories. Therefore, these results must be cautiously interpreted, until further 
replication in other studies. In addition, the activity of the different subpopulations was not 
measured in this study. 
As evident from the literature, various genetic polymorphisms may modulate the incidence 
of various diseases, particularly cancer, as well as genotoxic effects induced by 
occupational exposure to xenobiotics. In theory, studies on individual susceptibility should 
allow us to establish various favourable and adverse genotypes in order to minimise the 
exposure risk in sensitive individuals. In this study, we found interesting associations 
between metabolic polymorphisms in CYP2E1, GSTP1 and GSTM1 genes and the level 
of DNA damage induced by FA exposure. Our results also reveal a potential novel repair 
pathway involved in the repair of genetic lesions caused by FA-occupational exposure, the 
FANC repair pathway. The level of genetic damage induced by FA exposure was 
significantly affected by FANCA genotypes. This finding suggests the inclusion of the 
FANC pathway in further human biomonitoring studies to explore potential individual 
susceptibility to FA and other genotoxic agents.  
The present results show the importance of individual susceptibility factors in modulating 
genotoxicity, although cautious interpretations are required since the size of the studied 
population limits the power of many of the analysis. Because the effects of these 
polymorphisms are relatively subtle, and some important alleles are relatively rare, a 
much larger study population will be necessary to evaluate their effects on biomarkers, 
especially when gene-gene interactions are considered.  
Overall, our data indicates a potential health risk situation of anatomical pathology 
laboratory workers exposed to FA (0.38 ppm). Thus, implementation of security and 
hygiene measures may be crucial to decrease the risk associated to FA occupational 
exposure. Substitution of the chemical for one less hazardous is generally the first hazard 
control measure considered, since it is usually the less expensive and the most positive 
method for controlling hazards. However, in FA’s case because it is a long-established 
material, effective and inexpensive, few compounds can replace it without compromising 
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quality and cost, which delays its substitution in anatomo-pathology procedures by both 
producers and users. 
Control and minimisation of the exposure are the next step to protect workers from the 
high levels of airborne FA in the workplace. This may be achieved by engineering control 
measures, including the installation of equipment that allows an effective general 
ventilation and local (benches) exhaust, a control of the room temperature and ventilated 
sample cabinets or rooms. In addition, the use of appropriate masks to protect from FA 
vapours, may be determinant to reduce exposure in some tasks where communication is 
not required, for instance, during the disposal of waste solutions. Note that this task can 
be countered by hiring specialised companies for waste disposal solutions of formalin, 
which would eliminate a major source of exposure. Other crucial measures to control and 
reduce the risk to FA exposure in anatomical pathology laboratories are regular 
monitoring and surveillance activities, including, periodic air sampling and medical 
surveillance, as well as good practice campaigns, training programs and implementation 
of written policies and procedures.  
 
 “With respect to formaldehyde or any other “toxin of the moment, education and 
prevention are essential to minimizing the risk of becoming 
embroiled in “bet-the-company” litigation.” 
Excerpt from an advertising brochure of Thompson Hine, a top US business law firm. 
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AVALIAÇÃO DE RISCO DA EXPOSIÇÃO AO FORMALDEÍDO.  
ANÁLISE DO DANO GENÉTICO E SUSCEPTIBILIDADE GENÉTICA EM 
PROFISSIONAIS DE ANATOMIA PATOLÓGICA. 
 
 
Declaração de Consentimento 
 
 
Fui informado sobre os objectivos do estudo e compreendi com clareza o que me é 
pedido, como participante. 
 
Fui ainda informado que: 
 
1- Os dados que fornecer, bem como os resultados das análises que forem 
efectuadas sobre as amostras do meu sangue, urina e esfregaço bucal serão 
estritamente confidenciais. Assim que os procedimentos do estudo o permitam 
esses dados e resultados serão tornados anónimos, isto é, deixarão de poder ser 
relacionados com a minha identificação; 
2- Todos os investigadores e técnicos envolvidos neste estudo e que utilizam esses 
dados são afectos ao Instituto Nacional de Saúde Doutor Ricardo Jorge, I.P. 
(INSA, I.P.) pelo que de acordo com a política da Qualidade, Ambiente e 
Segurança do INSA, I.P. estão obrigados a manter a confidencialidade das 
informações a que tem acesso no âmbito da sua actividade.  
 
Nestas condições, declaro que aceito participar no estudo, disponibilizando-me para: 
 
1- Ser entrevistado e prestar informações sobre vários aspectos respeitantes a 
condições de saúde bem como a algumas características sócio-demográficas 
relevantes; 
2- Permitir a colheita de uma amostra de sangue, urina e esfregaço bucal para 
posterior análise laboratorial. 
 
 
Data:_____/______/______ 
 
Nome do participante:____________________________________________________ 
 
Assinatura:_____________________________________________________________ 
 
 
 
CÓDIGO DE IDENTIFICAÇÃO : _____________ 
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CÓDIGO DE IDENTIFICAÇÃO : ______________________  
 
Amostra recolhida por:__________________________  Data:_____/_____/___       Hora:____________ 
 
A) CARACTERIZAÇÃO SÓCIO-DEMOGRÁFICA : 
1. Data de Nascimento : _____/_____/______   (Idade=_________anos) 
2. Sexo:    M                   F    
3. Altura: ________                Peso: _________ 
4. Naturalidade:___________________      Localidade onde reside:_______________________ 
 
B) ACTIVIDADE PROFISSIONAL: 
5. Actividade profissional: _______________________________________________________ 
 
6.1 Posto de trabalho: ______________________   6.2 Há quanto tempo a exerce: __________ 
 
7. Em que consiste :           
_____________________________________________________________________________ 
 
8. Usa algum tipo de equipamento de protecção individual?             SIM             NÃO    
8.1 Qual?            
 
9. Exerce a sua actividade profissional noutro local :          SIM             NÃO    
9.1 Quantas horas por semana ? ___________________________________________________ 
 
10. Profissões anteriores :       Período :      
 
C) CARACTERIZAÇÃO DE ESTILO DE VIDA E SAÚDE: 
 
C1) Consumo de Álcool  
11. Consumo ..............................................  
Que quantidade de álcool consome em média, por dia?_________________________________________ 
Que tipo de bebida alcoólica bebe habitualmente? ____________________________________________ 
 
12. Não consumo ..............................................  
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C2) Hábitos Tabágicos 
13. É actualmente fumador?    SIM          NÃO    
 
 
14. Alguma vez fumou?            SIM          NÃO     
 
 
15. Se é fumador passivo : 
Tem contacto regular durante 2 ou mais horas com fumadores? 
Em casa   SIM             NÃO     
No trabalho    SIM             NÃO    
No café ou similar   SIM             NÃO    
 
C3) Historial Clínico 
16. Sofre de alergias respiratórias?    SIM             NÃO    
 
Se respondeu  SIM :        
16.1. Só desde que comecei a exercer a minha actual função...........   
16.2.  Sempre sofri..........                    
 
Se sempre sofreu,  sente que houve um agravamento desde que começou a exercer a sua actual 
actividade profissinal ?  SIM             NÃO    
 
17. Costuma sentir alguma da sintomatologia seguinte?  
17.1. Irritação na garganta........................  
17.2. Irritação no nariz.............................  
17.3. Irritação nos olhos...........................  
17.4. Aumento do lacrimejar....................  
17.5. Outros..............................................     Qual/Quais ?_____________________________ 
 
Se assinalou algum sintoma, pode especificar a altura do dia ou da semana em que sente mais? 
_____________________________________________________________________________________ 
Se é fumador: 
Com que idade começou a fumar?___________anos 
Quantos cigarros fuma por dia?________________ 
Se é  ex-fumador: 
Com que idade começou a fumar?___________anos 
Com que idade deixou de fumar?___________anos 
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18. No último ano fez algum tipo de Exame radiológico (Raios X) ?  SIM           NÃO    
Qual?________________________________________________________________________ 
 
19. Nos últimos 2 meses teve algum problema de saúde ?            SIM             NÃO    
Qual?________________________________________________________________________ 
 
20. No último ano foi submetido(a) a alguma intervenção cirúrgica ?  SIM           NÃO    
Qual?________________________________________________________________________ 
 
21. Toma algum tipo de medicação?    SIM             NÃO    
Qual/Quais ? __________________________________________________________________ 
 
22. Alguma vez tomou ou toma pílula contraceptiva ou faz terapêutica hormonal de 
substituição?  SIM             NÃO    
Há quanto tempo? ______________________________________________________________ 
 
23. Tomou alguma vacina nos últimos 12 meses?   SIM             NÃO    
Qual?________________________________________________________________________ 
 
C4) Hábitos Alimentares 
24.1. Consumo de chá................................... NÃO          SIM    Frequência _____________ 
24.2. Consumo de café.................................. NÃO          SIM    Frequência _____________ 
24.3. Consumo de fruta..................................NÃO          SIM    Frequência _____________ 
24.4. Consumo de vegetais.............................NÃO         SIM    Frequência _____________ 
24.5. Consumo de peixe e carne (por semana) ........... peixe __________   carne  ___________ 
24.5. Consumo de suplementos vitamínicos...NÃO         SIM    Frequência _____________ 
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Enquadramento 
 
 
O Formaldeído (FA) é um solvente orgânico largamente usado em actividades laboratoriais.  
 
Este produto é um fixador de tecidos pouco dispendioso e bastante eficiente, sendo, por isso, o 
eleito em procedimentos de rotina anátomo-patológicos. É também um bom desinfectante e um 
meio óptimo para conservar e armazenar biópsias e peças cirúrgicas.  
 
No Serviço de Anatomia Patológica, decorrem actividades que implicam a exposição dos 
trabalhadores ao FA, através da utilização e manuseamento do formol. A principal desvantagem 
apontada na utilização do formol é o facto de haver libertação de vapores durante o seu 
manuseamento, com consequente inalação por parte dos trabalhadores. Por ser um irritante 
primário, a sintomatologia mais comum associada à inalação de FA inclui, irritação do nariz e 
garganta e aumento do lacrimejar. 
 
Recentemente, a International Agency for Research on Cancer (IARC), classificou-o agente 
carcinogénico humano (Grupo 1)  
 
Objectivos 
 
 
Com este trabalho pretende-se avaliar o risco da exposição ocupacional a FA em profissionais dos 
Serviços de Anatomia Patológica. A abordagem ao tema será múltipla, por forma a relacionar 
diferentes tipos de biomarcadores o que permitirá caracterizar a exposição e efeitos na saúde.  
 
A avaliação da exposição ocupacional a FA será realizada através da medição da concentração do 
FA no ar (monitorização ambiental) e pela análise de diferentes indicadores biológicos 
(monitorização biológica). Na monitorização biológica serão estudados biomarcadores de dose 
interna (doseamento de FA na urina), biomarcadores de genotoxicidade (testes citogenéticos, teste 
do cometa) e biomarcadores de susceptibilidade genética (polimorfismos genéticos de enzimas 
envolvidas no metabolismo do FA e de reparação de lesões no ADN). 
 
O conjunto de dados obtidos contribuirão para um melhor conhecimento da relação entre os  
níveis ambientais do FA e os consequentes efeitos biológicos adversos na saúde humana. A 
informação recolhida será um contributo para as entidades encarregues de definir os níveis 
aceitáveis para a exposição humana a FA e para os serviços que têm a seu cargo a vigilância da 
saúde dos trabalhadores. 
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Table I. Genotype frequencies of studied polymorphisms coding for xenobiotic-metabolic 
enzymes among Caucasian and Asians. 
Gene Ethnicity Genotypes Frequency (%) References 
CYP2E1 
(rs6413432) 
Caucasians 
T/T 
T/A 
A/A 
78.9 
19.3 
1.8 
Teixeira et al (2004) 
Asians 
T/T 
T/A 
A/A 
54.5 
36.4 
9.1 
SNPedia * 
GSTT1 
(delection) 
Caucasians 
Present 
Null 
84.0 
16.0 
Costa et al (2012) 
Asians 
Present 
Null 
44.5 
55.5 
Raimondi et al (2006) 
GSTM1 
(delection) 
Caucasians 
Present 
Null 
46.1 
53.9 
Lopez-Címa et al (2012) 
Asians 
Present 
Null 
46.2 
53.8 
Cho et al (2005) 
GSTP1 
(rs1695) 
Caucasians 
Ile/ Ile 
Ile/Val 
Val/Val 
41.9 
46.4 
11.7 
Lopez-Címa et al (2012) 
Asians 
Ile/ Ile 
Ile/Val 
Val/Val 
70.6 
25.5 
2.8 
Cho et al (2005) 
* 1000 Genomes Project, data released on 13 December 2013; Cariaso and Lennon  (2012). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table II. Frequencies of polymorphic genes related to DNA-repair pathways among racial groups. 
Gene Ethnicity Genotypes Frequency (%) References 
XRCC1 (194) 
(rs1799782) 
Caucasians 
Arg/Arg 
Arg/Trp 
Trp/Trp 
89.0 
10.0 
1.0 
Santonocito et al (2012) 
Asians 
Arg/Arg 
Arg/Trp 
Trp/Trp 
78.7-36.8 
18.7-50.0 
2.6-13.2 
Hung et al (2005) 
XRCC1 (399) 
(rs25487) 
Caucasians 
Gln/Gln 
Gln/Arg 
Arg/Arg 
42.2 
44.6 
13.3 
Garcia-Léston et al ( 2012) 
Asians 
Gln/Gln 
Gln/Arg 
Arg/Arg 
56.6 
36.7 
6.6 
SNPedia * 
PARP1 
(rs1136410) 
Caucasians 
Val/Val 
Val/Ala 
Ala/Ala 
77.0 
21.0 
2.0 
Figueiroa et al (2007) 
Asians 
Val/Val 
Val/Ala 
Ala/Ala 
32.5 
48.1 
0.2 
Stern et al (2007) 
MUTYH 
(rs3219489) 
Caucasians 
Gln/Gln 
Gln/His 
His/His 
57.8 
36.1 
6.1 
SNPedia * 
Asians 
Gln/Gln 
Gln/His 
His/His 
33.5 
49.0 
17.5 
SNPedia * 
RAD51 
(rs1801321) 
Caucasians 
G/G 
G/T 
T/T 
30.6 
50.2 
19.2 
Silva et al (2010) 
Asians 
G/G 
G/T 
T/T 
86.4 
12.9 
0.7 
SNPedia * 
XRCC2 
(rs3218536) 
Caucasians 
Arg/Arg 
Arg/His 
His/His 
81.2 
18.8 
- 
Silva et al (2010) 
Asians 
Arg/Arg 
Arg/His 
His/His 
100 
- 
- 
SNPedia * 
XRCC3 
(rs861539) 
Caucasians 
Thr/Thr 
Thr/Met 
Met/Met 
37.9 
51.7 
10.4 
Iarmocovai et al (2006) 
Asians 
Thr/Thr 
Thr/Met 
Met/Met 
82.2 
17.5 
0.3 
SNPedia * 
FANCA 
(rs7190823) 
Caucasians 
Thr/Thr 
Thr/Al 
Ala/Ala 
17.9 
43.8 
38.3 
SNPedia * 
Asians 
Thr/Thr 
Thr/Al 
Ala/Ala 
97.2 
2.8 
- 
SNPedia * 
BRIP1 
(rs4986764) Caucasians 
Ser/Ser 
Ser/Pro 
Pro/Pro 
17.0 
51.3 
31.7 
Frank et al (2007) 
 Asians 
Ser/Ser 
Ser/Pro 
Pro/Pro 
5.3 
33.9 
60.8 
SNPedia * 
* 1000 Genomes Project, data released on 13 December 2013; Cariaso and Lennon (2012). 
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a b s t r a c t
Formaldehyde (FA) is a chemical traditionally used in pathology and anatomy laboratories as a tissue
preservative. Several epidemiological studies of occupational exposure to FA have indicated an increased
risk of nasopharyngeal cancers in industrial workers, embalmers and pathology anatomists. There is also
a clear evidence of nasal squamous cell carcinomas from inhalation studies in the rat. The postulated
mode of action for nasal tumours in rats was considered biologically plausible and considered likely
to be relevant to humans. Based on the available data IARC, the International Agency for Research on
Cancer, has recently classiﬁed FA as a human carcinogen. Although the in vitro genotoxic as well as the in
vivo carcinogenic potentials of FA are well documented in mammalian cells and in rodents, evidence for
genotoxic effects and carcinogenic properties in humans is insufﬁcient and conﬂicting thus remains to be
more documented. To evaluate the genetic effects of long-term occupational exposure to FA a group of
30 Pathological Anatomy laboratory workers was tested for a variety of biological endpoints, cytogenetic
tests (micronuclei, MN; sister chromatid exchange, SCE) and comet assay. The level of exposure to FA was
evaluated near the breathing zone of workers, time weighted average of exposure was calculated for each
subject. The association between the biomarkers and polymorphic genes of xenobiotic metabolising and
DNA repair enzymes was also assessed. The mean level of exposure was 0.44±0.08ppm (0.04–1.58ppm).
MN frequency was signiﬁcantly higher (p=0.003) in the exposed subjects (5.47±0.76) when compared
with controls (3.27±0.69). SCE mean value was signiﬁcantly higher (p<0.05) among the exposed group
(6.13±0.29) compared with control group (4.49±0.16). Comet assay data showed a signiﬁcant increase
(p<0.05) of TL in FA-exposed workers (60.00±2.31) with respect to the control group (41.85±1.97). A
positive correlation was found between FA exposure levels and MN frequency (r=0.384, p=0.001) and
TL (r=0.333, p=0.005). Regarding the genetic polymorphisms studied, no signiﬁcant effect was found on
the genotoxic endpoints. The results of the present biomonitoring study emphasize the need to develop
safety programs.
© 2008 Elsevier Ireland Ltd. All rights reserved.
1. Introduction
Formaldehyde (FA) is an important industrial compound with
numerous applications ranging from the production of resins to
medicine. At room temperature, it is a ﬂammable and colorless
∗ Corresponding author at: National Institute of Health, Environmental Health
Department, Prac¸a Coronel Pacheco 15, 4050-453 Porto, Portugal.
Tel.: +351 222 046 405; fax: +351 222 046 409.
E-mail addresses: solange.costa2@gmail.com, solange costa2@yahoo.co.uk
(S. Costa).
gas with a strong pungent odor. It is also a naturally occurring
biological compound present in all cells, tissues and body ﬂuids.
The highest level of human exposure to this aldehyde occurs in
occupational settings. Because of its widespread use a relatively
large number of workers are exposed to FA. Increased incidences
of nasopharyngeal cancer were found in populations occupation-
ally exposed to FA (Blair et al., 1990; Partanen, 1993; Armstrong
et al., 2000; Vaughan et al., 2000; Hildesheim et al., 2001; Coggon
et al., 2003; Hauptmann et al., 2004). Animal studies demonstrate
that high concentrations of FA can cause irreversible damage to
the nasal epithelium of rats and that in some cases rats exposed to
these concentrations developed neoplasia (Merk and Speit, 1998).
0300-483X/$ – see front matter © 2008 Elsevier Ireland Ltd. All rights reserved.
doi:10.1016/j.tox.2008.07.056
Author's personal copy
S. Costa et al. / Toxicology 252 (2008) 40–48 41
Based on available data the International Agency for Research on
Cancer (IARC) classiﬁed FA as carcinogenic to humans (group
1) (IARC, 2006). Epidemiological studies of industrial workers,
embalmers and pathology anatomists have associated FA expo-
sure with elevated risks for cancers at various sites, including nasal
cavities (Blair et al., 1990; Luce et al., 2002; Coggon et al., 2003),
lung (Gardner et al., 1993; Coggon et al., 2003), brain (Hayes et
al., 1990; Coggon et al., 2003), pancreas (Stone et al., 2001) and
lymphohematopoietic system (Hall et al., 1991; Hauptmann et al.,
2003; Pinkerton et al., 2004), however, these positive ﬁndings may
have been confounded by concomitant exposures and remain con-
troversial (Collins et al., 2001; Heck and Casanova, 2004; Marsh
and Youk, 2004, 2005; Golden et al., 2006). Nevertheless, it is
still unclear whether these tumours arose through a genotoxic
mechanism and/or as a consequence of cytotoxicity except for car-
cinogenesis in nasal tissues where FA seems to proceed both by
genotoxic and cytotoxic effects (Orsière et al., 2006). Several studies
have shown the potential genotoxic effect of FA in proliferating cul-
tured mammalian cell lines and in human lymphocytes. Induction
ofmicronucleus (MN) (Suruda et al., 1993;He et al., 1998;Orsière et
al., 2006), sister chromatid exchange (SCE) (He et al., 1998; Shaham
et al., 1997, 2002), chromosomal aberrations (CA) (He et al., 1998),
DNA-protein crosslinks (DPC) (Shaham et al., 1996, 1997, 2003)
and DNA damage (comet assay) (Yu et al., 2005) were reported in
industrial workers, embalmers and pathology anatomists exposed
to FA.
Occupational exposure to FA occurs mainly in pathologic
anatomy laboratories where it is used as a cytological ﬁxative
to preserve the integrity of cell structures for a wide variety of
purposes, including cell, tissue and organelle descriptive exam-
inations, clinical diagnoses and developmental studies. In these
settings, absorptionof FAoccursmainly through inhalation. Inhaled
FA primarily affects the upper airways; the severity and extent of
physiological response depends on its concentration in the air. Sev-
eral studies have consistently shown that the levels of airborne
FA in anatomy laboratories exceed recommended exposure crite-
ria (Shaham et al., 2002; Akbar-Khanzadeh and Pulido, 2003). Such
results along with the recent implications of human carcinogenic-
ity, point out for the need of close monitoring of FA exposures. A
wide range of methods is currently used for the detection of early
biological effects of DNA-damaging agents in occupational set-
tings. Assays measuring micronucleus (MN) and sister chromatid
exchanges in peripheral blood lymphocytes are well-established
cytogenetic techniques that have been used extensively for assess-
ingDNAdamage at the chromosomal level in humanbiomonitoring
(Carrano and Natarajan, 1988; Fenech, 1993). Recently it has been
reported that theMN test is also predictive of cancer risks in human
populations (Bonassi et al., 2007). In recent years, single cell gel
electrophoresis or comet assay has been proven to be a very sensi-
tive method of human biomonitoring for the detection of levels of
DNA damage, and as a useful tool for detection of genetic damage
at the individual cell level (Collins, 2004). The simultaneous use of
cytogenetic tests and comet assay in occupational studies allows
a comparison of the presence of DNA strand breaks, due to both
acute and chronic exposure, and of chromosome damage, due to
clastogenic and aneugenic events. In the case of chronic exposure,
comparing the levels of damage from a cytogenetic technique with
the comet assay couldprovide informationabout concurrent versus
past exposure (Albertini et al., 2000).
Polymorphic genes involved in the metabolism of xenobiotics
may modulate the levels of biomarkers arising from environmen-
tal and/or occupational exposure to genotoxic agents (Pavanello
and Clonfero, 2000). Knowledge of the real impact of genetic poly-
morphisms as biomarkers of susceptibility is of key signiﬁcance in
understanding the processes of genetic damage involved in muta-
genesis and carcinogenesis (Srám and Binková, 2000) and could
help to minimize risks for susceptible subjects (Laffon et al., 2006).
Glutathione S-transferases (GSTs) are a superfamily of polymor-
phic enzymes involved in the conjugation of reactive chemical
intermediates to soluble forms, and they play an important role
in the detoxiﬁcation of endogenous and exogenous compounds.
The polymorphic genes GSTM1 and GSTT1 code for GSTs that are
involved in thedetoxiﬁcationof avarietyofpotentially carcinogenic
compounds, including polyaromatic hydrocarbon diol-epoxides,
steroids and genotoxic lipoperoxidation products (Strange et al.,
2001). The GSTM1 and GSTT1 polymorphisms are the result of the
deletion of part of the gene, and this leads to the absence of activity
in individuals homozygous for thedeletion (null genotype) (Strange
et al., 2001). The GSTM1 and GSTT1 null genotypes have been asso-
ciated with increased risk for several cancers including, lung and
colorectal cancer (Raimondi et al., 2006; Hosgood et al., 2007; Loft
et al., 2007; Yeh et al., 2007). DNA repair is a key human cellular
response to DNA-damaging stimuli. DNA repair mechanisms are
vital responses to multiple types of DNA damage, including the
ones caused by exposure to environmental and endogenous car-
cinogens (Kiyohara and Yoshimasu, 2007;McWilliams et al., 2008).
Most of the alterations caused, if not repaired, can result in genetic
instability, mutagenesis and cell death. Thus genetic variations in
DNA repair genesmaymodulateDNA repair capacity and, therefore
inﬂuence risk for cancer development (Kiyohara et al., 2007). Poly-
morphisms in the NER (nucleotide excision repair) pathway have
been associated with increased risk for breast cancer (Milne et al.,
2006; Costa, 2007), head and neck cancer (Shen et al., 2001), lung
cancer (Kiyohara and Yoshimasu, 2007; Matakidou et al., 2007),
basal cell skin cancer (Winsey et al., 2000) and pancreatic adeno-
carcinoma (McWilliams et al., 2008).
The aimof the present studywas to evaluate bothDNAand cyto-
genetic damage in peripheral lymphocytes of FA-exposed workers
in pathologic anatomy laboratories. Air monitoring was performed
in order to evaluate occupational exposure to FA. A multiple
approachwasused inorder to integratedifferent biomarkers (effect
and susceptibility). Genetic damage was studied by means of MN,
SCE and comet assay (comet tail length, TL). In addition, the inﬂu-
ence of polymorphic genes of xenobiotic metabolising enzymes
(GSTM1,GSTT1) andDNArepair enzymes (ERCC1 (rs3212986: 196bp
3′ of STP T>G, Q504K), ERCC4 (rs1800067: Ex8+31G>A R415Q)
and ERCC5 (rs17655: Ex15-344G>C, D1104H; and rs2227869: Ex8-
369G>C, C529S)) on the biomarkers was also analysed.
2. Methods
2.1. Subjects
The study population consisted of 30 workers exposed to FA from four hospital
pathological anatomy laboratories, located in Portugal (Oporto and Aveiro districts),
and 30 non-exposed control employees, matched by age, sex, lifestyle and smoking
habits, working in the same area in administrative ofﬁces and without occupa-
tional exposure history to FA. The characteristics of both groups are described in
Table 1. Health conditions, medical history, medication, diagnostic tests (X-rays,
etc.) and lifestyle factors were assessed by means of questionnaires. Subjects of
the exposed group also gave information related to working practices such as use
of protective measures, years of employment, speciﬁc symptoms related to FA-
exposure and chronic respiratory diseases such as asthma and others. All subjects
were fully informed about the procedures and objectives of this study and each sub-
ject prior to the study signed an informed consent form. Ethical approval for this
study was obtained from the institutional Ethical Board of the National Institute of
Health.
2.2. Environmental monitoring
Air sampling was performed in the workers breathing zone for representative
working periods, analysis of the samples allowed the calculation of the 8-h time
weighted average (TWA) level of exposure to FA for each subject. Air sampling and
FA analysis were performed according to the NIOSH method no. 3500.
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Table 1
Characteristics of the study population
Control group Exposed group
Number of subjects 30 30
Gender 19 females 21 females
11 males 9 males
Age (years)a 37±10 (25–61) 38±8 (23–53)
Years of employmenta – 11±7 (0.5–27)
Smoking status
Non-smokers 23 (77%) 22 (73%)
Smokers 7 (23%) 8 (27%)
No cigarettes/daya 14±8 (6–30) 13±5 (5–20)
No years smokinga 21±17 (4–51) 14±8 (3–22)
a Mean± S.D.
2.3. Cytogenetic assays
Heparinized venous blood samples (10ml), were collected between 10 and
11a.m., fromeach donor, andwere immediately processed for the differentmethod-
ologies used in this study.Workers begin theirwork at 9 a.m. All sampleswere coded
and analysed under blind conditions.
2.3.1. MN test
Aliquots of 0.5ml of heparinized whole blood were used to establish dupli-
cate lymphocyte cultures for cytokinesis-blocked micronucleus test, as described
in Teixeira et al. (2004). Cultures were incubated at 37 ◦C in the dark for a total of
72h, cytochalasin B (6g/ml) was added at 44h to prevent cytokinesis. Cells were
collectedbycentrifugationand treated twicewithamixtureofRPMI (pH7.2) supple-
mented with 2% fetal bovine serum. The cells were centrifuged again and submitted
to a mild hypotonic treatment in a mixture of RPMI (pH 7.2):deionized water (1:4,
v/v), supplemented with 2% fetal bovine serum. Then, the centrifuged cells were
placed on dry slides and smears were performed. After air-drying, the slides were
ﬁxed with cold methanol:acetic acid (3:1, v/v). Air-dried slides were stained with
4% Giemsa in pH 6.8 phosphate buffer. Microscopic analyses were performed on a
Nikon Eclipse E400 light microscope. To determine the total number of MN in binu-
cleated cells, a total of 1000 binucleated cells with well-preserved cytoplasm (500
per replicate) were scored for each subject. MN were scored blindly by the same
reader and identiﬁed according to the criteria deﬁned by Caria et al. (1995).
2.3.2. SCE test
Lymphocyte cultures for SCE were established in duplicate as described previ-
ously (Teixeira et al., 2004) in the micronucleus assay, except for the addition of 5l
of 5-bromo-deoxyuridine (10g/ml) to the culture medium. Differential chromatid
staining was performed with the ﬂuorescence-plus-Giemsa procedure (Perry and
Wolff, 1974). A single observer scored 50 s division metaphases for each donor (25
from each duplicate culture) on coded slides to determine the number of SCE/cell.
2.3.3. Comet assay
Lymphocytes were isolated, in duplicate, from heparinized whole blood, by
centrifugation on a Ficoll density gradient. The lymphocyte layer (buffy coat) was
removed and washed three times with ice-cold phosphate buffer solution (PBS)
pH 7.4, at 1000 rpm (∼270× g) for 10min. Cell viability, determined by trypan blue
exclusion, was higher than 80% in all cases.
The alkaline version of the comet assay was performed as described by Singh
et al. (1988) with minor modiﬁcations. Brieﬂy, cells collected by centrifugation
(7500× g for 3min) and suspended in 100l of 0.6% low-melting-point agarose
(LMA) in PBS (pH 7.4) were dropped onto a frosted slide precoated with a layer of
1% normal melting point agarose. Slides were placed on ice for 4min and allowed to
solidify. Coverslipswere then removedandslideswere immersed in freshlyprepared
lysing solution (2.5MNaCl, 100mMNa2EDTA, 10mMTrisBase, 0.25MNaOH, pH 10)
for 1h at 4 ◦C, in thedark. After lysis, slideswereplacedonahorizontal electrophore-
sis tank in an ice bath. The tankwas ﬁlledwith freshlymade alkaline electrophoresis
solution (1mM Na2EDTA, 300mM NaOH, pH 13) to cover the slides, and they were
left for 20min in the dark to allow DNA unwinding and alkali-labile site expression.
Electrophoresis was carried out for 20min at 30V and 300mA (1V/cm). The slides
were then washed for 10min with 1ml of neutralizing solution (0.4M TrisBase, pH
7.5). After neutralization, gels were stained with 100l of ethidium bromide solu-
tion (20g/ml) and coveredwith coverslips for 20min. After staining the slideswere
washed twice with ice-cold bidistilled water for 20min. Two slides were prepared
for each donor and a ‘blind’ scorer examined 50 randomly selected cells from each
slide (100 cells/donor) using a magniﬁcation of 400×. Image capture and analysis
were performed with Comet Assay IV software (Perceptive Instruments). Comet tail
length (TL) was the DNA damage parameter evaluated. TL (m) indicates the extent
of migration of genetic material in the direction of the anode (Singh et al., 1988) and
is expected to be proportional to the level of single-strand breaks and alkali-labile
sites.
2.4. Genotype analysis
GenomicDNAwasobtained fromheparinizedwholeblood samplesusinga com-
mercially available kit according to the manufacturer’s instructions (QIAamp DNA
extraction kit; Qiagen, Hilden, Germany). Each DNA sample was stored at −20 ◦C
until analysis.
GSTM1 and GSTT1 genotyping for gene deletions were carried out by
a multiplex PCR as described by Lin et al. (1998) with minor modiﬁ-
cations described in Gaspar et al. (2004). DNA samples were ampliﬁed
with the primers (PerkinElmer Corp): 5′-GAACTCCCTGAAAAGCTAAAGC-
3′ (upstream) and 5′-GTTGGGCTCAAATATACGGTGG-3′ (downstream) for
GSTM1 which produced a 219bp product, 5′-TCACCGGATCATGGCCAGCA-
3′ (upstream) and 5′-TTCCTTACTGGTCCTCACATCTC-3′ (downstream) for
GSTT1 which produced a 459-bp product. The ampliﬁcation of albumin
gene with the primers 5′-GCCCTCTGCTAACAAGTCCTAC-3′ (upstream) and 5′-
GCCCTAAAAAGAAAATCCCCAATC-3′ (downstream) was used as an internal control
and produced a 350-bp product. PCR was performed in a ﬁnal volume of 50l,
consisting of DNA (0.1g), dNTP (0.2mM each) (PerkinElmer), MgCl2 (2.5mM),
each primer (1.0, 0.3 and 0.2M for GSTM1, GSTT1 and albumin, respectively),
AmplitaqGold polymerase (1.25 units) (PerkinElmer), reaction buffer and 2% DMSO.
Ampliﬁcation was performed with an initial denaturation at 95 ◦C for 12min,
followed by 35 cycles of ampliﬁcation performed at 94 ◦C for 1min, 62 ◦C for 1min
and 72 ◦C for 1min, and a ﬁnal extension at 72 ◦C for 10min, using a GeneAmp
9600 thermal cycler (PerkinElmer Corp). After electrophoretic separation (30min,
4V/cm) the ampliﬁed products were visualized, under ultraviolet light, in ethidium
bromide stained (1g/ml) agarose gel (1.5%).
All the genotype determinations were carried out twice in independent exper-
iments and all the inconclusive samples were reanalysed.
ERCC1 (rs3212986), ERCC4 (rs1800067), ERCC5 (rs17655 and rs2227869)
polymorphisms were determined using the TaqMan SNP genotyping assay
(Applied Biosystems) with corresponding codes of C 2532948 10, C 3285104 10,
C 1891743 10 and C 15956775 10. The 5′-nuclease allelic discrimination assay, or
TaqManassay, is aPCR-basedassay forgenotypingsinglenucleotidepolymorphisms.
The PCR ampliﬁcationwas performed in 10l reactions containing 10ng of genomic
DNA, 1× SNP Genotyping Assay Mix, and 1× TaqMan Universal PCR Master Mix
containing optimised buffer components and Rox reference dye. The ampliﬁcation
conditions consisted of an initial AmpliTaq Gold® activation at 95 ◦C during 10min,
followed by 40 or more ampliﬁcation cycles consisting of denaturation at 92 ◦C for
15 s and annealing/extension at 60 ◦C for 1min. Ampliﬁcation was performed in the
7300 Real-Time PCR System (Applied Biosystems) and sequences were detected by
the SDS-SequenceDetection Software (version 1.3.1). All the genotype determinations
were carried out twice in independent experiments and all the inconclusive samples
were reanalysed.
2.5. Statistical analysis
The distribution of variables was compared with the normal distribution by
means of theKolmogorov–Smirnov goodness-of-ﬁt test.MNwas the only parameter
that departed signiﬁcantly from normality and therefore the non-parametric tests
Mann–Whitney U-test and Kruskal–Wallis test were applied to data. Thus, analyses
of all the other variables were performed by use of parametric tests. The effect of
occupational exposure, gender, age, tobacco smoking, and GSTM1, GSTT1, ERCC1,
ERCC4, and ERCC5 genotypes on every parameter studied was evaluated by one-way
analysis of variance (ANOVA) and Student’s t-test. The associations between two
variableswereanalysedbyPearson’s (parametric) andSpearman’s (non-parametric)
correlation tests. The level of signiﬁcance considered was 0.05. All analyses were
conducted using the SPSS for Windows statistical package, version 11.0.
3. Results
To evaluate current exposure to FA in pathological anatomy lab-
oratories air sampleswere collected in theworkers’ breathing zone.
The main FA vapor emissions occurred during the macroscopic
examination of FA-preserved specimens and during the disposal of
specimens and waste solutions, during these tasks the mean room
FA concentrations were 1.50 and 4.43ppm, respectively. The mean
level of FA exposure of the 30 individuals studied was 0.44ppm
(0.04–1.58ppm). TheAmericanConferenceofGovernmental Indus-
trial Hygienists (ACGIH) has set for FA a ceiling limit at 0.3ppm
(ACGIH, 2008). The currentPortugueseoccupational exposure stan-
dard is also a 0.3ppm ceiling limit (ceiling level), meaning the
maximum safe FA-airborne concentration that should never be
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Table 2
Results of MN, SCE, and comet assay in the populations examined
Mean, MN± S.E. Mean, SCE± S.E. Mean, TL (m)± S.E.
Controls 3.27 ± 0.69 (0–17) 4.49 ± 0.16 (3.10–3.06) 41.85 ± 1.97 (28.85–66.52)
Exposed 5.47 ± 0.76* (1–17) 6.13 ± 0.29** (3.64–8.80) 60.00 ± 2.31** (33.76–99.09)
S.E.: mean standard error.
* p=0.003.
** p<0.05.
exceeded during any length of time in a workers’ breathing zone.
Thus, the FA air concentrations obtained in this study show that
workers in pathological anatomy laboratories are exposed to levels
of airborne FA that exceed recommended exposure criteria.
Effect of exposure on frequencies of cytogenetic biomarkers and
on DNA damage are shown in Table 2.
For all the variables studied signiﬁcant increases were found
in the exposed workers as compared with the controls. MN fre-
quency was signiﬁcantly higher (p=0.003) in the exposed subjects
(5.47±0.76)when comparedwith controls (3.27±0.69). SCEmean
value was signiﬁcantly higher (p<0.05) among the exposed group
(6.13±0.29) compared with control group (4.49±0.16). Comet
assay data showed signiﬁcantly increase (p<0.05) of comet tail
length (TL) in FA-exposed workers (60.00±2.31) with respect to
the control group (41.85±1.97). Fig. 1 shows the distribution of
MN and SCE frequencies and TL in the study populations. The dis-
tributions in the exposed group are displaced to higher values of
damage for the three parameters studied. Moreover the exposed
individuals were the only ones to have mean frequency SCE values
higher than 6.4 and mean TL values equal or higher than 70.4m.
Apositive correlationwas foundbetweenFAexposure levels and
MN frequency (r=0.384, p=0.001) and TL (r=0.333, p=0.005).
The effect of gender on the parameters examined is shown
in Table 3. MN frequency increased in females in both groups
compared with males, but the increase was not signiﬁcant. No
signiﬁcant association was found between males and females
from both groups for SCE frequency. Regarding DNA damage,
comet tail length was signiﬁcantly (p=0.014) increased in females
(63.06±2.60, n=21) compared with males (52.84±4.00, n=9) but
only in the exposed group.
In order to examine the effect of age, exposed and non-exposed
individuals were divided in three groups: <30 years, 30–40 years
and >40 years. No signiﬁcant effect of age was found in any of the
variables studied (data not shown). MN frequency increased with
age in both populations, but it did not reach statistical signiﬁcation.
Smoking habits did not inﬂuence MN frequency and DNA dam-
age (TL) (Table 4). However a signiﬁcant increase (p=0.014) was
found for SCE frequency in the control group; smokers had a higher
(5.24±0.39, n=7) frequency of SCE than non-smokers (4.27±0.15,
n=23). In theexposedgroupnosigniﬁcantdifferencewasobserved.
In order to analyse the effect of exposure time four groups of
exposed workers were established based on their years of employ-
ment. No signiﬁcant association was found between the duration
of exposure and the studied biomarkers (data not shown).
Distribution of the genotype frequencies of metabolic (GSTM1,
GSTT1) and DNA repair (ERCC1, ERCC4, ERCC5) genes in the study
population is presented in Table 5.
The GSTM1 null genotype was slightly more prevalent in con-
trols (48%) than among the exposed workers (43%), whereas the
distribution of the GSTT1 null genotype was 17% in the exposed
population and 7% in the controls. Among the whole study popu-
lation, the prevalence of GSTM1 and GSTT1 deleted genotypes was
46% and 7%, respectively, a ﬁnding consistent with previous results
described by other authors for Caucasians (To-Figueras et al., 1997;
Garte et al., 2001; Raimondi et al., 2006) and Portuguese popula-
tions (Martins andAlves, 1998;Gaspar et al., 2004). Thedistribution
of ERCC1, ERCC4, ERCC5 frequencies in the study population were
similar to the ones described in other studies for Caucasian popula-
tions (NCBI-SNP Database, 2008; SNP500Cancer Database, 2008).
Allele frequencies of the different ERCC1 genotypes obtained in the
study population are similar to those found for Caucasian popu-
lations NCBI-SNP Database, 2008; SNP500Cancer Database, 2008).
The distribution of ERCC4 genotypes in the whole studied popula-
tion was 78%, 20% and 2% for GG, GA and AA, respectively. These
results are identical to those described for Caucasian population,
GG 79%, GA 19% and AA 2% (SNP500Cancer Database, 2008). The
ERCC5 (rs17655) CC genotype frequency in all studied population
was 6%, which is in accordance with the 7% frequency described
for the European population (NCBI-SNP Database, 2008). Concern-
ing the frequency of the ERCC5 (rs2227869) genotypes among the
whole population, the prevalence of ERCC5 GG genotype was 93%,
a ﬁnding consistent with the frequency registered for Caucasian
populations (NCBI-SNP Database, 2008; SNP500Cancer Database,
2008).
Regarding the effect of the genetic polymorphisms studied we
did not ﬁnd any effect on the genotoxic endpoints.
4. Discussion
Occupational exposure to FA evaluated in the four pathologic
anatomy laboratories shows thatworkers are exposed tohigh levels
of FA.
Several studies (Shaham et al., 1997; Dufresne et al., 2002;
Akbar-KhanzadehandPulido, 2003)point theanatomy laboratories
Fig. 1. Distribution of MN frequency (A), SCE frequency (B), and comet tail length (C) in control and exposed populations.
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Table 3
Effect of gender on MN, SCE, and comet assay
Gender N MN± S.E. (range) SCE± S.E. (range) TL (m)± S.E. (range)
Controls
Females 19 4.11 ± 1.03 (0–17) 4.33 ± 0.17 (3.27–6.16) 40.84 ± 2.75 (29.80–66.52)
Males 11 1.82 ± 0.44 (0–5) 4.78 ± 0.33 (3.10–6.04) 43.60 ± 2.58 (28.85–53.70)
Exposed
Females 21 5.95 ± 0.80 (2–17) 6.10 ± 0.35 (3.72–8.80) 63.06 ± 2.60* (51.23–99.09)
Males 9 4.33 ± 1.72 (1–17) 6.18 ± 0.52 (3.64–8.10) 52.84 ± 4.00 (33.76–76.18)
S.E.: mean standard error.
* p=0.014, signiﬁcant difference with regard to males among exposed individuals.
Table 4
Effect of smoking on MN, SCE, and comet assay
Smoking habits N MN± S.E. (range) SCE± S.E. (range) TL (m)± S.E. (range)
Controls
Non-smokers 23 3.09 ± 0.81 (0–17) 4.27 ± 0.15 (3.10–6.04) 40.89 ± 2.06 (29.80–62.14)
Smokers 7 3.86 ± 1.44 (0–11) 5.24 ± 0.39* (3.12–6.16) 45.03 ± 5.17 (28.85–66.52)
Exposed
Non-smokers 22 5.35 ± 0.89 (1–17) 6.17 ± 0.32 (3.64–8.80) 59.16 ± 2.84 (33.76–99.09)
Smokers 8 5.70 ± 1.48 (2–17) 6.02 ± 0.64 (3.72–8.70) 61.66 ± 4.12 (41.01–66.10)
S.E.: mean standard error.
* p=0.014, signiﬁcant difference with regard to non-smokers among the controls.
as one of the occupational settings where the workers are fre-
quently exposed to levels of FA near or superior to recommended
limit values, which indicate a potential risk to workers’ health.
Keil et al. (2001) reported that average daily area concentrations
of airborne FA in a gross anatomy laboratory ranged from 0.635
to 1.82mg/m3 (0.51–1.46ppm). Shaham et al. (2002) reported for
14 pathology departments a mean low level and high level of FA
exposure of 0.4 and 2.24ppm, respectively. Ohmichi et al. (2006)
evaluated personal exposure levels and indoor FA concentrations in
a gross anatomy laboratory during 3 sessions of a total 20 sessions
over 10 weeks. Average personal FA-exposure levels for instruc-
tors and students ranged between 0.45 and 1.08ppm, room FA
average concentrations in the three sessions were 0.45, 0.38 and
0.68ppm.
The mean level of exposure to FA obtained in this study
was 0.44ppm (0.04–1.58ppm). Other authors reported similar
results; Akbar-Khanzadeh et al. (1994) reported for 34 workers of
a gross anatomy laboratory a mean FA-level exposure of 1.24ppm
(0.07–2.94ppm). Orsière et al. (2006) recently evaluated the occu-
pational exposure to FA in pathology and anatomy laboratories
by personal air sampling and reported a mean concentration of
0.1ppm (0.1–0.7ppm).
Our results show that DNA and chromosomal damage occurs in
peripheral lymphocytes of pathologic anatomy laboratory workers
exposed to FA. Signiﬁcant increases were found in all biomarkers
studied compared with control population.
SCE frequencies were higher in the FA-exposed subjects than in
controls. These results agree with those presented by Shaham et al.
(1997, 2002) who described a signiﬁcant increase of SCE frequency
in peripheral lymphocytes of 90 pathology workers from 14 hos-
pital pathology departments. The increase of SCE on FA exposed
individuals was previously described by Yager et al. (1986); SCE
measured in the peripheral lymphocytes of eight non-smoking
anatomy students after exposure to FA embalming solution during
a 10 week anatomy class showed a signiﬁcant increase (p=0.02)
when compared with samples obtained from the same individu-
als immediately before exposure began (breathing-zone samples
showed a mean FA concentration of 1.2ppm). Recently Ye et al.
(2005) reported signiﬁcantly increased SCE frequencies in a group
of 18 workers from a FA factory. The mean exposure duration
Table 5
Frequency of metabolic and repair genotypes in the study population
Genes DbSNP ID Genotypes All (%) Controls (%) Exposed (%)
GSTM1 Deletion
Present 32 (54) 15 (52) 17 (57)
Null 27 (46) 14 (48) 13 (43)
GSTT1 Deletion
Present 53 (88) 28 (93) 25 (83)
Null 7 (12) 2 (7) 5 (17)
TT 4 (7) 2 (8) 2 (7)
ERCC1 rs3212986
TG 22 (42) 11 (46) 11 (38)
GG 27 (51) 11 (46) 16 (55)
GG 43(78.2) 17 (68) 26 (87)
ERCC4 rs1800067
GA 11 (20) 8 (32) 3 (10)
AA 1(1.8) 0 1 (3)
GG 32 (59) 11 (46) 21 (70)
ERCC5 rs17655
GC 19 (35) 10 (42) 9 (30)
CC 3 (6) 3 (12) 0
ERCC5 rs2227869
GG 50 (93) 22 (92) 28 (93)
GC 4 (7) 2 (8) 2 (7)
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was 8.6 years and the level of exposure was 0.985±0.286mg/m3
(0.82±0.238ppm). In contrast, in other studies nodifferenceswere
found on SCE frequencies of subjects occupationally exposed to FA
(Suruda et al., 1993, level of FA exposure was 0.33ppm; Ying et al.,
1999, FA inhalation exposure was 0.508±0.299mg/m3).
Our results also showed a signiﬁcant increase in MN frequency
in workers compared with the controls. This ﬁnding is consistent
with previous studies on peripheral lymphocytes and on epithe-
lial cells (nasal and buccal) of FA exposed workers. Suruda et al.
(1993) examined the effect of low level exposure to FA (0.33ppm)
on oral, nasal and lymphocyte biological markers in a group of 29
mortician students during an embalming course. Epithelial cells
from the buccal mucosa showed a 12-fold increase in micronuclei
frequency. Micronucleated lymphocytes frequency increased 26%
and nasal epithelial micronuclei increased 22% during the study
period. A dose–response relationship was observed with cumu-
lative exposure to FA. Ying et al. (1997) evaluated micronuclei
frequency on lymphocytes and on oral and nasal mucosa cells of 25
anatomy students exposed to FA over an 8-week period. A higher
frequency ofmicronuclei was observed in nasal and oral exfoliative
cells after FA exposure, but no signiﬁcant increase in the frequency
of lymphocyte micronuclei was found. He et al. (1998) applied
cytokinesis-blocked micronucleus (CBMN) assay as a biological
dosimeter to detect abnormalities in human peripheral lympho-
cytes of 13 students exposed to FA during a 12-week anatomy
class. Breathing-zone air samples collected during dissection pro-
cedures showedameanconcentrationof2.37ppm;MNfrequencies
in the exposed group were signiﬁcantly increased (p<0.01) com-
pared with controls. FA-exposed group also showed a signiﬁcant
increase in CA (p<0.01) and SCE (p<0.05). A correlation between
MN and CA in individuals was observed. The results indicated that
FA might damage the chromosomes of human lymphocytes. Yu et
al. (2005) also found signiﬁcantly higher frequencies ofmicronuclei
on peripheral lymphocytes in 151 workers occupationally exposed
to FA from two plywood factories compared with control popu-
lation (p<0.05). Recently a study was conducted to evaluate the
genotoxic effect of occupational exposure to FA on 59 pathol-
ogy and anatomy laboratory workers, assessment of chromosomal
damage was carried out by use of the CBMN assay in peripheral
lymphocytes. The frequency of binucleated micronucleated cells
was signiﬁcantly higher in pathologists/anatomists than in controls
(p=0.001) (Orsière et al., 2006). Orsière et al. (2006) also reported
a signiﬁcantly higher frequency of monocentromeric micronuclei
in FA-exposed pathologists/anatomists than in controls (p<0.001),
whereas for acentromeric micronuclei frequency no differences
were obtained between the exposed and control group, suggest-
ing an aneugenic effect of FA in peripheral lymphocytes of exposed
subjects. The potential aneugenic effects of FA have also been sug-
gested in vitro. Pfuhler and Wolf (2002) reported the ability of FA to
disturb the kinetochore-microtubule attachment and mitotic spin-
dle checkpoint using isolated tubulin from pig brains. On the other
hand, a signiﬁcantly higher fraction of acentromeric micronuclei
was reported in buccal and nasal cells ofmortuary science students
exposed to FA before and after a 90-day embalming class (Titenko-
Holland et al., 1996), suggesting a clastogenic effect of FA as the
primary mechanism of micronucleus formation.
Only in the last few years the comet assay has being introduced
as a useful technique in human biomonitoring studies allowing the
evaluation of DNAdamage at the single cell level. Therefore, few are
the studies published on FA occupational exposure in which this
biomarker is used. However, there are already some in vitro stud-
ies in cellular lines and in animal and human leukocytes culture
cells in which the comet assay proved to be a sensitive biological
indicator in the evaluation of the genotoxic effect of FA (Frenzilli
et al., 2000; Im et al., 2006; Liu et al., 2006; Sul et al., 2007). In
this study, the levels of DNA damage, measured as TL, were signiﬁ-
cantly increased in the exposed group comparedwith controls. This
result agreeswith those presented by Yu et al. (2005)who reported
a signiﬁcantly increase of TL and olive tail moment in peripheral
blood lymphocyte of 151 workers from two plywood factories. The
levels of FA-exposed workers were between 0.10 and 7.88mg/m3
(0.08–6.54ppm).
In human biomonitoring studies it is important to assess the
inﬂuence of major confounding factors such as gender, age and
smoking habits in the endpoints studied. In this work we did not
ﬁnd signiﬁcant differences between females and males in MN and
SCE frequencies. However, females presented an increase in MN
frequencies compared with males. This is in agreement with cur-
rent knowledge on the effect of gender on genetic damage which
determines a 1.5-fold greater MN frequency in females than in
males (Fenech et al., 1999). The inﬂuence of gender in MN fre-
quencies can be explained by supposed preferential aneugenic
events involving the X-chromosome (Costa et al., 2007). Surrallés
et al. (1996) reported an excessive overrepresentation of this chro-
mosome in micronuclei of lymphocytes cultured from women.
Signiﬁcant increases were found for comet tail length only among
exposed individuals, females had higher comet tail length than
males. Although in the past the effect of gender on the level of
DNA damage was regarded as a matter of controversy (Møller et
al., 2000), recent studies have shown that this is not a factor that
inﬂuences the damage evaluated by this indicator (Møller, 2006;
Angerer et al., 2007).
Regarding the inﬂuence of age, no differences were obtained for
the three biomarkers studied, although MN frequencies tended to
risewithage inbothgroups itdidnot reachstatistical signiﬁcance. It
has been postulated that the age affect in MN frequency is related
to a progressive increase in spontaneous chromosome instability
and the loss of efﬁciency in DNA repair mechanisms which may
result in the accumulation of genetic lesions with increasing age
(Bolognesi et al., 1999; Kirsch-Volders et al., 2006; Orsière et al.,
2006).
Tobacco smoke contains a high number of mutagenic and car-
cinogenic substances, hence smoking is an important variable to
consider in biomonitoring studies (IARC, 2002; Bonassi et al., 2003).
In the present study no signiﬁcant differences were obtained for
MN and TL. However in both groups the smokers presented slightly
higher MN frequencies and TL than non-smokers. There are some
conﬂicting results regarding the effect of smoking on MN frequen-
cies and comet assay parameters (Laffon et al., 2002; Bhalli et
al., 2006; Ergene et al., 2007), nevertheless in two recent meta-
analysis studies no association between smoking and these two
genotoxic endpoints was found (Bonassi et al., 2003; Hoffmann
and Speit, 2005). Signiﬁcant differences were obtained in SCE fre-
quencies among the control group. Smoking is known to increase
SCE frequencies, there are numerous reports describing the effect
of smoking on SCE frequency of occupationally exposed subjects
(Shaham et al., 1997, 2002; Cebulska-Wasilewska et al., 1999;
Rowland and Harding, 1999; Ergene et al., 2007). However it is
important to note the low number of smoker subjects included in
this study, which may have affected our results.
No association was found between time of exposure and the
biomarkers studied. One possible explanation may be an adapta-
tion of various systems (induction of metabolising and detoxifying
enzymes, induction of DNA repair processes) over time.
In the present study, no association between GSTM1, GSTT1,
ERCC1, ERCC4, and ERCC5 polymorphisms and the three genotoxic
endopoints were detected.
Genotoxicity of FA is conﬁrmed in a variety of experimental
systems ranging from bacteria to rodents. Although the posi-
tive ﬁndings from in vivo animal studies may provide a basis for
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extrapolation to humans, the cytogenetic assays in humans have
been conﬂicting with both positive and negative outcomes. Evi-
dence for the genotoxic effects of FA exposure on ﬁrst contact sites
such as nose and respiratory tract have emerged increasingly, the
biological evidence of toxicity on distant-site such as peripheral
lymphocytes and bone marrow is still controversial.
Data obtained in this study indicate that genotoxic risk due to
FA occupational exposure cannot be excluded. In the current FA
level of exposuremeasured in pathologic anatomy laboratories, the
DNA and chromosomal damage observed in peripheral blood lym-
phocytes of exposed workers might be induced by FA exposure,
and be increased with the levels of exposure (positive correlation
between FA exposure levels and MN frequency and TL). Although
in this study the presence of centromeric signals in the MN was not
assessed, the signiﬁcant increase in DNA damage obtained in the
comet assay (a clastogenicity assay) suggests a clastogenic mode of
action of FA as the primary cause of the observed damage. Never-
theless, these results must be cautiously interpreted, owing to the
relatively low number of exposed and control individuals included
in this study.
The main determinants of FA exposure in the pathologic
anatomy laboratories were the presence and efﬁciency of local
exhaust systems, the efﬁciency of the general ventilation, the
size and number of ﬁxed anatomical parts to be handled and
work methods. The highest room FA concentrations observed in
this study occurred during the macroscopic examination of FA-
preserved specimens and during the disposal of specimens and
waste solutions. During this tasks in most of the cases the workers
were not using respirators but when they used them the respi-
rators were not the appropriate ones. The main reason presented
by workers for the non-use of the respirators and goggles was
the interference in the efﬁciency of the activities taken, namely
communication difﬁculties, talking notes and handling material.
Control aspects must take these factors into account. Implementa-
tion of security and hygiene measures in this sector as well as good
practices campaigns may be crucial to decrease professional risk of
FA exposed workers.
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CYTOGENETIC AND IMMUNOLOGICAL EFFECTS ASSOCIATED
WITH OCCUPATIONAL FORMALDEHYDE EXPOSURE
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Susana Silva1, Beatriz Porto5, Blanca Laffon2, João Paulo Teixeira1,3
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2Toxicology Unit, Department of Psychobiology, University of A Coruña, Edificio de Servicios
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3ICETA, Institute of Agricultural and Agri-foodstuffs Sciences and Technologies, University of
Porto, Porto, Portugal
4ISPUP, Institute of Public Health, University of Porto, Porto, Portugal
5ICBAS, Biomedical Sciences Institute of Abel Salazar, University of Porto, Porto, Portugal
Formaldehyde (FA) is a widely used industrial chemical for which exposure is associated
with nasopharyngeal and sinonasal cancer. Based on sufficient evidence of carcinogenicity
from human investigations, supporting studies on mechanisms underlying carcinogenesis,
and experimental evidence in animals, FA status was recently revised and reclassified as
a human carcinogen. The highest level of exposure to FA occurs in occupational settings.
Although several studies reported FA ability to induce genotoxic responses in exposed work-
ers, not all findings were conclusive. In addition, published studies on the immunological
effects of FA indicate that this compound may be able to modulate immune responses,
although data in exposed subjects are still preliminary. In this study a group of pathology
anatomy workers exposed to FA was evaluated for cytogenetic and immunological param-
eters. A control group with similar sociodemographic characteristics and without known
occupational exposure to FA was also included. Genotoxicity was evaluated by means of
micronucleus (MN) test, sister chromatid exchanges (SCE), and T-cell receptor (TCR) muta-
tion assay. Percentages of different lymphocyte subpopulations were selected as immunotoxic
biomarkers. The mean level of FA environmental exposure was 0.36 ± 0.03 ppm. MN and
SCE frequencies were significantly increased in the exposed group. A significant decrease of
the percentage of B cells in the exposed group was also found. Data obtained in this study
indicate that genotoxic and immunotoxic increased risk due to FA occupational exposure can-
not be excluded. Implementation of effective control measures along with hazard prevention
campaigns may be crucial to decrease the risk.
Formaldehyde (FA) is a high-volume pro-
duction chemical produced globally with a
large range of industrial and medical pur-
poses. Listed, since 2004, by IARC as a human
carcinogen (group 1), FA status was recently
revised by the U.S. government, which reclassi-
fied this compound as known to be a human
carcinogen (group A). Both reclassifications
This work is supported by Fundação para a Ciência e a Tecnologia (FCT) under the grants SFRH/BD/46929/2008 and PTDC/SAU-
ESA/102367/2008.
Address correspondence to Solange Costa, National Institute of Health, Environmental Health Department; Rua Alexandre
Herculano, 321, 4000-055 Porto, Portugal. E-mail: solange.costa2@gmail.com
are based on sufficient evidence of carcino-
genicity from human investigations, supporting
studies on mechanisms underlying carcinogen-
esis, and experimental evidence in animals.
Numerous epidemiological studies of occu-
pational exposed populations demonstrated
a causal relationship between exposure to
FA and cancer (IARC, 2006; NTP, 2010).
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Consistent findings of increased risks of cer-
tain types of rare cancers, namely, nasopha-
ryngeal and sinonasal cancer, were found
among workers with higher measures of expo-
sure to FA (exposure level or duration). The
mechanisms by which FA induced cancer are
not completely understood but most likely
involve multiple modes of action, such as DNA
reactivity, gene mutation, epigenetic effects,
chromosomal breakage, aneuploidy, and oxida-
tive stress (Lu et al., 2008; NTP, 2010). Zhang
et al. (2010) suggested a potential causal asso-
ciation between occupational exposure to FA
and excess mortality from leukemia, espe-
cially myeloid leukemia. However, due to
mix results, evidence for FA leukemogenic-
ity remains controversial (Checkoway et al.,
2012). Given its economic importance and
widespread use, many individuals are envi-
ronmentally and/or occupationally exposed to
FA. Nonoccupational exposure includes vehi-
cles emissions, tobacco smoke, and house-
hold products. The highest level of human
exposure to this aldehyde occurs in occupa-
tional settings. Occupational exposure involves
not only individuals employed in the direct
manufacture of FA and products containing it
(Paustenbach et al., 1997), but also those using
these products, such as those working in pathol-
ogy anatomy labs where it is commonly used as
a fixative and tissue preservative.
In the last decade a large number of toxi-
cological studies were published regarding FA.
FA-induced genotoxicity was confirmed in a
variety of experimental systems ranging from
bacteria to rodents. Although these positive
findings may provide a basis for extrapolation to
humans, the cytogenetic assays in humans have
been conflicting with both positive and neg-
ative outcomes. Genotoxic endpoint analyses
are of great interest in risk assessment of occu-
pational carcinogens because they precede
adverse health effects, thus offering a greater
potential for preventive intervention (Mayeux,
2004). Genotoxicity evaluation constitutes a
valuable tool for studying the most important
occupational and environmental hazards to
public health occurring in the past few decades
and allows a reasonable epidemiological eval-
uation of cancer prediction (Bonassi et al.,
2005; Laffon et al., 2006). Cytogenetic markers
such as micronuclei (MN) and sister chromatid
exchange (SCE) are well-established endpoints
that were extensively used for assessing DNA
damage at the chromosomal level in human
biomonitoring studies (Carrano and Natarajan,
1988; Fenech, 1993).
Evaluation of potential adverse effects on
the immune system is also an important com-
ponent of the overall evaluation of a com-
pound toxicity (Luebke et al., 2006). The
immune response is a complex process involv-
ing the interaction of various components from
anatomical barriers to specialized cells. This
interaction among the various components
of the immune system is extremely advanta-
geous for the organism as the continuing dia-
logue between innate and acquired immune
response, and efficiency is ensured. A number
of biological or chemical agents have the ability
to alter the functionality of the immune system,
potentially compromising the organism’s abil-
ity to recognize, control, or eliminate infectious
agents or neoplastic cells (Veraldi et al., 2006).
Studies on immunological effects induced by
FA predominantly focused on the allergic reac-
tions such as contact dermatitis and occupa-
tional asthma. In fact, a few investigations on
immunological parameters (Tang et al., 2009,
Hosgood et al. 2012) suggested that FA may
alter these endpoints in exposed individuals.
The aim of the present study was to
evaluate both genotoxic and immunotoxic
parameters using peripheral lymphocytes of
FA-exposed workers employed in pathology
anatomy labs. Air sampling was performed
in order to determine FA levels of expo-
sure in each worker. Genotoxic damage was
studied by means of MN test, „ and T-cell
receptor (TCR) mutation assay. Percentages
of major lymphocyte subsets, namely, T
lymphocytes (%CD3+), T-helper lymphocytes
(%CD4+), T-cytotoxic lymphocytes (%CD8+), B
lymphocytes (%CD19+), and natural killer (NK)
cells (%CD16-56+), were selected as immuno-
toxicity markers.
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METHODS
Subject Selection and Blood Sample
Collection
The study population consisted of 35 sub-
jects working for at least 1 yr in 4 hospital
pathology anatomy labs, located in Portugal,
and 35 nonexposed control employees, work-
ing in the same area in administrative offices
but without occupational exposure history to
formaldehyde (FA). The characteristics of both
groups are described in Table 1. Relevant indi-
vidual information on age, smoking habits,
health conditions, medical history, medication,
and diagnostic tests (x-rays etc.) was assessed by
means of questionnaires. Subjects that stopped
smoking for more than 2 yr were consid-
ered nonsmokers. Workers also provided infor-
mation related to working practices such as
use of protective measures, years of employ-
ment, specific symptoms related to FA expo-
sure and chronic respiratory diseases and other
disorders. Ethical approval for this study was
obtained from the Ethical Board of the National
Institute of Health. All subjects were fully
informed about the procedures and aims of
this study and each subject prior to the study
signed an informed consent form. Peripheral
blood samples were collected by venipuncture
from each donor between 10 and 11 a.m. All
samples were coded and analyzed under blind
conditions.
Environmental Monitoring
Air sampling was performed in the work-
ers breathing zone for representative working
periods. Analysis of the samples allowed the
calculation of the 8-h time-weighted average
(TWA) level of exposure to FA for each subject.
Air sampling and FA analysis were performed
according to the NIOSH method number 3500
(NIOSH, 1994).
Micronucleus (MN) Test
Aliquots of 0.5 ml of heparinized whole
blood were used to establish duplicate
lymphocyte cultures for cytokinesis-blocked
MN test as described by Teixeira et al. (2004).
Microscopic analyses were performed using a
Nikon Eclipse E400 light microscope. To deter-
mine the total number of MN in binucleated
cells, a total of 1000 binucleated cells with
well-preserved cytoplasm (500 per replicate)
was scored for each subject. MN were scored
blindly by the same reader and identified
according to the criteria defined by Fenech
(2007).
Sister Chromatid Exchanges (SCE)
Lymphocyte cultures for SCE were estab-
lished in duplicate as described by Teixeira
et al. (2004). Differential chromatid staining
TABLE 1. Characteristics of the Study Population
Control (n = 35) Exposed (n = 35) p Value
Gender .513b
Females 31 28
Males 4 7
Age (yr)a 39.8 ± 10.0 (24–61) 41.2 ± 8.7 (26–56) .527c
Years of employmenta — 12.5 ± 8.1 (1–30)
BMI (kg/m2)a 24.1 ± 4.8 (19–38) 23.4 ± 3.3 (17–32) .464c
Smoking status
Nonsmokers 28 (80%) 28 (80%)
Smokers 7 (20%) 7 (20%)
Packs per yeara 13.9 ± 10.3 (2.8–32.3) 12.9 ± 11.2 (0.6–35.0) .863c
aMean ± SD (range).
bFisher’s exact test.
cStudent’s t-test.
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was performed with the fluorescence-plus-
Giemsa procedure (Perry and Wolff, 1974).
Microscopic analyses were performed using a
Nikon Eclipse E400 light microscope. A single
observer scored 50 second-division metaphases
for each donor (25 from each duplicate culture)
on coded slides to determine the number of
SCE per cell.
TCR Mutation Assay
Peripheral blood mononuclear leukocytes
were isolated in BD Vacutainer Cell Preparation
Tubes (CPT) with sodium heparin according to
the manufacturer’s instructions. After centrifu-
gation, cells were washed thrice with ice-cold
pH 7.4 phosphate buffer solution. TCR muta-
tion assay was performed by a flow cytomet-
ric methodology according to Akiyama et al.
(1995) with minor modifications (García-Lestón
et al., 2011). Cell suspensions were analyzed
by a FACScalibur flow cytometer with Cell
Quest Pro software (Becton Dickinson). A min-
imum of 2.5 × 105 lymphocyte-gated events
was acquired, and mutation frequencies of TCR
(TCR-Mf) were calculated as the number of
events in the mutant cell window (CD3−CD4+
cells) divided by the total number of events
corresponding to CD4+ cells.
Lymphocyte Subpopulations
Cell percentages of total T lymphocytes
(%CD3+), T-helper (Th) lymphocytes (%CD4+),
T-cytotoxic (Tc) lymphocytes (%CD8+), B
lymphocytes (%CD19+), and natural killer
(NK) cells (%CD16-56+) were determined
by flow cytometric measurements using a
three-color direct immunofluorescence sur-
face marker methodology described by García-
Lestón et al. (2011). Analyses were carried out
in a FACScalibur flow cytometer using Cell
Quest Pro software (Becton Dickinson). After
gating the lymphocytes based on forward/side
scatter plots, fluorescence data from FL1 (FITC),
FL2 (PE), and FL3 (PECy5) were obtained.
At least 104 events in the lymphocytes window
were acquired.
Statistical Analysis
All analyses were conducted using the
SPSS for Windows statistical package 16.0.
The statistical differences between means and
the relationship between categorical variables
in the characteristics of the study population
were assessed by means of Student’s t-test
and Fisher’s exact test, respectively. All results
obtained in the study were assessed for nor-
mal distribution using the Kolmogorov–Smirnov
test and graphic evaluation (histograms, Q–
Q plots, P–P plots). When the assumption
of normality was not fitted, data were trans-
formed to normalize the distribution. TCR-
Mf, B lymphocytes, NK cells, and Th/Tc ratio
were the only parameters that departed sig-
nificantly from normality and therefore these
data were transformed on the natural logarithm
scale (ln). The effect of exposure on the level
of genotoxicity and immunological biomarkers
was preliminarily tested using Student’s t-test.
Multivariant analysis was carried out to evalu-
ate the contribution of exposure and potential
confounding factors to the response variables
considered. Correlation between variables was
analyzed by Pearson’s correlation test. The level
of significance considered was .05.
RESULTS
The general characteristics of the stud-
ied population are summarized in Table 1.
In total, 70 subjects (35 exposed and 35 con-
trols) were involved in the study. Both groups
were similar in gender distribution, age,
body mass index (BMI), and smoking habits.
The mean level of worker’s exposure to
formaldehyde (FA) was 0.36 ± 0.03 ppm
(range 0.23–0.69 ppm). The peak emission of
FA occurred during two routine tasks: macro-
scopic examination of FA-preserved specimens,
and disposal of specimens and waste solutions.
The current Portuguese occupational expo-
sure limit is 0.3 ppm (ceiling level), indicating
this is the maximum safe FA concentration
that should never be exceeded during any
length of time in a worker’s breathing zone.
The American Conference of Governmental
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Industrial Hygienists (ACGIH) also set a ceil-
ing exposure limit of 0.3 ppm (ACGIH, 2008).
Our results show that workers in the pathol-
ogy anatomy labs analyzed were exposed to
airborne concentrations of FA that exceeded
the national guideline limit value and ACGIH-
recommended exposure criteria.
The genotoxicity biomarkers results are
shown in Figure 1 as a univariant analy-
sis. MN frequency was significantly 2.5-fold
higher in FA-exposed workers than in unex-
posed individuals. In addition, SCE mean value
was significantly increased in exposed group
by 1.3-fold. A positive significant correlation
was found between these two cytogenetic
biomarkers. TCR-Mf did not differ markedly
between exposed and control subjects.
Data obtained from univariant analysis of
lymphocyte subpopulations in FA-exposed sub-
jects and controls are illustrated in Figure 2.
No significant differences were found for T
cells—total %CD3+ T lymphocytes, %CD4+ T
helper cells (Th), %CD8+ T cytotoxic cells (Tc),
Th/Tc ratio—and for %CD16-56+ NK cells.
However, a significant decrease of 0.7-fold in
%CD19+ B lymphocytes was noted in exposed
individuals.
Table 2 summarizes the results obtained
in the multivariant analysis of the effect
biomarkers, taking into account lifestyle fac-
tors, including age, gender, and smoking habits,
in addition to exposure. It should be noted
that only significant results are shown. The
significant effect of exposure was confirmed
in the MN test and SCE as increases and in
0
1
2
3
4
5
6
7
8
MN (‰) SCE/cell TCR-Mf (x10–4)
Control Group
Exposed Group
*
*
FIGURE 1. Results of MN test, SCE, and TCR mutation assay
in the study population. Asterisk indicates significantly different
from control group, p < .05, according to Student’s t-test.
%CD19+ B lymphocytes as a decrease. Further,
a significant correlation was obtained between
frequencies of MN and SCE, and a nearly sig-
nificant correlation was found between SCE
and %CD19+. A significant effect of age was
observed on SCE frequency; a rise was also
detected for MN rate that did not reach signifi-
cance. Indeed, a significant positive correlation
was found between age and SCE frequency.
No significant influence of gender or smoking
habits was observed. Besides, exposure time
(years of employment) was not significantly cor-
related with any genotoxicity or immunological
parameters.
When considering the FA environmen-
tal levels corresponding to each exposed
individual, a significant influence of the
FA level of exposure was found for some
lymphocyte subpopulations based upon signif-
icant results collected in Table 3. Total %CD3+
T lymphocytes and %CD4+ Th cells was sig-
nificantly elevated with FA-level of exposure,
whereas %CD16-56+ NK cells was significantly
reduced. In fact, these results agree with the
correlations found between the FA-exposure
levels and %CD3+, %CD4+, and %CD16-
56+ NK cells. Significant correlations were also
observed between %CD16-56+ NK cells and
%CD3+ T lymphocytes and %CD4+ Th cells.
No significant effect of gender, smoking habits,
or age was noted in these studies.
DISCUSSION
In pathology anatomy labs, FA is a well-
known compound traditionally used as a fixa-
tive and tissue preservative. Indoor air analyses
consistently show that the levels of airborne
FA in pathology anatomy labs exceeded rec-
ommended exposure criteria (Shaham et al.,
2002; Akbar-Khanzadeh and Pulido, 2003).
In these settings, absorption of FA occurs mainly
through inhalation. Inhaled FA primarily affects
the upper airways; the severity and extent of
physiological response depend upon chemical
concentration in the air. In the current study
the mean FA level of exposure found, 0.36
± 0.03 ppm, was higher than the established
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FIGURE 2. Percentages of lymphocyte subsets analyzed in the study population. Asterisk indicates significantly different from control
group, p < .05, according to Student’s t-test.
TABLE 2. Influence of Exposure, Gender, Smoking Habits, and Age on MN, SCE, and B Lymphocytes (%CD19+)
Model
Unstandardized
coefficients β 95% CI
Partial
p value R2
Model
p value
1. MN (‰) .232 .002
Exposed vs. nonexposed 2.1 1.025 to 3.174 <.001
Females vs. males 0.334 1.170 to 1.838 .659
Smokers vs. nonsmokers 0.061 −1.302 to 1.423 .929
Age (yr) 0.05 −0.008 to 0.109 .088
2. SCE/cell .250 .001
Exposed vs. nonexposed 1.245 0.594 to 1.897 <.001
Females vs. males 0.514 −0.398 to 1.426 .264
Smokers vs. nonsmokers 0.28 −0.546 to 1.106 .501
Age (yr) 0.036 0.001 to 0.071 .045
3. B lymphocytes (%CD19+) .174 .014
Exposed vs. nonexposed −1.387 −1.714 to − 1.121 .003
Females vs. males −1.097 −1.477 to 1.228 .536
Smokers vs. nonsmokers 1.198 −1.093 to 1.568 .185
Age (yr) −1.007 −1.019 to 1.004 .228
p < 0.05, significantly different.
national ceiling limit of 0.3 ppm. It is important
to note that 54% of the workers were exposed
to FA levels greater than or equal to 0.3 ppm,
and half of these were exposed to concentra-
tions above 0.4 ppm. Therefore, data obtained
show that workers are exposed to levels of FA
that are greater than both national and interna-
tional recommended limit values (IARC, 2006),
indicating a potential risk to workers’ health.
The main FA vapor emissions occurred dur-
ing macroscopic examination of FA-preserved
specimens and during the disposal of speci-
mens and waste solutions. In most cases during
these tasks the workers were only using masks
for biological hazard, not appropriate to protect
from FA vapors. The primary reason given by
workers for not using goggles and appropri-
ate masks (when available) was interference in
efficiency in performance of activities, namely,
difficulties in communication, taking notes, and
handling material. Implementation of security
and hygiene measures, such as periodic air
sampling and medical surveillance, as well as
good practice campaigns may be crucial to
lower the risk associated with FA occupational
exposure.
As shown in Figure 1, frequencies of MN
and SCE were significantly elevated in FA-
exposed individuals compared to unexposed
controls. The increase in MN formation in
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TABLE 3. Influence of FA Environmental Level, Gender, Smoking Habits, and Age on T Lymphocytes (%CD3+), T-Helper Cells (%CD4+),
and NK Cells (%CD16-56+), Only in the Exposed Population
Model 95% CI
Partial
p value R2
Model
p value
1. Lymphocytes T (%CD3+) .303 .024
FA level of exposure 14.092 to 55.191 .002
Females vs. males −4.570 to 11.131 .400
Smokers vs. nonsmokers −9.623 to 5.928 .631
Age (yr) −0.371 to 0.380 .981
2. T-helper cells (%CD4+) .280 .037
FA level of exposure 8.907 to 47.963 .006
Females vs. males −4.366 to 10.554 .404
Smokers vs. nonsmokers −2.009 to 12.769 .147
Age (yr) −0.429 to 0.285 .682
3. NK cells (%CD16-56+) .500 <.001
FA level of exposure −98.593 to − 6.821 <.001
Females vs. males −2.604 to 1.066 .084
Smokers vs. nonsmokers −1.255 to 2.190 .270
Age (yr) −1.027 to 1.022 .820
p < 0.05, significantly different.
individuals occupationally exposed to FA is
well established. Suruda et al. (1993) found
elevated frequencies of MN in lymphocytes
(26%), nasal epithelial cells (22%), and buccal
mucosa cells (12-fold) in a group of morti-
cian students, before and after attending an
embalming course. A dose-response relation-
ship was observed with cumulative exposure to
FA. In a population of 151 workers exposed to
FA from two plywood factories, Yu et al. (2005)
reported a significantly higher frequency of MN
in peripheral lymphocytes. Further, a higher fre-
quency of MN in lymphocytes was observed
in pathology anatomy lab workers in two inde-
pendent Portuguese studies (Costa et al., 2008;
Viegas et al., 2010). Orsière et al. (2006) found
a significantly higher frequency of monocen-
tromeric MN in FA-exposed workers, suggesting
an aneugenic effect of FA. However, recent
studies by Costa et al. (2011) of FA-exposed
pathology anatomy workers and by Speit et al.
(2011) in mammalian cell lines indicated a clas-
togenic effect attributed to FA as the primary
mechanism underlying MN formation, confirm-
ing previous reports (Titenko-Holland et al.,
1996).
Our results on SCE frequency also agree
with data from other studies that also reported a
higher frequency of this cytogenetic biomarker
in FA exposed workers. Yager et al. (1986)
were the first to describe a rise in SCE in the
peripheral lymphocytes of FA-exposed individ-
uals. SCE were measured in blood samples
collected from 8 nonsmoking anatomy students
before and after a 10-wk anatomy class with
a mean FA concentration in breathing-zone
samples of 1.2 ppm. The results showed that
SCE frequency was significantly higher in sam-
ples taken at the end of the course compared
to samples obtained from the same individ-
uals immediately before FA exposure began.
Shaham et al. (1997, 2002) examined a group
of 90 pathology workers. Based on different FA
exposure levels, the exposed group was divided
into a low-exposure group (0.04 to 0.7 ppm)
and a high-exposure group (0.72 to 5.6 ppm).
Both exposed groups displayed significantly
higher SCE frequencies. Ye et al. (2005) exam-
ined two different groups of FA-exposed work-
ers. One group was composed of 18 workers
in a FA manufacturing facility (8-h TWA level of
exposure was 0.82 ± 0.24 ppm), whereas the
second group included 16 waiters who were
exposed to low levels of FA while working in
a new ballroom for 12 wk (5-h TWA level of
exposure was 0.09± 0.05 ppm). The first group
showed a significantly elevated frequency of
SCE in lymphocytes, whereas no significant dif-
ference was found in waiters, probably due to
the low level of exposure to FA. Finally, Costa
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et al. (2008) in a group of pathology anatomy
workers (TWA = 0.44 ppm) also noted a
1.4-fold increase in SCE frequency. However,
other investigators did not find greater SCE
rates in subjects occupationally exposed to FA
(Thomson et al., 1984; Suruda et al., 1993;
Ying et al., 1999). In the current study no signif-
icant differences were found in TCR-Mf. To our
knowledge this is the first report in which TCR-
Mf was evaluated in workers exposed to FA.
Thus, more studies are needed to confirm these
findings.
The immunological status of exposed and
control subjects was also addressed by assess-
ing percent of different lymphocyte subsets
in peripheral blood. The reference values for
lymphocyte subsets in Caucasian population
are 60–87% for total CD3+ T lymphocytes,
32–61% for CD4+ T helper cells, 14–43% for
CD8+ T cytotoxic cells, 5–20% for CD19+
B cells, and 4–28% for NK cells (CD16+-
56+) (Santagostino et al., 2009). Our results in
both groups are within these expected ranges
and also in accordance with recent data in
a Portuguese population (García-Lestón et al.,
2011).
Regarding the FA-exposure effect when
comparing both groups, no statistical dif-
ferences were found for total %CD3+ T
lymphocytes, %CD4+ T helper cells (Th),
%CD8+ T cytotoxic cells (Tc), Th/Tc ratio, and
%CD16-56+ NK cells. However a significant
decrease of percent B cells was found in the
exposed group. In addition, a nearly significant
correlation obtained between SCE and B cells
indicates a reliable association between these
two parameters influenced by FA exposure.
Our results are in agreement with other
studies which showed that FA exposure may
affect immunological parameters. Tang et al.
(2009) summarized eight Chinese studies con-
cerning FA-induced hematotoxicity. The major-
ity of these reports noted a decrease in total
white blood cells (WBC) counts in FA-exposed
workers. In one of the studies concerning
clinical pathology personnel (FA levels were
between 0.2 and 0.8 ppm). Tang et al. (2009)
found that a significantly higher proportion of
the exposed subjects (14%) showed abnormal
WBC counts compared to controls (5%). In a
recent study on the ability of FA to disrupt
hematopoiesis in a group of exposed work-
ers with mean FA 8-h TWA of 1.28 ppm,
Zhang et al. (2010) also reported a significant
reduction in WBC counts, granulocytes, and
lymphocytes. However, there are also studies
where WBC counts were not markedly influ-
enced by FA exposure (Madison et al., 1991;
Tang et al., 2009).
In our study a decreased percentage of B
cells was found in exposed individuals, sug-
gesting immunosuppression and therefore a
reduced immune response. B cells are involved
in organism humoral responses against anti-
gens and are also engaged in adaptive immune
responses. Further, %CD16-56+ NK cells were
inversely correlated with FA levels of expo-
sure. NK cells are effector lymphocytes of
the innate immune system that control sev-
eral types of tumors and microbial infections
by limiting their spread and subsequent tissue
damage (Vivier et al., 2009). Indeed, several
studies describe a reduced resistance to infec-
tions, including upper respiratory tract infec-
tions, recurrent rhinitis, and pneumonitis in
individuals occupationally exposed to FA. In the
study by Zhang et al. (2010), 40% of the
exposed subjects had recent respiratory infec-
tions. Evidence suggests that FA exposure may
result in functional changes in neutrophils and
possibly influence the host capacity to respond
to infections (Lyapina et al., 2004). Lyapina
et al. (2004) tested this hypothesis by measuring
neutrophil respiratory burst activity (NRBA) in
29 workers exposed to FA (mean FA level 0.71
± 0.32 ppm). Exposed workers displayed a sig-
nificant rise in upper respiratory tract inflamma-
tions, but no significant differences were found
between groups in spontaneous or stimulated
NRBA assays.
In a population-based case-control study
conducted by Hildesheim et al. (2001), the risk
of nasopharyngeal carcinoma and ever expo-
sure to FA was higher among Epstein–Barr
virus (EBV) seropositive individuals than among
nonseropositive subjects. Viral-associated can-
cers are increased in immunosuppressed indi-
viduals, due most likely to the inability of
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the organism to limit viral replication and/or
expansion of infected cells (Schulz, 2009).
Epstein–Barr virus (EBV) is implicated in the
etiology of nasopharyngeal carcinoma (Marsh
et al., 2007; Bosetti et al., 2008). Thompson
and Grafstrom (2009) suggested that FA may
exert an indirect influence in EBV reactivation
through deregulation of nitrosothiol homeosta-
sis and may also interact with the virus to
promote epithelial cell transformation.
Although our results are in agreement with
published data, lymphocyte subpopulations
were affected differently in some other stud-
ies. Ying et al. (1999) assessed the lymphocyte
subsets in 23 nonsmoking medical students
exposed to FA during an 8-wk anatomy lab
course (8-h TWA= 0.413 ± 0.243 ppm) and
found a significant increase in B cells and a
significant fall in total T cells, T-helper-inducer
cells, and T-cytotoxic-suppressor cells at the
end of the study. A similar result was reported
by Ye et al. (2005) for a group of workers
from a FA manufacturing facility. In a recent
cross-sectional study conducted in China, a
decreased in NK cells, regulatory T cells, and
CD8 effector memory T cells was reported
among FA-exposed workers (Hosgood et al.,
2012). The small sample size or/and higher
FA level of exposure may have contributed to
the different outcomes observed between these
and the present study.
Another important factor that may also
explain the different results is individual sus-
ceptibility. One of the enzymes involved in
FA detoxification is the mitochondrial aldehyde
dehydrogenase-2 (ALDH2) (Teng et al., 2001).
ALDH2 gene contains an inactive ALDH2∗2
allele; the presence of the mutant allele leads
to a decrease or absence of ALDH2 catalytic
activity (Brennan et al., 2004). Approximately
50% of East Asians carry the mutant inac-
tive ALDH2∗2 null allele (Goedde et al.,
1992; Oota et al., 2004), whereas nearly all
Caucasians carry the functional ALDH2∗1/1
genotype (Chambers et al., 2002; Brennan
et al., 2004). Thus, larger human studies com-
bining genotoxic, immunological parameters
and susceptibility biomarkers are needed in
order to understand the potential relationship
between FA exposure and these endpoints.
Finally, significant associations were found
between FA level of exposure and total %CD3+
T lymphocytes, %CD4+ Th cells, and %CD16-
56+ NK cells in exposed individuals, indicating
a reliable relationship between level of expo-
sure and alterations in these immunological
markers. Regarding the influence of lifestyle
factors and exposure time on the endpoints
studied, in this study no significant influence of
gender, smoking habits, or years of employment
was observed. Age was the only confounder
that showed a significant influence but only
with respect to SCE frequency. This effect was
confirmed with the significant positive corre-
lation noted between age and SCE frequency.
Our data agree with previous studies (Kirsch-
Volders et al., 2006; Teixeira et al., 2010)
reporting a positive association between age
and cytogenetic biomarkers related to a pro-
gressive increase in spontaneous chromosome
instability and loss of efficiency in DNA repair
mechanisms, which may result in accumulation
of genetic lesions with increasing age (Bolognesi
et al., 1999).
CONCLUSIONS
Data obtained in this study indicate that
increased genotoxic risk due to FA occupa-
tional exposure cannot be excluded. MN and
SCE frequencies were significantly elevated in
peripheral lymphocytes of pathology anatomy
workers exposed to FA. A significant decrease
of percentage of B cells in exposed group was
also found. Further, a significant relationships
between FA level of exposure and increases
in %total T lymphocytes and %Th-cells and
fall in %NK cells were noted in exposed
individuals, indicating that FA exposure may
influence immunological parameters. However,
these results need to be interpreted with cau-
tion, owing to the relatively low number of
exposed and control individuals included in this
study.
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Abstract 
Formaldehyde (FA) is a high-volume production chemical produced worldwide 
with a large range of industrial and medical uses. Listed, since 2004, by IARC as 
a human carcinogen, FA status was recently revised by the US government who 
reclassified this compound as known to be a human carcinogen. Both 
reclassifications are based on sufficient evidence of carcinogenicity from 
epidemiologic studies, supporting data on mechanisms of carcinogenesis and 
experimental evidence in animals. The highest level of human exposure to FA 
occurs in occupational settings. Consistent findings of increased risks of certain 
types of rare cancers were found among workers with higher measures of 
exposure to FA (exposure level or duration). The aim of the present study was to 
assess the genotoxic effects of occupational exposure to FA. A group of 
pathology and anatomy workers was evaluated for micronuclei in lymphocytes 
and in exfoliated buccal cells. Genotoxic endpoints are of great interest in the 
risk assessment of occupational carcinogens because they precede by a long time 
the potential health effects, thus offering a greater potential for preventive 
measures. Micronuclei in lymphocytes and in exfoliated buccal cells were 
significantly higher in the exposed subjects when compared with controls. Air 
sampling was performed in the workers’ breathing zone for representative 
working periods and an 8h-time weighted average was assessed. Results 
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obtained confirm an association between genetic damage and occupational 
exposure to FA. Such results along with the recent implications of human 
carcinogenicity, point out the need for close monitoring of FA exposures. 
Implementation of effective control measures along with hazard prevention 
campaigns may be crucial to decrease the risk. 
Keywords: formaldehyde, genotoxicity, micronucleus test, lymphocytes, 
exfoliated buccal cells. 
1 Introduction 
Over the years several epidemiological studies have revealed an increased risk of 
cancer development among workers exposed to chemicals [1]. Human 
monitoring is a frequently used approach to provide early warning signals for 
excessive exposure to toxic substances and for prediction of health risk [2].  
     Establishing the health outcomes of various activities and exposures requires 
information about the levels of exposure and the biological effects resulting 
from the interaction between the exposed organism and the chemical agent. 
Genomic damage is probably the primary basic cause of developmental and 
degenerative disease. It is well established that genomic damage may result from 
lifestyle factors, medical procedures (e.g., chemotherapy, radiotherapy), diet, 
individual susceptibility and environmental/occupational exposure to genotoxic 
compounds. 
     A wide range of bioindicators are currently used for the detection of early 
biological effects of genotoxic agents, namely cytogenetic alterations. The 
relevance of increased frequency of cytogenetic alterations as a cancer risk 
biomarker is further supported by epidemiological studies suggesting that a high 
frequency of chromosomal aberrations or micronucleus are predictive of an 
increase risk of cancer [3]. 
     Micronucleus (MN) test is a sensitive and well established tool extensively 
used in human biomonitoring studies to assess DNA damage at chromosomal 
level [4]. Micronuclei are extra-nuclear DNA containing bodies formed as a 
result of chromosomal fragments or whole chromosomes not being incorporated 
into the daughter nuclei during nuclear division. Since MN represents a measure 
of both chromosome breakage and chromosome loss, an increased frequency of 
micronucleated cells can reflect exposure to genotoxic agents with clastogenic or 
aneugenic modes of action. In human studies, peripheral blood lymphocytes are 
usually the most frequently used tissue for MN test. However exfoliated 
epithelial cells (urothelial, buccal or nasal cells) are increasingly popular, as they 
can be easily collected and in some cases are better models than lymphocytes, 
since they are target tissues of some cancers. 
     Formaldehyde (FA) is a building-block for many chemical compounds with a 
wide range of industrial and medical uses. It is a high-volume production 
chemical produced worldwide, which many people are exposed to. At room 
temperature it is a flammable and colorless gas with a strong pungent odor. In 
2006, the International Agency for Research on Cancer, IARC, reclassified FA 
from Group 2A (probably carcinogenic to humans) to Group 1 (carcinogenic to 
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humans) [5]. More recently, FA carcinogenic status was also revised by the US 
National Toxicology Programme (NTP). After a rigorous scientific review, FA 
was reassigned, in the NTP 12th Report on Carcinogens, as known to be a human 
carcinogen [6]. Both reclassifications are based on sufficient evidence of 
carcinogenicity from studies in humans, supporting studies on mechanisms of 
carcinogenesis and experimental evidence in animals.  
     Epidemiological studies demonstrated a causal relationship between 
occupational exposure to FA and cancer [5, 6]. Consisting findings of increased 
risks of certain types of rare cancers, namely nasopharyngeal and sinonasal 
carcinomas were found among workers with higher measures of exposure to FA 
(exposure level or duration). Studies have also suggested that FA may affect the 
lymphatic and blood systems and that exposure to FA may cause leukemia, 
particularly myeloid leukemia, in humans [7–9], yet due to mix results and 
biological implausibility the evidence for FA leukemogenicity remains 
controversial and needs further investigation [5, 10]. FA also caused tumors in 
two rodent species (rats and mice), at several different tissue sites, and by two 
different routes of exposure (inhalation and ingestion) [6]. 
     The highest level of human exposure to FA occurs in occupational settings, 
namely in pathology and anatomy laboratories where it is used as a fixative and 
tissue preservative for more than 100 years. Indoor air analyses have consistently 
shown that the levels of airborne FA in anatomy laboratories exceed 
recommended exposure criteria [11, 12]. In these settings, absorption of FA 
occurs mainly through inhalation, affecting primarily the upper airways. 
     In the last decade a large number of toxicological studies were published 
about FA. FA’s genotoxicity is confirmed in a variety of experimental systems 
ranging from bacteria to rodents. Although these positive findings may provide a 
basis for extrapolation to humans, the cytogenetic assays in humans have been 
inconsistent with both positive and negative outcomes [5]. Biological evidence 
of toxicity on distant-site such as peripheral lymphocytes and bone marrow is 
still insufficient and conflicting [13]. Some authors stated that since inhaled FA 
is rapidly metabolized it would not be expected to enter the systemic circulation 
and for that reason genotoxic and carcinogenic effects (leukemia) in animals and 
humans are limited to local effects, in the area of first contact [14, 15]. The 
principal aim of the present study was to evaluate MN frequency in both 
peripheral blood lymphocytes (PBLs) and in exfoliated buccal cells of FA- 
exposed workers from pathology anatomy laboratories. An association on MN 
frequency in these two biological tissues, a first contact tissue and a systemic 
tissue, was also investigated. Air sampling was also performed in order to 
determine FA-level of exposure of each worker.  
2 Methods 
2.1 Study population 
The general characteristics of the studied population are summarized in Table 1. 
In total, 80 women were involved in the study, 38 working for at least one year 
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in pathology and anatomy laboratories located in Portugal, and 42 non-exposed 
control females, working in administrative offices in the same area and without 
occupational exposure history to formaldehyde (FA). Both groups were similar 
in age and smoking habits. Health conditions, medical history, medication, 
diagnostic tests (X-rays, etc) and important individual information namely age 
and smoking habits was elicited by means of questionnaires. Subjects that 
stopped smoking for more than two years were considered non-smokers. 
Workers also gave information related to working practices such as use of 
protective measures, years of employment, specific symptoms related to FA-
exposure and chronic respiratory diseases and others. Ethical approval for this 
study was obtained from the Ethical Board of the National Institute of Health. 
All subjects were fully informed about the procedures and aims of this study and 
each subject prior to the study signed an informed consent form.  
 
Table 1:  Characteristics of the study population. 
  
Control Group 
(N=42)  
Exposed Group 
(N=38) P-value 
Age (years) a  
38.90 ± 11.99 
(20–61)  
39.68 ± 8.49 
(26–56) 0.74
b 
Years of employment a  
_____  
11.82 ± 7.10 
(1–32)  
Smoking status 
Non-smokers 34 (81%) 30 (79%) 
Smokers 8 (19%) 8 (21%) 
Packs per year a 
 
13.14 ± 9.76 
(2.85–32.25)  
9.07 ± 6.32 
(0.25–18.00) 0.34
b 
aMean + SD (range). 
bStudent’s t-test. 
2.2 Environmental monitoring 
Air sampling was performed in the workers breathing zone for representative 
working periods; analysis of the samples allowed the calculation of the 8h-TWA 
(time weighed average) level of exposure to FA for each subject. Air sampling 
and FA analysis were performed according to the NIOSH method no. 3500 [16]. 
2.3 Biologic samples collection 
For lymphocytes culture peripheral blood samples were collected by 
venipuncture from each donor. After rinsing the mouth with tap water, buccal 
cells were collected from each donor. This was performed inside of both cheeks 
with different cytobrush to sample left and right areas of the mouth, to eliminate 
any unknown bias that may be caused by sampling one cheek only. All samples 
were collected between 10 and 11 am, coded, and analyzed under blind 
conditions.  
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2.4 Lymphocyte cytokinesis-block micronucleus assay 
Aliquots of 0.5 mL of whole blood were used to establish duplicate lymphocyte 
cultures for cytokinesis-blocked micronucleus (MN) test, as described by 
Teixeira et al. [17]. Microscopic analyses were performed on a Nikon Eclipse 
E400 light microscope. To determine the total number of MN in binucleated 
cells, a total of 1000 binucleated cells with well-preserved cytoplasm (500 per 
replicate) were scored for each subject. MN were scored blindly by the same 
reader and identified according to the criteria defined by Fenech [18]. 
2.5 Buccal micronucleus cytome assay 
Buccal micronucleus cytome assay was performed as described by Thomas et al. 
[19] with minor modifications.Briefly, for every subject, an individual sample 
from each cheek was collected and suspended in a 10 mL tube with buccal cell 
buffer (0.01M Tris-HCl, 0.1M EDTA, 0.02 NaCl, pH7). Cells were then spun for 
10 min at 1500 rpm. Supernatant was removed and replaced with fresh buffer 
and washed twice more. After the last wash, cells were resuspended in small 
volume of buffer and placed in clean labeled slides (3 slides for each cheek). 
After air-drying, slides were fixed with cold ethanol: acetic acid (3:1, v/v) 
solution for 20 min. Air-dried slides were then treated in 5M HCl for 30 min and 
washed in running tap water for 3 min. Slides were then stained with Schiff’s 
reagent at room temperature, in the dark, for at least 60 min. Next, slides were 
washed in running tap water for 5 min and 1 min in deionised water and left to 
dry in the dark for 10 min. Slides were then stained for 5 sec in 1% Fast Green 
solution and washed in ethanol 3 times, 2min each. After that, slides were 
allowed to air dry, then covered with coverslips and mounted with Entellan®. 
Slides were scored blindly by the same person using a Nikon Eclipse E400 light 
microscope. For each subject a total of 1000 cells were scored for basal cells, 
differentiated cells, binucleated cells and cell death parameters such as 
condensed chromatin, karyorrhectic, pyknotic and karyolitic cells. A total of 
2000 differentiated cells were scored for micronuclei, nuclear buds and 
nucleoplasmic bridges. Cells containing micronuclei were confirmed under 
fluorescence to eliminate false positives. The scoring criteria were based in 
Tolbert et al. [20] and Thomas et al. [19]. 
2.6 Statistical analysis  
All analyses were conducted using the SPSS for Windows statistical package 
16.0. The statistical differences between means in the characteristics of the study 
population were assessed by means of students’ t-test. All results obtained in the 
study were assessed for normal distribution using Kolmogorov-Smirnov test and 
graphic evaluation (histograms, Q-Q plots). Since both dependent variables 
departed from normal distribution non-parametric tests were applied to data. The 
effect of exposure on the level of genotoxicity was preliminarily tested through 
Mann-Whitney U-test. Multivariant analysis with Negative Binomial model 
(with log link) was applied to evaluate the contribution of exposure and potential 
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confounding factors to the response variables considered. Correlation between 
variables was analyzed by Spearman’s correlation test. The level of significance 
considered was 0.05. 
3 Results and discussion 
To evaluate current exposure to formaldehyde (FA) in pathology and anatomy 
laboratories air samples were collected in the worker’s breathing zone. The mean 
level of worker’s exposure to FA was 0.35 ± 0.03 ppm (range 0.18–0.69 ppm). 
Current Portuguese occupational exposure limit is 0.30 ppm (ceiling level), 
meaning the maximum safe FA concentration that should never be exceeded 
during any length of time in a worker’s breathing zone. The American 
Conference of Governmental Industrial Hygienists (ACGIH) also set a ceiling 
exposure limit of 0.30 ppm [21]. Our results show that in the laboratories 
analysed the pathology anatomy workers are exposed to air concentrations of FA 
that exceed national guidelines and ACGIH recommended exposure criteria. 
Several reports on indoor FA levels have consistently shown that the airborne 
concentrations in anatomy laboratories approach or exceed recommended 
guidelines [11, 12]. Implementation of security and hygiene measures, such as 
periodic air sampling, efficient air extraction, temperature control, as well as 
good practice campaigns, may be crucial to decrease FA exposure in this 
workplace. 
     The results of MN frequency in peripheral blood lymphocytes (PBLs) and 
buccal cells are shown in Table 2. Compared to unexposed controls MN 
frequency was significantly increased in FA-exposed females in both PBLs and 
exfoliated buccal cells. MN frequency in PBLs was found to be 2.1-times higher 
in the exposed workers compared to control subjects, whereas in buccal cells a 
5.9-fold increase was observed.  
Table 2:  Results of biomarkers of genotoxicity in studied groups (mean ± SE 
and range). 
 Control Group Exposed Group 
PBLs MN (‰)  
1.71 ± 0.25 
(0–6)  
3.51 ± 0.35* 
(0–8) 
Buccal MN (‰)  0.12 ± 0.06 (0–2) 
 0.71 ± 0.12 * 
(0–4) 
     
S.E., mean standard error. 
*P< 0.05. 
 
     Our results are in agreement with data obtained in other studies that reported 
an increased frequency of MN in PBLs and/or epithelial cells among mortuary 
students and, more recently, in hospital staff exposed to FA. In 1993, Suruda et 
al. [22] reported a significant increase in post-exposure MN frequency in 
lymphocytes (26%) and buccal mucosa cells (12-fold) among mortician students 
exposed to FA (TWA=0.33ppm), whereas in nasal epithelial cells the increase 
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(22%) was not significant. Also, a significant dose-response relationship was 
found between buccal micronuclei increase and cumulative exposure to FA, but 
only in male subjects. Ying et al. [23] also assessed MN frequency in 
lymphocytes, oral and nasal mucosa cells of 25 anatomy students exposed to FA 
over an 8-week period. A higher frequency of MN was found in nasal and oral 
exfoliated cells, but no significant increase in lymphocytes was observed. In 
contrast, a significant elevated frequency in micronucleated lymphocytes was 
found among 59 pathology and anatomy laboratory workers in a study conducted 
by Orsière et al. [24]. Burgaz et al. [25, 26] also evaluated MN induction on 
pathology and anatomy workers exposed to FA but only in buccal and nasal 
epithelium; an increased frequency of MN in both epithelial cells was found in 
exposed subjects compared to controls. More recently in a group of Portuguese 
histopathology laboratory workers (Ladeira et al. [27]) reported elevated MN  
frequencies in PBLs and buccal epithelial cells, confirming previous reports by 
Costa et al. [13, 28] and Viegas et al. [29]. 
     Increased frequencies of this biomarker were also found among FA-exposed 
workers from industrial units. In fact, Ballarin et al. [30] were the first to 
describe an increase in micronucleated nasal cells collected from 15 non-
smoking workers from a plywood factory. TWA levels of exposure to FA were 
0.08 ppm in the saw mill and shearing-press departments and 0.32 ppm in the 
warehouse area, there was also a concurrent exposure to wood dust (0.19 to 
0.6 ppm). Later on, in a population of 151 plywood factory workers exposed to 
FA, Yu et al. [31] also reported a significantly higher frequency of MN but in 
PBLs, compared to a control group. 
     Overall, the majority of the studies show a link between the exposure to this 
chemical and the increase of this cytogenetic endpoint in lymphocytes, oral and 
nasal epithelium, confirming that MN is a sensitive indicator for the mutagenic 
action of FA. 
     Micronuclei formation may result from aneugenic or clastogenic actions. On 
additional slides from Suruda et al. [22] study, Titenko-Holland et al. [32] 
detected a greater increase in centromere-negative micronuclei content in buccal 
and nasal tissues from FA-exposed subjects suggesting chromosome breakage as 
the primary mechanism of FA micronucleus formation. In contrast, Orsière et al. 
[24], in their study found higher significant frequencies of centromere-positive 
micronuclei (monocentric) in the FA-exposed workers. However, recent studies 
[28, 33] indicate a clastogenic effect of FA, confirming earlier results from 
Titenko-Holland et al. [32] study. 
     In the present work we found a significant positive association (r=0.449, 
P<0.001) between MN frequencies in PBLs and exfoliated buccal cells. The 
concomitant increase of MN formation in buccal cells, a local FA-target tissue, 
and in PBLs indicates not only that inhaled FA is able to induce cytogenetic 
alterations in circulating systemic lymphocytes (distal tissue) but also that the 
damage between this two tissues may be associated, giving relevance to Zhang et 
al. [9, 34] hypothesis of FA capability to induce directly or indirectly genotoxic 
damage in distal cells. Although the biological mechanisms associated with FA-
induced cancer are not completely understood, it is important to acknowledge 
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that chemicals can act through multiple toxicity pathways and modes and/or 
mechanisms of action to induce cancer or other health outcomes [35]. 
     Potential carcinogenic modes of actions for FA include DNA reactivity, gene 
mutation, chromosomal breakage, aneuploidy, enzyme-mediated DNA 
damage/repair, cell signaling other than nuclear-receptor mediated, immune 
response modulation, inflammation, and cytotoxicity [6]. 
     Among the exposed group, was also found a near significant positive 
association (r=0.324, P=0.051) between MN frequency in PBLs and FA 
exposure levels, which reinforces the relevance of using this cytogenetic damage 
biomarker to assess FA genotoxic effects in occupational exposed populations. 
     The evaluation of the effects of age and smoking habits in addition to 
exposure was performed using a multivariate model. Table 3 summarizes the 
results obtained.  
Table 3:  Influence of exposure, smoking habits and age on MN frequency in 
PBLs and buccal cells. 
Model  β SE 95% Wald CI Wald χ2 P-value 
1. PBLs MN (‰) 
Exposed vs. non-exposed 0.72 0.27 0.19 to 1.25 7.20 <0.05 
Smokers vs. non-smokers 0.03 0.33 -0.62 to 0.67 0.01 0.93 
Age (years) 0.01 0.01 -0.01 to 0.04 1.26 0.26 
2. Buccal MN (‰) 
Exposed vs. non-exposed 1.92 0.56 0.81 to 3.02 11.54 <0.05 
Smokers vs. non-smokers 0.85 0.46 -0.06 to 1.75 3.36 0.07 
Age (years) 0.04 0.03 -0.01 to 0.09 2.25 0.13 
  
 
     In the present study no significant influence of age, smoking habits or years 
of employment was observed. A significant positive correlation was found 
between age and MN frequency in buccal cells (r=0.257, P<0.05). The increase 
of MN frequency in buccal cells with age is a documented fact [36] confirmed in 
a recent pooled analysis by Bonassi et al. [37] with more than 5000 subjects, 
being this increase significant from age forty.  
     In conclusion, results found in the present study substantiate an association 
between MN formation and occupational exposure to FA, confirming this 
endpoint as a sensitive indicator for evaluating FA genotoxic effect in 
occupational exposed populations. Moreover, a significant positive correlation 
between MN frequency in PBLs and MN frequency in buccal cell was found. 
Such results along with the recent implications of human carcinogenicity, point 
out for the need of close monitoring of FA exposures. Development of training 
programs, medical surveillance programs, valuable data for program evaluation 
and effective purchase and implementation of control measures may be crucial to 
decrease the risk associated to FA occupational exposure. 
90  Environmental Health Risk VII
 
 www.witpress.com, ISSN 1743-3525 (on-line) 
WIT Transactions on Biomedicine and Health, Vol 16, © 2013 WIT Press
Acknowledgements 
This work is supported by Fundaçãopara a Ciência e a Tecnologia (FCT) under 
the grants SFRH/BD/46929/2008 and PTDC/SAU-ESA/102367/2008.  
References 
[1] Clapp, R.W., Jacobs, M.M. and Loechler, E.L., Environmental and 
occupational causes of cancer: new evidence 2005–2007. Rev Environ 
Health, 23(1), pp. 1–37, 2008. 
[2] Cebulska-Wasilewska, A., Srám, R. J. and Au, W.W., Human Monitoring 
for Genetic Effects (NATO ASI SERIES), IOS Press: Amsterdam, volume 
351, 2003. 
[3] Bonassi, S., Znaor, A., Ceppi, M., Lando, C., Chang, W.P., Holland, N., 
Kirsch-Volders, M. and et al., An increased micronucleus frequency in 
peripheral blood lymphocytes predicts the risk of cancer in humans. 
Carcinogenesis, 28(3), pp. 625–31, 2007. 
[4] Fenech, M., Holland, N., Chang, W. P., Zeiger, E. and Bonassi, S., The 
Human MicroNucleus Project – An international collaborative study on the 
use of the micronucleus technique for measuring DNA damage in humans. 
Mutat. Res., 428, pp. 271–28, 1999. 
[5] International Agency for Research on Cancer, IARC Monographs on the 
Evaluation of Carcinogenic Risks to Human, Volume 88: Formaldehyde, 2-
Butoxyethanol and 1-tert-Butoxy-2-propanol. World Health Organization: 
Lyon, 2006. 
[6] National Toxicology Program, Final Report on Carcinogens Background 
Document for Formaldehyde. Rep Carcinog Backgr Doc. 10-5981: i-512, 
2010. 
[7] Bosetti, C., McLaughlin, J.K., Tarone, R.E., Pira, E., and La Vecchia C., 
Formaldehyde and cancer risk: a quantitative review of cohort studies 
through 2006. Ann Oncol, 19(1), pp. 29–43, 2008. 
[8] Beane-Freeman L.E., Blair, A., Lubin, J.H., Stewart, P.A., Hayes, R.B., 
Hoover, R.N. and Hauptmann, M., Mortality from lymphohematopoietic 
malignancies among workers in formaldehyde industries: the National 
Cancer Institute Cohort. J Natl Cancer Inst, 101(10), pp. 751–761, 2009. 
[9] Zhang, L., Steinmaus, C., Eastmond, D.A., Xin, X.K. and Smith, M.T. 
Formaldehyde exposure and leukemia: a new meta-analysis and potential 
mechanisms. Mutat Res, 681(2–3), pp. 150–168, 2009. 
[10] Speit, G., Zeller, J., Schmid, O., Elhajouji, A., Ma-Hock. L and Neuss S. 
Inhalation of formaldehyde does not induce systemic genotoxic effects in 
rats. Mutat Res, 677(1–2), pp. 76–85, 2009. 
[11] Akbar-Khanzadeh, F. and Pulido, E.V., Using Respirators and Goggles to 
Control Exposure to Air Pollutants in an Anatomy Laboratory. Am. J. Ind. 
Med., 43, pp. 326–331, 2003. 
[12] Ohmichi, K., Komiyama, M., Matsuno, Y., Takanashi, Y., Miyamoto, H., 
Kadota, T., Maekawa, M., Toyama, Y., Tatsugi, Y., Kohno, T., Ohmichi, 
Environmental Health Risk VII  91
 
 www.witpress.com, ISSN 1743-3525 (on-line) 
WIT Transactions on Biomedicine and Health, Vol 16, © 2013 WIT Press
M. and Mori, C., Formaldehyde exposure in a gross anatomy laboratory – 
personal exposure level is higher than indoor concentration. Environ. Sci. 
Pollut. Res. Int., 13, pp. 120–4, 2006. 
[13] Costa, S., Coelho, P., Costa, C., Silva, S., Mayan, O., Santos, L.S, Gaspar, 
J. and Teixeira, J.P., Genotoxic damage in pathology anatomy laboratory 
workers exposed to formaldehyde. Toxicology, 252(1–3), pp. 40–48, 2008. 
[14] Heck, H. and Casanova, M., The implausibility of leukemia induction by 
formaldehyde: a critical review of the biological evidence on distant-site 
toxicity. Regul Toxicol Pharmacol 40(2), pp. 92–106, 2004. 
[15] Pyatt, D., Natelson, E. and Golden, R. Is inhalation exposure to 
formaldehyde a biologically plausible cause of lymphohematopoietic 
malignancies? Regul Toxicol Pharmacol 51(1), pp. 119–133, 2008.  
[16] National Institute for Occupational Safety and Health, Formaldehyde: 
Method 3500 (Issue 2), in: NIOSH (Eds.), NIOSH Manual of Analytical 
Method. U.S. Department of Health and Human Services: Cincinnati, Ohio, 
pp. 2–5, 1994. 
[17] Teixeira, J., Gaspar, J., Silva, S., Torres, J., Silva, S., Azevedo, M., Neves, 
P., Laffon, B., Mendez, J., Goncalves, C., Mayan, O., Farmer, P. and Rueff, 
J., Occupational exposure to styrene: modulation of cytogenetic damage 
and levels of urinary metabolites of styrene by polymorphisms in genes 
CYP2E1, EPHX1, GSTM1, GSTT1 and GSTP1. Toxicology 195, pp. 231–
42, 2004. 
[18] Fenech, M., Cytokinesis-block micronucleus cytome assay. Nat. Protoc. 2, 
pp. 1084–1104, 2007. 
[19] Thomas, P., Holland, N., Bolognesi, C., Kirsch-Volders, M., Bonassi, S., 
Zeiger, E., Knasmueller, S. and Fenech M., Buccal micronucleus cytome 
assay. Nat Protoc. 4(6), pp. 825–37, 2009. 
[20] Tolbert, P.E., Shy, C.M. and Allen, J.W., Micronuclei and other nuclear 
anomalies in buccal smears: methods development. Mutat. Res. 271, 
pp. 69–77, 1992. 
[21] American Conference of Governmental Industrial Hygienists TLVs and 
BEIs, Based on the Documentation of the Threshold Limit Values for 
Chemical Substances and Physical Agents and Biological Exposure Indices. 
American Conference of Governmental Industrial Hygienists: Cincinnati, 
2008. 
[22] Suruda, A., Schulte, P., Boeniger, M., Hayes, R.B., Livingston, G.K. and 
Steenland, K., Cytogenetic effects of formaldehyde exposure in students of 
mortuary science. Cancer Epidemiol. Biomarkers Prev. 2, pp. 453–460, 
1993. 
[23] Ying, C.J., Yan, W.S., Zhao, M.Y., Ye, X.L., Xie, H., Yin, S.Y. and Zhu, 
X.S., Micronuclei in nasal mucosa, oral mucosa and lymphocytes in 
students exposed to formaldehyde vapor in anatomy class. Biomed. 
Environ. Sci.10, pp. 451–5, 1997. 
[24] Orsière, T., Sari-Minodier, I., Iarmarcovai, G. and Botta, A. Genotoxic risk 
assessment of pathology and anatomy laboratory workers exposed to 
92  Environmental Health Risk VII
 
 www.witpress.com, ISSN 1743-3525 (on-line) 
WIT Transactions on Biomedicine and Health, Vol 16, © 2013 WIT Press
formaldehyde by use of personal air sampling and analysis of DNA damage 
in peripheral lymphocytes. Mutat. Res. 605 (1–2), pp. 30–41, 2006. 
[25] Burgaz, S., Cakmak, G., Erdem, O., Yilmaz, M. and Karakaya, A.E., 
Micronuclei frequencies in exfoliated nasal mucosa cells from pathology 
and anatomy laboratory workers exposed to formaldehyde. Neoplasma 48 
(2), pp. 144–147, 2001. 
[26] Burgaz, S., Erdem, O., Cakmak, G., Erdem, N., Karakaya, A., and 
Karakaya, A.E., Cytogenetic analysis of buccal cells from shoe-workers 
and pathology and anatomy laboratory workers exposed to n-hexane, 
toluene, methyl ethyl ketone and formaldehyde. Biomarkers 7(2), pp. 151–
61, 2002. 
[27] Ladeira, C., Viegas, S., Carolino, E., Prista, J., Gomes, M.C. and Brito, M., 
Genotoxicity biomarkers in occupational exposure to formaldehyde – the 
case of histopathology laboratories.Mutat Res.,721(1), pp. 15–20, 2011. 
[28] Costa, S., Pina, C., Coelho, P., Costa, C., Silva, S., Porto, B., Laffon, B. and 
Teixeira, J.P., Occupational exposure to formaldehyde: genotoxic risk 
evaluation by comet assay and micronucleus test using human peripheral 
lymphocytes. J Toxicol Environ Health A. 74(15–16), pp. 1040–51, 2011. 
[29] Viegas, S., Ladeira, C., Nunes, C., Malta-Vacas, J., Gomes, M., Brito, M., 
Mendonca, P., Prista, J., Genotoxic effects in occupational exposure to 
formaldehyde: A study in anatomy and pathology laboratories and 
formaldehyde-resins production. J Occup Med Toxicol. 5(25), pp. 1–8, 
2010. 
[30] Ballarin C, Sarto F, Giacomelli L, Bartolucci GB, Clonfero E., 
Micronucleated cells in nasal mucosa of formaldehyde-exposed workers. 
Mutat Res 280(1), pp. 1–7, 1992. 
[31] Yu, L.Q., Jiang, S.F., Leng, S.G., He, F.S., and Zheng, Y.X., Early genetic 
effects on workers occupationally exposed to formaldehyde. Chinese 
Journal of Preventive Medicine 39, pp. 392–5, 2005. [abstract]. 
[32] Titenko-Holland, N., Levine, A.J., Smith, M.T., Quintana, P.J., Boeniger, 
M., Hayes, R., Suruda, A. and Schulte, P., Quantification of epithelial cell 
micronuclei by fluorescence in situ hybridization (FISH) in mortuary 
science students exposed to formaldehyde. Mutat. Res. 371, pp. 237–48, 
1996. 
[33] Speit, G., Kuhner, S., Linsenmeyer, R., and Schutz, P., Does formaldehyde 
induce aneuploidy? Mutagenesis 26, pp. 805–811, 2011. 
[34] Zhang, L., Beane-Freeman, L., Nakamura, J., Hecht, S., Vandenburg, J., 
Smith, M., and Sonawane, B., Formaldehyde and leukemia: Epidemiology, 
potential mechanisms, and implications for risk assessment. Environ Mol 
Mutagen., 51(3), pp. 181–91, 2009. 
[35] Guyton, K.Z., Kyle, A.D., Aubrecht, J., Cogliano, V.J., Eastmond, D.A., 
Jackson , M., Keshava, N., Sandy, M.S., Sonawane, B., Zhang, L., Waters, 
M.D., and Smith, M.T. Improving prediction of chemical carcinogenicity 
by considering multiple mechanisms and applying toxicogenomic 
approaches. Mutat Res, 681(2–3), pp. 230–240, 2009. 
Environmental Health Risk VII  93
 
 www.witpress.com, ISSN 1743-3525 (on-line) 
WIT Transactions on Biomedicine and Health, Vol 16, © 2013 WIT Press
[36] Heuser, V.D., Erdtmann, B., Kvitko, K., Rohr, P., and da Silva, J., 
Evaluation of genetic damage in Brazilian footwear-workers: biomarkers of 
exposure, effect, and susceptibility. Toxicology, 232(3), pp. 235–47, 2007. 
[37] Bonassi, S., Coskun, E., Ceppi, M., Lando, C., Bolognesi, C., Burgaz, S., 
Holland, N., et al. The HUman MicroNucleus project on eXfoLiated buccal 
cells (HUMN(XL)): the role of life-style, host factors, occupational 
exposures, health status, and assay protocol. Mutat Res., 728(3), pp. 88–97, 
2011. 
94  Environmental Health Risk VII
 
 www.witpress.com, ISSN 1743-3525 (on-line) 
WIT Transactions on Biomedicine and Health, Vol 16, © 2013 WIT Press
ACKNOWLEDGMENTS 
 
Começo por agradecer a todos os profissionais de Anatomia Patológica que aceitaram 
participar neste projeto. Obrigada também pela disponibilidade e cordialidade com que 
nos receberam.  
Agradeço às Instituições e aos responsáveis pelos Serviços de Anatomia Patológica por 
terem permitido a realização do estudo. 
Qualquer percurso de aprendizagem assenta numa teia de relações que envolve um 
vasto conjunto de pessoas e não num trabalho individual. Este espaço é dedicado a 
todos aqueles que contribuíram para o desenvolvimento deste estudo. A todos eles deixo 
aqui o meu agradecimento sincero. 
In this learning journey, there were many people that helped me and gave me support, 
regarding my professional as well as my personal life. Thus, I would like to take this 
opportunity to thank: 
All the individuals that agreed to participate in this study, as well as the competent 
authorities involved in the sensitisation campaigns. 
Dr. João Paulo Teixeira, my supervisor. Thank you very much for your guidance, support, 
enthusiasm, advice and encouragement. It has been a pleasure to be a part of your team 
during these years! Thank you for believing in me frequently more than I have believed in 
myself! Thank you very much for everything! 
Dr. Beatriz Porto, my co-adviser. Thank you for your constructive critics, for sharing your 
knowledge, for all the interesting discussions and great support. 
To Dr. Andrew Collins, I am especially grateful for giving me the chance to work and learn 
with an extraordinary scientist: himself.  
I also want to thank you the opportunity that you gave me to work with promising young 
scientists, such as Yolanda Lorenzo, Amaya Azqueta, Naouale El Yamani and Zuzana 
Magdolenova. To Yolanda and Marit Sandvik a very special Tusen Takk, you are 
extraordinary and it has been a complete pleasure to work with you. 
Dr. Julia García-Léston for her availability and work even during difficult times… and also 
a very special GRACIAS, to the rest of the team at University of A Coruña for their 
precious and vast knowledge and professional support. 
My gratitude to Dr. Jorge Gaspar for bringing some light into possible sources of 
susceptibility, and to Luís Silva Santos for his availability, work and support. 
261 
 
I especially want to thank the support and collaboration of Dr. Paula Guedes team 
(Toxicology Laboratory) and Dr. Patrícia Valentão team (Farmacognosia Laboratory) of 
the Faculty of Pharmacy, University of Porto, in the last phase of study. 
Um agradecimento muito especial à Susana pelo incansável acompanhamento pessoal e 
profissional e pelo valor incalculável dos seus ensinamentos e conhecimentos. À Carla 
Costa e à Patrícia Coelho agradeço o acrescento tanto a nível profissional, pelo apoio 
laboratorial e científico decisivo para o enriquecimento do trabalho, como a nível pessoal, 
pela amizade sentida. 
A todas as “meninas do formaldeído”, Carolina, Marta, Fátima e Sandra, muito obrigada 
pelo vosso trabalho e suporte nesta jornada. 
A todos os elementos da família DSA-UASO agradeço a ajuda, simpatia e o excelente 
ambiente de companheirismo e trabalho com que me brindaram durante o período de 
elaboração deste trabalho. Deste fantástico grupo de pessoas preciso destacar a 
preciosa colaboração e profissionalismo da Paula Neves e Lívia Aguiar nas saídas de 
campo. 
Deixo também uma nota de agradecimento aos amigos “fora do laboratório” (sabem 
quem são) por todo o apoio, pela compreensão nas ausências e por todos os momentos 
memoráveis passados, presentes e futuros. 
Agradeço sobretudo à minha Mãe e Pai, e toda a família por toda a paciência e apoio 
durante mais esta jornada… 
 
A todos um Muito Obrigada  
Gracias 
Thank You 
Tusen Takk  
 
Porto, Dezembro de 2013 
 
Solange Costa 
 
 
262 
 
